<html lang="en" class="pb-page fonts-loaded fonts-loaded" data-request-id="0524d367-193a-4c3b-aa8b-3f2b8e89d3b9" style="--article-sticky-top: 82.00019999999999px; --scroll-padding: 163.594px auto auto;"><head data-pb-dropzone="head"><meta name="pbContext" content=";product:product:elsevier\:product\:cell;website:website:cell-site;ctype:string:Journal Content;journal:journal:cell;pageGroup:string:Article View;article:article:pii\:S0092867421008795;page:string:Show Full Text;requestedJournal:journal:cell;issue:issue:pii\:S0092867420X00195;wgroup:string:Default Website Group;subPage:string:Full Text">




<!-- if there is any customization for Responsive Project widget  -->


























    
    







    
            
        



        
                <meta name="robots" content="noarchive,nocache">
            
    






    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=1, user-scalable=1">











        <meta property="og:title" content="Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy">
    


        <meta property="og:type" content="Article">
    


        <meta property="og:url" content="https://www.cell.com/cell/abstract/S0092-8674(21)00879-5">
    



        <meta property="og:site_name" content="Cell">
    


        <meta property="og:image" content="https://www.cell.com/cms/asset/537c0936-e5b0-43db-977f-46aacf06de07/fx1.jpg">
    


        <meta property="og:description" content="Pin1 can drive the desmoplastic and immunosuppressive tumor microenvironment in addition
to its known oncogenic functions.">
    











        <meta name="twitter:title" content="Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy">
    




        <meta name="twitter:image" content="https://www.cell.com/cms/asset/537c0936-e5b0-43db-977f-46aacf06de07/fx1.jpg">
    


        <meta name="twitter:description" content="Pin1 can drive the desmoplastic and immunosuppressive tumor microenvironment in addition
to its known oncogenic functions.">
    

        <meta name="twitter:card" content="summary_large_image">
    











    
    
            
            
        <link rel="canonical" href="https://www.cell.com/cell/fulltext/S0092-8674(21)00879-5">
    


<meta name="tdm-reservation" content="1">
<meta name="tdm-policy" content="https://www.elsevier.com/tdm/tdmrep-policy.json">

<title>Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy: Cell</title><meta name="citation_journal_title" content="Cell"> <meta name="citation_journal_abbrev" content="Cell"> <meta name="citation_publisher" content="Elsevier"> <meta name="citation_title" content="Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy"> <meta name="citation_date" content="2021/09/02"> <meta name="citation_online_date" content="2021/08/12"> <meta name="citation_volume" content="184"> <meta name="citation_issue" content="18"> <meta name="citation_firstpage" content="4753"> <meta name="citation_lastpage" content="4771.e27"> <meta name="citation_pmid" content="34388391"> <meta name="citation_abstract_html_url" content="https://www.cell.com/action/showAbstract?pii=S0092867421008795"> <meta name="citation_fulltext_html_url" content="https://www.cell.com/action/showFullText?pii=S0092867421008795"> <meta name="citation_pdf_url" content="https://www.cell.com/action/showPdf?pii=S0092867421008795"> <meta name="citation_issn" content="0092-8674"> <meta name="citation_issn" content="1097-4172"> <meta name="citation_language" content="English"> <meta name="citation_doi" content="10.1016/j.cell.2021.07.020"> <meta name="citation_pmid" content="34388391"> <meta name="citation_author" content="Kazuhiro Koikawa"><meta name="citation_author_orcid" content="0000-0002-3208-9447"><meta name="citation_author_institution" content="Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author_institution" content="Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan"><meta name="citation_author" content="Shin Kibe"><meta name="citation_author_institution" content="Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author_institution" content="Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan"><meta name="citation_author_institution" content="Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA"><meta name="citation_author" content="Futoshi Suizu"><meta name="citation_author_institution" content="Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author_institution" content="Division of Cancer Biology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan"><meta name="citation_author" content="Nobufumi Sekino"><meta name="citation_author_orcid" content="0000-0002-7705-036X"><meta name="citation_author_institution" content="Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author_institution" content="Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA"><meta name="citation_author" content="Nami Kim"><meta name="citation_author_institution" content="Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author" content="Theresa D. Manz"><meta name="citation_author_institution" content="Department of Cancer Biology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author" content="Benika J. Pinch"><meta name="citation_author_institution" content="Department of Cancer Biology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author" content="Dipikaa Akshinthala"><meta name="citation_author_institution" content="Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author" content="Ana Verma"><meta name="citation_author_orcid" content="0000-0001-9057-171X"><meta name="citation_author_institution" content="Ludwig Center at Harvard, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author_institution" content="Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author_institution" content="Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author" content="Giorgio Gaglia"><meta name="citation_author_orcid" content="0000-0002-5179-4256"><meta name="citation_author_institution" content="Ludwig Center at Harvard, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author_institution" content="Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author_institution" content="Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author" content="Yutaka Nezu"><meta name="citation_author_institution" content="Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author" content="Shizhong Ke"><meta name="citation_author_institution" content="Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author_institution" content="Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA"><meta name="citation_author" content="Chenxi Qiu"><meta name="citation_author_institution" content="Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author_institution" content="Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA"><meta name="citation_author" content="Kenoki Ohuchida"><meta name="citation_author_orcid" content="0000-0003-4792-1168"><meta name="citation_author_institution" content="Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan"><meta name="citation_author" content="Yoshinao Oda"><meta name="citation_author_institution" content="Department of Anatomical Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan"><meta name="citation_author" content="Tae Ho Lee"><meta name="citation_author_institution" content="Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author" content="Babara Wegiel"><meta name="citation_author_institution" content="Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Division of Surgical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author" content="John G. Clohessy"><meta name="citation_author_institution" content="Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Preclinical Murine Pharmacogenetics Facility, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author" content="Nir London"><meta name="citation_author_institution" content="Department of Chemical and Structural Biology, The Weizmann Institute of Science, Rehovot, 7610001, Israel"><meta name="citation_author" content="Sandro Santagata"><meta name="citation_author_institution" content="Ludwig Center at Harvard, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author_institution" content="Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author_institution" content="Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author" content="Gerburg M. Wulf"><meta name="citation_author_orcid" content="0000-0001-7868-6231"><meta name="citation_author_institution" content="Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author" content="Manuel Hidalgo"><meta name="citation_author_institution" content="Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author" content="Senthil K. Muthuswamy"><meta name="citation_author_orcid" content="0000-0001-6564-9634"><meta name="citation_author_institution" content="Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author" content="Masafumi Nakamura"><meta name="citation_author_institution" content="Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan"><meta name="citation_author" content="Nathanael S. Gray"><meta name="citation_author_orcid" content="0000-0001-5354-7403"><meta name="citation_author_institution" content="Department of Chemical and Systems Biology, Chem-H and Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA"><meta name="citation_author" content="Xiao Zhen Zhou"><meta name="citation_author_email" content="xzhouenator@gmail.com"><meta name="citation_author_institution" content="Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author_institution" content="Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA"><meta name="citation_author" content="Kun Ping Lu"><meta name="citation_author_email" content="klu@broadinstitute.org"><meta name="citation_author_institution" content="Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"><meta name="citation_author_institution" content="Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author_institution" content="Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA"><meta name="citation_keywords" content="Pin1; pancreatic cancer; tumor microenvironment; tumor immune microenvironment; cancer-associated fibroblasts; immuni checkpoint therapy; chemotherapy; combination therapy; cancer immune evasion; targeted therapy"><meta name="citation_reference" content="citation_title=Pancreatic Cancer Chemoresistance to Gemcitabine; citation_author=M. Amrutkar; citation_author=I.P. Gladhaug; citation_journal_title=Cancers (Basel); citation_volume=9; citation_firstpage=157; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Pin1 is a novel prognostic marker in prostate cancer; citation_author=G. Ayala; citation_author=D. Wang; citation_author=G. Wulf; citation_author=A. Frolov; citation_author=R. Le; citation_author=T. Wheeler; citation_author=J.M. Sowadski; citation_author=K.P. Lu; citation_author=L. Bao; citation_journal_title=Cancer Research; citation_volume=63; citation_firstpage=6244; citation_lastpage=6251; citation_publication_date=2003; "><meta name="citation_reference" content="citation_title=Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells; citation_author=M.G. Bachem; citation_author=M. Schünemann; citation_author=M. Ramadani; citation_author=M. Siech; citation_author=H. Beger; citation_author=A. Buck; citation_author=S. Zhou; citation_author=A. Schmid-Kotsas; citation_author=G. Adler; citation_journal_title=Gastroenterology; citation_volume=128; citation_firstpage=907; citation_lastpage=921; citation_publication_date=2005; "><meta name="citation_reference" content="citation_title=Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities; citation_author=V.P. Balachandran; citation_author=G.L. Beatty; citation_author=S.K. Dougan; citation_journal_title=Gastroenterology; citation_volume=156; citation_firstpage=2056; citation_lastpage=2072; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Prevalent overexpression of prolyl isomerase Pin1 in human cancers; citation_author=L. Bao; citation_author=A. Kimzey; citation_author=G. Sauter; citation_author=J.M. Sowadski; citation_author=K.P. Lu; citation_author=D.G. Wang; citation_journal_title=Am. J. Pathol.; citation_volume=164; citation_firstpage=1727; citation_lastpage=1737; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T&nbsp;cell immunity in pancreatic cancer; citation_author=L.J. Bayne; citation_author=G.L. Beatty; citation_author=N. Jhala; citation_author=C.E. Clark; citation_author=A.D. Rhim; citation_author=B.Z. Stanger; citation_author=R.H. Vonderheide; citation_journal_title=Cancer Cell; citation_volume=21; citation_firstpage=822; citation_lastpage=835; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=ilastik: interactive machine learning for (bio)image analysis; citation_author=S. Berg; citation_author=D. Kutra; citation_author=T. Kroeger; citation_author=C.N. Straehle; citation_author=B.X. Kausler; citation_author=C. Haubold; citation_author=M. Schiegg; citation_author=J. Ales; citation_author=T. Beier; citation_author=M. Rudy; citation_author=et al.; citation_journal_title=Nat. Methods; citation_volume=16; citation_firstpage=1226; citation_lastpage=1232; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes; citation_author=A.V. Biankin; citation_author=N. Waddell; citation_author=K.S. Kassahn; citation_author=M.C. Gingras; citation_author=L.B. Muthuswamy; citation_author=A.L. Johns; citation_author=D.K. Miller; citation_author=P.J. Wilson; citation_author=A.M. Patch; citation_author=J. Wu; citation_author=Australian Pancreatic Cancer Genome Initiative; citation_author=et al.; citation_journal_title=Nature; citation_volume=491; citation_firstpage=399; citation_lastpage=405; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Understanding the tumor immune microenvironment (TIME) for effective therapy; citation_author=M. Binnewies; citation_author=E.W. Roberts; citation_author=K. Kersten; citation_author=V. Chan; citation_author=D.F. Fearon; citation_author=M. Merad; citation_author=L.M. Coussens; citation_author=D.I. Gabrilovich; citation_author=S. Ostrand-Rosenberg; citation_author=C.C. Hedrick; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=24; citation_firstpage=541; citation_lastpage=550; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Xenograft and organoid model systems in cancer research; citation_author=M. Bleijs; citation_author=M. van de Wetering; citation_author=H. Clevers; citation_author=J. Drost; citation_journal_title=EMBO J.; citation_volume=38; citation_firstpage=e101654; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Oncogenic kinase signalling; citation_author=P. Blume-Jensen; citation_author=T. Hunter; citation_journal_title=Nature; citation_volume=411; citation_firstpage=355; citation_lastpage=365; citation_publication_date=2001; "><meta name="citation_reference" content="citation_title=Safety and activity of anti-PD-L1 antibody in patients with advanced cancer; citation_author=J.R. Brahmer; citation_author=S.S. Tykodi; citation_author=L.Q. Chow; citation_author=W.J. Hwu; citation_author=S.L. Topalian; citation_author=P. Hwu; citation_author=C.G. Drake; citation_author=L.H. Camacho; citation_author=J. Kauh; citation_author=K. Odunsi; citation_author=et al.; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=366; citation_firstpage=2455; citation_lastpage=2465; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity; citation_author=M.L. Burr; citation_author=C.E. Sparbier; citation_author=Y.C. Chan; citation_author=J.C. Williamson; citation_author=K. Woods; citation_author=P.A. Beavis; citation_author=E.Y.N. Lam; citation_author=M.A. Henderson; citation_author=C.C. Bell; citation_author=S. Stolzenburg; citation_author=et al.; citation_journal_title=Nature; citation_volume=549; citation_firstpage=101; citation_lastpage=105; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Mechanisms Controlling PD-L1 Expression in Cancer; citation_author=J.H. Cha; citation_author=L.C. Chan; citation_author=C.W. Li; citation_author=J.L. Hsu; citation_author=M.C. Hung; citation_journal_title=Mol. Cell; citation_volume=76; citation_firstpage=359; citation_lastpage=370; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Targeting PIN1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis; citation_author=L. Chen; citation_author=X. Xu; citation_author=X. Wen; citation_author=S. Xu; citation_author=L. Wang; citation_author=W. Lu; citation_author=M. Jiang; citation_author=J. Huang; citation_author=D. Yang; citation_author=J. Wang; citation_author=et al.; citation_journal_title=Cancer Sci.; citation_volume=110; citation_firstpage=2442; citation_lastpage=2455; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology; citation_author=Z. Dantes; citation_author=H.Y. Yen; citation_author=N. Pfarr; citation_author=C. Winter; citation_author=K. Steiger; citation_author=A. Muckenhuber; citation_author=A. Hennig; citation_author=S. Lange; citation_author=T. Engleitner; citation_author=R. Öllinger; citation_author=et al.; citation_journal_title=JCI Insight; citation_volume=5; citation_firstpage=137809; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Preclinical mouse cancer models: a maze of opportunities and challenges; citation_author=C.P. Day; citation_author=G. Merlino; citation_author=T. Van Dyke; citation_journal_title=Cell; citation_volume=163; citation_firstpage=39; citation_lastpage=53; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Acute promyelocytic leukaemia: novel insights into the mechanisms of cure; citation_author=H. de Thé; citation_author=Z. Chen; citation_journal_title=Nat. Rev. Cancer; citation_volume=10; citation_firstpage=775; citation_lastpage=783; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids; citation_author=K.K. Dijkstra; citation_author=C.M. Cattaneo; citation_author=F. Weeber; citation_author=M. Chalabi; citation_author=J. van de Haar; citation_author=L.F. Fanchi; citation_author=M. Slagter; citation_author=D.L. van der Velden; citation_author=S. Kaing; citation_author=S. Kelderman; citation_author=et al.; citation_journal_title=Cell; citation_volume=174; citation_firstpage=1586; citation_lastpage=1598; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity; citation_author=R.D. Dorand; citation_author=J. Nthale; citation_author=J.T. Myers; citation_author=D.S. Barkauskas; citation_author=S. Avril; citation_author=S.M. Chirieleison; citation_author=T.K. Pareek; citation_author=D.W. Abbott; citation_author=D.S. Stearns; citation_author=J.J. Letterio; citation_author=et al.; citation_journal_title=Science; citation_volume=353; citation_firstpage=399; citation_lastpage=403; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging; citation_author=Z. Du; citation_author=J.R. Lin; citation_author=R. Rashid; citation_author=Z. Maliga; citation_author=S. Wang; citation_author=J.C. Aster; citation_author=B. Izar; citation_author=P.K. Sorger; citation_author=S. Santagata; citation_journal_title=Nat. Protoc.; citation_volume=14; citation_firstpage=2900; citation_lastpage=2930; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo; citation_author=C. Dubiella; citation_author=B.J. Pinch; citation_author=K. Koikawa; citation_author=D. Zaidman; citation_author=E. Poon; citation_author=T.D. Manz; citation_author=B. Nabet; citation_author=S. He; citation_author=E. Resnick; citation_author=A. Rogel; citation_author=et al.; citation_journal_title=Nat. Chem. Biol.; citation_doi=10.1038/s41589-021-00786-7; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Autophagy Is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mice; citation_author=S. Endo; citation_author=K. Nakata; citation_author=K. Ohuchida; citation_author=S. Takesue; citation_author=H. Nakayama; citation_author=T. Abe; citation_author=K. Koikawa; citation_author=T. Okumura; citation_author=M. Sada; citation_author=K. Horioka; citation_author=et al.; citation_journal_title=Gastroenterology; citation_volume=152; citation_firstpage=1492; citation_lastpage=1506; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Activated pancreatic stellate cells sequester CD8+ T&nbsp;cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma; citation_author=A. Ene-Obong; citation_author=A.J. Clear; citation_author=J. Watt; citation_author=J. Wang; citation_author=R. Fatah; citation_author=J.C. Riches; citation_author=J.F. Marshall; citation_author=J. Chin-Aleong; citation_author=C. Chelala; citation_author=J.G. Gribben; citation_author=et al.; citation_journal_title=Gastroenterology; citation_volume=145; citation_firstpage=1121; citation_lastpage=1132; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=StellaTUM: current consensus and discussion on pancreatic stellate cell research; citation_author=M. Erkan; citation_author=G. Adler; citation_author=M.V. Apte; citation_author=M.G. Bachem; citation_author=M. Buchholz; citation_author=S. Detlefsen; citation_author=I. Esposito; citation_author=H. Friess; citation_author=T.M. Gress; citation_author=H.J. Habisch; citation_author=et al.; citation_journal_title=Gut; citation_volume=61; citation_firstpage=172; citation_lastpage=178; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer; citation_author=J.J. Farrell; citation_author=H. Elsaleh; citation_author=M. Garcia; citation_author=R. Lai; citation_author=A. Ammar; citation_author=W.F. Regine; citation_author=R. Abrams; citation_author=A.B. Benson; citation_author=J. Macdonald; citation_author=C.E. Cass; citation_author=et al.; citation_journal_title=Gastroenterology; citation_volume=136; citation_firstpage=187; citation_lastpage=195; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer; citation_author=C. Feig; citation_author=J.O. Jones; citation_author=M. Kraman; citation_author=R.J. Wells; citation_author=A. Deonarine; citation_author=D.S. Chan; citation_author=C.M. Connell; citation_author=E.W. Roberts; citation_author=Q. Zhao; citation_author=O.L. Caballero; citation_author=et al.; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=110; citation_firstpage=20212; citation_lastpage=20217; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-beta-catenin signaling to slow tumor progression; citation_author=F.E. Froeling; citation_author=C. Feig; citation_author=C. Chelala; citation_author=R. Dobson; citation_author=C.E. Mein; citation_author=D.A. Tuveson; citation_author=H. Clevers; citation_author=I.R. Hart; citation_author=H.M. Kocher; citation_journal_title=Gastroenterology; citation_volume=141; citation_firstpage=1486; citation_lastpage=1497; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=NFκB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12; citation_author=B. Garg; citation_author=B. Giri; citation_author=S. Modi; citation_author=V. Sethi; citation_author=I. Castro; citation_author=O. Umland; citation_author=Y. Ban; citation_author=S. Lavania; citation_author=R. Dawra; citation_author=S. Banerjee; citation_author=et al.; citation_journal_title=Gastroenterology; citation_volume=155; citation_firstpage=880; citation_lastpage=891; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Intratumor heterogeneity and branched evolution revealed by multiregion sequencing; citation_author=M. Gerlinger; citation_author=A.J. Rowan; citation_author=S. Horswell; citation_author=M. Math; citation_author=J. Larkin; citation_author=D. Endesfelder; citation_author=E. Gronroos; citation_author=P. Martinez; citation_author=N. Matthews; citation_author=A. Stewart; citation_author=et al.; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=366; citation_firstpage=883; citation_lastpage=892; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Personalized RNA Medicine for Pancreatic Cancer; citation_author=M.E. Gilles; citation_author=L. Hao; citation_author=L. Huang; citation_author=R. Rupaimoole; citation_author=P.P. Lopez-Casas; citation_author=E. Pulver; citation_author=J.C. Jeong; citation_author=S.K. Muthuswamy; citation_author=M. Hidalgo; citation_author=S.N. Bhatia; citation_author=F.J. Slack; citation_journal_title=Clin. Cancer Res.; citation_volume=24; citation_firstpage=1734; citation_lastpage=1747; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=A Pin1/mutant p53 axis promotes aggressiveness in breast cancer; citation_author=J.E. Girardini; citation_author=M. Napoli; citation_author=S. Piazza; citation_author=A. Rustighi; citation_author=C. Marotta; citation_author=E. Radaelli; citation_author=V. Capaci; citation_author=L. Jordan; citation_author=P. Quinlan; citation_author=A. Thompson; citation_author=et al.; citation_journal_title=Cancer Cell; citation_volume=20; citation_firstpage=79; citation_lastpage=91; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=The Sla2p/HIP1/HIP1R family: similar structure, similar function in endocytosis?; citation_author=I. Gottfried; citation_author=M. Ehrlich; citation_author=U. Ashery; citation_journal_title=Biochem. Soc. Trans.; citation_volume=38; citation_firstpage=187; citation_lastpage=191; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Prospects for combining targeted and conventional cancer therapy with immunotherapy; citation_author=P. Gotwals; citation_author=S. Cameron; citation_author=D. Cipolletta; citation_author=V. Cremasco; citation_author=A. Crystal; citation_author=B. Hewes; citation_author=B. Mueller; citation_author=S. Quaratino; citation_author=C. Sabatos-Peyton; citation_author=L. Petruzzelli; citation_author=et al.; citation_journal_title=Nat. Rev. Cancer; citation_volume=17; citation_firstpage=286; citation_lastpage=301; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells; citation_author=J. Guan; citation_author=H. Zhang; citation_author=Z. Wen; citation_author=Y. Gu; citation_author=Y. Cheng; citation_author=Y. Sun; citation_author=T. Zhang; citation_author=C. Jia; citation_author=Z. Lu; citation_author=J. Chen; citation_journal_title=Cancer Lett.; citation_volume=345; citation_firstpage=132; citation_lastpage=139; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Hallmarks of cancer: the next generation; citation_author=D. Hanahan; citation_author=R.A. Weinberg; citation_journal_title=Cell; citation_volume=144; citation_firstpage=646; citation_lastpage=674; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients; citation_author=R.S. Herbst; citation_author=J.C. Soria; citation_author=M. Kowanetz; citation_author=G.D. Fine; citation_author=O. Hamid; citation_author=M.S. Gordon; citation_author=J.A. Sosman; citation_author=D.F. McDermott; citation_author=J.D. Powderly; citation_author=S.N. Gettinger; citation_author=et al.; citation_journal_title=Nature; citation_volume=515; citation_firstpage=563; citation_lastpage=567; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer; citation_author=G.S. Herter-Sprie; citation_author=S. Koyama; citation_author=H. Korideck; citation_author=J. Hai; citation_author=J. Deng; citation_author=Y.Y. Li; citation_author=K.A. Buczkowski; citation_author=A.K. Grant; citation_author=S. Ullas; citation_author=K. Rhee; citation_author=et al.; citation_journal_title=JCI Insight; citation_volume=1; citation_firstpage=e87415; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice; citation_author=S.R. Hingorani; citation_author=L. Wang; citation_author=A.S. Multani; citation_author=C. Combs; citation_author=T.B. Deramaudt; citation_author=R.H. Hruban; citation_author=A.K. Rustgi; citation_author=S. Chang; citation_author=D.A. Tuveson; citation_journal_title=Cancer Cell; citation_volume=7; citation_firstpage=469; citation_lastpage=483; citation_publication_date=2005; "><meta name="citation_reference" content="citation_title=The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities; citation_author=W.J. Ho; citation_author=E.M. Jaffee; citation_author=L. Zheng; citation_journal_title=Nat. Rev. Clin. Oncol.; citation_volume=17; citation_firstpage=527; citation_lastpage=540; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Pancreatic cancer stroma: an update on therapeutic targeting strategies; citation_author=A.N. Hosein; citation_author=R.A. Brekken; citation_author=A. Maitra; citation_journal_title=Nat. Rev. Gastroenterol. Hepatol.; citation_volume=17; citation_firstpage=487; citation_lastpage=505; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1; citation_author=Q. Hu; citation_author=Y. Qin; citation_author=B. Zhang; citation_author=C. Liang; citation_author=S. Ji; citation_author=S. Shi; citation_author=W. Xu; citation_author=J. Xiang; citation_author=D. Liang; citation_author=Q. Ni; citation_author=et al.; citation_journal_title=Oncol. Rep.; citation_volume=38; citation_firstpage=2069; citation_lastpage=2077; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=SynergyFinder 2.0: visual analytics of multi-drug combination synergies; citation_author=A. Ianevski; citation_author=A.K. Giri; citation_author=T. Aittokallio; citation_journal_title=Nucleic Acids Res.; citation_volume=48; citation_number=W1; citation_firstpage=W488; citation_lastpage=W493; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Single-agent liposomal all-trans-retinoic Acid as initial therapy for acute promyelocytic leukemia: 13-year follow-up data; citation_author=P. Jain; citation_author=H. Kantarjian; citation_author=E. Estey; citation_author=S. Pierce; citation_author=J. Cortes; citation_author=G. Lopez-Berestein; citation_author=F. Ravandi; citation_journal_title=Clin. Lymphoma Myeloma Leuk.; citation_volume=14; citation_firstpage=e47; citation_lastpage=e49; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy; citation_author=H. Jiang; citation_author=S. Hegde; citation_author=B.L. Knolhoff; citation_author=Y. Zhu; citation_author=J.M. Herndon; citation_author=M.A. Meyer; citation_author=T.M. Nywening; citation_author=W.G. Hawkins; citation_author=I.M. Shapiro; citation_author=D.T. Weaver; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=22; citation_firstpage=851; citation_lastpage=860; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression; citation_author=S. Jiao; citation_author=W. Xia; citation_author=H. Yamaguchi; citation_author=Y. Wei; citation_author=M.K. Chen; citation_author=J.M. Hsu; citation_author=J.L. Hsu; citation_author=W.H. Yu; citation_author=Y. Du; citation_author=H.H. Lee; citation_author=et al.; citation_journal_title=Clin. Cancer Res.; citation_volume=23; citation_firstpage=3711; citation_lastpage=3720; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Pancreatic cancer; citation_author=J. Kleeff; citation_author=M. Korc; citation_author=M. Apte; citation_author=C. La Vecchia; citation_author=C.D. Johnson; citation_author=A.V. Biankin; citation_author=R.E. Neale; citation_author=M. Tempero; citation_author=D.A. Tuveson; citation_author=R.H. Hruban; citation_author=J.P. Neoptolemos; citation_journal_title=Nat. Rev. Dis. Primers; citation_volume=2; citation_firstpage=16022; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer; citation_author=H.M. Kocher; citation_author=B. Basu; citation_author=F.E.M. Froeling; citation_author=D. Sarker; citation_author=S. Slater; citation_author=D. Carlin; citation_author=N.M. deSouza; citation_author=K.N. De Paepe; citation_author=M.R. Goulart; citation_author=C. Hughes; citation_author=et al.; citation_journal_title=Nat. Commun.; citation_volume=11; citation_firstpage=4841; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma; citation_author=K. Koikawa; citation_author=K. Ohuchida; citation_author=Y. Ando; citation_author=S. Kibe; citation_author=H. Nakayama; citation_author=S. Takesue; citation_author=S. Endo; citation_author=T. Abe; citation_author=T. Okumura; citation_author=C. Iwamoto; citation_author=et al.; citation_journal_title=Cancer Lett.; citation_volume=425; citation_firstpage=65; citation_lastpage=77; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Pancreatic stellate cells reorganize matrix components and lead pancreatic cancer invasion via the function of Endo180; citation_author=K. Koikawa; citation_author=K. Ohuchida; citation_author=S. Takesue; citation_author=Y. Ando; citation_author=S. Kibe; citation_author=H. Nakayama; citation_author=S. Endo; citation_author=T. Abe; citation_author=T. Okumura; citation_author=K. Horioka; citation_author=et al.; citation_journal_title=Cancer Lett.; citation_volume=412; citation_firstpage=143; citation_lastpage=154; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy; citation_author=A. Kondo; citation_author=K. Shahpasand; citation_author=R. Mannix; citation_author=J. Qiu; citation_author=J. Moncaster; citation_author=C.-H. Chen; citation_author=Y. Yao; citation_author=Y.-M. Lin; citation_author=J. Driver; citation_author=Y. Sun; citation_author=et al.; citation_journal_title=Nature; citation_volume=523; citation_firstpage=431; citation_lastpage=436; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells; citation_author=S. Kozono; citation_author=Y.M. Lin; citation_author=H.S. Seo; citation_author=B. Pinch; citation_author=X. Lian; citation_author=C. Qiu; citation_author=M.K. Herbert; citation_author=C.H. Chen; citation_author=L. Tan; citation_author=Z.J. Gao; citation_author=et al.; citation_journal_title=Nat. Commun.; citation_volume=9; citation_firstpage=3069; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression; citation_author=H. Laklai; citation_author=Y.A. Miroshnikova; citation_author=M.W. Pickup; citation_author=E.A. Collisson; citation_author=G.E. Kim; citation_author=A.S. Barrett; citation_author=R.C. Hill; citation_author=J.N. Lakins; citation_author=D.D. Schlaepfer; citation_author=J.K. Mouw; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=22; citation_firstpage=497; citation_lastpage=505; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Pharmacokinetics of oral all-trans retinoic acid in patients with acute promyelocytic leukemia; citation_author=P. Lefebvre; citation_author=G. Thomas; citation_author=B. Gourmel; citation_author=A. Agadir; citation_author=S. Castaigne; citation_author=C. Dreux; citation_author=L. Degos; citation_author=C. Chomienne; citation_journal_title=Leukemia; citation_volume=5; citation_firstpage=1054; citation_lastpage=1058; citation_publication_date=1991; "><meta name="citation_reference" content="citation_title=The rs2233678 polymorphism in PIN1 promoter region reduced cancer risk: a meta-analysis; citation_author=Q. Li; citation_author=Z. Dong; citation_author=Y. Lin; citation_author=X. Jia; citation_author=Q. Li; citation_author=H. Jiang; citation_author=L. Wang; citation_author=Y. Gao; citation_journal_title=PLoS ONE; citation_volume=8; citation_firstpage=e68148; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Mouse-Derived Allografts: A Complementary Model to the KPC Mice on Researching Pancreatic Cancer In&nbsp;Vivo; citation_author=J. Li; citation_author=W. Qian; citation_author=T. Qin; citation_author=Y. Xiao; citation_author=L. Cheng; citation_author=J. Cao; citation_author=X. Chen; citation_author=Q. Ma; citation_author=Z. Wu; citation_journal_title=Comput. Struct. Biotechnol. J.; citation_volume=17; citation_firstpage=498; citation_lastpage=506; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Deubiquitination and Stabilization of PD-L1 by CSN5; citation_author=S.O. Lim; citation_author=C.W. Li; citation_author=W. Xia; citation_author=J.H. Cha; citation_author=L.C. Chan; citation_author=Y. Wu; citation_author=S.S. Chang; citation_author=W.C. Lin; citation_author=J.M. Hsu; citation_author=Y.H. Hsu; citation_author=et al.; citation_journal_title=Cancer Cell; citation_volume=30; citation_firstpage=925; citation_lastpage=939; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes; citation_author=J.R. Lin; citation_author=B. Izar; citation_author=S. Wang; citation_author=C. Yapp; citation_author=S. Mei; citation_author=P.M. Shah; citation_author=S. Santagata; citation_author=P.K. Sorger; citation_journal_title=eLife; citation_volume=7; citation_firstpage=e31657; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes; citation_author=Y.C. Liou; citation_author=A. Ryo; citation_author=H.K. Huang; citation_author=P.J. Lu; citation_author=R. Bronson; citation_author=F. Fujimori; citation_author=T. Uchida; citation_author=T. Hunter; citation_author=K.P. Lu; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=99; citation_firstpage=1335; citation_lastpage=1340; citation_publication_date=2002; "><meta name="citation_reference" content="citation_title=An IRAK1-PIN1 signalling axis drives intrinsic tumour resistance to radiation therapy; citation_author=P.H. Liu; citation_author=R.B. Shah; citation_author=Y. Li; citation_author=A. Arora; citation_author=P.M. Ung; citation_author=R. Raman; citation_author=A. Gorbatenko; citation_author=S. Kozono; citation_author=X.Z. Zhou; citation_author=V. Brechin; citation_author=et al.; citation_journal_title=Nat. Cell Biol.; citation_volume=21; citation_firstpage=203; citation_lastpage=213; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Prolyl isomerase Pin1 in cancer; citation_author=Z. Lu; citation_author=T. Hunter; citation_journal_title=Cell Res.; citation_volume=24; citation_firstpage=1033; citation_lastpage=1049; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Principles of cancer therapy: oncogene and non-oncogene addiction; citation_author=J. Luo; citation_author=N.L. Solimini; citation_author=S.J. Elledge; citation_journal_title=Cell; citation_volume=136; citation_firstpage=823; citation_lastpage=837; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Inactivation of the prolyl isomerase Pin1 sensitizes BRCA1-proficient breast cancer to PARP inhibition; citation_author=M.L. Luo; citation_author=F. Zheng; citation_author=W. Chen; citation_author=Z.M. Liang; citation_author=G. Chandramouly; citation_author=J. Tan; citation_author=N.A. Willis; citation_author=C.H. Chen; citation_author=M.O. Taveira; citation_author=X.Z. Zhou; citation_author=et al.; citation_journal_title=Cancer Res.; citation_volume=80; citation_firstpage=3033; citation_lastpage=3045; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer; citation_author=T.A. Mace; citation_author=R. Shakya; citation_author=J.R. Pitarresi; citation_author=B. Swanson; citation_author=C.W. McQuinn; citation_author=S. Loftus; citation_author=E. Nordquist; citation_author=Z. Cruz-Monserrate; citation_author=L. Yu; citation_author=G. Young; citation_author=et al.; citation_journal_title=Gut; citation_volume=67; citation_firstpage=320; citation_lastpage=332; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Combination cancer immunotherapy and new immunomodulatory targets; citation_author=K.M. Mahoney; citation_author=P.D. Rennert; citation_author=G.J. Freeman; citation_journal_title=Nat. Rev. Drug Discov.; citation_volume=14; citation_firstpage=561; citation_lastpage=584; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma; citation_author=R. Maréchal; citation_author=J.B. Bachet; citation_author=J.R. Mackey; citation_author=C. Dalban; citation_author=P. Demetter; citation_author=K. Graham; citation_author=A. Couvelard; citation_author=M. Svrcek; citation_author=A. Bardier-Dupas; citation_author=P. Hammel; citation_author=et al.; citation_journal_title=Gastroenterology; citation_volume=143; citation_firstpage=664; citation_lastpage=674; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T&nbsp;cells; citation_author=S. Mariathasan; citation_author=S.J. Turley; citation_author=D. Nickles; citation_author=A. Castiglioni; citation_author=K. Yuen; citation_author=Y. Wang; citation_author=E.E. Kadel; citation_author=H. Koeppen; citation_author=J.L. Astarita; citation_author=R. Cubas; citation_author=et al.; citation_journal_title=Nature; citation_volume=554; citation_firstpage=544; citation_lastpage=548; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future; citation_author=N. McGranahan; citation_author=C. Swanton; citation_journal_title=Cell; citation_volume=168; citation_firstpage=613; citation_lastpage=628; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution; citation_author=N. McGranahan; citation_author=R. Rosenthal; citation_author=C.T. Hiley; citation_author=A.J. Rowan; citation_author=T.B.K. Watkins; citation_author=G.A. Wilson; citation_author=N.J. Birkbak; citation_author=S. Veeriah; citation_author=P. Van Loo; citation_author=J. Herrero; citation_author=C. Swanton; citation_author=TRACERx Consortium; citation_journal_title=Cell; citation_volume=171; citation_firstpage=1259; citation_lastpage=1271; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Epsin deficiency impairs endocytosis by stalling the actin-dependent invagination of endocytic clathrin-coated pits; citation_author=M. Messa; citation_author=R. Fernández-Busnadiego; citation_author=E.W. Sun; citation_author=H. Chen; citation_author=H. Czapla; citation_author=K. Wrasman; citation_author=Y. Wu; citation_author=G. Ko; citation_author=T. Ross; citation_author=B. Wendland; citation_author=P. De Camilli; citation_journal_title=eLife; citation_volume=3; citation_firstpage=e03311; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Identification of CMTM6 and CMTM4 as PD-L1 protein regulators; citation_author=R. Mezzadra; citation_author=C. Sun; citation_author=L.T. Jae; citation_author=R. Gomez-Eerland; citation_author=E. de Vries; citation_author=W. Wu; citation_author=M.E.W. Logtenberg; citation_author=M. Slagter; citation_author=E.A. Rozeman; citation_author=I. Hofland; citation_author=et al.; citation_journal_title=Nature; citation_volume=549; citation_firstpage=106; citation_lastpage=110; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy; citation_author=V. Mugoni; citation_author=R. Panella; citation_author=G. Cheloni; citation_author=M. Chen; citation_author=O. Pozdnyakova; citation_author=D. Stroopinsky; citation_author=J. Guarnerio; citation_author=E. Monteleone; citation_author=J.D. Lee; citation_author=L. Mendez; citation_author=et al.; citation_journal_title=Cell Res.; citation_volume=29; citation_firstpage=446; citation_lastpage=459; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer; citation_author=S.A. Oh; citation_author=D.C. Wu; citation_author=J. Cheung; citation_author=A. Navarro; citation_author=H. Xiong; citation_author=R. Cubas; citation_author=K. Totpal; citation_author=H. Chiu; citation_author=Y. Wu; citation_author=L. Comps-Agrar; citation_author=et al.; citation_journal_title=Nat. Can.; citation_volume=1; citation_firstpage=681; citation_lastpage=691; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Adipose tissue-derived stromal cells are sources of cancer-associated fibroblasts and enhance tumor progression by dense collagen matrix; citation_author=T. Okumura; citation_author=K. Ohuchida; citation_author=S. Kibe; citation_author=C. Iwamoto; citation_author=Y. Ando; citation_author=S. Takesue; citation_author=H. Nakayama; citation_author=T. Abe; citation_author=S. Endo; citation_author=K. Koikawa; citation_author=et al.; citation_journal_title=Int. J. Cancer; citation_volume=144; citation_firstpage=1401; citation_lastpage=1413; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival; citation_author=B.C. Özdemir; citation_author=T. Pentcheva-Hoang; citation_author=J.L. Carstens; citation_author=X. Zheng; citation_author=C.C. Wu; citation_author=T.R. Simpson; citation_author=H. Laklai; citation_author=H. Sugimoto; citation_author=C. Kahlert; citation_author=S.V. Novitskiy; citation_author=et al.; citation_journal_title=Cancer Cell; citation_volume=25; citation_firstpage=719; citation_lastpage=734; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer; citation_author=C. Pantelidou; citation_author=O. Sonzogni; citation_author=M. De Oliveria Taveira; citation_author=A.K. Mehta; citation_author=A. Kothari; citation_author=D. Wang; citation_author=T. Visal; citation_author=M.K. Li; citation_author=J. Pinto; citation_author=J.A. Castrillon; citation_author=et al.; citation_journal_title=Cancer Discov.; citation_volume=9; citation_firstpage=722; citation_lastpage=737; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=A BaSiC tool for background and shading correction of optical microscopy images; citation_author=T. Peng; citation_author=K. Thorn; citation_author=T. Schroeder; citation_author=L. Wang; citation_author=F.J. Theis; citation_author=C. Marr; citation_author=N. Navab; citation_journal_title=Nat. Commun.; citation_volume=8; citation_firstpage=14836; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States; citation_author=L. Rahib; citation_author=B.D. Smith; citation_author=R. Aizenberg; citation_author=A.B. Rosenzweig; citation_author=J.M. Fleshman; citation_author=L.M. Matrisian; citation_journal_title=Cancer Res.; citation_volume=74; citation_firstpage=2913; citation_lastpage=2921; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Highly multiplexed immunofluorescence images and single-cell data of immune markers in tonsil and lung cancer; citation_author=R. Rashid; citation_author=G. Gaglia; citation_author=Y.A. Chen; citation_author=J.R. Lin; citation_author=Z. Du; citation_author=Z. Maliga; citation_author=D. Schapiro; citation_author=C. Yapp; citation_author=J. Muhlich; citation_author=A. Sokolov; citation_author=et al.; citation_journal_title=Sci. Data; citation_volume=6; citation_firstpage=323; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma; citation_author=A.D. Rhim; citation_author=P.E. Oberstein; citation_author=D.H. Thomas; citation_author=E.T. Mirek; citation_author=C.F. Palermo; citation_author=S.A. Sastra; citation_author=E.N. Dekleva; citation_author=T. Saunders; citation_author=C.P. Becerra; citation_author=I.W. Tattersall; citation_author=et al.; citation_journal_title=Cancer Cell; citation_volume=25; citation_firstpage=735; citation_lastpage=747; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=An in&nbsp;vivo platform for translational drug development in pancreatic cancer; citation_author=B. Rubio-Viqueira; citation_author=A. Jimeno; citation_author=G. Cusatis; citation_author=X. Zhang; citation_author=C. Iacobuzio-Donahue; citation_author=C. Karikari; citation_author=C. Shi; citation_author=K. Danenberg; citation_author=P.V. Danenberg; citation_author=H. Kuramochi; citation_author=et al.; citation_journal_title=Clin. Cancer Res.; citation_volume=12; citation_firstpage=4652; citation_lastpage=4661; citation_publication_date=2006; "><meta name="citation_reference" content="citation_title=Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer; citation_author=M. Ruscetti; citation_author=J.P. Morris; citation_author=R. Mezzadra; citation_author=J. Russell; citation_author=J. Leibold; citation_author=P.B. Romesser; citation_author=J. Simon; citation_author=A. Kulick; citation_author=Y.J. Ho; citation_author=M. Fennell; citation_author=et al.; citation_journal_title=Cell; citation_volume=181; citation_firstpage=424; citation_lastpage=441; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=A framework for advancing our understanding of cancer-associated fibroblasts; citation_author=E. Sahai; citation_author=I. Astsaturov; citation_author=E. Cukierman; citation_author=D.G. DeNardo; citation_author=M. Egeblad; citation_author=R.M. Evans; citation_author=D. Fearon; citation_author=F.R. Greten; citation_author=S.R. Hingorani; citation_author=T. Hunter; citation_author=et al.; citation_journal_title=Nat. Rev. Cancer; citation_volume=20; citation_firstpage=174; citation_lastpage=186; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma; citation_author=N. Samuel; citation_author=T.J. Hudson; citation_journal_title=Nat. Rev. Gastroenterol. Hepatol.; citation_volume=9; citation_firstpage=77; citation_lastpage=87; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=The future of immune checkpoint therapy; citation_author=P. Sharma; citation_author=J.P. Allison; citation_journal_title=Science; citation_volume=348; citation_firstpage=56; citation_lastpage=61; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy; citation_author=M.H. Sherman; citation_author=R.T. Yu; citation_author=D.D. Engle; citation_author=N. Ding; citation_author=A.R. Atkins; citation_author=H. Tiriac; citation_author=E.A. Collisson; citation_author=F. Connor; citation_author=T. Van Dyke; citation_author=S. Kozlov; citation_author=et al.; citation_journal_title=Cell; citation_volume=159; citation_firstpage=80; citation_lastpage=93; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring; citation_author=Y. Shi; citation_author=W. Gao; citation_author=N.K. Lytle; citation_author=P. Huang; citation_author=X. Yuan; citation_author=A.M. Dann; citation_author=M. Ridinger-Saison; citation_author=K.E. DelGiorno; citation_author=C.E. Antal; citation_author=G. Liang; citation_author=et al.; citation_journal_title=Nature; citation_volume=569; citation_firstpage=131; citation_lastpage=135; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Cancer Statistics, 2021; citation_author=R.L. Siegel; citation_author=K.D. Miller; citation_author=H.E. Fuchs; citation_author=A. Jemal; citation_journal_title=CA Cancer J. Clin.; citation_volume=71; citation_firstpage=7; citation_lastpage=33; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Phosphorylation-dependent Akt-Inversin interaction at the basal body of primary cilia; citation_author=F. Suizu; citation_author=N. Hirata; citation_author=K. Kimura; citation_author=T. Edamura; citation_author=T. Tanaka; citation_author=S. Ishigaki; citation_author=T. Donia; citation_author=H. Noguchi; citation_author=T. Iwanaga; citation_author=M. Noguchi; citation_journal_title=EMBO J.; citation_volume=35; citation_firstpage=1346; citation_lastpage=1363; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma; citation_author=B. Tessier-Cloutier; citation_author=S.E. Kalloger; citation_author=M. Al-Kandari; citation_author=K. Milne; citation_author=D. Gao; citation_author=B.H. Nelson; citation_author=D.J. Renouf; citation_author=B.S. Sheffield; citation_author=D.F. Schaeffer; citation_journal_title=BMC Cancer; citation_volume=17; citation_firstpage=618; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Mechanisms of specificity in protein phosphorylation; citation_author=J.A. Ubersax; citation_author=J.E. Ferrell; citation_journal_title=Nat. Rev. Mol. Cell Biol.; citation_volume=8; citation_firstpage=530; citation_lastpage=541; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=Natural killer cells act as rheostats modulating antiviral T&nbsp;cells; citation_author=S.N. Waggoner; citation_author=M. Cornberg; citation_author=L.K. Selin; citation_author=R.M. Welsh; citation_journal_title=Nature; citation_volume=481; citation_firstpage=394; citation_lastpage=398; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=HIP1R targets PD-L1 to lysosomal degradation to alter T&nbsp;cell-mediated cytotoxicity; citation_author=H. Wang; citation_author=H. Yao; citation_author=C. Li; citation_author=H. Shi; citation_author=J. Lan; citation_author=Z. Li; citation_author=Y. Zhang; citation_author=L. Liang; citation_author=J.Y. Fang; citation_author=J. Xu; citation_journal_title=Nat. Chem. Biol.; citation_volume=15; citation_firstpage=42; citation_lastpage=50; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy; citation_author=X. Wang; citation_author=F. Wang; citation_author=M. Zhong; citation_author=Y. Yarden; citation_author=L. Fu; citation_journal_title=Mol. Cancer; citation_volume=19; citation_firstpage=81; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer; citation_author=A.M. Waters; citation_author=C.J. Der; citation_journal_title=Cold Spring Harb. Perspect. Med.; citation_volume=8; citation_firstpage=a031435; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer; citation_author=S. Wei; citation_author=S. Kozono; citation_author=L. Kats; citation_author=M. Nechama; citation_author=W. Li; citation_author=J. Guarnerio; citation_author=M. Luo; citation_author=M.H. You; citation_author=Y. Yao; citation_author=A. Kondo; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=21; citation_firstpage=457; citation_lastpage=466; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets; citation_author=M.C. Whittle; citation_author=S.R. Hingorani; citation_journal_title=Gastroenterology; citation_volume=156; citation_firstpage=2085; citation_lastpage=2096; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Modeling breast cancer in&nbsp;vivo and ex&nbsp;vivo reveals an essential role of Pin1 in tumorigenesis; citation_author=G. Wulf; citation_author=P. Garg; citation_author=Y.C. Liou; citation_author=D. Iglehart; citation_author=K.P. Lu; citation_journal_title=EMBO J.; citation_volume=23; citation_firstpage=3397; citation_lastpage=3407; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=Pin1 is overexpressed in breast cancer and potentiates the transcriptional activity of phosphorylated c-Jun towards the cyclin D1 gene; citation_author=G.M. Wulf; citation_author=A. Ryo; citation_author=G.G. Wulf; citation_author=S.W. Lee; citation_author=T. Niu; citation_author=V. Petkova; citation_author=K.P. Lu; citation_journal_title=EMBO J; citation_volume=20; citation_firstpage=3459; citation_lastpage=3472; citation_publication_date=2001; "><meta name="citation_reference" content="citation_title=PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8+ tumor-infiltrating lymphocytes: highly sensitive detection using phosphor-integrated dot staining; citation_author=S. Yamaki; citation_author=H. Yanagimoto; citation_author=K. Tsuta; citation_author=H. Ryota; citation_author=M. Kon; citation_journal_title=Int. J. Clin. Oncol.; citation_volume=22; citation_firstpage=726; citation_lastpage=733; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I; citation_author=K. Yamamoto; citation_author=A. Venida; citation_author=J. Yano; citation_author=D.E. Biancur; citation_author=M. Kakiuchi; citation_author=S. Gupta; citation_author=A.S.W. Sohn; citation_author=S. Mukhopadhyay; citation_author=E.Y. Lin; citation_author=S.J. Parker; citation_author=et al.; citation_journal_title=Nature; citation_volume=581; citation_firstpage=100; citation_lastpage=105; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance; citation_author=J. Zhang; citation_author=X. Bu; citation_author=H. Wang; citation_author=Y. Zhu; citation_author=Y. Geng; citation_author=N.T. Nihira; citation_author=Y. Tan; citation_author=Y. Ci; citation_author=F. Wu; citation_author=X. Dai; citation_author=et al.; citation_journal_title=Nature; citation_volume=553; citation_firstpage=91; citation_lastpage=95; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target; citation_author=X.Z. Zhou; citation_author=K.P. Lu; citation_journal_title=Nat. Rev. Cancer; citation_volume=16; citation_firstpage=463; citation_lastpage=478; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations; citation_author=W. Zou; citation_author=J.D. Wolchok; citation_author=L. Chen; citation_journal_title=Sci. Transl. Med.; citation_volume=8; citation_firstpage=328rv4; citation_publication_date=2016; "><meta name="citation_abstract" content="<h2>Summary</h2><p>Pancreatic ductal adenocarcinoma (PDAC) is characterized by notorious resistance to current therapies attributed to inherent tumor heterogeneity and highly desmoplastic and immunosuppressive tumor microenvironment (TME). Unique proline isomerase Pin1 regulates multiple cancer pathways, but its role in the TME and cancer immunotherapy is unknown. Here, we find that Pin1 is overexpressed both in cancer cells and cancer-associated fibroblasts (CAFs) and correlates with poor survival in PDAC patients. Targeting Pin1 using clinically available drugs induces complete elimination or sustained remissions of aggressive PDAC by synergizing with anti-PD-1 and gemcitabine in diverse model systems. Mechanistically, Pin1 drives the desmoplastic and immunosuppressive TME by acting on CAFs and induces lysosomal degradation of the PD-1 ligand PD-L1 and the gemcitabine transporter ENT1 in cancer cells, besides activating multiple cancer pathways. Thus, Pin1 inhibition simultaneously blocks multiple cancer pathways, disrupts the desmoplastic and immunosuppressive TME, and upregulates PD-L1 and ENT1, rendering PDAC eradicable by immunochemotherapy.</p>"><meta charset="UTF-8"><!--

    Pagebuild admin UI
-->



<script type="text/javascript" src="https://bam.nr-data.net/1/16e2192192?a=916957862&amp;sa=1&amp;v=1177.96a4d39&amp;t=Unnamed%20Transaction&amp;rst=7459&amp;ck=1&amp;ref=https://www.cell.com/cell/fulltext/S0092-8674(21)00879-5&amp;be=3642&amp;fe=7412&amp;dc=6928&amp;af=err,xhr,stn,ins,spa&amp;perf=%7B%22timing%22:%7B%22of%22:1749591303092,%22n%22:0,%22f%22:3012,%22dn%22:3013,%22dne%22:3013,%22c%22:3013,%22s%22:3013,%22ce%22:3013,%22rq%22:3013,%22rp%22:3626,%22rpe%22:4507,%22dl%22:3631,%22di%22:4749,%22ds%22:6928,%22de%22:6940,%22dc%22:7412,%22l%22:7412,%22le%22:7448%7D,%22navigation%22:%7B%7D%7D&amp;jsonp=NREUM.setToken"></script><script src="https://js-agent.newrelic.com/nr-spa-1177.min.js"></script><script type="text/javascript">
    ;window.NREUM||(NREUM={});NREUM.init={privacy:{cookies_enabled:true}};
    window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{c.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(26),c={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(c.console=!0,o.indexOf("dev")!==-1&&(c.dev=!0),o.indexOf("nr_dev")!==-1&&(c.nrDev=!0))}catch(s){}c.nrDev&&i.on("internal-error",function(t){r(t.stack)}),c.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),c.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(c,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,c){try{l?l-=1:o(c||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,s.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:s.now();i("err",[t,n])}var i=t("handle"),a=t(27),c=t("ee"),s=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError",l=0;s.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(13),t(12),"addEventListener"in window&&t(6),s.xhrWrappable&&t(14),d=!0)}c.on("fn-start",function(t,e,n){d&&(l+=1)}),c.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),c.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),c.on("internal-error",function(t){i("ierr",[t,s.now(),!0])})},{}],3:[function(t,e,n){t("loader").features.ins=!0},{}],4:[function(t,e,n){function r(){_++,T=g.hash,this[u]=y.now()}function o(){_--,g.hash!==T&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var c="-start",s="-end",f="-body",u="fn"+c,d="fn"+s,p="cb"+c,l="cb"+s,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable){var x=t(10),b=t(11),E=t(8),R=t(6),O=t(13),N=t(7),M=t(14),P=t(9),S=t("ee"),C=S.get("tracer");t(16),y.features.spa=!0;var T,_=0;S.on(u,r),S.on(p,r),S.on(d,o),S.on(l,o),S.buffer([u,d,"xhr-done","xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+s,"clearTimeout"+c,u]),M.buffer([u,"new-xhr","send-xhr"+c]),N.buffer([m+c,m+"-done",m+f+c,m+f+s]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+c]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(M,"send-xhr"+c),a(S,"xhr-resolved"),a(S,"xhr-done"),a(N,m+c),a(N,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,!0),w[v]("load",i,!0),w[v]("popstate",function(){i(0,_>1)},!0)}},{}],5:[function(t,e,n){function r(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var o=t("ee"),i=t("handle"),a=t(13),c=t(12),s="learResourceTimings",f="addEventListener",u="resourcetimingbufferfull",d="bstResource",p="resource",l="-start",h="-end",m="fn"+l,v="fn"+h,w="bstTimer",g="pushState",y=t("loader");y.features.stn=!0,t(8),"addEventListener"in window&&t(6);var x=NREUM.o.EV;o.on(m,function(t,e){var n=t[0];n instanceof x&&(this.bstStart=y.now())}),o.on(v,function(t,e){var n=t[0];n instanceof x&&i("bst",[n,e,this.bstStart,y.now()])}),a.on(m,function(t,e,n){this.bstStart=y.now(),this.bstType=n}),a.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),this.bstType])}),c.on(m,function(){this.bstStart=y.now()}),c.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),"requestAnimationFrame"])}),o.on(g+l,function(t){this.time=y.now(),this.startPath=location.pathname+location.hash}),o.on(g+h,function(t){i("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),f in window.performance&&(window.performance["c"+s]?window.performance[f](u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["c"+s]()},!1):window.performance[f]("webkit"+u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["webkitC"+s]()},!1)),document[f]("scroll",r,{passive:!0}),document[f]("keypress",r,!1),document[f]("click",r,!1)}},{}],6:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){c.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),c=t("wrap-function")(a,!0),s=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1],r=s(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?c(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],7:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var c=r.apply(this,t);return o.emit(n+"start",[t,a],c),c.then(function(t){return o.emit(n+"end",[null,t],c),t},function(t){throw o.emit(n+"end",[t],c),t})})}var o=t("ee").get("fetch"),i=t(27),a=t(26);e.exports=o;var c=window,s="fetch-",f=s+"body-",u=["arrayBuffer","blob","json","text","formData"],d=c.Request,p=c.Response,l=c.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(c,"fetch",s),o.on(s+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(s+"done",[null,e],n)}else o.emit(s+"done",[t],n)}))},{}],8:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],9:[function(t,e,n){function r(t){function e(){s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}function n(){s.emit("jsonp-error",[],p),s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var u=c(a),d="function"==typeof u.parent[u.key];if(d){var p={};f.inPlace(u.parent,[u.key],"cb-",p),t.addEventListener("load",e,!1),t.addEventListener("error",n,!1),s.emit("new-jsonp",[t.src],p)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(u);return e?e[1]:null}function a(t,e){var n=t.match(p),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function c(t){var e=t.match(d);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var s=t("ee").get("jsonp"),f=t("wrap-function")(s);if(e.exports=s,o()){var u=/[?&](?:callback|cb)=([^&#]+)/,d=/(.*)\.([^.]+)/,p=/^(\w+)(\.|$)(.*)$/,l=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?f.inPlace(Node.prototype,l,"dom-"):(f.inPlace(HTMLElement.prototype,l,"dom-"),f.inPlace(HTMLHeadElement.prototype,l,"dom-"),f.inPlace(HTMLBodyElement.prototype,l,"dom-")),s.on("dom-start",function(t){r(t[0])})}},{}],10:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],11:[function(t,e,n){function r(t){var e=a.context(),n=c(t,"executor-",e),r=new f(n);return a.context(r).getCtx=function(){return e},a.emit("new-promise",[r,e],e),r}function o(t,e){return e}var i=t("wrap-function"),a=t("ee").get("promise"),c=i(a),s=t(26),f=NREUM.o.PR;e.exports=a,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){a.emit("propagate",[null,!o],i),o=o||!t}}var o=!1;s(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var i=e.apply(f,arguments),c=f.resolve(i);return c}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&a.emit("propagate",[t,!0],n),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),s(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),a.on("executor-start",function(t){t[0]=c(t[0],"resolve-",this),t[1]=c(t[1],"resolve-",this)}),a.on("executor-err",function(t,e,n){t[1](n)}),c.inPlace(f.prototype,["then"],"then-",o),a.on("then-start",function(t,e){this.promise=e,t[0]=c(t[0],"cb-",this),t[1]=c(t[1],"cb-",this)}),a.on("then-end",function(t,e,n){this.nextPromise=n;var r=this.promise;a.emit("propagate",[r,!0],n)}),a.on("cb-end",function(t,e,n){a.emit("propagate",[n,!0],this.nextPromise)}),a.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=a.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],12:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],13:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),c="setTimeout",s="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[c,"setImmediate"],c+d),a.inPlace(window,[s],s+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(s+u,r),i.on(c+u,o)},{}],14:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",c)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,g,"fn-",c)}function i(t){y.push(t),h&&(b?b.then(a):v?v(a):(E=-E,R.data=E))}function a(){for(var t=0;t<y.length;t++)r([],y[t]);y.length&&(y=[])}function c(t,e){return e}function s(t,e){for(var n in t)e[n]=t[n];return e}t(6);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=NREUM.o,l=p.XHR,h=p.MO,m=p.PR,v=p.SI,w="readystatechange",g=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],y=[];e.exports=u;var x=window.XMLHttpRequest=function(t){var e=new l(t);try{u.emit("new-xhr",[e],e),e.addEventListener(w,o,!1)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(s(l,x),x.prototype=l.prototype,d.inPlace(x.prototype,["open","send"],"-xhr-",c),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),h){var b=m&&m.resolve();if(!v&&!m){var E=1,R=document.createTextNode(E);new h(a).observe(R,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===w||a()})},{}],15:[function(t,e,n){function r(t){if(!c(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||s(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&s(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",c=1,s="",f="";return o+"@nr="+i+"-"+c+"-"+n+"-"+r+"-"+t+"-"+a+"-"+s+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var c={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(c.d.tk=i),btoa(JSON.stringify(c))}function c(t){return f()&&s(t)}function s(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(23),h=t(17);e.exports={generateTracePayload:r,shouldGenerateTrace:c}},{}],16:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,u.emit("xhr-done",[t],t),c("xhr",[e,n,this.startTime]))}}function o(t,e){var n=s(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=s(e),t.sameOrigin=t.parsedOrigin.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable){var c=t("handle"),s=t(17),f=t(15).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(21),m=t(20),v=t(18),w=window.XMLHttpRequest;a.features.xhr=!0,t(14),t(7),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,t.addEventListener("load",function(n){i(e,t)},!1),h&&(h>34||h<10)||window.opera||t.addEventListener("progress",function(t){e.lastSize=t.loaded},!1)}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var c=0;c<p;c++)e.addEventListener(d[c],this.listener,!1)}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("addEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof w&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url&&(n=t[0].url),n&&(this.parsedOrigin=s(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)})}},{}],17:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,c=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||c),"/"===o.pathname&&(r[t]=o),o}},{}],18:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(20);e.exports=r},{}],19:[function(t,e,n){function r(){}function o(t,e,n){return function(){return i(t,[f.now()].concat(c(arguments)),e?null:this,n),e?void 0:this}}var i=t("handle"),a=t(26),c=t(27),s=t("ee").get("tracer"),f=t("loader"),u=NREUM;"undefined"==typeof window.newrelic&&(newrelic=u);var d=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],p="api-",l=p+"ixn-";a(d,function(t,e){u[e]=o(p+e,!0,"api")}),u.addPageAction=o(p+"addPageAction",!0),u.setCurrentRouteName=o(p+"routeName",!0),e.exports=newrelic,u.interaction=function(){return(new r).get()};var h=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(l+"tracer",[f.now(),t,n],r),function(){if(s.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw s.emit("fn-err",[arguments,this,t],n),t}finally{s.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){h[e]=o(l+e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),i("err",[t,f.now(),!1,e])}},{}],20:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],21:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],22:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?d("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&d("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();n.length>0&&d("lcp",[n[n.length-1]])}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||d("cls",[t])})}function a(t){if(t instanceof h&&!v){var e=Math.round(t.timeStamp),n={type:t.type};e<=p.now()?n.fid=p.now()-e:e>p.offset&&e<=Date.now()?(e-=p.offset,n.fid=p.now()-e):e=p.now(),v=!0,d("timing",["fi",e,n])}}function c(t){d("pageHide",[p.now(),t])}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var s,f,u,d=t("handle"),p=t("loader"),l=t(25),h=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){s=new PerformanceObserver(r);try{s.observe({entryTypes:["paint"]})}catch(m){}f=new PerformanceObserver(o);try{f.observe({entryTypes:["largest-contentful-paint"]})}catch(m){}u=new PerformanceObserver(i);try{u.observe({type:"layout-shift",buffered:!0})}catch(m){}}if("addEventListener"in document){var v=!1,w=["click","keydown","mousedown","pointerdown","touchstart"];w.forEach(function(t){document.addEventListener(t,a,!1)})}l(c)}},{}],23:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",c=0;c<i.length;c++)o=i[c],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(31)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],24:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var c=navigator.userAgent,s=c.match(a);s&&c.indexOf("Chrome")===-1&&c.indexOf("Chromium")===-1&&(o="Safari",i=s[1])}e.exports={agent:o,version:i,match:r}},{}],25:[function(t,e,n){function r(t){function e(){t(a&&document[a]?document[a]:document[o]?"hidden":"visible")}"addEventListener"in document&&i&&document.addEventListener(i,e,!1)}e.exports=r;var o,i,a;"undefined"!=typeof document.hidden?(o="hidden",i="visibilitychange",a="visibilityState"):"undefined"!=typeof document.msHidden?(o="msHidden",i="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(o="webkitHidden",i="webkitvisibilitychange",a="webkitVisibilityState")},{}],26:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],27:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],28:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?s(t,c,i):i()}function n(n,r,o,i){if(!p.aborted||i){t&&t(n,r,o);for(var a=e(o),c=m(n),s=c.length,f=0;f<s;f++)c[f].apply(a,r);var d=u[y[n]];return d&&d.push([x,n,r,a]),a}}function l(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return d[t]=d[t]||o(n)}function w(t,e){f(t,function(t,n){e=e||"feature",y[n]=e,e in u||(u[e]=[])})}var g={},y={},x={on:l,addEventListener:l,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:a,aborted:!1};return x}function i(){return new r}function a(){(u.api||u.feature)&&(p.aborted=!0,u=p.backlog={})}var c="nr@context",s=t("gos"),f=t(26),u={},d={},p=e.exports=o();p.backlog=u},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!E++){var t=b.info=NREUM.info,e=l.getElementsByTagName("script")[0];if(setTimeout(u.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return u.abort();f(y,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+b.offset],null,"api"),s("timing",["load",n]);var r=l.createElement("script");r.src="https://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===l.readyState&&i()}function i(){s("mark",["domContent",a()+b.offset],null,"api")}function a(){return R.exists&&performance.now?Math.round(performance.now()):(c=Math.max((new Date).getTime(),c))-b.offset}var c=(new Date).getTime(),s=t("handle"),f=t(26),u=t("ee"),d=t(24),p=window,l=p.document,h="addEventListener",m="attachEvent",v=p.XMLHttpRequest,w=v&&v.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:v,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var g=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1177.min.js"},x=v&&w&&w[h]&&!/CriOS/.test(navigator.userAgent),b=e.exports={offset:c,now:a,origin:g,features:{},xhrWrappable:x,userAgent:d};t(19),t(22),l[h]?(l[h]("DOMContentLoaded",i,!1),p[h]("load",r,!1)):(l[m]("onreadystatechange",o),p[m]("onload",r)),s("mark",["firstbyte",c],null,"api");var E=0,R=t(28)},{}],"wrap-function":[function(t,e,n){function r(t){return!(t&&t instanceof Function&&t.apply&&!t[a])}var o=t("ee"),i=t(27),a="nr@original",c=Object.prototype.hasOwnProperty,s=!1;e.exports=function(t,e){function n(t,e,n,o){function nrWrapper(){var r,a,c,s;try{a=this,r=i(arguments),c="function"==typeof n?n(r,a):n||{}}catch(f){p([f,"",[r,a,o],c])}u(e+"start",[r,a,o],c);try{return s=t.apply(a,r)}catch(d){throw u(e+"err",[r,a,d],c),d}finally{u(e+"end",[r,a,s],c)}}return r(t)?t:(e||(e=""),nrWrapper[a]=t,d(t,nrWrapper),nrWrapper)}function f(t,e,o,i){o||(o="");var a,c,s,f="-"===o.charAt(0);for(s=0;s<e.length;s++)c=e[s],a=t[c],r(a)||(t[c]=n(a,f?c+o:o,i,c))}function u(n,r,o){if(!s||e){var i=s;s=!0;try{t.emit(n,r,o,e)}catch(a){p([a,n,r,o])}s=i}}function d(t,e){if(Object.defineProperty&&Object.keys)try{var n=Object.keys(t);return n.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(r){p([r])}for(var o in t)c.call(t,o)&&(e[o]=t[o]);return e}function p(e){try{t.emit("internal-error",e)}catch(n){}}return t||(t=o),n.inPlace=f,n.flag=a,n}},{}]},{},["loader",2,16,5,3,4]);
    ;NREUM.loader_config={accountID:"2095297",trustKey:"2038175",agentID:"916957862",licenseKey:"16e2192192",applicationID:"916957862"}
    ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"16e2192192",applicationID:"916957862",sa:1}
</script>
    <script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="dada9834-04e2-4bcd-b5ba-cae44d498dfa"></script>
    <script type="text/javascript">
        function getCookie(name) {
            var value = "; " + document.cookie;
            var parts = value.split("; " + name + "=");
            if (parts.length == 2) {
                return true;
            }
        }
            function OptanonWrapper() {
                var optCookie = getCookie("OptanonAlertBoxClosed");
                var isActiveCategory = "false";
                var isFoundCookieBox = "false";
                if(isActiveCategory == 'false' && isFoundCookieBox == 'false' && optCookie) {
                    OneTrust.InsertScript('/pb-assets/adobe/prod/adobedtm-1616606406233.js', 'head', null, null, '2');
                }
            }
    </script>


<noscript>
    <style>.requiresJS {
        display: none
    }

    .dartAd {
        display: block !important
    }</style>
</noscript>
        <script type="text/javascript" src="/wro/o4ny~selected-legacy.js"></script>
        <link rel="stylesheet" type="text/css" href="/wro/o4ny~selected-legacy.css">
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans">
        <script>window.MSInputMethodContext && document.documentMode && document.write('<script src="https://cdn.jsdelivr.net/gh/nuxodin/ie11CustomProperties@4.1.0/ie11CustomProperties.min.js"><\x2fscript>');</script><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/build-b26f3342b722959c7931.css"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/print-b26f3342b722959c7931.css" media="print"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/themes/theme-cell.css">







        
        
        <script class="optanon-category-4" type="text/plain" async="" src="https://www.youtube.com/iframe_api"></script>
        
    





<!---->
<meta http-equiv="X-UA-Compatible" content="IE=edge">












<script src="https://cdn.cookielaw.org/scripttemplates/202411.2.0/otBannerSdk.js" async="" type="text/javascript"></script><style id="onetrust-style">#onetrust-banner-sdk .onetrust-vendors-list-handler{cursor:pointer;color:#1f96db;font-size:inherit;font-weight:bold;text-decoration:none;margin-left:5px}#onetrust-banner-sdk .onetrust-vendors-list-handler:hover{color:#1f96db}#onetrust-banner-sdk:focus{outline:2px solid #000;outline-offset:-2px}#onetrust-banner-sdk a:focus{outline:2px solid #000}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{outline-offset:1px}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{height:64px;width:64px}#onetrust-banner-sdk .ot-tcf2-vendor-count.ot-text-bold{font-weight:bold}#onetrust-banner-sdk .ot-close-icon,#onetrust-pc-sdk .ot-close-icon,#ot-sync-ntfy .ot-close-icon{background-size:contain;background-repeat:no-repeat;background-position:center;height:12px;width:12px}#onetrust-banner-sdk .powered-by-logo,#onetrust-banner-sdk .ot-pc-footer-logo a,#onetrust-pc-sdk .powered-by-logo,#onetrust-pc-sdk .ot-pc-footer-logo a,#ot-sync-ntfy .powered-by-logo,#ot-sync-ntfy .ot-pc-footer-logo a{background-size:contain;background-repeat:no-repeat;background-position:center;height:25px;width:152px;display:block;text-decoration:none;font-size:.75em}#onetrust-banner-sdk .powered-by-logo:hover,#onetrust-banner-sdk .ot-pc-footer-logo a:hover,#onetrust-pc-sdk .powered-by-logo:hover,#onetrust-pc-sdk .ot-pc-footer-logo a:hover,#ot-sync-ntfy .powered-by-logo:hover,#ot-sync-ntfy .ot-pc-footer-logo a:hover{color:#565656}#onetrust-banner-sdk h3 *,#onetrust-banner-sdk h4 *,#onetrust-banner-sdk h6 *,#onetrust-banner-sdk button *,#onetrust-banner-sdk a[data-parent-id] *,#onetrust-pc-sdk h3 *,#onetrust-pc-sdk h4 *,#onetrust-pc-sdk h6 *,#onetrust-pc-sdk button *,#onetrust-pc-sdk a[data-parent-id] *,#ot-sync-ntfy h3 *,#ot-sync-ntfy h4 *,#ot-sync-ntfy h6 *,#ot-sync-ntfy button *,#ot-sync-ntfy a[data-parent-id] *{font-size:inherit;font-weight:inherit;color:inherit}#onetrust-banner-sdk .ot-hide,#onetrust-pc-sdk .ot-hide,#ot-sync-ntfy .ot-hide{display:none !important}#onetrust-banner-sdk button.ot-link-btn:hover,#onetrust-pc-sdk button.ot-link-btn:hover,#ot-sync-ntfy button.ot-link-btn:hover{text-decoration:underline;opacity:1}#onetrust-pc-sdk .ot-sdk-row .ot-sdk-column{padding:0}#onetrust-pc-sdk .ot-sdk-container{padding-right:0}#onetrust-pc-sdk .ot-sdk-row{flex-direction:initial;width:100%}#onetrust-pc-sdk [type=checkbox]:checked,#onetrust-pc-sdk [type=checkbox]:not(:checked){pointer-events:initial}#onetrust-pc-sdk [type=checkbox]:disabled+label::before,#onetrust-pc-sdk [type=checkbox]:disabled+label:after,#onetrust-pc-sdk [type=checkbox]:disabled+label{pointer-events:none;opacity:.8}#onetrust-pc-sdk #vendor-list-content{transform:translate3d(0, 0, 0)}#onetrust-pc-sdk li input[type=checkbox]{z-index:1}#onetrust-pc-sdk li .ot-checkbox label{z-index:2}#onetrust-pc-sdk li .ot-checkbox input[type=checkbox]{height:auto;width:auto}#onetrust-pc-sdk li .host-title a,#onetrust-pc-sdk li .ot-host-name a,#onetrust-pc-sdk li .accordion-text,#onetrust-pc-sdk li .ot-acc-txt{z-index:2;position:relative}#onetrust-pc-sdk input{margin:3px .1ex}#onetrust-pc-sdk .pc-logo,#onetrust-pc-sdk .ot-pc-logo{height:60px;width:180px;background-position:center;background-size:contain;background-repeat:no-repeat;display:inline-flex;justify-content:center;align-items:center}#onetrust-pc-sdk .pc-logo img,#onetrust-pc-sdk .ot-pc-logo img{max-height:100%;max-width:100%}#onetrust-pc-sdk .screen-reader-only,#onetrust-pc-sdk .ot-scrn-rdr,.ot-sdk-cookie-policy .screen-reader-only,.ot-sdk-cookie-policy .ot-scrn-rdr{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}#onetrust-pc-sdk.ot-fade-in,.onetrust-pc-dark-filter.ot-fade-in,#onetrust-banner-sdk.ot-fade-in{animation-name:onetrust-fade-in;animation-duration:400ms;animation-timing-function:ease-in-out}#onetrust-pc-sdk.ot-hide{display:none !important}.onetrust-pc-dark-filter.ot-hide{display:none !important}#ot-sdk-btn.ot-sdk-show-settings,#ot-sdk-btn.optanon-show-settings{color:#fff;background-color:#468254;height:auto;white-space:normal;word-wrap:break-word;padding:.8em 2em;font-size:.8em;line-height:1.2;cursor:pointer;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease}#ot-sdk-btn.ot-sdk-show-settings:hover,#ot-sdk-btn.optanon-show-settings:hover{color:#fff;background-color:#2c6415}#ot-sdk-btn.ot-sdk-show-settings:active,#ot-sdk-btn.optanon-show-settings:active{color:#fff;background-color:#2c6415;border:1px solid rgba(162,192,169,.5)}.onetrust-pc-dark-filter{background:rgba(0,0,0,.5);z-index:2147483646;width:100%;height:100%;overflow:hidden;position:fixed;top:0;bottom:0;left:0}@keyframes onetrust-fade-in{0%{opacity:0}100%{opacity:1}}.ot-cookie-label{text-decoration:underline}@media only screen and (min-width: 426px)and (max-width: 896px)and (orientation: landscape){#onetrust-pc-sdk p{font-size:.75em}}#onetrust-banner-sdk .banner-option-input:focus+label{outline:1px solid #000;outline-style:auto}.category-vendors-list-handler+a:focus,.category-vendors-list-handler+a:focus-visible{outline:2px solid #000}#onetrust-pc-sdk .ot-userid-title{margin-top:10px}#onetrust-pc-sdk .ot-userid-title>span,#onetrust-pc-sdk .ot-userid-timestamp>span{font-weight:700}#onetrust-pc-sdk .ot-userid-desc{font-style:italic}#onetrust-pc-sdk .ot-host-desc a{pointer-events:initial}#onetrust-pc-sdk .ot-ven-hdr>p a{position:relative;z-index:2;pointer-events:initial}#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info a{margin-right:auto}#onetrust-pc-sdk .ot-pc-footer-logo img{width:136px;height:16px}#onetrust-pc-sdk .ot-pur-vdr-count{font-weight:400;font-size:.7rem;padding-top:3px;display:block}#onetrust-banner-sdk .ot-optout-signal,#onetrust-pc-sdk .ot-optout-signal{border:1px solid #32ae88;border-radius:3px;padding:5px;margin-bottom:10px;background-color:#f9fffa;font-size:.85rem;line-height:2}#onetrust-banner-sdk .ot-optout-signal .ot-optout-icon,#onetrust-pc-sdk .ot-optout-signal .ot-optout-icon{display:inline;margin-right:5px}#onetrust-banner-sdk .ot-optout-signal svg,#onetrust-pc-sdk .ot-optout-signal svg{height:20px;width:30px;transform:scale(0.5)}#onetrust-banner-sdk .ot-optout-signal svg path,#onetrust-pc-sdk .ot-optout-signal svg path{fill:#32ae88}#onetrust-consent-sdk .ot-general-modal{overflow:hidden;position:fixed;margin:0 auto;top:50%;left:50%;width:40%;padding:1.5rem;max-width:575px;min-width:575px;z-index:2147483647;border-radius:2.5px;transform:translate(-50%, -50%)}#onetrust-consent-sdk .ot-signature-health-group{margin-top:1rem;padding-left:1.25rem;padding-right:1.25rem;margin-bottom:.625rem;width:calc(100% - 2.5rem)}#onetrust-consent-sdk .ot-signature-health-group .ot-signature-health-form{gap:.5rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:70%;gap:.35rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-input{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-consent-sdk .ot-signature-health .ot-signature-subtitle{font-size:1.125rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-group-title{font-size:1.25rem;font-weight:bold}#onetrust-consent-sdk .ot-signature-health,#onetrust-consent-sdk .ot-signature-health-group{display:flex;flex-direction:column;gap:1rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-cont{display:flex;flex-direction:column;gap:.25rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-paragraph,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-paragraph{margin:0;line-height:20px;font-size:max(14px,.875rem)}#onetrust-consent-sdk .ot-signature-health .ot-health-signature-error,#onetrust-consent-sdk .ot-signature-health-group .ot-health-signature-error{color:#4d4d4d;font-size:min(12px,.75rem)}#onetrust-consent-sdk .ot-signature-health .ot-signature-buttons-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-buttons-cont{margin-top:max(.75rem,2%);gap:1rem;display:flex;justify-content:flex-end}#onetrust-consent-sdk .ot-signature-health .ot-signature-button,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button{flex:1;height:auto;color:#fff;cursor:pointer;line-height:1.2;min-width:125px;font-weight:600;font-size:.813em;border-radius:2px;padding:12px 10px;white-space:normal;word-wrap:break-word;word-break:break-word;background-color:#68b631;border:2px solid #68b631}#onetrust-consent-sdk .ot-signature-health .ot-signature-button.reject,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button.reject{background-color:#fff}#onetrust-consent-sdk .ot-input-field-cont{display:flex;flex-direction:column;gap:.5rem}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:65%}#onetrust-consent-sdk .ot-signature-health-form{display:flex;flex-direction:column}#onetrust-consent-sdk .ot-signature-health-form .ot-signature-label{margin-bottom:0;line-height:20px;font-size:max(14px,.875rem)}@media only screen and (max-width: 600px){#onetrust-consent-sdk .ot-general-modal{min-width:100%}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:100%}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:100%}}#onetrust-banner-sdk,#onetrust-pc-sdk,#ot-sdk-cookie-policy,#ot-sync-ntfy{font-size:16px}#onetrust-banner-sdk *,#onetrust-banner-sdk ::after,#onetrust-banner-sdk ::before,#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before,#ot-sdk-cookie-policy *,#ot-sdk-cookie-policy ::after,#ot-sdk-cookie-policy ::before,#ot-sync-ntfy *,#ot-sync-ntfy ::after,#ot-sync-ntfy ::before{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}#onetrust-banner-sdk div,#onetrust-banner-sdk span,#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-banner-sdk p,#onetrust-banner-sdk img,#onetrust-banner-sdk svg,#onetrust-banner-sdk button,#onetrust-banner-sdk section,#onetrust-banner-sdk a,#onetrust-banner-sdk label,#onetrust-banner-sdk input,#onetrust-banner-sdk ul,#onetrust-banner-sdk li,#onetrust-banner-sdk nav,#onetrust-banner-sdk table,#onetrust-banner-sdk thead,#onetrust-banner-sdk tr,#onetrust-banner-sdk td,#onetrust-banner-sdk tbody,#onetrust-banner-sdk .ot-main-content,#onetrust-banner-sdk .ot-toggle,#onetrust-banner-sdk #ot-content,#onetrust-banner-sdk #ot-pc-content,#onetrust-banner-sdk .checkbox,#onetrust-pc-sdk div,#onetrust-pc-sdk span,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#onetrust-pc-sdk p,#onetrust-pc-sdk img,#onetrust-pc-sdk svg,#onetrust-pc-sdk button,#onetrust-pc-sdk section,#onetrust-pc-sdk a,#onetrust-pc-sdk label,#onetrust-pc-sdk input,#onetrust-pc-sdk ul,#onetrust-pc-sdk li,#onetrust-pc-sdk nav,#onetrust-pc-sdk table,#onetrust-pc-sdk thead,#onetrust-pc-sdk tr,#onetrust-pc-sdk td,#onetrust-pc-sdk tbody,#onetrust-pc-sdk .ot-main-content,#onetrust-pc-sdk .ot-toggle,#onetrust-pc-sdk #ot-content,#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk .checkbox,#ot-sdk-cookie-policy div,#ot-sdk-cookie-policy span,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy p,#ot-sdk-cookie-policy img,#ot-sdk-cookie-policy svg,#ot-sdk-cookie-policy button,#ot-sdk-cookie-policy section,#ot-sdk-cookie-policy a,#ot-sdk-cookie-policy label,#ot-sdk-cookie-policy input,#ot-sdk-cookie-policy ul,#ot-sdk-cookie-policy li,#ot-sdk-cookie-policy nav,#ot-sdk-cookie-policy table,#ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy tr,#ot-sdk-cookie-policy td,#ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy .ot-main-content,#ot-sdk-cookie-policy .ot-toggle,#ot-sdk-cookie-policy #ot-content,#ot-sdk-cookie-policy #ot-pc-content,#ot-sdk-cookie-policy .checkbox,#ot-sync-ntfy div,#ot-sync-ntfy span,#ot-sync-ntfy h1,#ot-sync-ntfy h2,#ot-sync-ntfy h3,#ot-sync-ntfy h4,#ot-sync-ntfy h5,#ot-sync-ntfy h6,#ot-sync-ntfy p,#ot-sync-ntfy img,#ot-sync-ntfy svg,#ot-sync-ntfy button,#ot-sync-ntfy section,#ot-sync-ntfy a,#ot-sync-ntfy label,#ot-sync-ntfy input,#ot-sync-ntfy ul,#ot-sync-ntfy li,#ot-sync-ntfy nav,#ot-sync-ntfy table,#ot-sync-ntfy thead,#ot-sync-ntfy tr,#ot-sync-ntfy td,#ot-sync-ntfy tbody,#ot-sync-ntfy .ot-main-content,#ot-sync-ntfy .ot-toggle,#ot-sync-ntfy #ot-content,#ot-sync-ntfy #ot-pc-content,#ot-sync-ntfy .checkbox{font-family:inherit;font-weight:normal;-webkit-font-smoothing:auto;letter-spacing:normal;line-height:normal;padding:0;margin:0;height:auto;min-height:0;max-height:none;width:auto;min-width:0;max-width:none;border-radius:0;border:none;clear:none;float:none;position:static;bottom:auto;left:auto;right:auto;top:auto;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;white-space:normal;background:none;overflow:visible;vertical-align:baseline;visibility:visible;z-index:auto;box-shadow:none}#onetrust-banner-sdk label:before,#onetrust-banner-sdk label:after,#onetrust-banner-sdk .checkbox:after,#onetrust-banner-sdk .checkbox:before,#onetrust-pc-sdk label:before,#onetrust-pc-sdk label:after,#onetrust-pc-sdk .checkbox:after,#onetrust-pc-sdk .checkbox:before,#ot-sdk-cookie-policy label:before,#ot-sdk-cookie-policy label:after,#ot-sdk-cookie-policy .checkbox:after,#ot-sdk-cookie-policy .checkbox:before,#ot-sync-ntfy label:before,#ot-sync-ntfy label:after,#ot-sync-ntfy .checkbox:after,#ot-sync-ntfy .checkbox:before{content:"";content:none}#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{position:relative;width:100%;max-width:100%;margin:0 auto;padding:0 20px;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{width:100%;float:left;box-sizing:border-box;padding:0;display:initial}@media(min-width: 400px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:90%;padding:0}}@media(min-width: 550px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:100%}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{margin-left:4%}#onetrust-banner-sdk .ot-sdk-column:first-child,#onetrust-banner-sdk .ot-sdk-columns:first-child,#onetrust-pc-sdk .ot-sdk-column:first-child,#onetrust-pc-sdk .ot-sdk-columns:first-child,#ot-sdk-cookie-policy .ot-sdk-column:first-child,#ot-sdk-cookie-policy .ot-sdk-columns:first-child{margin-left:0}#onetrust-banner-sdk .ot-sdk-two.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-two.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-two.ot-sdk-columns{width:13.3333333333%}#onetrust-banner-sdk .ot-sdk-three.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-three.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-three.ot-sdk-columns{width:22%}#onetrust-banner-sdk .ot-sdk-four.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-four.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-four.ot-sdk-columns{width:30.6666666667%}#onetrust-banner-sdk .ot-sdk-eight.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eight.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eight.ot-sdk-columns{width:65.3333333333%}#onetrust-banner-sdk .ot-sdk-nine.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-nine.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-nine.ot-sdk-columns{width:74%}#onetrust-banner-sdk .ot-sdk-ten.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-ten.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-ten.ot-sdk-columns{width:82.6666666667%}#onetrust-banner-sdk .ot-sdk-eleven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eleven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eleven.ot-sdk-columns{width:91.3333333333%}#onetrust-banner-sdk .ot-sdk-twelve.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-twelve.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-twelve.ot-sdk-columns{width:100%;margin-left:0}}#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6{margin-top:0;font-weight:600;font-family:inherit}#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem;line-height:1.2}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem;line-height:1.25}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem;line-height:1.3}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem;line-height:1.35}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem;line-height:1.5}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem;line-height:1.6}@media(min-width: 550px){#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem}}#onetrust-banner-sdk p,#onetrust-pc-sdk p,#ot-sdk-cookie-policy p{margin:0 0 1em 0;font-family:inherit;line-height:normal}#onetrust-banner-sdk a,#onetrust-pc-sdk a,#ot-sdk-cookie-policy a{color:#565656;text-decoration:underline}#onetrust-banner-sdk a:hover,#onetrust-pc-sdk a:hover,#ot-sdk-cookie-policy a:hover{color:#565656;text-decoration:none}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{display:inline-block;height:38px;padding:0 30px;color:#555;text-align:center;font-size:.9em;font-weight:400;line-height:38px;letter-spacing:.01em;text-decoration:none;white-space:nowrap;background-color:rgba(0,0,0,0);border-radius:2px;border:1px solid #bbb;cursor:pointer;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-button:hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#onetrust-pc-sdk .ot-sdk-button:hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#ot-sdk-cookie-policy .ot-sdk-button:hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus{color:#333;border-color:#888;opacity:.9}#onetrust-banner-sdk .ot-sdk-button:focus,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:focus,#onetrust-pc-sdk .ot-sdk-button:focus,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:focus,#ot-sdk-cookie-policy .ot-sdk-button:focus,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:focus{outline:2px solid #000}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-banner-sdk button.ot-sdk-button-primary,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-pc-sdk button.ot-sdk-button-primary,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary,#ot-sdk-cookie-policy button.ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary{color:#fff;background-color:#33c3f0;border-color:#33c3f0}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-banner-sdk button.ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-banner-sdk button.ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:focus,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-pc-sdk button.ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-pc-sdk button.ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:focus{color:#fff;background-color:#1eaedb;border-color:#1eaedb}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{-webkit-appearance:none;-moz-appearance:none;appearance:none}#onetrust-banner-sdk input[type=text]:focus,#onetrust-pc-sdk input[type=text]:focus,#ot-sdk-cookie-policy input[type=text]:focus{border:1px solid #000;outline:0}#onetrust-banner-sdk label,#onetrust-pc-sdk label,#ot-sdk-cookie-policy label{display:block;margin-bottom:.5rem;font-weight:600}#onetrust-banner-sdk input[type=checkbox],#onetrust-pc-sdk input[type=checkbox],#ot-sdk-cookie-policy input[type=checkbox]{display:inline}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{list-style:circle inside}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{padding-left:0;margin-top:0}#onetrust-banner-sdk ul ul,#onetrust-pc-sdk ul ul,#ot-sdk-cookie-policy ul ul{margin:1.5rem 0 1.5rem 3rem;font-size:90%}#onetrust-banner-sdk li,#onetrust-pc-sdk li,#ot-sdk-cookie-policy li{margin-bottom:1rem}#onetrust-banner-sdk th,#onetrust-banner-sdk td,#onetrust-pc-sdk th,#onetrust-pc-sdk td,#ot-sdk-cookie-policy th,#ot-sdk-cookie-policy td{padding:12px 15px;text-align:left;border-bottom:1px solid #e1e1e1}#onetrust-banner-sdk button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-container:after,#onetrust-banner-sdk .ot-sdk-row:after,#onetrust-pc-sdk .ot-sdk-container:after,#onetrust-pc-sdk .ot-sdk-row:after,#ot-sdk-cookie-policy .ot-sdk-container:after,#ot-sdk-cookie-policy .ot-sdk-row:after{content:"";display:table;clear:both}#onetrust-banner-sdk .ot-sdk-row,#onetrust-pc-sdk .ot-sdk-row,#ot-sdk-cookie-policy .ot-sdk-row{margin:0;max-width:none;display:block}#onetrust-banner-sdk{box-shadow:0 0 18px rgba(0,0,0,.2)}#onetrust-banner-sdk.otFlat{position:fixed;z-index:2147483645;bottom:0;right:0;left:0;background-color:#fff;max-height:90%;overflow-x:hidden;overflow-y:auto}#onetrust-banner-sdk.otFlat.top{top:0px;bottom:auto}#onetrust-banner-sdk.otRelFont{font-size:1rem}#onetrust-banner-sdk>.ot-sdk-container{overflow:hidden}#onetrust-banner-sdk::-webkit-scrollbar{width:11px}#onetrust-banner-sdk::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-banner-sdk{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-banner-sdk #onetrust-policy{margin:1.25em 0 .625em 2em;overflow:hidden}#onetrust-banner-sdk #onetrust-policy .ot-gv-list-handler{float:left;font-size:.82em;padding:0;margin-bottom:0;border:0;line-height:normal;height:auto;width:auto}#onetrust-banner-sdk #onetrust-policy-title{font-size:1.2em;line-height:1.3;margin-bottom:10px}#onetrust-banner-sdk #onetrust-policy-text{clear:both;text-align:left;font-size:.88em;line-height:1.4}#onetrust-banner-sdk #onetrust-policy-text *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk #onetrust-policy-text a{font-weight:bold;margin-left:5px}#onetrust-banner-sdk #onetrust-policy-title,#onetrust-banner-sdk #onetrust-policy-text{color:dimgray;float:left}#onetrust-banner-sdk #onetrust-button-group-parent{min-height:1px;text-align:center}#onetrust-banner-sdk #onetrust-button-group{display:inline-block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{background-color:#68b631;color:#fff;border-color:#68b631;margin-right:1em;min-width:125px;height:auto;white-space:normal;word-break:break-word;word-wrap:break-word;padding:12px 10px;line-height:1.2;font-size:.813em;font-weight:600}#onetrust-banner-sdk #onetrust-pc-btn-handler.cookie-setting-link{background-color:#fff;border:none;color:#68b631;text-decoration:underline;padding-left:0;padding-right:0}#onetrust-banner-sdk .onetrust-close-btn-ui{width:44px;height:44px;background-size:12px;border:none;position:relative;margin:auto;padding:0}#onetrust-banner-sdk .banner_logo{display:none}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{position:absolute;top:50%;transform:translateY(-50%);left:0px}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-policy{margin-left:65px}#onetrust-banner-sdk .ot-b-addl-desc{clear:both;float:left;display:block}#onetrust-banner-sdk #banner-options{float:left;display:table;margin-right:0;margin-left:1em;width:calc(100% - 1em)}#onetrust-banner-sdk .banner-option-input{cursor:pointer;width:auto;height:auto;border:none;padding:0;padding-right:3px;margin:0 0 10px;font-size:.82em;line-height:1.4}#onetrust-banner-sdk .banner-option-input *{pointer-events:none;font-size:inherit;line-height:inherit}#onetrust-banner-sdk .banner-option-input[aria-expanded=true]~.banner-option-details{display:block;height:auto}#onetrust-banner-sdk .banner-option-input[aria-expanded=true] .ot-arrow-container{transform:rotate(90deg)}#onetrust-banner-sdk .banner-option{margin-bottom:12px;margin-left:0;border:none;float:left;padding:0}#onetrust-banner-sdk .banner-option:first-child{padding-left:2px}#onetrust-banner-sdk .banner-option:not(:first-child){padding:0;border:none}#onetrust-banner-sdk .banner-option-header{cursor:pointer;display:inline-block}#onetrust-banner-sdk .banner-option-header :first-child{color:dimgray;font-weight:bold;float:left}#onetrust-banner-sdk .banner-option-header .ot-arrow-container{display:inline-block;border-top:6px solid rgba(0,0,0,0);border-bottom:6px solid rgba(0,0,0,0);border-left:6px solid dimgray;margin-left:10px;vertical-align:middle}#onetrust-banner-sdk .banner-option-details{display:none;font-size:.83em;line-height:1.5;padding:10px 0px 5px 10px;margin-right:10px;height:0px}#onetrust-banner-sdk .banner-option-details *{font-size:inherit;line-height:inherit;color:dimgray}#onetrust-banner-sdk .ot-arrow-container,#onetrust-banner-sdk .banner-option-details{transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-banner-sdk .ot-dpd-container{float:left}#onetrust-banner-sdk .ot-dpd-title{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-title,#onetrust-banner-sdk .ot-dpd-desc{font-size:.88em;line-height:1.4;color:dimgray}#onetrust-banner-sdk .ot-dpd-title *,#onetrust-banner-sdk .ot-dpd-desc *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text *{margin-bottom:0}#onetrust-banner-sdk.ot-iab-2 .onetrust-vendors-list-handler{display:block;margin-left:0;margin-top:5px;clear:both;margin-bottom:0;padding:0;border:0;height:auto;width:auto}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk.ot-close-btn-link{padding-top:25px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container{top:15px;transform:none;right:15px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container button{padding:0;white-space:pre-wrap;border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em}#onetrust-banner-sdk #onetrust-policy-text,#onetrust-banner-sdk .ot-dpd-desc,#onetrust-banner-sdk .ot-b-addl-desc{font-size:.813em;line-height:1.5}#onetrust-banner-sdk .ot-dpd-desc{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-desc>.ot-b-addl-desc{margin-top:10px;margin-bottom:10px;font-size:1em}@media only screen and (max-width: 425px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:6px;right:2px}#onetrust-banner-sdk #onetrust-policy{margin-left:0;margin-top:3em}#onetrust-banner-sdk #onetrust-button-group{display:block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk .onetrust-close-btn-ui{top:auto;transform:none}#onetrust-banner-sdk #onetrust-policy-title{display:inline;float:none}#onetrust-banner-sdk #banner-options{margin:0;padding:0;width:100%}}@media only screen and (min-width: 426px)and (max-width: 896px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:0;right:0}#onetrust-banner-sdk #onetrust-policy{margin-left:1em;margin-right:1em}#onetrust-banner-sdk .onetrust-close-btn-ui{top:10px;right:10px}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:95%}#onetrust-banner-sdk.ot-iab-2 #onetrust-group-container{width:100%}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-button-group-parent{padding-left:50px}#onetrust-banner-sdk #onetrust-button-group-parent{width:100%;position:relative;margin-left:0}#onetrust-banner-sdk #onetrust-button-group button{display:inline-block}#onetrust-banner-sdk #onetrust-button-group{margin-right:0;text-align:center}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler{float:left}#onetrust-banner-sdk .has-reject-all-button #onetrust-reject-all-handler,#onetrust-banner-sdk .has-reject-all-button #onetrust-accept-btn-handler{float:right}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group{width:calc(100% - 2em);margin-right:0}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler.cookie-setting-link{padding-left:0px;text-align:left}#onetrust-banner-sdk.ot-buttons-fw .ot-sdk-three button{width:100%;text-align:center}#onetrust-banner-sdk.ot-buttons-fw #onetrust-button-group-parent button{float:none}#onetrust-banner-sdk.ot-buttons-fw #onetrust-pc-btn-handler.cookie-setting-link{text-align:center}}@media only screen and (min-width: 550px){#onetrust-banner-sdk .banner-option:not(:first-child){border-left:1px solid #d8d8d8;padding-left:25px}}@media only screen and (min-width: 425px)and (max-width: 550px){#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group,#onetrust-banner-sdk.ot-iab-2 #onetrust-policy,#onetrust-banner-sdk.ot-iab-2 .banner-option{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler{float:left}}@media only screen and (min-width: 769px){#onetrust-banner-sdk #onetrust-button-group{margin-right:30%}#onetrust-banner-sdk #banner-options{margin-left:2em;margin-right:5em;margin-bottom:1.25em;width:calc(100% - 7em)}}@media only screen and (min-width: 897px)and (max-width: 1023px){#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:75%;transform:translateY(-50%)}#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;padding:0;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{position:relative;margin:0;right:-22px;top:2px}}@media only screen and (min-width: 1024px){#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{right:-12px}#onetrust-banner-sdk #onetrust-policy{margin-left:2em}#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:60%;transform:translateY(-50%)}#onetrust-banner-sdk .ot-optout-signal{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-title{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text,#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:1em;width:50%;border-right:1px solid #d8d8d8;padding-right:1rem}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-container{width:45%;padding-left:1rem;display:inline-block;float:none}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-title{line-height:1.7}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group-parent{left:auto;right:4%;margin-left:0}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:auto;width:30%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:60%}#onetrust-banner-sdk #onetrust-button-group{margin-right:auto}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{margin-top:1em}}@media only screen and (min-width: 890px){#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group-parent{padding-left:3%;padding-right:4%;margin-left:0}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{margin-right:0;margin-top:1.25em;width:100%}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button{width:100%;margin-bottom:5px;margin-top:5px}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type{margin-bottom:20px}}@media only screen and (min-width: 1280px){#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:55%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{width:44%;padding-left:2%;padding-right:2%}#onetrust-banner-sdk:not(.ot-iab-2).vertical-align-content #onetrust-button-group-parent{position:absolute;left:55%}}
        #onetrust-consent-sdk #onetrust-banner-sdk {background-color: #FFF;}
            #onetrust-consent-sdk #onetrust-policy-title,
                    #onetrust-consent-sdk #onetrust-policy-text,
                    #onetrust-consent-sdk .ot-b-addl-desc,
                    #onetrust-consent-sdk .ot-dpd-desc,
                    #onetrust-consent-sdk .ot-dpd-title,
                    #onetrust-consent-sdk #onetrust-policy-text *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk .ot-dpd-desc *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk #onetrust-banner-sdk #banner-options *,
                    #onetrust-banner-sdk .ot-cat-header,
                    #onetrust-banner-sdk .ot-optout-signal
                    {
                        color: #2E2E2E;
                    }
            #onetrust-consent-sdk #onetrust-banner-sdk .banner-option-details {
                    background-color: #E9E9E9;}
             #onetrust-consent-sdk #onetrust-banner-sdk a[href],
                    #onetrust-consent-sdk #onetrust-banner-sdk a[href] font,
                    #onetrust-consent-sdk #onetrust-banner-sdk .ot-link-btn
                        {
                            color: #007398;
                        }#onetrust-consent-sdk #onetrust-accept-btn-handler,
                         #onetrust-banner-sdk #onetrust-reject-all-handler {
                            background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-banner-sdk *:focus,
            #onetrust-consent-sdk #onetrust-banner-sdk:focus {
               outline-color: #000000;
               outline-width: 1px;
            }
            #onetrust-consent-sdk #onetrust-pc-btn-handler,
            #onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link {
                color: #6CC04A; border-color: #6CC04A;
                background-color:
                #FFF;
            }/*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
#onetrust-pc-sdk.otPcCenter{overflow:hidden;position:fixed;margin:0 auto;top:5%;right:0;left:0;width:40%;max-width:575px;min-width:575px;border-radius:2.5px;z-index:2147483647;background-color:#fff;-webkit-box-shadow:0px 2px 10px -3px #999;-moz-box-shadow:0px 2px 10px -3px #999;box-shadow:0px 2px 10px -3px #999}#onetrust-pc-sdk.otPcCenter[dir=rtl]{right:0;left:0}#onetrust-pc-sdk.otRelFont{font-size:1rem}#onetrust-pc-sdk .ot-optout-signal{margin-top:.625rem}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus,#onetrust-pc-sdk .ot-hide-tgl{visibility:hidden}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr *,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus *,#onetrust-pc-sdk .ot-hide-tgl *{visibility:hidden}#onetrust-pc-sdk #ot-gn-venlst .ot-ven-item .ot-acc-hdr{min-height:40px}#onetrust-pc-sdk .ot-pc-header{height:39px;padding:10px 0 10px 30px;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk #ot-pc-title,#onetrust-pc-sdk #ot-category-title,#onetrust-pc-sdk .ot-cat-header,#onetrust-pc-sdk #ot-lst-title,#onetrust-pc-sdk .ot-ven-hdr .ot-ven-name,#onetrust-pc-sdk .ot-always-active{font-weight:bold;color:dimgray}#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:55%;font-weight:700}#onetrust-pc-sdk .ot-cat-item p{clear:both;float:left;margin-top:10px;margin-bottom:5px;line-height:1.5;font-size:.812em;color:dimgray}#onetrust-pc-sdk .ot-close-icon{height:44px;width:44px;background-size:10px}#onetrust-pc-sdk #ot-pc-title{float:left;font-size:1em;line-height:1.5;margin-bottom:10px;margin-top:10px;width:100%}#onetrust-pc-sdk #accept-recommended-btn-handler{margin-right:10px;margin-bottom:25px;outline-offset:-1px}#onetrust-pc-sdk #ot-pc-desc{clear:both;width:100%;font-size:.812em;line-height:1.5;margin-bottom:25px}#onetrust-pc-sdk #ot-pc-desc *{font-size:inherit;line-height:inherit}#onetrust-pc-sdk #ot-pc-desc ul li{padding:10px 0px}#onetrust-pc-sdk a{color:#656565;cursor:pointer}#onetrust-pc-sdk a:hover{color:#3860be}#onetrust-pc-sdk label{margin-bottom:0}#onetrust-pc-sdk #vdr-lst-dsc{font-size:.812em;line-height:1.5;padding:10px 15px 5px 15px}#onetrust-pc-sdk button{max-width:394px;padding:12px 30px;line-height:1;word-break:break-word;word-wrap:break-word;white-space:normal;font-weight:bold;height:auto}#onetrust-pc-sdk .ot-link-btn{padding:0;margin-bottom:0;border:0;font-weight:normal;line-height:normal;width:auto;height:auto}#onetrust-pc-sdk #ot-pc-content{position:absolute;overflow-y:scroll;padding-left:2px;padding-right:30px;top:60px;bottom:110px;margin:1px 3px 0 30px;width:calc(100% - 63px)}#onetrust-pc-sdk .ot-vs-list .ot-always-active,#onetrust-pc-sdk .ot-cat-grp .ot-always-active{float:right;clear:none;color:#3860be;margin:0;font-size:.813em;line-height:1.3}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-track{margin-right:20px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar{width:11px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-thumb{border-radius:10px;background:#d8d8d8}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-pc-scrollbar{scrollbar-arrow-color:#d8d8d8;scrollbar-darkshadow-color:#d8d8d8;scrollbar-face-color:#d8d8d8;scrollbar-shadow-color:#d8d8d8}#onetrust-pc-sdk .save-preference-btn-handler{margin-right:20px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-right:10px}#onetrust-pc-sdk #ot-pc-desc .privacy-notice-link{margin-left:0;margin-right:8px}#onetrust-pc-sdk #ot-pc-desc .ot-imprint-handler{margin-left:0;margin-right:8px}#onetrust-pc-sdk .ot-subgrp-cntr{display:inline-block;clear:both;width:100%;padding-top:15px}#onetrust-pc-sdk .ot-switch+.ot-subgrp-cntr{padding-top:10px}#onetrust-pc-sdk ul.ot-subgrps{margin:0;font-size:initial}#onetrust-pc-sdk ul.ot-subgrps li p,#onetrust-pc-sdk ul.ot-subgrps li h5{font-size:.813em;line-height:1.4;color:dimgray}#onetrust-pc-sdk ul.ot-subgrps .ot-switch{min-height:auto}#onetrust-pc-sdk ul.ot-subgrps .ot-switch-nob{top:0}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr{display:inline-block;width:100%}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-txt{margin:0}#onetrust-pc-sdk ul.ot-subgrps li{padding:0;border:none}#onetrust-pc-sdk ul.ot-subgrps li h5{position:relative;top:5px;font-weight:bold;margin-bottom:0;float:left}#onetrust-pc-sdk li.ot-subgrp{margin-left:20px;overflow:auto}#onetrust-pc-sdk li.ot-subgrp>h5{width:calc(100% - 100px)}#onetrust-pc-sdk .ot-cat-item p>ul,#onetrust-pc-sdk li.ot-subgrp p>ul{margin:0px;list-style:disc;margin-left:15px;font-size:inherit}#onetrust-pc-sdk .ot-cat-item p>ul li,#onetrust-pc-sdk li.ot-subgrp p>ul li{font-size:inherit;padding-top:10px;padding-left:0px;padding-right:0px;border:none}#onetrust-pc-sdk .ot-cat-item p>ul li:last-child,#onetrust-pc-sdk li.ot-subgrp p>ul li:last-child{padding-bottom:10px}#onetrust-pc-sdk .ot-pc-logo{height:40px;width:120px}#onetrust-pc-sdk .ot-pc-footer{position:absolute;bottom:0px;width:100%;max-height:160px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-refuse-all-handler{margin-bottom:0px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:160px}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-footer button{width:100%;max-width:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:0 30px;width:calc(100% - 60px);padding-right:0}#onetrust-pc-sdk .ot-pc-footer-logo{height:30px;width:100%;text-align:right;background:#f4f4f4}#onetrust-pc-sdk .ot-pc-footer-logo a{display:inline-block;margin-top:5px;margin-right:10px}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo{direction:rtl}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo a{margin-right:25px}#onetrust-pc-sdk .ot-tgl{float:right;position:relative;z-index:1}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background-color:#468254;border:1px solid #fff}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{-webkit-transform:translateX(20px);-ms-transform:translateX(20px);transform:translateX(20px);background-color:#fff;border-color:#fff}#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch{outline:#000 solid 1px}#onetrust-pc-sdk .ot-switch{position:relative;display:inline-block;width:45px;height:25px}#onetrust-pc-sdk .ot-switch-nob{position:absolute;cursor:pointer;top:0;left:0;right:0;bottom:0;background-color:#767676;border:1px solid #ddd;transition:all .2s ease-in 0s;-moz-transition:all .2s ease-in 0s;-o-transition:all .2s ease-in 0s;-webkit-transition:all .2s ease-in 0s;border-radius:20px}#onetrust-pc-sdk .ot-switch-nob:before{position:absolute;content:"";height:18px;width:18px;bottom:3px;left:3px;background-color:#fff;-webkit-transition:.4s;transition:.4s;border-radius:20px}#onetrust-pc-sdk .ot-chkbox input:checked~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox label{position:relative;display:inline-block;padding-left:30px;cursor:pointer;font-weight:500}#onetrust-pc-sdk .ot-chkbox label::before,#onetrust-pc-sdk .ot-chkbox label::after{position:absolute;content:"";display:inline-block;border-radius:3px}#onetrust-pc-sdk .ot-chkbox label::before{height:18px;width:18px;border:1px solid #3860be;left:0px;top:auto}#onetrust-pc-sdk .ot-chkbox label::after{height:5px;width:9px;border-left:3px solid;border-bottom:3px solid;transform:rotate(-45deg);-o-transform:rotate(-45deg);-ms-transform:rotate(-45deg);-webkit-transform:rotate(-45deg);left:4px;top:5px}#onetrust-pc-sdk .ot-label-txt{display:none}#onetrust-pc-sdk .ot-chkbox input,#onetrust-pc-sdk .ot-tgl input{position:absolute;opacity:0;width:0;height:0}#onetrust-pc-sdk .ot-arw-cntr{float:right;position:relative;pointer-events:none}#onetrust-pc-sdk .ot-arw-cntr .ot-arw{width:16px;height:16px;margin-left:5px;color:dimgray;display:inline-block;vertical-align:middle;-webkit-transition:all 150ms ease-in 0s;-moz-transition:all 150ms ease-in 0s;-o-transition:all 150ms ease-in 0s;transition:all 150ms ease-in 0s}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw-cntr svg{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-tgl-cntr,#onetrust-pc-sdk .ot-arw-cntr{display:inline-block}#onetrust-pc-sdk .ot-tgl-cntr{width:45px;float:right;margin-top:2px}#onetrust-pc-sdk #ot-lst-cnt .ot-tgl-cntr{margin-top:10px}#onetrust-pc-sdk .ot-always-active-subgroup{width:auto;padding-left:0px !important;top:3px;position:relative}#onetrust-pc-sdk .ot-label-status{font-size:.75em;display:none;font-size:.75em;position:relative;top:2px;padding-right:5px;float:left}#onetrust-pc-sdk .ot-arw-cntr{margin-top:-1px}#onetrust-pc-sdk .ot-arw-cntr svg{-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s;transition:all 300ms ease-in 0s;height:10px;width:10px}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk .ot-arw{width:10px;margin-left:15px;transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0}#onetrust-pc-sdk .ot-hlst-cntr{margin-top:5px;display:inline-block;width:100%}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{clear:both;color:#3860be;margin-left:0;font-size:.813em;text-decoration:none;float:left;overflow:hidden}#onetrust-pc-sdk .category-vendors-list-handler:hover,#onetrust-pc-sdk .category-vendors-list-handler+a:hover,#onetrust-pc-sdk .category-host-list-handler:hover{text-decoration-line:underline}#onetrust-pc-sdk .category-vendors-list-handler+a{clear:none}#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{display:inline-block;height:13px;width:13px;background-repeat:no-repeat;margin-left:1px;margin-top:6px;cursor:pointer}#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{margin-bottom:-1px}#onetrust-pc-sdk .back-btn-handler{font-size:1em;text-decoration:none}#onetrust-pc-sdk .back-btn-handler:hover{opacity:.6}#onetrust-pc-sdk #ot-lst-title h3{display:inline-block;word-break:break-word;word-wrap:break-word;margin-bottom:0;color:#656565;font-size:1em;font-weight:bold;margin-left:15px}#onetrust-pc-sdk #ot-lst-title{margin:10px 0 10px 0px;font-size:1em;text-align:left}#onetrust-pc-sdk #ot-pc-hdr{margin:0 0 0 30px;height:auto;width:auto}#onetrust-pc-sdk #ot-pc-hdr input::placeholder{color:#707070;font-style:italic}#onetrust-pc-sdk #vendor-search-handler{height:31px;width:100%;border-radius:50px;font-size:.8em;padding-right:35px;padding-left:15px;float:left;margin-left:15px}#onetrust-pc-sdk .ot-ven-name{display:block;width:auto;padding-right:5px}#onetrust-pc-sdk #ot-lst-cnt{overflow-y:auto;margin-left:20px;margin-right:7px;width:calc(100% - 27px);max-height:calc(100% - 80px);height:100%;transform:translate3d(0, 0, 0)}#onetrust-pc-sdk #ot-pc-lst{width:100%;bottom:100px;position:absolute;top:60px}#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr *{visibility:hidden}#onetrust-pc-sdk #ot-pc-lst .ot-tgl-cntr{right:12px;position:absolute}#onetrust-pc-sdk #ot-pc-lst .ot-arw-cntr{float:right;position:relative}#onetrust-pc-sdk #ot-pc-lst .ot-arw{margin-left:10px}#onetrust-pc-sdk #ot-pc-lst .ot-acc-hdr{overflow:hidden;cursor:pointer}#onetrust-pc-sdk .ot-vlst-cntr{overflow:hidden}#onetrust-pc-sdk #ot-sel-blk{overflow:hidden;width:100%;position:sticky;position:-webkit-sticky;top:0;z-index:3}#onetrust-pc-sdk #ot-back-arw{height:12px;width:12px}#onetrust-pc-sdk .ot-lst-subhdr{width:100%;display:inline-block}#onetrust-pc-sdk .ot-search-cntr{float:left;width:78%;position:relative}#onetrust-pc-sdk .ot-search-cntr>svg{width:30px;height:30px;position:absolute;float:left;right:-15px}#onetrust-pc-sdk .ot-fltr-cntr{float:right;right:50px;position:relative}#onetrust-pc-sdk #filter-btn-handler{background-color:#3860be;border-radius:17px;display:inline-block;position:relative;width:32px;height:32px;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease;padding:0;margin:0}#onetrust-pc-sdk #filter-btn-handler:hover{background-color:#3860be}#onetrust-pc-sdk #filter-btn-handler svg{width:12px;height:12px;margin:3px 10px 0 10px;display:block;position:static;right:auto;top:auto}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{color:#3860be;text-decoration:none;font-weight:100;display:inline-block;padding-top:10px;transform:translate(0, 1%);-o-transform:translate(0, 1%);-ms-transform:translate(0, 1%);-webkit-transform:translate(0, 1%);position:relative;z-index:2}#onetrust-pc-sdk .ot-ven-link *,#onetrust-pc-sdk .ot-ven-legclaim-link *{font-size:inherit}#onetrust-pc-sdk .ot-ven-link:hover,#onetrust-pc-sdk .ot-ven-legclaim-link:hover{text-decoration:underline}#onetrust-pc-sdk .ot-ven-hdr{width:calc(100% - 160px);height:auto;float:left;word-break:break-word;word-wrap:break-word;vertical-align:middle;padding-bottom:3px}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{letter-spacing:.03em;font-size:.75em;font-weight:400}#onetrust-pc-sdk .ot-ven-dets{border-radius:2px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-ven-dets li:first-child p:first-child{border-top:none}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:not(:first-child){border-top:1px solid #ddd !important}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(odd){width:30%}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(even){width:50%;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p,#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{padding-top:5px;padding-bottom:5px;display:block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-last-child(-n+1){padding-bottom:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-child(-n+2):not(.disc-pur){padding-top:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur-cont{display:inline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur{position:relative;width:50% !important;word-break:break-word;word-wrap:break-word;left:calc(30% + 17px)}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur:nth-child(-n+1){position:static}#onetrust-pc-sdk .ot-ven-dets p,#onetrust-pc-sdk .ot-ven-dets h5,#onetrust-pc-sdk .ot-ven-dets span{font-size:.69em;text-align:left;vertical-align:middle;word-break:break-word;word-wrap:break-word;margin:0;padding-bottom:10px;padding-left:15px;color:#2e3644}#onetrust-pc-sdk .ot-ven-dets h5{padding-top:5px}#onetrust-pc-sdk .ot-ven-dets span{color:dimgray;padding:0;vertical-align:baseline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-pur h5{border-top:1px solid #e9e9e9;border-bottom:1px solid #e9e9e9;padding-bottom:5px;margin-bottom:5px;font-weight:bold}#onetrust-pc-sdk #ot-host-lst .ot-sel-all{float:right;position:relative;margin-right:42px;top:10px}#onetrust-pc-sdk #ot-host-lst .ot-sel-all input[type=checkbox]{width:auto;height:auto}#onetrust-pc-sdk #ot-host-lst .ot-sel-all label{height:20px;width:20px;padding-left:0px}#onetrust-pc-sdk #ot-host-lst .ot-acc-txt{overflow:hidden;width:95%}#onetrust-pc-sdk .ot-host-hdr{position:relative;z-index:1;pointer-events:none;width:calc(100% - 125px);float:left}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-desc{display:inline-block;width:90%}#onetrust-pc-sdk .ot-host-name{pointer-events:none}#onetrust-pc-sdk .ot-host-hdr>a{text-decoration:underline;font-size:.82em;position:relative;z-index:2;float:left;margin-bottom:5px;pointer-events:initial}#onetrust-pc-sdk .ot-host-name+a{margin-top:5px}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a,#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{color:dimgray;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a{font-weight:bold;font-size:.82em;line-height:1.3}#onetrust-pc-sdk .ot-host-name a{font-size:1em}#onetrust-pc-sdk .ot-host-expand{margin-top:3px;margin-bottom:3px;clear:both;display:block;color:#3860be;font-size:.72em;font-weight:normal}#onetrust-pc-sdk .ot-host-expand *{font-size:inherit}#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{font-size:.688em;line-height:1.4;font-weight:normal}#onetrust-pc-sdk .ot-host-desc{margin-top:10px}#onetrust-pc-sdk .ot-host-opt{margin:0;font-size:inherit;display:inline-block;width:100%}#onetrust-pc-sdk .ot-host-opt li>div div{font-size:.8em;padding:5px 0}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(1){width:30%;float:left}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(2){width:70%;float:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-info{border:none;display:inline-block;width:calc(100% - 10px);padding:10px;margin-bottom:10px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-host-info>div{overflow:auto}#onetrust-pc-sdk #no-results{text-align:center;margin-top:30px}#onetrust-pc-sdk #no-results p{font-size:1em;color:#2e3644;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #no-results p span{font-weight:bold}#onetrust-pc-sdk #ot-fltr-modal{width:100%;height:auto;display:none;-moz-transition:.2s ease;-o-transition:.2s ease;-webkit-transition:2s ease;transition:.2s ease;overflow:hidden;opacity:1;right:0}#onetrust-pc-sdk #ot-fltr-modal .ot-label-txt{display:inline-block;font-size:.85em;color:dimgray}#onetrust-pc-sdk #ot-fltr-cnt{z-index:2147483646;background-color:#fff;position:absolute;height:90%;max-height:300px;width:325px;left:210px;margin-top:10px;margin-bottom:20px;padding-right:10px;border-radius:3px;-webkit-box-shadow:0px 0px 12px 2px #c7c5c7;-moz-box-shadow:0px 0px 12px 2px #c7c5c7;box-shadow:0px 0px 12px 2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-scrlcnt{overflow-y:auto;overflow-x:hidden;clear:both;max-height:calc(100% - 60px)}#onetrust-pc-sdk #ot-anchor{border:12px solid rgba(0,0,0,0);display:none;position:absolute;z-index:2147483647;right:55px;top:75px;transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);-webkit-transform:rotate(45deg);background-color:#fff;-webkit-box-shadow:-3px -3px 5px -2px #c7c5c7;-moz-box-shadow:-3px -3px 5px -2px #c7c5c7;box-shadow:-3px -3px 5px -2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-btns{margin-left:15px}#onetrust-pc-sdk #filter-apply-handler{margin-right:15px}#onetrust-pc-sdk .ot-fltr-opt{margin-bottom:5px;margin-left:15px;min-height:20px;width:75%;position:relative}#onetrust-pc-sdk .ot-fltr-opt p{display:inline-block;margin:0;font-size:.9em;color:#2e3644}#onetrust-pc-sdk .ot-chkbox label span{font-size:.85em;color:dimgray}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox][aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk #ot-selall-vencntr,#onetrust-pc-sdk #ot-selall-adtlvencntr,#onetrust-pc-sdk #ot-selall-hostcntr,#onetrust-pc-sdk #ot-selall-licntr,#onetrust-pc-sdk #ot-selall-gnvencntr{right:15px;position:relative;width:20px;height:20px;float:right}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label,#onetrust-pc-sdk #ot-selall-gnvencntr label{float:left;padding-left:0}#onetrust-pc-sdk #ot-ven-lst:first-child{border-top:1px solid #e2e2e2}#onetrust-pc-sdk ul{list-style:none;padding:0}#onetrust-pc-sdk ul li{position:relative;margin:0;padding:15px 15px 15px 10px;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk ul li h3,#onetrust-pc-sdk ul li h4{font-size:.75em;color:#656565;margin:0;display:inline-block;width:70%;height:auto;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk ul li p{margin:0;font-size:.7em}#onetrust-pc-sdk ul li input[type=checkbox]{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0}#onetrust-pc-sdk .ot-cat-item>button:focus,#onetrust-pc-sdk .ot-acc-cntr>button:focus,#onetrust-pc-sdk li>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-cat-item>button,#onetrust-pc-sdk .ot-acc-cntr>button,#onetrust-pc-sdk li>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-host-item>button:focus,#onetrust-pc-sdk .ot-ven-item>button:focus{outline:0;border:2px solid #000}#onetrust-pc-sdk .ot-hide-acc>button{pointer-events:none}#onetrust-pc-sdk .ot-hide-acc .ot-plus-minus>*,#onetrust-pc-sdk .ot-hide-acc .ot-arw-cntr>*{visibility:hidden}#onetrust-pc-sdk .ot-hide-acc .ot-acc-hdr{min-height:30px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt){padding-right:10px;width:calc(100% - 37px);margin-top:10px;max-height:calc(100% - 90px)}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk{background-color:#f9f9fc;border:1px solid #e2e2e2;width:calc(100% - 2px);padding-bottom:5px;padding-top:5px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt{border:unset;background-color:unset}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all-hdr{display:none}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all{padding-right:.5rem}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all .ot-chkbox{right:0}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all{padding-right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all-chkbox{width:auto}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) ul li{border:1px solid #e2e2e2;margin-bottom:10px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-acc-cntr>.ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk.ot-addtl-vendors .ot-sel-all-chkbox{float:right}#onetrust-pc-sdk.ot-addtl-vendors .ot-plus-minus~.ot-sel-all-chkbox{right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-ven-lst:first-child{border-top:none}#onetrust-pc-sdk .ot-acc-cntr{position:relative;border-left:1px solid #e2e2e2;border-right:1px solid #e2e2e2;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr input{z-index:1}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr{background-color:#f9f9fc;padding:5px 0 5px 15px;width:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-plus-minus{vertical-align:middle;top:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-arw-cntr{right:10px}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr input{z-index:2}#onetrust-pc-sdk .ot-acc-cntr.ot-add-tech .ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk .ot-acc-cntr>input[type=checkbox]:checked~.ot-acc-hdr{border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-txt{padding-left:10px;padding-right:10px}#onetrust-pc-sdk .ot-acc-cntr button[aria-expanded=true]~.ot-acc-txt{width:auto}#onetrust-pc-sdk .ot-acc-cntr .ot-addtl-venbox{display:none}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0;width:100%}#onetrust-pc-sdk .ot-vensec-title{font-size:.813em;vertical-align:middle;display:inline-block}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a{margin-left:0;margin-top:10px}#onetrust-pc-sdk #ot-selall-vencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-adtlvencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-licntr.line-through label::after,#onetrust-pc-sdk #ot-selall-hostcntr.line-through label::after,#onetrust-pc-sdk #ot-selall-gnvencntr.line-through label::after{height:auto;border-left:0;transform:none;-o-transform:none;-ms-transform:none;-webkit-transform:none;left:5px;top:9px}#onetrust-pc-sdk #ot-category-title{float:left;padding-bottom:10px;font-size:1em;width:100%}#onetrust-pc-sdk .ot-cat-grp{margin-top:10px}#onetrust-pc-sdk .ot-cat-item{line-height:1.1;margin-top:10px;display:inline-block;width:100%}#onetrust-pc-sdk .ot-btn-container{text-align:right}#onetrust-pc-sdk .ot-btn-container button{display:inline-block;font-size:.75em;letter-spacing:.08em;margin-top:19px}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon{position:absolute;top:10px;right:0;z-index:1;padding:0;background-color:rgba(0,0,0,0);border:none}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon svg{display:block;height:10px;width:10px}#onetrust-pc-sdk #clear-filters-handler{margin-top:20px;margin-bottom:10px;float:right;max-width:200px;text-decoration:none;color:#3860be;font-size:.9em;font-weight:bold;background-color:rgba(0,0,0,0);border-color:rgba(0,0,0,0);padding:1px}#onetrust-pc-sdk #clear-filters-handler:hover{color:#2285f7}#onetrust-pc-sdk #clear-filters-handler:focus{outline:#000 solid 1px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl,#onetrust-pc-sdk .ot-enbl-chr h4~.ot-always-active{right:45px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl+.ot-tgl{right:120px}#onetrust-pc-sdk .ot-enbl-chr .ot-pli-hdr.ot-leg-border-color span:first-child{width:90px}#onetrust-pc-sdk .ot-enbl-chr li.ot-subgrp>h5+.ot-tgl-cntr{padding-right:25px}#onetrust-pc-sdk .ot-plus-minus{width:20px;height:20px;font-size:1.5em;position:relative;display:inline-block;margin-right:5px;top:3px}#onetrust-pc-sdk .ot-plus-minus span{position:absolute;background:#27455c;border-radius:1px}#onetrust-pc-sdk .ot-plus-minus span:first-of-type{top:25%;bottom:25%;width:10%;left:45%}#onetrust-pc-sdk .ot-plus-minus span:last-of-type{left:25%;right:25%;height:10%;top:45%}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:first-of-type,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{transform:rotate(90deg)}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{left:50%;right:50%}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk .ot-host-item .ot-plus-minus,#onetrust-pc-sdk .ot-ven-item .ot-plus-minus{float:left;margin-right:8px;top:10px}#onetrust-pc-sdk .ot-ven-item ul{list-style:none inside;font-size:100%;margin:0}#onetrust-pc-sdk .ot-ven-item ul li{margin:0 !important;padding:0;border:none !important}#onetrust-pc-sdk .ot-pli-hdr{color:#77808e;overflow:hidden;padding-top:7.5px;padding-bottom:7.5px;width:calc(100% - 2px);border-top-left-radius:3px;border-top-right-radius:3px}#onetrust-pc-sdk .ot-pli-hdr span:first-child{top:50%;transform:translateY(50%);max-width:90px}#onetrust-pc-sdk .ot-pli-hdr span:last-child{padding-right:10px;max-width:95px;text-align:center}#onetrust-pc-sdk .ot-li-title{float:right;font-size:.813em}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color{background-color:#f4f4f4;border:1px solid #d8d8d8}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color span:first-child{text-align:left;width:70px}#onetrust-pc-sdk li.ot-subgrp>h5,#onetrust-pc-sdk .ot-cat-header{width:calc(100% - 130px)}#onetrust-pc-sdk li.ot-subgrp>h5+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-acc-grpdesc{margin-bottom:5px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-acc-grpcntr .ot-vlst-cntr+.ot-subgrp-cntr{border-top:none}#onetrust-pc-sdk .ot-acc-hdr .ot-arw-cntr+.ot-tgl-cntr,#onetrust-pc-sdk .ot-acc-txt h4+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-subgrp>h5,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header{width:calc(100% - 145px)}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item h5+.ot-tgl-cntr,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header+.ot-tgl{padding-left:28px}#onetrust-pc-sdk .ot-sel-all-hdr,#onetrust-pc-sdk .ot-sel-all-chkbox{display:inline-block;width:100%;position:relative}#onetrust-pc-sdk .ot-sel-all-chkbox{z-index:1}#onetrust-pc-sdk .ot-sel-all{margin:0;position:relative;padding-right:23px;float:right}#onetrust-pc-sdk .ot-consent-hdr,#onetrust-pc-sdk .ot-li-hdr{float:right;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-li-hdr{max-width:100px;padding-right:10px}#onetrust-pc-sdk .ot-consent-hdr{max-width:55px}#onetrust-pc-sdk #ot-selall-licntr{display:block;width:21px;height:auto;float:right;position:relative;right:80px}#onetrust-pc-sdk #ot-selall-licntr label{position:absolute}#onetrust-pc-sdk .ot-ven-ctgl{margin-left:66px}#onetrust-pc-sdk .ot-ven-litgl+.ot-arw-cntr{margin-left:81px}#onetrust-pc-sdk .ot-enbl-chr .ot-host-cnt .ot-tgl-cntr{width:auto}#onetrust-pc-sdk #ot-lst-cnt:not(.ot-host-cnt) .ot-tgl-cntr{width:auto;top:auto;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox label{position:absolute;padding:0;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-acc-grpdesc+.ot-leg-btn-container{padding-left:20px;padding-right:20px;width:calc(100% - 40px);margin-bottom:5px}#onetrust-pc-sdk .ot-subgrp .ot-leg-btn-container{margin-bottom:5px}#onetrust-pc-sdk #ot-ven-lst .ot-leg-btn-container{margin-top:10px}#onetrust-pc-sdk .ot-leg-btn-container{display:inline-block;width:100%;margin-bottom:10px}#onetrust-pc-sdk .ot-leg-btn-container button{height:auto;padding:6.5px 8px;margin-bottom:0;letter-spacing:0;font-size:.75em;line-height:normal}#onetrust-pc-sdk .ot-leg-btn-container svg{display:none;height:14px;width:14px;padding-right:5px;vertical-align:sub}#onetrust-pc-sdk .ot-active-leg-btn{cursor:default;pointer-events:none}#onetrust-pc-sdk .ot-active-leg-btn svg{display:inline-block}#onetrust-pc-sdk .ot-remove-objection-handler{text-decoration:underline;padding:0;font-size:.75em;font-weight:600;line-height:1;padding-left:10px}#onetrust-pc-sdk .ot-obj-leg-btn-handler span{font-weight:bold;text-align:center;font-size:inherit;line-height:1.5}#onetrust-pc-sdk.ot-close-btn-link #close-pc-btn-handler{border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em;background:none;right:15px;top:15px;width:auto;font-weight:normal}#onetrust-pc-sdk .ot-pgph-link{font-size:.813em !important;margin-top:5px;position:relative}#onetrust-pc-sdk .ot-pgph-link.ot-pgph-link-subgroup{margin-bottom:1rem}#onetrust-pc-sdk .ot-pgph-contr{margin:0 2.5rem}#onetrust-pc-sdk .ot-pgph-title{font-size:1.18rem;margin-bottom:2rem}#onetrust-pc-sdk .ot-pgph-desc{font-size:1rem;font-weight:400;margin-bottom:2rem;line-height:1.5rem}#onetrust-pc-sdk .ot-pgph-desc:not(:last-child):after{content:"";width:96%;display:block;margin:0 auto;padding-bottom:2rem;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk .ot-cat-header{float:left;font-weight:600;font-size:.875em;line-height:1.5;max-width:90%;vertical-align:middle}#onetrust-pc-sdk .ot-vnd-item>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-vnd-item>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{position:relative;border-radius:2px;margin:0;padding:0;border:1px solid #d8d8d8;border-top:none;width:calc(100% - 2px);float:left}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{margin-top:10px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc{padding-left:20px;padding-right:20px;width:calc(100% - 40px);font-size:.812em;margin-bottom:10px;margin-top:15px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul{padding-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul li{padding-top:0;line-height:1.5;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout div+.ot-acc-grpdesc{margin-top:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:first-child{margin-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:last-child,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr:last-child{margin-bottom:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding-top:11.5px;padding-bottom:11.5px;padding-left:20px;padding-right:20px;width:calc(100% - 40px);display:inline-block}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-txt{width:100%;padding:0}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp-cntr{padding-left:20px;padding-right:15px;padding-bottom:0;width:calc(100% - 35px)}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp{padding-right:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpcntr{z-index:1;position:relative}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr{position:absolute;top:50%;transform:translateY(-50%);right:20px;margin-top:-2px}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr .ot-arw{width:15px;height:20px;margin-left:5px;color:dimgray}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{float:none;color:#2e3644;margin:0;display:inline-block;height:auto;word-wrap:break-word;min-height:inherit}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding-left:20px;width:calc(100% - 20px);display:inline-block;margin-top:0;padding-bottom:2px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{position:relative;min-height:25px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl,#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{position:absolute;top:50%;transform:translateY(-50%);right:20px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl+.ot-tgl{right:95px}#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler,#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler+a{margin-top:5px}#onetrust-pc-sdk #ot-lst-cnt{margin-top:1rem;max-height:calc(100% - 96px)}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list,#onetrust-pc-sdk .ot-vnd-serv{width:auto;padding:1rem 1.25rem;padding-bottom:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:600;font-size:.95em;line-height:2;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item{border:none;margin:0;padding:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button{outline:none;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button[aria-expanded=true],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button[aria-expanded=true]{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:first-child{margin-top:.25rem;border-top:unset}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child{margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child button{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 1.75rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-lbl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-cnt,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt{padding-left:40px}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-size:.8em}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-cat-header{font-size:.8em}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv{margin-bottom:1rem;padding:1rem .95rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:700;font-size:.8em;line-height:20px;margin-left:.82rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-cat-header{font-weight:700;font-size:.8em;line-height:20px}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-vnd-serv .ot-vnd-lst-cont .ot-accordion-layout .ot-acc-hdr div.ot-chkbox{margin-left:.82rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr{padding:.7rem 0;margin:0;display:flex;width:100%;align-items:center;justify-content:space-between}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:first-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:first-child{margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:last-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:last-child{margin-right:.5rem;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-always-active{position:relative;right:unset;top:unset;transform:unset}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-plus-minus{top:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-arw-cntr{float:none;top:unset;right:unset;transform:unset;margin-top:-2px;position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-cat-header{flex:1;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-tgl{position:relative;transform:none;right:0;top:0;float:none}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox{position:relative;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label{padding:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label::before{position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox input{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0;z-index:1}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h5.ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h4.ot-cat-header{margin:0}#onetrust-pc-sdk .ot-vs-config .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp h5{top:0;line-height:20px}#onetrust-pc-sdk .ot-vs-list{display:flex;flex-direction:column;padding:0;margin:.5rem 4px}#onetrust-pc-sdk .ot-vs-selc-all{display:flex;padding:0;float:unset;align-items:center;justify-content:flex-start}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf{justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf.ot-caret-conf .ot-sel-all-chkbox{margin-right:48px}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf .ot-sel-all-chkbox{margin:0;padding:0;margin-right:14px;justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-chkbox,#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-tgl{display:inline-block;right:unset;width:auto;height:auto;float:none}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr label{width:45px;height:25px}#onetrust-pc-sdk .ot-vs-selc-all .ot-sel-all-chkbox{margin-right:11px;margin-left:.75rem;display:flex;align-items:center}#onetrust-pc-sdk .ot-vs-selc-all .sel-all-hdr{margin:0 1.25rem;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-vnd-list-cnt #ot-selall-vencntr.ot-chkbox{float:unset;right:0}#onetrust-pc-sdk[dir=rtl] #ot-back-arw,#onetrust-pc-sdk[dir=rtl] input~.ot-acc-hdr .ot-arw{transform:rotate(180deg);-o-transform:rotate(180deg);-ms-transform:rotate(180deg);-webkit-transform:rotate(180deg)}#onetrust-pc-sdk[dir=rtl] input:checked~.ot-acc-hdr .ot-arw{transform:rotate(270deg);-o-transform:rotate(270deg);-ms-transform:rotate(270deg);-webkit-transform:rotate(270deg)}#onetrust-pc-sdk[dir=rtl] .ot-chkbox label::after{transform:rotate(45deg);-webkit-transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);border-left:0;border-right:3px solid}#onetrust-pc-sdk[dir=rtl] .ot-search-cntr>svg{right:0}@media only screen and (max-width: 600px){#onetrust-pc-sdk.otPcCenter{left:0;min-width:100%;height:100%;top:0;border-radius:0}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:1px 3px 0 10px;padding-right:10px;width:calc(100% - 23px)}#onetrust-pc-sdk .ot-btn-container button{max-width:none;letter-spacing:.01em}#onetrust-pc-sdk #close-pc-btn-handler{top:10px;right:17px}#onetrust-pc-sdk p{font-size:.7em}#onetrust-pc-sdk #ot-pc-hdr{margin:10px 10px 0 5px;width:calc(100% - 15px)}#onetrust-pc-sdk .vendor-search-handler{font-size:1em}#onetrust-pc-sdk #ot-back-arw{margin-left:12px}#onetrust-pc-sdk #ot-lst-cnt{margin:0;padding:0 5px 0 10px;min-width:95%}#onetrust-pc-sdk .switch+p{max-width:80%}#onetrust-pc-sdk .ot-ftr-stacked button{width:100%}#onetrust-pc-sdk #ot-fltr-cnt{max-width:320px;width:90%;border-top-right-radius:0;border-bottom-right-radius:0;margin:0;margin-left:15px;left:auto;right:40px;top:85px}#onetrust-pc-sdk .ot-fltr-opt{margin-left:25px;margin-bottom:10px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-bottom:0}#onetrust-pc-sdk #ot-fltr-cnt{right:40px}}@media only screen and (max-width: 476px){#onetrust-pc-sdk .ot-fltr-cntr,#onetrust-pc-sdk #ot-fltr-cnt{right:10px}#onetrust-pc-sdk #ot-anchor{right:25px}#onetrust-pc-sdk button{width:100%}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-sel-all{padding-right:9px}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr{right:0}}@media(min-width: 768px){#onetrust-pc-sdk.ot-tgl-with-label .ot-label-status{display:inline}#onetrust-pc-sdk.ot-tgl-with-label #ot-pc-lst .ot-label-status{display:none}}@media only screen and (max-width: 896px)and (max-height: 425px)and (orientation: landscape){#onetrust-pc-sdk.otPcCenter{left:0;top:0;min-width:100%;height:100%;border-radius:0}#onetrust-pc-sdk .ot-pc-header{height:auto;min-height:20px}#onetrust-pc-sdk .ot-pc-header .ot-pc-logo{max-height:30px}#onetrust-pc-sdk .ot-pc-footer{max-height:60px;overflow-y:auto}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk #ot-pc-lst{bottom:70px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:70px}#onetrust-pc-sdk #ot-anchor{left:initial;right:50px}#onetrust-pc-sdk #ot-lst-title{margin-top:12px}#onetrust-pc-sdk #ot-lst-title *{font-size:inherit}#onetrust-pc-sdk #ot-pc-hdr input{margin-right:0;padding-right:45px}#onetrust-pc-sdk .switch+p{max-width:85%}#onetrust-pc-sdk #ot-sel-blk{position:static}#onetrust-pc-sdk #ot-pc-lst{overflow:auto}#onetrust-pc-sdk #ot-lst-cnt{max-height:none;overflow:initial}#onetrust-pc-sdk #ot-lst-cnt.no-results{height:auto}#onetrust-pc-sdk input{font-size:1em !important}#onetrust-pc-sdk p{font-size:.6em}#onetrust-pc-sdk #ot-fltr-modal{width:100%;top:0}#onetrust-pc-sdk ul li p,#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{font-size:.6em}#onetrust-pc-sdk.ot-shw-fltr #ot-anchor{display:none !important}#onetrust-pc-sdk.ot-shw-fltr #ot-pc-lst{height:100% !important;overflow:hidden;top:0px}#onetrust-pc-sdk.ot-shw-fltr #ot-fltr-cnt{margin:0;height:100%;max-height:none;padding:10px;top:0;width:calc(100% - 20px);position:absolute;right:0;left:0;max-width:none}#onetrust-pc-sdk.ot-shw-fltr .ot-fltr-scrlcnt{max-height:calc(100% - 65px)}}
            #onetrust-consent-sdk #onetrust-pc-sdk,
                #onetrust-consent-sdk #ot-search-cntr,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-switch.ot-toggle,
                #onetrust-consent-sdk #onetrust-pc-sdk ot-grp-hdr1 .checkbox,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title:after
                ,#onetrust-consent-sdk #onetrust-pc-sdk #ot-sel-blk,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-cnt,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-anchor {
                    background-color: #FFF;
                }
               
            #onetrust-consent-sdk #onetrust-pc-sdk h3,
                #onetrust-consent-sdk #onetrust-pc-sdk h4,
                #onetrust-consent-sdk #onetrust-pc-sdk h5,
                #onetrust-consent-sdk #onetrust-pc-sdk h6,
                #onetrust-consent-sdk #onetrust-pc-sdk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-ven-lst .ot-ven-opts p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-desc,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-li-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-sel-all-hdr span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-modal #modal-header,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-checkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-sel-blk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-lst-title h3,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .back-btn-handler p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .ot-ven-name,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-ven-lst .consent-category,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-label-status,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-chkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #clear-filters-handler,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-optout-signal
                {
                    color: #2E2E2E;
                }
             #onetrust-consent-sdk #onetrust-pc-sdk .privacy-notice-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-pgph-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler + a,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-host-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-legclaim-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-name a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-acc-hdr .ot-host-expand,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-content #ot-pc-desc .ot-link-btn,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info a
                    {
                        color: #007398;
                    }
            #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler:hover { text-decoration: underline;}
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-subgrp-tgl .ot-switch.ot-toggle
             {
                background-color: #F8F8F8;
            }
             #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-ven-dets
                            {
                                background-color: #F8F8F8;
                            }
        #onetrust-consent-sdk #onetrust-pc-sdk
            button:not(#clear-filters-handler):not(.ot-close-icon):not(#filter-btn-handler):not(.ot-remove-objection-handler):not(.ot-obj-leg-btn-handler):not([aria-expanded]):not(.ot-link-btn),
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-active-leg-btn {
                background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {
                border-color: #007398;
            }
            
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-remove-objection-handler{
                background-color: transparent;
                border: 1px solid transparent;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn {
                background-color: #FFFFFF;
                color: #4D4D4D; border-color: #4D4D4D;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-tgl input:focus + .ot-switch, .ot-switch .ot-switch-nob, .ot-switch .ot-switch-nob:before,
            #onetrust-pc-sdk .ot-checkbox input[type="checkbox"]:focus + label::before,
            #onetrust-pc-sdk .ot-chkbox input[type="checkbox"]:focus + label::before {
                outline-color: #000000;
                outline-width: 1px;
                outline-offset: 1px;
            }
            #onetrust-pc-sdk .ot-host-item > button:focus, #onetrust-pc-sdk .ot-ven-item > button:focus {
                border: 1px solid #000000;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk *:focus,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-vlst-cntr > a:focus {
               outline: 1px solid #000000;
               outline-offset: 1px;
            }#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,  #onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{
                    background-image: url('https://cdn.cookielaw.org/logos/static/ot_external_link.svg');
                }
            /*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
.ot-sdk-cookie-policy{font-family:inherit;font-size:16px}.ot-sdk-cookie-policy.otRelFont{font-size:1rem}.ot-sdk-cookie-policy h3,.ot-sdk-cookie-policy h4,.ot-sdk-cookie-policy h6,.ot-sdk-cookie-policy p,.ot-sdk-cookie-policy li,.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy th,.ot-sdk-cookie-policy #cookie-policy-description,.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}.ot-sdk-cookie-policy h4{font-size:1.2em}.ot-sdk-cookie-policy h6{font-size:1em;margin-top:2em}.ot-sdk-cookie-policy th{min-width:75px}.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy a:hover{background:#fff}.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}.ot-sdk-cookie-policy .ot-mobile-border{display:none}.ot-sdk-cookie-policy section{margin-bottom:2em}.ot-sdk-cookie-policy table{border-collapse:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy{font-family:inherit;font-size:1rem}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup{margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group-desc,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-table-header,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td{font-size:.9em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td a{font-size:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group{font-size:1em;margin-bottom:.6em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-title{margin-bottom:1.2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy>section{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th{min-width:75px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a:hover{background:#fff}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-mobile-border{display:none}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy section{margin-bottom:2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li{list-style:disc;margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li h4{display:inline-block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{border-collapse:inherit;margin:auto;border:1px solid #d7d7d7;border-radius:5px;border-spacing:initial;width:100%;overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border-bottom:1px solid #d7d7d7;border-right:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr th:last-child,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr td:last-child{border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:25%}.ot-sdk-cookie-policy[dir=rtl]{text-align:left}#ot-sdk-cookie-policy h3{font-size:1.5em}@media only screen and (max-width: 530px){.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) table,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tbody,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) th,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{display:block}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead tr{position:absolute;top:-9999px;left:-9999px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{margin:0 0 1em 0}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd),.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd) a{background:#f6f6f4}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td{border:none;border-bottom:1px solid #eee;position:relative;padding-left:50%}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{position:absolute;height:100%;left:6px;width:40%;padding-right:10px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) .ot-mobile-border{display:inline-block;background-color:#e4e4e4;position:absolute;height:100%;top:0;left:45%;width:2px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{content:attr(data-label);font-weight:bold}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border:none;border-bottom:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{display:block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:auto}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{margin:0 0 1em 0}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{height:100%;width:40%;padding-right:10px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{content:attr(data-label);font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead tr{position:absolute;top:-9999px;left:-9999px;z-index:-9999}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:1px solid #d7d7d7;border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td:last-child{border-bottom:0px}}
                
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h5,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group {
                        color: #696969;
                    }
                    
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title {
                            color: #696969;
                        }
                    
            
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th {
                            background-color: #F8F8F8;
                        }
                    
            .ot-floating-button__front{background-image:url('https://cdn.cookielaw.org/logos/static/ot_persistent_cookie_icon.png')}</style><script src="https://static.addtoany.com/menu/modules/core.pt5ow5lr.js" type="module"></script><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><style></style><style>stream {
  position: relative;
  display: block;
}
</style><link href="https://crossmark-cdn.crossref.org/widget/v2.0/style.css" type="text/css" rel="stylesheet"></head>
<body class="pb-ui">
    <div class="skip">
        <a href="#page-body-id" id="skipNavigationLink" title="Skip to Main Content" tabindex="0" class="skipToContent">Skip to Main Content</a>
        <a href="#mega-menu-nav" id="skipToMainMenu" title="Skip to Main Menu" tabindex="0" class="skipToContent">Skip to Main Menu</a>
    </div>



    <div id="pb-page-content" data-ng-non-bindable="">
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="ux3-layout-widget" data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" class="ux3">
        
    

        


    

            

            
                <div class="cell fonts-loaded">
            

            <div data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" data-widget-name="ux3-layout-widget"><div>
    

        


    

            

            

            <div id="a1f1ba25-79af-4194-aaa9-66206104a800" class="widget loginPopup none widget-none widget-compact-all"><div class="wrapped"><div class="widget-body body body-none body-compact-all"><div role="dialog" aria-modal="true" aria-label="Login" class="popup login-popup hidden"><div class="content"><a href="#" aria-label="Close login popup" title="Close login popup" role="button" class="close"><i class="icon-close_thin"></i></a><h2 class="login-title">Login to your account</h2><div class="login-form"><p tabindex="-1" class="message error"></p><form action="/action/doLogin?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900879-5" method="post"><input type="hidden" name="redirectUri" value="https://www.cell.com/cell/fulltext/S0092-8674(21)00879-5"><input type="hidden" name="referer" value="/cell/fulltext/S0092-8674(21)00879-5"><input type="hidden" name="ecommRedirect"><input type="hidden" name="code" value="cell-site"><input type="hidden" name="UX3LoginWidget" value="true"><input type="hidden" name="isPopup" value="true"><div class="input-group login-input--wrapper"><div class="label"><label for="login">Email/Username</label></div><input id="login" type="text" name="login" value="" size="15" class="login"><div role="alert" class="error-hint js--hidden"><div class="error-hint__text"><div class="error-text">Your email address is a required field.</div><div class="email-example">E.g., j.smith@mail.com</div></div></div></div><div class="input-group login-input--wrapper"><div class="label"><label for="password">Password</label></div><input id="password" type="password" name="password" value="" autocomplete="off" class="password"><a href="#" class="login__field__action js-show-password">Show</a><div role="alert" class="error-hint js--hidden"><span class="error-hint__text">Your password is a required field.</span></div><div class="actions"><a href="https://www.cell.com/action/requestResetPassword" class="link show-request-reset-password">Forgot password?</a></div></div><div class="remember"><input type="checkbox" name="savePassword" id="a1f1ba25-79af-4194-aaa9-66206104a800-remember" value="1" checked="checked"><label for="a1f1ba25-79af-4194-aaa9-66206104a800-remember">Remember me</label></div><div class="submit"><input type="submit" name="submit" value="Log in" class="button submit primary"></div></form></div><div class="create-account"><div>Don’t have an account?</div><a href="/action/registration?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900879-5" class="show-registration">Create a Free Account</a></div></div></div></div></div></div>

            

        

    

        


    

            

            

            <div role="dialog" aria-modal="true" aria-label="Reset password" class="popup top-drawer request-reset-password-drawer hidden"><div class="content"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" role="button" class="close"><i class="icon-close_thin"></i></a><div class="request-reset"><div class="form"><p class="sub">If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password</p><div tabindex="-1" class="message error"></div><form action="/action/requestResetPassword" method="post" class="request-reset-password-form"><input type="hidden" name="platform"><input type="hidden" name="requestResetPassword" value="true"><input type="hidden" name="codeSite" value="cell-site"><div class="input-group"><div class="label"><label for="reset-password-email">Email*</label></div><input id="reset-password-email" type="text" name="email" value="" size="15" class="email"></div><div class="submit" disabled="disabled"><input type="submit" name="submit" value="Submit" disabled="disabled" class="button primary submit"></div></form></div><div class="success-template hidden"><p>If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password</p></div></div><div class="request-reset-cancel"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" class="cancel">Cancel</a></div></div></div>

            

        

    

        


    

            

            
                <div class="ux3-ads">
            

            <div class="pb-ad">
            <!-- Do Not Modify without contacting ELS-HSOnlineCampaign@elsevier.com -->
<!-- To be kept in sync with Global Commercial Publishing Operations-->
<!-- Start: GPT Async -->
<div id="gpt-Variables" data-adfile="CELLJOURNAL">
	<input type="hidden" id="gptSite" value="cell">
	<input type="hidden" id="gptLoggedIn" value="no">
	<input type="hidden" id="gptAccessType" value="ae:ANON_GUEST|ae:ANON_GUEST">
	<input type="hidden" id="gptDefaultSite" value="cell">
</div>
<div id="gpt-Interscroller" class="gpt-InScrollBox" style="display:none;">
	<div class="gpt-InScrollLabel">ADVERTISEMENT</div>
	<div class="gpt-InScrollContainer">
		<div class="gpt-InScrollWrapper">
			<div class="gpt-InScrollInner">
				<div class="gpt-adinterscroller" data-adsize="interscroller"></div>
			</div>
		</div>
	</div>
	<div class="gpt-InScrollLabel">SCROLL TO CONTINUE WITH CONTENT</div>
</div>
<div id="gpt-DebugDiv" class="gpt-DebugDiv" style="display:none;">
	<div style="width: 100%; display: table;">
		<div style="display: table-row">
			<div style="width: 200px; display: table-cell;">
				<button class="gpt-DebugBtn" onclick="gpt_ShowConsole()">Open GPT Console</button><br>
				<button id="gpt_GrapeShotDebugBtn" class="gpt-DebugBtn" onclick="gpt_GrapeShotDebug();">Open Oracle Keywords</button><br>
				<br>
				<button class="gpt-DebugBtn" onclick="gpt_LoadDebugValues()">Refresh Values</button>
			</div>
			<div style="display: table-cell;">
				<table class="gpt-DebugTable">
					<thead>
						<tr>
							<th>Property</th>
							<th>Value</th>
						</tr>
					</thead>
					<tbody>
						<tr><td class="gpt-DebugTitle">Status</td><td><div class="gptStatus_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Version</td><td><div class="gptVersion_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad File</td><td><div class="gptAdFile_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Disable Ads Flag</td><td><div class="gptDisableAds_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Environment</td><td><div class="gptTestENV_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Init</td><td><div class="gptMoatInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Ready</td><td><div class="gptMoatReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Ready</td><td><div class="gptContextualReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual URL</td><td><div class="gptContextualURL_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Initial Segments</td><td><div class="gptContextualInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Used Segments</td><td><div class="gptContextualResult_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">AdUnit</td><td><div class="gptSite_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">SubAdUnit</td><td><div class="gptPage_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Custom Targeting</td><td><div class="gptCustomTargeting_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad Events</td><td><div class="gptEvent_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Invalid Ad Sizes</td><td><div class="gptInvalidAdSize_Debug"></div></td></tr>
					</tbody>
				</table>
			</div>
		</div>
	</div>
</div>
<style type="text/css">
	.gpt-DebugBtn {
		display: inline-block;
		text-align: center;
		text-decoration: none;
		margin: 2px 0;
		border: solid 1px #122b40;
		border-radius: 0.4em;
		padding: 0.5em 1em;
		color: #ffffff;
		background-color: #204d74;
		font-weight: normal;
		font-size: 12px;
	}

	.gpt-DebugDiv {
		margin: 5px;
	}

	.gpt-DebugTitle {
		font-weight: bold;
	}

	.gpt-DebugTable {
		border: 1px solid #dddddd;
		border-collapse: collapse;
		margin: 5px;
		font-size: 0.9em;
		font-family: sans-serif;
		min-width: 400px;
		margin-bottom: 25px;
	}

		.gpt-DebugTable td:first-child {
			padding: 5px;
		}

		.gpt-DebugTable thead tr th {
			background-color: #d9edf7;
			color: #ffffff;
			text-align: left;
			padding: 5px;
			border-bottom: 2px solid #204d74;
		}

		.gpt-DebugTable th,
		.gpt-DebugTable td {
			padding: 5px;
		}

		.gpt-DebugTable tbody tr {
			border-bottom: 1px solid #dddddd;
		}

			.gpt-DebugTable tbody tr:nth-of-type(even) {
				background-color: #f3f3f3;
			}

			.gpt-DebugTable tbody tr:last-of-type {
				border-bottom: 2px solid #204d74;
			}

	.gpt-InScrollLabel {
		background-color: rgb(0, 0, 0);
		color: rgb(255, 255, 255);
		position: relative;
		max-width: 100vw;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		padding: 0;
		text-align: center;
		width: 100vw !important;
		font-size: 10px;
	}

	.gpt-InScrollBox {
		height: 100vh !important;
		width: 100vw;
		cursor: pointer;
		max-width: 100vw;
		position: relative;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		margin-bottom: 50px;
		padding-top: 5px;
		padding-bottom: 5px;
		z-index: 10001;
		background-color: white;
	}

		.gpt-InScrollBox .gpt-InScrollContainer {
			height: 95vh !important;
			position: relative;
		}

		.gpt-InScrollBox .gpt-InScrollWrapper {
			position: absolute !important;
			top: 0 !important;
			left: 0;
			width: 100%;
			height: 95vh !important;
			border: 0 !important;
			margin: 0 !important;
			padding: 0 !important;
			clip: rect(0, auto, auto, 0) !important;
			-webkit-clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
			clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
		}

		.gpt-InScrollBox .gpt-InScrollInner {
			position: fixed !important;
			top: 0 !important;
			left: 0 !important;
			bottom: 0;
			margin: auto;
			width: 100vw;
			height: 95vh;
			-webkit-transform: translateZ(0) !important;
			display: -webkit-box;
			display: -ms-flexbox;
			display: flex;
			-webkit-box-orient: vertical;
			-webkit-box-direction: normal;
			-ms-flex-direction: column;
			flex-direction: column;
			-webkit-box-align: center;
			-ms-flex-align: center;
			align-items: center;
			-webkit-box-pack: center;
			-ms-flex-pack: center;
			justify-content: center;
			text-align: center;
		}
</style>
<script class="optanon-category-4" type="text/plain">
	//--------------------------------------------------------------------------
	var gpt_Version = '04072023';
	var gpt_AdFile = $('#gpt-Variables').data('adfile');
	var gpt_MaxMOATInitAttempts = 11;
	var gpt_MaxMOATReadyAttempts = 11;
	var gpt_MaxContextualReadyAttempts = 21;
	var gpt_MOATInitAttempts = 0;
	var gpt_MOATReadyAttempts = 0;
	var gpt_ContextualReadyAttempts = 0;
	var gpt_IsProd = true;
	var gpt_StartTime;
	var gs_channels = 'DEFAULT';
	var gpt_ContextualReady = false;
	var gpt_ContextualURL = 'Not enabled outside of Production';
	var gpt_DisableAdsFlagFound = false;

	var gptEvent_Debug = '';
	var gptCustomTargeting_Debug = '';
	var gptSite_Debug = "";
	var gptPage_Debug = "";
	var gptContextualEnabled = false;
	var gptContextualResult_Debug = '';
	var gptContextualInit_Debug = '';
	var gptContextualURL_Debug = '';
	var gptContextualReady_Debug = '';
	var gptMoatReady_Debug = '';
	var gptMoatInit_Debug = '';
	var gptTestENV_Debug = '';
	var gptDisableAds_Debug = '';
	var gptStatus_Debug = 'GPT Still Loading - Refresh Values';
	var gptInvalidAdSize_Debug = '';
	//--------------------------------------------------------------------------
	$(document).ready(function () {
		//Check to see if we are on a development env
		gpt_CheckEnvironment();

		if (!gpt_DisableAdsFlagFound) {
			gpt_StartTime = new Date();
			if (gpt_AdFile !== "PU") {
				//Once the dom has loaded, begin the process to init the ads.
				gpt_InitScripts();
				gpt_CheckForMOATInit();
			}
		}
	});
</script>
<script type="text/javascript">
	function gpt_CheckEnvironment() {
		if ($('#gptDisableAds').length > 0) {
			gptDisableAds_Debug = 'Flag Detected - Ads Disabled';
			gpt_DisableAdsFlagFound = true;
		}
		else {
			gptDisableAds_Debug = 'Ads Enabled';
			gpt_DisableAdsFlagFound = false;
		}
		switch (gpt_AdFile) {
			case 'PU':
				gptContextualEnabled = true;
				if ($("#Environment").val() !== "Prod") {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			case 'JBS':
			case 'LANCET':
				gptContextualEnabled = true;
				if ($(".gpt-ad").length > 0) {
					//Other ads exist, allow the Prestitial
					$(document.body).append("<div class='gpt-ad' data-adsize='prestitial'></div>");
				}
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			default:
				//Cell
				gptContextualEnabled = false;
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
    function gpt_GetNonCMEArticle() {
        var url;
        $('.articleCitation').each(function (i, obj) {
            if ($(obj).find('.toc__item__detials').length > 0) {
                var itemDetails = $(obj).first().find('.toc__item__detials');
                var cmeFound = 0;
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='CME']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='(CME)']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='Education']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='education']").length; }
                if (cmeFound == 0) {
                    var itemLink = $(itemDetails).first().find('.toc__item__title');
                    var linkCount = $(itemLink).first().find("a:contains('CME')").length;
                    if (linkCount == 0) {
                        url = $(itemLink).first().find('a').attr('href');
                        return false;   //Found a URL, break the loop
                    }
                }
            }
        });
        return url;
    }
	//--------------------------------------------------------------------------
	function gpt_GetElapsedTime() {
		var endTime = new Date();
		var timeDiff = endTime - gpt_StartTime; //in ms
		// strip the ms
		timeDiff /= 1000;

		// get seconds
		return seconds = Math.round(timeDiff) + " seconds";
	}
	//--------------------------------------------------------------------------
	function gpt_CheckSSC() {
		//Check for ScreenShot Client
		var gpt_SSC = gpt_GetQuerystring('gpt_ssc', '');
		if (gpt_SSC == '1') {
			//it's the ScreenShotClient, disable MOAT IVT Detection
			$('#gpt-Variables').append('<input type="hidden" id="gptm_data">');
			$('#gptm_data').val(0);
			gpt_Target("m_data");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_LocalSS(adTypeId) {
		window.scrollTo(0, 0);
		gpt_Sleep(1000);
		gpt_ScrollToAd(adTypeId);
		gpt_PreTearsheet(adTypeId);
	}
	//--------------------------------------------------------------------------
	function gpt_InitScripts() {
		if (gpt_AdFile == "PU") {
			if (gpt_IsProd) {
				gpt_ContextualURL = gpt_CheckForNULL($('#canonicalurl').val());
				if (gpt_ContextualURL === null) {
					gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				}
				else {
					gpt_ContextualURL = window.location.origin + gpt_ContextualURL;
				}
				var useSSL = 'https:' == document.location.protocol;
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}
		}
		else {
			//JBS-Cell-Lancet
			var useSSL = 'https:' == document.location.protocol;

			var gads = document.createElement('script');
			gads.async = true;
			gads.type = 'text/javascript';
			gads.src = (useSSL ? 'https:' : 'http:') + '//securepubads.g.doubleclick.net/tag/js/gpt.js';
			document.head.appendChild(gads);

			if (gpt_IsProd && gptContextualEnabled) {
				gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}

			var elsevierMoatHeader = document.createElement('link');
			elsevierMoatHeader.rel = 'preload';
			elsevierMoatHeader.as = 'script';
			elsevierMoatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(elsevierMoatHeader);

			var elsevierMoatAds = document.createElement('link');
			elsevierMoatAds.rel = 'preconnect';
			elsevierMoatAds.src = (useSSL ? 'https:' : 'http:') + '//mb.moatads.com';
			document.head.appendChild(elsevierMoatAds);

			var moatHeader = document.createElement('script');
			moatHeader.async = true; gads.type = 'text/javascript';
			moatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(moatHeader);
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForMOATInit() {
		//Check every 1/10 of a second until MOAT is Loaded or 1 second timeout
		if (gpt_MOATInitAttempts < gpt_MaxMOATInitAttempts) {
			gpt_MOATInitAttempts += 1;
			if (typeof window.moatPrebidApi === "object") {
				//MOAT LOADED
				gptMoatInit_Debug = '0.0' + gpt_MOATInitAttempts + ' seconds';
				gpt_CheckForMOATReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATInit(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not LOADED
			gptMoatInit_Debug = 'Timeout Expired';
			var googletag = googletag || {};
			googletag.cmd = googletag.cmd || [];
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForMOATReady() {
		//Check every 1/10 of a second until MOAT is Ready or 1 second timeout
		if (gpt_MOATReadyAttempts < gpt_MaxMOATReadyAttempts) {
			gpt_MOATReadyAttempts += 1;
			if (window.moatPrebidApi.safetyDataAvailable()) {
				//MOAT Ready
				gptMoatReady_Debug = '0.0' + gpt_MOATReadyAttempts + " seconds";
				gpt_CheckForContextualReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATReady(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not Ready
			gptMoatReady_Debug = 'Timeout Expired';
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForContextualReady() {
		//Check every 1/10 of a second until Contextual is Ready or 2 second timeout
		if (gpt_IsProd && gptContextualEnabled) {
			//Enabled
			if (gpt_ContextualReadyAttempts < gpt_MaxContextualReadyAttempts) {
				gpt_ContextualReadyAttempts += 1;
				if (gpt_ContextualReady) {
					//Contextual Ready
					gptContextualURL_Debug = gpt_ContextualURL;
					gptContextualReady_Debug = '0.0' + gpt_ContextualReadyAttempts + " seconds";
					gptContextualInit_Debug = gs_channels;
					gpt_InitAds();
				}
				else {
					setTimeout(() => { gpt_CheckForContextualReady(); }, 100);
				}
			}
			else {
				//LOG TIMEOUT error
				//REMOVE FOR NOW (SHOULD LOG TO A DIFF LOCATION)
				//TIMEOUT: Contextual Not Ready
				$('#gpt_GrapeShotDebugBtn').remove();
				gptContextualURL_Debug = gpt_ContextualURL;
				gptContextualReady_Debug = 'Timeout Expired';
				gptContextualInit_Debug = "";
				gpt_InitAds();
			}
		}
		else {
			//Not Enabled
			$('#gpt_GrapeShotDebugBtn').remove();
			switch (gpt_AdFile) {
				case 'PU':
				case 'LANCET':
				case 'JBS':
					gptContextualURL_Debug = 'Not enabled outside of Production';
					gptContextualReady_Debug = 'Not enabled outside of Production';
					gptContextualInit_Debug = 'Not enabled outside of Production';
					break;
				case "CELLJOURNAL":
				case "CELLBUCKET":
					gptContextualReady_Debug = 'Not enabled on Cell';
					gptContextualInit_Debug = 'Not enabled on Cell';
					gptContextualURL_Debug = 'Not enabled on Cell';
					break;
			}
			gpt_InitAds();
		}
	}
	//--------------------------------------------------------------------------
	function GPT_GetPageByURL() {
		var host = window.location.host.toLocaleLowerCase()
		var localpath = window.location.pathname.toLocaleLowerCase();

		///Check for Cell.com
		if (host.indexOf('cell.com') >= 0) {
			return null;
		}

		///Check for Cell.com (marlin-stag)
		if (host.indexOf('www-cell-com') >= 0) {
			return null;
		}

		///Check for Lancet
		if (host.indexOf('thelancet') >= 0) {
			return null;
		}

		if (localpath.indexOf('/article/') >= 0) {
			return 'article.fulltext';
		}

		if (localpath.indexOf('/action/dosearch') >= 0) {
			return 'search.searchResults';
		}

		if (localpath.indexOf('/content/') >= 0) {
			return 'periodical.editorial';
		}

		return 'periodical.home';
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForNULL(x, valueifnull) {
		if (typeof valueifnull == "undefined") {
			valueifnull = null;
		}

		if (typeof x == 'undefined') {
			return valueifnull;
		}
		if (x == null) {
			return valueifnull;
		}
		if (x == "null") {
			return valueifnull;
		}
		if ($.trim(x) == '') {
			return valueifnull;
		}

		return x;
	}
	//--------------------------------------------------------------------------
	function gpt_GetAdditionalTargeting() {
		//adds page level targeting of custom variables
		//the id (minus gpt) and the value will be used as a key-value pair
		//eg: <input type="hidden" id="gptissuepii" value="x" class="gpt-Target">
		//eg: target issuepii=x
		$(".gpt-Target").each(function (index) {
			var gptTargetId = $(this).attr('id');
			gptTargetId = gptTargetId.replace('gpt', '').toLowerCase();
			if (gptTargetId !== '') {
				gpt_Target(gptTargetId);
			}
		})
	}
	//--------------------------------------------------------------------------
	function gpt_GetQuerystring(key, default_) {
		//function to read querystring variables
		if (default_ === null) default_ = '';
		key = key.replace(/[\[]/, "\\\[").replace(/[\]]/, "\\\]");
		var regex = new RegExp("[\\?&]" + key + "=([^&#]*)");
		var qs = regex.exec(window.location.href);
		if (qs === null)
			return default_;
		else
			return qs[1];
	}
	//--------------------------------------------------------------------------
	function gpt_GetDFPTestId() {
		//Get any request for a test id from querystring and set custom targeting parameter
		var gptDFPTestId = gpt_GetQuerystring('dfptestid', '');
		if (gptDFPTestId !== '') {
			$('#gpt-Variables').append('<input type="hidden" id="gptDFPTestId">');
			$('#gptDFPTestId').val(gptDFPTestId);
			gpt_Target("DFPTestId");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Target(targetName) {
		//Set page level target if value is found
		if ($('#gpt' + targetName).length > 0) {
			var targetValue = $('#gpt' + targetName).val();

			if (targetValue !== '') {
				targetValue = targetValue.replace(/[^-a-z0-9]/ig, '');	//Only Allow a-z, 0-9
				googletag.pubads().setTargeting(targetName.toLowerCase(), targetValue.toLowerCase());
				gptCustomTargeting_Debug = gptCustomTargeting_Debug + targetName.toLowerCase() + ' = ' + targetValue.toLowerCase() + '<br>';
			}
		}
	}
	//--------------------------------------------------------------------------
	function gpt_TargetAccessType() {
		var currentAccessType = $('#gptAccessType').val();
		if (typeof currentAccessType == "undefined") {
			currentAccessType = "";
		}
		if (currentAccessType.indexOf('ANON_IP') >= 0) {
			googletag.pubads().setTargeting("loggedin", "yes");
		}
		else {
			gpt_Target("LoggedIn");
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_PreTearsheet(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		//Remove Elsevier Cookie Policy Notice
		if ($("#onetrust-consent-sdk").length > 0) {
			$("#onetrust-consent-sdk").remove();
		}

        //Mobile Nav
        $('#skip').remove();
        $('skipNavigationLink').remove();

		//JBS Modals
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.usabilla__overlay').length > 0) {
			$('.usabilla__overlay').remove();
		}

		//Pendo
		if ($('._pendo-step-container').length > 0) {
			$('._pendo-step-container').remove();
		}
		if ($('._pendo-guide-tt_').length > 0) {
			$('._pendo-guide-tt_').remove();
		}
		if ($('._pendo-image').length > 0) {
			$('._pendo-image').remove();
		}
		if ($('._pendo-badge-image').length > 0) {
			$('._pendo-badge-image').remove();
		}

		switch (gpt_AdFile) {
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Mobile Bug Fix on Cell
				if (parseInt(adTypeId) == 5) {
					$('.widget-horizontalAd').css('position', 'static');
					$('.body-horizontalAd').css('display', 'block');
				}
				break;
			case "JBS":
			case "LANCET":
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 3: //MPU
					case 4: //SkyScraper
						//BUGFIX: Show Sidebar ad for JBS
						//skyscraper & mpu
						if ($('.widget-verticalAd').length > 0) {
							$('.widget-verticalAd').css('display', 'block');
						}
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
					case 6:     //Prestitial
						$('#backgroundLayer').css('display', 'block');
						break;
					default:
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Sleep(ms) {
		return new Promise(resolve => setTimeout(resolve, ms));
	}
	//--------------------------------------------------------------------------
	async function gpt_ScrollToAd(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		var adId = "";
		var offset = 0;
		var objLeaderboard = "";
		var gpt_ScrollToAd = true;

		switch (gpt_AdFile) {
			case "PU": //PracticeUpdate
				var hideOtherAds = true;
				$('#modalPrestitial').modal('hide');
				$('.jumbotron-welcome').hide();
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 2:
						//LeaderBoard, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 3:
						//MPU
						adId = "adSlot2";
						break;
					case 4:
						//SkyScraper
						adId = "adSlot3";
						$('.most-read').hide();
						break;
					case 5:
						//Mobile, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 6:
						//Interstitial
						gpt_ScrollToAd = false;
						adId = "adSlot15";
						await gpt_Sleep(1000);
						$(objLeaderboard).hide();
						$('#modalPrestitial').unbind();
						$('#modalPrestitial').modal();
						break;
					case 7:
						//Native Ad
						break;
					case 10:
						//Master Companion
						hideOtherAds = false;
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
				}
				if (hideOtherAds) {
					//Hide all other ads
					$('.ad-container').each(function (i, obj) {
						if (this.id !== adId) {
							var tempParent = this.id;
							tempParent = tempParent.replace("adSlot", "adParent");
							$("#" + tempParent).addClass('hide');
						}
					});
				}
				break;
			case "JBS":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$(".widget-verticalAd").hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="sidebar"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					case 13:	    //Phone - Portrait
					case 14:        //Phone - Landscape
						$(objLeaderboard).hide();
						offset = 60;
						adId = 'gpt-Interscroller';
						gpt_ScrollToAd = true;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
			case "CELLJOURNAL":
			case "CELLBUCKET":
				objLeaderboard = ".js__adToHide";
				offset = 260;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="boombox"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				//Hide the second ad if found
				var tCount = 0;
				$(".widget.literatumAd.none.GPT-ad-placeholder.widget-horizontalAd.widget-compact-all").each(function (index) {
					tCount += 1;
					if (tCount !== 1) {
						$(this).hide();
					}
				});
				break;
			case "LANCET":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="skyscraper"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
		}

		//Scroll to Top
		var gpt_container = $("html,body");
		gpt_container.animate({ scrollTop: 0, scrollLeft: 0 });

		if (gpt_ScrollToAd) {
			//If Adexists, scroll to it
			var gpt_scrollTo = $('#' + adId);
			if (gpt_scrollTo.length > 0) {
				//Scroll to the Ad
				var gpt_topPosition = gpt_scrollTo.offset().top - gpt_container.offset().top + gpt_container.scrollTop();
				if (gpt_topPosition > 0) {
					gpt_container.animate({ scrollTop: gpt_topPosition, scrollLeft: 0 });
					if (gpt_topPosition - offset > 0 && offset > 0) {
						gpt_container.animate({ scrollTop: gpt_topPosition - offset, scrollLeft: 0 });
					}
				}
			}
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForCookiePolicy() {
		var returnVal = false;
		if ($('#onetrust-accept-btn-handler').length > 0) {
			$('#onetrust-accept-btn-handler').click();
			returnVal = true;
		}
		return returnVal;
	}
	//--------------------------------------------------------------------------
	function gpt_InitAds() {
		var gpt_ResponsiveHomepage = false;

		switch (gpt_AdFile) {
			case "JBS":
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Responsive Check
				if ($('#hdrHomeBrand').length > 0) {
					gpt_ResponsiveHomepage = true;
				}
				break;
		}

		//InterScroller Check
		if (gpt_AdFile === "JBS") {
			var gpt_InterScrollerEnabled = false;
			var gpt_InterScrollerInsertObj;

			if ($("#articleHeader").length > 0) {
				//It's an article Page
				if ($('.article__sections > section').length > 0) {
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".article__sections > section");
				}
			}
			else {
				if ($('.toc__section').length > 0) {
					//It's a TOC Page
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".toc__section").first();
				}
			}

			//Add the Interscroller
			if (gpt_InterScrollerEnabled) {
				gpt_InterScrollerInsertObj.first().append($("#gpt-Interscroller").clone());
				$("#gpt-Interscroller").remove();
				$(".gpt-adinterscroller").addClass("gpt-ad");
			}
		}

		googletag.cmd.push(function () {
			var gptBoomBoxSizeMapping;
			var gptFluidMapping;
			var gptHomePageSidebarMapping;
			var gptCellHomePageSidebarMapping;
			var gptInterscrollerMapping;
			var gptLeaderboardSizeMapping;
			var gptMobileSizeMapping;
			var gptPrestitialMapping;
			var gptRectangleShortSizeMapping;
			var gptRectangleSizeMapping;
			var gptSideBarSizeMapping;
			var gptTallSizeMapping;
			var gptWideSizeMapping;
			var gptWideRectangleSizeMapping;

			//***********************************************
			//Start Define Size mapping based on client Viewport
			//***********************************************
			if (gpt_AdFile === 'PU') {
				gptTallSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 600], [160, 600], [120, 600]]).
					addSize([0, 0], []).
					build();

				gptRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250]]).
					addSize([0, 0], []).
					build();

				gptRectangleShortSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250], [320, 50], [300, 50]]).
					addSize([0, 0], [[300, 250], [320, 50], [300, 50]]).
					build();

				gptWideSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([760, 0], [[728, 90], [320, 50], [300, 50]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptWideRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], []).
					addSize([760, 0], [[320, 50], [300, 50], [300, 250]]).
					addSize([0, 0], [[320, 50], [300, 50], [300, 250]]).
					build();

				gptMobileSizeMapping = googletag.sizeMapping().
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([760, 0], [[1, 1]]).
					build();
			}
			else {
				//JBS-CELL-LANCET
				gptLeaderboardSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([768, 0], [[728, 90]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptHomePageSidebarMapping = googletag.sizeMapping().
					addSize([2090, 795], [[300, 600], [300, 250], [160, 600], [120, 600]]).
					addSize([1910, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptCellHomePageSidebarMapping = googletag.sizeMapping().
                    addSize([2180, 795], [[300, 600], [160, 600], [120, 600], [300, 250], [336, 280]]).
					addSize([2180, 445], [[336, 280]]).
                    addSize([2090, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
                    addSize([2090, 445], [[300, 250]]).
					addSize([1830, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptSideBarSizeMapping = googletag.sizeMapping().
					addSize([1140, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
					addSize([1140, 445], [[300, 250]]).
					addSize([0, 0], []). 				
					build();

				gptBoomBoxSizeMapping = googletag.sizeMapping().
					addSize([768, 0], [[300, 250], [336, 280]]).
					addSize([0, 0], []). 						
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([600, 700], [[1, 1]]).
					addSize([0, 0], []).
					build();

				gptInterscrollerMapping = googletag.sizeMapping().
					addSize([1140, 445], []).
					addSize([1024, 768], [[1024, 768]]).
					addSize([768, 1024], [[768, 1024]]).
					addSize([480, 320], [[480, 320]]).
					addSize([320, 480], [[320, 480]]).
					build();
			}
			//***********************************************
			//End Define Size mapping based on client Viewport
			//***********************************************

			//***********************************************
			//Start detection for ad slots on page
			//***********************************************
			var gptMasterPage = gpt_CheckForNULL($('#gptPage').val());
			var gptMasterSite;

			if (gpt_AdFile === 'PU') {
				gptMasterSite = $('#gptSite').val();
			}
			else {
				//JBS-CELL-LANCET
				gptMasterSite = "dev";

				if (gpt_IsProd) {
					gptMasterSite = gpt_CheckForNULL($('#gptSite').val());

					//If there is no master site, check for a defaultsite
					if (gptMasterSite == null) {
						gptMasterSite = gpt_CheckForNULL($('#gptDefaultSite').val());
					}
				}
				else {
					//Dev ENV
					//If the page has no gptSite Value, assume no value which will disable ads
					if (gpt_CheckForNULL($('#gptSite').val()) === null) {
						gptMasterSite = null;
					}
				}

				//If there is no master Page, check for a Page using the URL
				if (gptMasterPage === null) {
					gptMasterPage = GPT_GetPageByURL();
				}
			}

			$(".gpt-ad").each(function (index) {
				var gptPage = '';
				var adSizeMapping = '';
				var gptPOS;
				var gptTC;
				var gptNative;
				var adId;
				var gptSite;
				var tempSlot = null;


                if (gpt_IsProd) {
					if (gpt_AdFile !== "CELLJOURNAL") {
						//Check if the ad slot has it's own site defined
						if (typeof $(this).data('site') === 'undefined') {
							gptSite = gptMasterSite;
						}
						else {
							gptSite = gpt_CheckForNULL($(this).data('site'));
						}
					}
					else {
						gptSite = gptMasterSite;
					}
                }
                else {
					gptSite = gptMasterSite;
                }



				if (gpt_AdFile === 'PU') {
					adId = $(this).attr('id');
				}
				else {
					//JBS-CELL-LANCET
					adId = 'gpt-ad-' + index + 1;
				}

				if (gpt_CheckForNULL(gptSite) !== null) {
					gptSite_Debug = gptSite;

					gptPOS = parseInt($(this).data('pos')) || -1;
					if (gptPOS === -1) {
						gptPOS = index + 1;
					}

					//Check if the ad slot has it's own page defined
					gptPage = $(this).data('page');
					if (gpt_CheckForNULL(gptPage) == null) {
						//Use the Master Page
						gptPage = gptMasterPage;
					}

					//If the page is not null, preceed it with a slash
					if (gptPage !== null) {
						gptPage = '/' + gptPage;
					}
					else {
						gptPage = '';
					}
					gptPage_Debug = gptPage;


					gptTC = $(this).data('tc');
					if (typeof gptTC === "undefined") {
						gptTC = '';
					}

					gptNative = $(this).data('native');
					if (typeof gptNative === "undefined") {
						gptNative = '';
					}

					//Determine sizemapping based on data-adsize
					if (gpt_AdFile === 'PU') {
						switch ($(this).data('adsize')) {
							case 'tall':
								adSizeMapping = gptTallSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600]], adId);
								break;
							case 'rectangle':
								adSizeMapping = gptRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								break;
							case 'rectangleshort':
								adSizeMapping = gptRectangleShortSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [320, 50], [300, 50]], adId);
								break;
							case 'wide':
								adSizeMapping = gptWideSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'widerectangle':
								adSizeMapping = gptWideRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50], [300, 250]], adId);
								break;
							case 'mobile':
								adSizeMapping = gptMobileSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50]], adId);
								break;
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[1, 1]], adId);
								break;
						}
					}
					else {
						//JBS-CELL-LANCET
						switch ($(this).data('adsize')) {
							case 'cell-leaderboard':
							case 'leaderboard':
								adSizeMapping = gptLeaderboardSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'bottom':
								if (gpt_ResponsiveHomepage) {
									adSizeMapping = gptHomePageSidebarMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'boombox':
								if (gpt_AdFile === "CELLJOURNAL" || gpt_AdFile == "CELLBUCKET") {
									if (gpt_ResponsiveHomepage) {
										adSizeMapping = gptCellHomePageSidebarMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250], [336, 280]], adId);
									}
									else {
										adSizeMapping = gptBoomBoxSizeMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [336, 280]], adId);
									}
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'interscroller':
								adSizeMapping = gptInterscrollerMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 480], [480, 320], [768, 1024], [1024, 768]], adId);
								break;
							case 'sidebar':
							case 'skyscraper':
								adSizeMapping = gptSideBarSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								break;
							case 'native':
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
						}
					}
				}

				//Ignore any invalid adsizes that could be on the page
				if (adSizeMapping !== '') {
					$(this).addClass('gpt-ad-defined');
					if (gpt_AdFile !== 'PU') {
						$(this).attr('id', adId);
					}
					tempSlot.defineSizeMapping(adSizeMapping).addService(googletag.pubads()).setTargeting("pos", gptPOS);

					if (gptTC !== '') {
						tempSlot.setTargeting("tc", gptTC);
					}
					if (gptNative !== '') {
						tempSlot.setTargeting("native", gptNative);
					}
					gptEvent_Debug = gptEvent_Debug + $(this).data('adsize') + ' Requested<br>';
				}
				else {
					gptInvalidAdSize_Debug = gptInvalidAdSize_Debug + "Invalid Size Found, Id: " + $(this).prop('id') + ', adSize: ' + $(this).data('adsize') + '<br>';
					$(this).remove();
				}
			});
			if (gpt_CheckForNULL(gptInvalidAdSize_Debug) === null) {
				gptInvalidAdSize_Debug = "None Detected";
			}
			//***********************************************
			//End detection for ad slots on page
			//***********************************************

			//***********************************************
			//Start page level targeting
			//***********************************************
			if (gpt_AdFile !== 'PU') {
				//Logged in or IP Access
				gpt_TargetAccessType();

				//Check for Screenshot Client
				gpt_CheckSSC();
			}

			//Check for DFP Test
			gpt_GetDFPTestId();

			//Check for Additional Targeting
			gpt_GetAdditionalTargeting();

			if (gpt_IsProd && gptContextualEnabled) {
				var gpt_ContextualRetry = false;
				//Check for Contextual Targeting
				if (gs_channels !== "DEFAULT") {
					var gpt_ContextualCategories = Array.from(gs_channels);
					for (var i = 0; i < gpt_ContextualCategories.length; i++) {
						if (gpt_ContextualCategories[i] == 'gx_retry') {
							gpt_ContextualRetry = true;
						}
						if (!gpt_ContextualCategories[i].startsWith("custom_")) {
							//Remove any tag that is not custom
							gpt_ContextualCategories.splice(i, 1);
							i--;
						}
						else {
							//Strip the 'custom_' from the tag
							gpt_ContextualCategories[i] = gpt_ContextualCategories[i].replace("custom_", "")
						}
					}
					if (gpt_ContextualCategories.length > 0) {
						googletag.pubads().setTargeting("gs_cat", gpt_ContextualCategories);
					}
					else {
						gpt_ContextualCategories = 'none';
					}
					if (gpt_ContextualRetry) {
						gpt_ContextualCategories = "*Indexing*";
					}
					gptContextualResult_Debug = gpt_ContextualCategories;
				}
				else {
					gptContextualResult_Debug = 'No segments found';
				}
			}
			else {
				//Not Prod || Contextual not enabled
				gptContextualResult_Debug = 'Not enabled';
				
				if (!gpt_IsProd) {
                    var gpt_DevSite = gpt_CheckForNULL($('#gptSite').val(), "dev");
                    $('#gpt-Variables').append('<input type="hidden" id="gptEnvironment" value="' + gpt_DevSite + '">');
                    gpt_Target("Environment");
                }

			}
			//***********************************************
			//End page level targeting
			//***********************************************

			//Enable google dfp services
			if (parseInt($('#gptLazyLoading').val()) === 1) {
				googletag.pubads().enableLazyLoad({
					fetchMarginPercent: 200,
					renderMarginPercent: 0,
					mobileScaling: 2.0
				});
			}
			else {
				googletag.pubads().enableSingleRequest();
			}

			//Add Listener for RenderEnded
			googletag.pubads().addEventListener('slotRenderEnded', function (event) {
				if (!event.isEmpty) {
					if (typeof LocalAdLoaded === "function") {
						LocalAdLoaded(event);
					}
					if (gpt_ResponsiveHomepage) {
						if (typeof positionAd === "function") {
							positionAd();
						}
					}
					if (event.size[0] == "480" || event.size[1] == "480") {
						$('.gpt-InScrollBox').css('display', 'block');
						gptEvent_Debug = gptEvent_Debug + 'Interscroller ' + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}
					else {
						gptEvent_Debug = gptEvent_Debug + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}

				}
			});

			if (gpt_AdFile !== 'PU') {
				googletag.pubads().collapseEmptyDivs();
			}
			googletag.enableServices();

			//Populate Defined Ad Slots
			$(".gpt-ad-defined").each(function (index) {
				var adId = $(this).attr('id');
				googletag.cmd.push(function () { googletag.display(adId); });
			});

			gptStatus_Debug = 'GPT Complete';
		});
	}
	//--------------------------------------------------------------------------
	function gpt_DisplayDebug() {
		//Clone the template and append to Body
		$(document.body).append($('#gpt-DebugDiv').clone());
		$('#gpt-DebugDiv').remove();

		//Populate the Values
		gpt_LoadDebugValues();

		//Display and scroll to debug section
		$('.gpt-DebugDiv').css('display', 'block');
		window.scrollTo(0, document.body.scrollHeight);
	}
	//--------------------------------------------------------------------------
	function gpt_LoadDebugValues() {
		$('.gpt-DebugBtn').blur();
		$('.gptVersion_Debug').text(gpt_Version);
		$('.gptAdFile_Debug').html(gpt_AdFile);
		$('.gptEvent_Debug').html(gptEvent_Debug);
		$('.gptCustomTargeting_Debug').html(gptCustomTargeting_Debug);
		$('.gptSite_Debug').text(gptSite_Debug);
		$('.gptContextualResult_Debug').text(gptContextualResult_Debug);
		$('.gptContextualInit_Debug').text(gptContextualInit_Debug);
		$('.gptContextualURL_Debug').text(gptContextualURL_Debug);
		$('.gptContextualReady_Debug').text(gptContextualReady_Debug);
		$('.gptMoatReady_Debug').text(gptMoatReady_Debug);
		$('.gptMoatInit_Debug').text(gptMoatInit_Debug);
		$('.gptTestENV_Debug').text(gptTestENV_Debug);
		$('.gptDisableAds_Debug').text(gptDisableAds_Debug);
		$('.gptStatus_Debug').text(gptStatus_Debug);
		$('.gptPage_Debug').text(gptPage_Debug);
		$('.gptInvalidAdSize_Debug').html(gptInvalidAdSize_Debug);
	}
	//--------------------------------------------------------------------------
	function gpt_GrapeShotDebug() {
		$('.gpt-DebugBtn').blur();
		window.open("http://admin-elsevier.grapeshot.co.uk/custom/bookmarklet.cgi?blocking=1&vn=2&url=" + encodeURIComponent(document.location), "GRAPESHOT_POPUP", "width=650,height=600,scrollbars=yes,screenX=40,screenY=50,menubar=no,toolbar=no,resizable=yes", "Custom").focus();
	}
	//--------------------------------------------------------------------------
	function gpt_ShowConsole() {
		$('.gpt-DebugBtn').blur();
		googletag.openConsole();
	}
	//--------------------------------------------------------------------------
</script>
        </div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="912135d6-7135-4d45-b457-b503cacc3c8b" data-widget-name="ux3-layout-widget"><header class="header base fixed">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header js__adToHide widget-horizontalAd" id="9d6062d7-fad6-4e64-81cc-7dd25d99b23d">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 1 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="1"></div>
<!-- End AdSlot 1 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" class="header__wrapper clearfix" data-db-parent-of="quickSearch"><div id="brandingRow"><a href="/" data-aa-name="science that inspires" data-aa-region="cp global header" title="Visit Cell.com">Science that inspires</a><p id="brandingRowRight"><a href="/" data-aa-name="cell press endorsement" data-aa-region="cp global header" title="Visit Cell.com">A Cell Press journal</a></p></div>
        
    

        


    

            

            

            <div data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" data-widget-name="ux3-layout-widget"><div class="col-xs-6 header__left-side">
    

        


    

            

            
                <a href="/home" id="cpIconLnk" data-aa-name="cell press logo" data-aa-region="cp global header" title="Cell Press" target="_blank"><svg id="cp_logo" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 100 98.1" style="enable-background:new 0 0 100 98.1;" xml:space="preserve" height="100" width="98.1"><path style="fill:#FFFFFF;" d="M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z"></path></svg></a><div class="journal-logos">
            

            <span data-widget-id="35d8d734-3aa0-4ec8-9e2d-14babe803594" data-widget-name="ux3-general-image"><a href="/cell/home" title="Cell"><img alt="Cell" src="/pb-assets/ux3/logos/cell/Cell_white-1532516611593.svg"></a></span>

            
                </div>
            

        

    

        


    

            

            
                <div class="journal-logos">
            

            <span data-widget-id="3ffcbf1f-79fd-4ba3-85b5-bef10a63475f" data-widget-name="ux3-general-image"><a href="https://www.cell.com/open-access?utm_source=oa-label&amp;__hstc=109691226.e4e812b53ff324eccbdbdb2e4fb9a6ab.1644503737405.1644524234622.1644587109507.4&amp;__hssc=109691226.7.1644587109507&amp;__hsfp=3253153019" title="This journal offers authors two options (open access or subscription) to publish research"><img alt="This journal offers authors two options (open access or subscription) to publish research" src="/pb-assets/ux3/logos/cell/Supports_open_access_border-1645554937897.svg"></a></span>

            
                </div>
            

        
</div><div class="col-xs-6">
    

        


    

            

            

            <div data-widget-id="2555f6db-b333-4edb-8b15-ef9213f1f0a5" data-widget-name="ux3-layout-widget"><div class="header__nav row">
    

        


    

            

            

            <ul data-widget-id="52432d24-0331-4c9d-85f3-2033edc7208b" data-widget-name="UX3ProfileLinksWidget" class="rlist rlist--inline profile-links"><li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login-dropdown"><div class="profile-links__user-list__wrapper"><button data-db-target-for="loginmenu-139119" aria-expanded="false" aria-controls="login-links-139119" title="Log in links dropdown" class="profile-links__username"><span>Log in</span></button><div data-db-target-of="loginmenu-139119" id="login-links--139119" class="profile-links__user-list__holder dropBlock__holder"><ul class="rlist profile-links__list"><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900879-5" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900879-5" target="_self" data-profile-link="true">Get Institutional Access</a></li></ul></div></div></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900879-5" target="_self" data-profile-link="true">Register</a></li><li class="hidden-lg"> <div class="profile-links__controls"> <button aria-expanded="false" aria-controls="links-dialog-139119" data-opens="#links-dialog-139119" class="profile-links__btn--open"><span class="sr-only">open links dialog</span><i aria-hidden="true" class="icon-gizmo-person"></i></button></div><dialog id="links-dialog-139119" aria-modal="true"><button data-closes="#links-dialog-139119" class="profile-links__btn--close"><span class="sr-only">close links dialog</span><i aria-hidden="true" class="icon-close-solid"></i></button><ul>   <li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900879-5" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900879-5" target="_self" data-profile-link="true">Get Institutional Access</a></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900879-5" target="_self" data-profile-link="true">Register</a></li></ul></dialog></li></ul>

            

        
</div></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasInstitutionBanner none  widget-none" id="51b7fa33-2137-4f58-9e98-9746c4400513" style="display: none;">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><div class="ui-state-highlight ui-corner-all csas-institution-banner hidden" data-doi="10.1016/j.cell.2021.07.020">
    <span class="ui-icon ui-icon-close banner-close"></span>
    <p>
        Access provided by <span class="accountName"></span>
    </p>
</div>

<style>
    .csas-institution-banner {
        padding: 10px 0 0 10px;
        margin: 5px;
    }

    .csas-institution-banner.ui-state-highlight .ui-icon {
        background-image: url("/templates/jsp/css/jquery-ui-1.10.2/base/images/ui-icons_454545_256x240.png");
        margin-right: 5px;
        margin-top: -4px;
    }

    .csas-institution-banner .banner-close {
        float: right;
    }
</style>

<script>

    function resetBanner(doi) {
        $.get('/action/getAccount?doi=' + doi, function(data) {
            if (data) {
                $(".csas-institution-banner p .accountName").html(data);
                $(".csasInstitutionBanner").fadeIn();
                $(".csas-institution-banner").fadeIn();
            }
        });
    }

    var flag = 0;
    $(document).ready(function() {
        if(!$(".csas-institution-banner").is(":visible")){
            $(".csasInstitutionBanner").hide();
        }

        $(".banner-close").click(function() {
            $.get("/action/dismissBanner", function(data) {
                $(".csasInstitutionBanner").fadeOut(function () {
                    if(typeof UX !== 'undefined') {
                        UX.pageBody.init();
                    }
                });
            });
        });

        $(".articleContent .tabs li[role='tab'].showFullText").click(function() {
           flag = 1;
        });

        $(document).on("reloadTabsContent", function() {
            var isSelected = $(".articleContent .tabs li[role='tab'].showFullText").hasClass("active");
            if (isSelected) {
                var isHidden =  $(".csas-institution-banner").is(".hidden");
                if (!isHidden) {
                    resetBanner($(".csas-institution-banner").data("doi"));
                    console.log("fadeIn");
                }
            } else {
                $(".csas-institution-banner").fadeOut();
                console.log("fadeOut");
            }
            flag = 0;
        });

        $(document).on("click", ".articleContent .tabs li[role='tab']", function() {

        });
    });
</script></div>
                </div>
                </div>

        
</header></div>

            

        










        <div data-widget-def="graphQueryWidget" data-widget-id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" class="ux3">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget graphQueryWidget none top-padding-handler noMargin axel-mega-menu widget-none widget-compact-all fonts-loaded" id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" style="padding-top: 115.594px;">
                
                
                    
                

                <div class="wrapped " id="CP TOP LEVEL NAV MENU">
                    
                    <div class="widget-body body body-none  body-compact-all"><nav id="mega-menu-nav" role="navigation" class="mega-menu-nav">
  <!--.skip//a(href='#searchText' aria-label='Skip menu') Skip menu
  -->
  <div class="mega-menu-nav__wrapper">
    <button class="mega-menu__toggle"><span class="sr-only">Main menu</span><i aria-hidden="true" class="icon-gizmo-hamburger"></i></button>
    <ul role="menubar" class="mega-menu rlist">
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-1" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-1" data-item-link="main-menu-link-1" data-index="0" class="mega-menu__item-link menu-link"><span>This journal</span></a>
        <div id="main-menu-panel-1" aria-labelledby="main-menu-link-1" data-item-wrapper="main-menu-link-1" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <div aria-label="Menu dropzone section" tabindex="-1" class="listDropZone">
    

        


    

            

            

            <div class="cover-image"><div class="cover-image__thumb"><a href="/issue/S0092-8674(24)X0012-4" class="menu-link"><img src="/cms/asset/atypon:cms:attachment:img:d5e6:rev:1748270185670-389:pii:S0092867424X00124/cover.tif.jpg" alt="Cover Image - Cell, Volume 188, Issue 11"></a></div><div class="cover-image__meta"></div></div>

            

        
</div>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-2" class="sub-menu__heading">Read
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/newarticles" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Online now</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/current" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Current issue</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/archive" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Archive</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/action/showPreferences?menuTab=Alerts" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Publication alerts</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sneakpeek" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Sneak Peek - preprints</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-3" class="sub-menu__heading">About
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-2">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/advisory-board" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Advisory board</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/aims" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Aims and scope</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/contact" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/editors-and-staff" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Editors and staff</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/editorial-ethics" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Ethics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/permissions" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Permissions</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Reviewer instructions</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-2" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-2" data-item-link="main-menu-link-2" data-index="1" class="mega-menu__item-link menu-link"><span>Journals</span></a>
        <div id="main-menu-panel-2" aria-labelledby="main-menu-link-2" data-item-wrapper="main-menu-link-2" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-1" class="sub-menu__heading">Life &amp; medical sciences
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-4">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cancer-cell/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cancer Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-chemical-biology" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Chemical Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-genomics/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Genomics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-host-microbe/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Host &amp; Microbe</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-metabolism/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-medicine/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-stem-cell/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Stem Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-systems/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Systems</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/current-biology/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Current Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/developmental-cell/home" data-index="11" role="menuitem" class="sub-menu__item-link menu-link"><span>Developmental Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/immunity/home" data-index="12" role="menuitem" class="sub-menu__item-link menu-link"><span>Immunity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/med/home" data-index="13" role="menuitem" class="sub-menu__item-link menu-link"><span>Med</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-cell/home" data-index="14" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/neuron/home" data-index="15" role="menuitem" class="sub-menu__item-link menu-link"><span>Neuron</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/structure/home" data-index="16" role="menuitem" class="sub-menu__item-link menu-link"><span>Structure</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/ajhg/home" data-index="17" role="menuitem" class="sub-menu__item-link menu-link"><span>American Journal of Human Genetics (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysj/home" data-index="18" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Journal (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysreports/home" data-index="19" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/hgg-advances/home" data-index="20" role="menuitem" class="sub-menu__item-link menu-link"><span>Human Genetics and Genomics Advances (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-plant/home" data-index="21" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Plant (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/molecular-therapy/home" data-index="22" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/methods/home" data-index="23" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Methods &amp; Clinical Development (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/nucleic-acids/home" data-index="24" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Nucleic Acids (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/oncology/home" data-index="25" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Oncology (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/plant-communications/home" data-index="26" role="menuitem" class="sub-menu__item-link menu-link"><span>Plant Communications (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/stem-cell-reports/home" data-index="27" role="menuitem" class="sub-menu__item-link menu-link"><span>Stem Cell Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biochemical-sciences/home" data-index="28" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biochemical Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cancer/home" data-index="29" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cancer</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cell-biology/home" data-index="30" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cell Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/ecology-evolution/home" data-index="31" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Ecology &amp; Evolution</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/endocrinology-metabolism/home" data-index="32" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Endocrinology &amp; Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/genetics/home" data-index="33" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Genetics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/immunology/home" data-index="34" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Immunology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/microbiology/home" data-index="35" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Microbiology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/molecular-medicine/home" data-index="36" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Molecular Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/neurosciences/home" data-index="37" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Neurosciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/parasitology/home" data-index="38" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Parasitology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/pharmacological-sciences/home" data-index="39" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Pharmacological Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/plant-science/home" data-index="40" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Plant Science</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 5/6" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-2" class="sub-menu__heading">Physical sciences &amp; engineering
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-biomaterials/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Biomaterials</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-physical-science/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Physical Science</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem-catalysis/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem Catalysis</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/device/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Device</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/joule/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Joule</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/matter/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Matter</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/newton/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Newton</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/chemistry/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Chemistry</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 6/7" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-3" class="sub-menu__heading">Multidisciplinary
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-methods/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Methods</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-sustainability/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Sustainability</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/heliyon/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Heliyon</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/iscience/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>iScience</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/one-earth/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>One Earth</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/patterns/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Patterns</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/star-protocols/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Protocols</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/nexus/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Nexus (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/the-innovation/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>The Innovation (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biotechnology/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biotechnology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cognitive-sciences/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cognitive Sciences</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-3" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-3" data-item-link="main-menu-link-3" data-index="2" class="mega-menu__item-link menu-link"><span>Publish</span></a>
        <div id="main-menu-panel-3" aria-labelledby="main-menu-link-3" data-item-wrapper="main-menu-link-3" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-1" class="sub-menu__heading">Authors
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://www.editorialmanager.com/cell?__hstc=25856994.7201670a4397fa03148684920d4a8d38.1672762013831.1694716659709.1694718909620.146&amp;__hssc=25856994.15.1694718909620&amp;__hsfp=1366844671" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Submit article
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/information-for-authors" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for authors</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/multi-journal-submission" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Multi-Journal Submission</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/star-authors-guide" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Methods</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-2" class="sub-menu__heading">Reviewers
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for reviewers</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-4" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-4" data-item-link="main-menu-link-4" data-index="3" class="mega-menu__item-link menu-link"><span>News &amp; events</span></a>
        <div id="main-menu-panel-4" aria-labelledby="main-menu-link-4" data-item-wrapper="main-menu-link-4" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/newsroom" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Newsroom</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/events" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Events</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/symposia" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Symposia</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/webinars" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Webinars</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/consortia" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Consortia Hub</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-5" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-5" data-item-link="main-menu-link-5" data-index="4" class="mega-menu__item-link menu-link"><span>About Cell Press</span></a>
        <div id="main-menu-panel-5" aria-labelledby="main-menu-link-5" data-item-wrapper="main-menu-link-5" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-1" class="sub-menu__heading">Cell Press
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/about" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>About Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/contact" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact us</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="https://service.elsevier.com/app/overview/cell-press/" data-index="2" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Help &amp; support
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access at Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/diversity" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Inclusion and diversity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-50" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>50th anniversary</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-2" class="sub-menu__heading">Hubs
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/biotechnology-bioengineering" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Biotechnology and bioengineering</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-chemistry" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Chemistry</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/clinical-translational" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Clinical and translational</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/covid-19" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>COVID-19</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/fundamental-biology" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Fundamental biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sustainability" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Sustainability</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/4" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-3" class="sub-menu__heading">Careers
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Press careers
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
    </ul>
    <div class="mega-menu-nav__quick-search">
    

        


    

            

            

            <div data-widget-id="a1f05748-166f-41e0-b01a-ca8ac1cc95d4" data-widget-name="UX3QuickSearchWidget" class="quick-search"><div class="dropBlock"><form action="https://www.cell.com/action/doSearch?journalCode=cell" name="quickSearchBar" method="get" title="Quick Search"><input id="type" type="hidden" value="quicksearch" name="type"><div class="quick-search__toggle autoCompleteWrapper"><input id="searchText" type="text" name="text1" placeholder="Search for..." enterkeyhint="search" autocomplete="off" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" data-group-titles-conf="3" data-publication-items-conf="3" aria-label="Enter a search term" class="searchText searchText-autocomplete ui-autocomplete-input"><button type="submit" title="Search" aria-label="Submit the search form" class="btn quick-search__button icon-search"><span>Go search</span></button><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" unselectable="on" style="display: none;"></ul></div><div class="quick-search__box"><div class="quick-search__box-inner"><div class="quick-search__box-wrapper"><select name="field1" aria-label="Select a search area"><option value="AllField">All content</option><option value="Title">Article title</option><option value="Contrib">Authors</option><option value="Keyword">Keywords</option><option value="Abstract">Abstract</option><option value="AbstractTitleKeywordFilterField">Article title, abstract, keywords</option></select><input type="hidden" name="journalCode" value="cell"><div class="quick-search__scope-options"><span>Search within:</span><label title="This journal" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeSeries-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" title="This journal" value="cell" checked="checked" aria-label="Search within current journal"><span>This journal</span></label><label title="Full site" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeFullSite-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" value="" title="Full site" aria-label="Search within full site"><span>Full site</span></label></div><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a></div><a href="javascript:void(0)" aria-label="Close search options" title="Close search options" class="quick-search__box-close"><i aria-hidden="true" class="icon-tools_close"></i></a></div></div><div class="quick-search__alert hidden"><p>Please enter a term before submitting your search.</p><a href="#" class="quick-search__alert--close"> Ok</a></div></form></div></div>

            

        
</div>
  </div>
</nav>
<div id="page-body-id" class="page-body-flag"></div></div>
                </div>
                </div>

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="f8c6daf9-9df1-4fd9-ba3a-7f5d7b3d4466" data-widget-name="UX3HTMLWidget"><style>
.journal-logos:nth-of-type(2) img {
max-height: 30px !important;
}
.journal-logos:nth-of-type(3) img {
max-height: 30px !important;
}
.ux3 .journal-logos + .journal-logos {
margin-left: 30px;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 55%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 45%;
}
@media screen and (max-width: 1000px) {
.ux3 .journal-logos + .journal-logos {
display: none;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 50%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 50%;
}
}

.ux3 .journal-logos:first-of-type {
   max-width: 500px;
}

.profile-links {
   white-space: nowrap;
}

@media only screen and (min-width: 740px) and (max-width: 1600px) {
   .journal-logos:nth-of-type(2) img {
      max-width: 250px !important;
   }
}

@media only screen and (min-width: 1024px) and (max-width: 1600px) {
   .header__wrapper.clearfix .col-xs-6:first-of-type {
      width: 60% !important;
   }
   .header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
      width: 40% !important;
   }
}

@media only screen and (max-width: 1240px) {
   .ux3 .journal-logos + .journal-logos {
      display: none !important;
   }
}

</style></div>

            

        
</div></div>

            
                </div>
            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget axelPublicationContent none  widget-none" id="cadc9b41-a542-448a-9de4-8d0803320174">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><link id="build-style-article" rel="stylesheet" type="text/css" href="/products/marlin/cell/releasedAssets/css/build-article-b26f3342b722959c7931.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail" vocab="http://schema.org/" typeof="ScholarlyArticle" data-pii="S0092-8674(21)00879-5" lang="en" dir="ltr"><div data-core-wrapper="header"><header data-extent="frontmatter"><div class="core-container"><div data-article-access="free" data-article-access-type="open" class="meta-panel"><span class="meta-panel__left-content"><span class="meta-panel__type"><span>Article</span></span></span><span class="meta-panel__middle-content"><span class="meta-panel__volumeIssue"><a href="/cell/issue?pii=S0092-8674(20)X0019-5"><span>Volume 184</span>, <span>Issue 18</span></a></span><span class="meta-panel__pages"><span>p4753-4771.e27</span></span><span class="meta-panel__onlineDate">September 02, 2021</span></span><span class="meta-panel__right-content"><span class="meta-panel__access meta-panel__access--archive"><span>Open Archive</span></span></span><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=184&amp;issue=18&amp;pii=S0092-8674%2820%29X0019-5" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div><h1 property="name">Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy</h1><div class="contributors"><span class="authors"><span role="list"><span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au1" aria-controls="axel_author_au1"><span property="givenName">Kazuhiro</span> <span property="familyName">Koikawa</span></a><div id="au1" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Kazuhiro</span> <span property="familyName">Koikawa</span> <a class="orcid-id" href="https://orcid.org/0000-0002-3208-9447" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-3208-9447</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan</span></div></div><div class="core-author-link"><a href="/authored-by/Koikawa/Kazuhiro" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au2" aria-controls="axel_author_au2"><span property="givenName">Shin</span> <span property="familyName">Kibe</span></a><div id="au2" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Shin</span> <span property="familyName">Kibe</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan</span></div><div property="affiliation" typeof="Organization"><span property="name">Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Kibe/Shin" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">5</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">6</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au3" aria-controls="axel_author_au3"><span property="givenName">Futoshi</span> <span property="familyName">Suizu</span></a><div id="au3" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Futoshi</span> <span property="familyName">Suizu</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Division of Cancer Biology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan</span></div></div><div class="core-author-link"><a href="/authored-by/Suizu/Futoshi" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">7</a></sup></span><span data-displayed-on="all"> ∙ … </span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au4" aria-controls="axel_author_au4"><span property="givenName">Nobufumi</span> <span property="familyName">Sekino</span></a><div id="au4" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Nobufumi</span> <span property="familyName">Sekino</span> <a class="orcid-id" href="https://orcid.org/0000-0002-7705-036X" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-7705-036X</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Sekino/Nobufumi" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">6</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au5" aria-controls="axel_author_au5"><span property="givenName">Nami</span> <span property="familyName">Kim</span></a><div id="au5" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Nami</span> <span property="familyName">Kim</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Kim/Nami" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au6" aria-controls="axel_author_au6"><span property="givenName">Theresa D.</span> <span property="familyName">Manz</span></a><div id="au6" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Theresa D.</span> <span property="familyName">Manz</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Cancer Biology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Manz/Theresa+D" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">8</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">9</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au7" aria-controls="axel_author_au7"><span property="givenName">Benika J.</span> <span property="familyName">Pinch</span></a><div id="au7" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Benika J.</span> <span property="familyName">Pinch</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Cancer Biology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Pinch/Benika+J" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">8</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">9</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au8" aria-controls="axel_author_au8"><span property="givenName">Dipikaa</span> <span property="familyName">Akshinthala</span></a><div id="au8" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Dipikaa</span> <span property="familyName">Akshinthala</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Akshinthala/Dipikaa" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au9" aria-controls="axel_author_au9"><span property="givenName">Ana</span> <span property="familyName">Verma</span></a><div id="au9" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Ana</span> <span property="familyName">Verma</span> <a class="orcid-id" href="https://orcid.org/0000-0001-9057-171X" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-9057-171X</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Ludwig Center at Harvard, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Verma/Ana" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">10</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">11</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">12</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au10" aria-controls="axel_author_au10"><span property="givenName">Giorgio</span> <span property="familyName">Gaglia</span></a><div id="au10" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Giorgio</span> <span property="familyName">Gaglia</span> <a class="orcid-id" href="https://orcid.org/0000-0002-5179-4256" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-5179-4256</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Ludwig Center at Harvard, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Gaglia/Giorgio" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">10</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">11</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">12</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au11" aria-controls="axel_author_au11"><span property="givenName">Yutaka</span> <span property="familyName">Nezu</span></a><div id="au11" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Yutaka</span> <span property="familyName">Nezu</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Nezu/Yutaka" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au12" aria-controls="axel_author_au12"><span property="givenName">Shizhong</span> <span property="familyName">Ke</span></a><div id="au12" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Shizhong</span> <span property="familyName">Ke</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Ke/Shizhong" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">6</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au13" aria-controls="axel_author_au13"><span property="givenName">Chenxi</span> <span property="familyName">Qiu</span></a><div id="au13" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Chenxi</span> <span property="familyName">Qiu</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Qiu/Chenxi" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">6</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au14" aria-controls="axel_author_au14"><span property="givenName">Kenoki</span> <span property="familyName">Ohuchida</span></a><div id="au14" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au14"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Kenoki</span> <span property="familyName">Ohuchida</span> <a class="orcid-id" href="https://orcid.org/0000-0003-4792-1168" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0003-4792-1168</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan</span></div></div><div class="core-author-link"><a href="/authored-by/Ohuchida/Kenoki" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au15" aria-controls="axel_author_au15"><span property="givenName">Yoshinao</span> <span property="familyName">Oda</span></a><div id="au15" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au15"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Yoshinao</span> <span property="familyName">Oda</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Anatomical Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan</span></div></div><div class="core-author-link"><a href="/authored-by/Oda/Yoshinao" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">13</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au16" aria-controls="axel_author_au16"><span property="givenName">Tae Ho</span> <span property="familyName">Lee</span></a><div id="au16" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Tae Ho</span> <span property="familyName">Lee</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Lee/Tae+Ho" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au17" aria-controls="axel_author_au17"><span property="givenName">Babara</span> <span property="familyName">Wegiel</span></a><div id="au17" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au17"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Babara</span> <span property="familyName">Wegiel</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Division of Surgical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Wegiel/Babara" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">14</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">15</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au18" aria-controls="axel_author_au18"><span property="givenName">John G.</span> <span property="familyName">Clohessy</span></a><div id="au18" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au18"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">John G.</span> <span property="familyName">Clohessy</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Preclinical Murine Pharmacogenetics Facility, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Clohessy/John+G" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">16</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au27" aria-controls="axel_author_au27"><span property="givenName">Nir</span> <span property="familyName">London</span></a><div id="au27" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au27"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Nir</span> <span property="familyName">London</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Chemical and Structural Biology, The Weizmann Institute of Science, Rehovot, 7610001, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/London/Nir" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">18</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au19" aria-controls="axel_author_au19"><span property="givenName">Sandro</span> <span property="familyName">Santagata</span></a><div id="au19" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au19"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Sandro</span> <span property="familyName">Santagata</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Ludwig Center at Harvard, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Santagata/Sandro" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">10</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">11</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">12</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au20" aria-controls="axel_author_au20"><span property="givenName">Gerburg M.</span> <span property="familyName">Wulf</span></a><div id="au20" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au20"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Gerburg M.</span> <span property="familyName">Wulf</span> <a class="orcid-id" href="https://orcid.org/0000-0001-7868-6231" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-7868-6231</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Wulf/Gerburg+M" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au21" aria-controls="axel_author_au21"><span property="givenName">Manuel</span> <span property="familyName">Hidalgo</span></a><div id="au21" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au21"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Manuel</span> <span property="familyName">Hidalgo</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Hidalgo/Manuel" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au22" aria-controls="axel_author_au22"><span property="givenName">Senthil K.</span> <span property="familyName">Muthuswamy</span></a><div id="au22" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au22"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Senthil K.</span> <span property="familyName">Muthuswamy</span> <a class="orcid-id" href="https://orcid.org/0000-0001-6564-9634" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-6564-9634</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Muthuswamy/Senthil+K" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au23" aria-controls="axel_author_au23"><span property="givenName">Masafumi</span> <span property="familyName">Nakamura</span></a><div id="au23" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au23"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Masafumi</span> <span property="familyName">Nakamura</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan</span></div></div><div class="core-author-link"><a href="/authored-by/Nakamura/Masafumi" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au24" aria-controls="axel_author_au24"><span property="givenName">Nathanael S.</span> <span property="familyName">Gray</span></a><div id="au24" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au24"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Nathanael S.</span> <span property="familyName">Gray</span> <a class="orcid-id" href="https://orcid.org/0000-0001-5354-7403" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-5354-7403</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Chemical and Systems Biology, Chem-H and Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Gray/Nathanael+S" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">17</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au25" aria-controls="axel_author_au25"><span property="givenName">Xiao Zhen</span> <span property="familyName">Zhou</span></a><div id="au25" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au25"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Xiao Zhen</span> <span property="familyName">Zhou</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0010" href="mailto:xzhouenator@gmail.com" property="email" title="Send email to Xiao Zhen Zhou">xzhouenator@gmail.com</a></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Zhou/Xiao+Zhen" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">6</a></sup> <a id="eadd0010" href="mailto:xzhouenator@gmail.com" property="email" title="Send email to Xiao Zhen Zhou">xzhouenator@gmail.com</a></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au26" aria-controls="axel_author_au26"><span property="givenName">Kun Ping</span> <span property="familyName">Lu</span></a><div id="au26" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au26"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Kun Ping</span> <span property="familyName">Lu</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0015" href="mailto:klu@broadinstitute.org" property="email" title="Send email to Kun Ping Lu">klu@broadinstitute.org</a></div></div><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">19</div><div id="fn1"><div id="ntpara0010" role="paragraph">Lead contact</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Lu/Kun+Ping" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">6</a>,<a role="doc-noteref">19</a></sup> <a id="eadd0015" href="mailto:klu@broadinstitute.org" property="email" title="Send email to Kun Ping Lu">klu@broadinstitute.org</a></span><span data-displayed-on="all"> … <span><span data-action="reveal" tabindex="0" role="listitem">Show more</span></span> </span><span data-displayed-on="none" data-on-display="all" aria-hidden="true"> <span data-action="hide" tabindex="0" role="listitem">Show less</span></span></span></span></div><div class="core-self-citation"><div class="expandable-triggers"><button aria-controls="core-affiliations-notes" aria-expanded="false" tabindex="0" role="button"><span>Affiliations &amp; Notes</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button><button aria-controls="core-content-info" aria-expanded="false" tabindex="0" role="button"><span>Article Info</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button></div><div id="core-linked-content">
    

        

</div><div class="expandable-content"><div id="core-affiliations-notes" role="region" data-expandable="item" style="display: none;"><div class="affiliations"><div property="affiliation" typeof="Organization"><span class="label">1</span><span id="aff1" property="name">Division of Translational Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">2</span><span id="aff2" property="name">Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">3</span><span id="aff3" property="name">Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">4</span><span id="aff4" property="name">Program in Neuroscience, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">5</span><span id="aff5" property="name">Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan</span></div><div property="affiliation" typeof="Organization"><span class="label">6</span><span id="aff6" property="name">Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">7</span><span id="aff7" property="name">Division of Cancer Biology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan</span></div><div property="affiliation" typeof="Organization"><span class="label">8</span><span id="aff8" property="name">Department of Cancer Biology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">9</span><span id="aff9" property="name">Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">10</span><span id="aff10" property="name">Ludwig Center at Harvard, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">11</span><span id="aff11" property="name">Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">12</span><span id="aff12" property="name">Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">13</span><span id="aff13" property="name">Department of Anatomical Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan</span></div><div property="affiliation" typeof="Organization"><span class="label">14</span><span id="aff14" property="name">Division of Surgical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">15</span><span id="aff15" property="name">Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">16</span><span id="aff16" property="name">Preclinical Murine Pharmacogenetics Facility, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">17</span><span id="aff17" property="name">Department of Chemical and Systems Biology, Chem-H and Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">18</span><span id="aff18" property="name">Department of Chemical and Structural Biology, The Weizmann Institute of Science, Rehovot, 7610001, Israel</span></div></div><div class="core-authors-notes"><div role="doc-footnote" data-has="label"><div class="label">19</div><div id="fn1"><div id="ntpara0010" role="paragraph">Lead contact</div></div></div></div></div><div id="core-content-info" role="region" data-expandable="item" style="display: none;"><div class="history"><div>Publication History:</div><div><span>Received September 16, 2020</span>; <span>Revised April 21, 2021</span>; <span>Accepted July 15, 2021</span>; <span>Published online August 12, 2021</span></div></div><div class="core-links"><span class="doi">DOI: <a href="https://doi.org/10.1016/j.cell.2021.07.020" property="sameAs" target="_blank">10.1016/j.cell.2021.07.020 <span class="sr-only">External Link</span></a></span><span class="science-direct">Also available on <a href="https://www.sciencedirect.com/science/article/pii/S0092867421008795" target="_blank">ScienceDirect <span class="sr-only">External Link</span></a></span></div><div role="paragraph">Copyright: © 2021 Elsevier Inc.</div><div class="core-links"><span>User License: <a href="http://www.elsevier.com/open-access/userlicense/1.0/" target="_blank">Elsevier user license</a> | <a href="https://www.elsevier.com/open-access" target="_blank">Elsevier's open access license policy</a></span></div><div class="core-crossmark-badge"><a data-target="crossmark" href="#" title="Check for updates on crossmark" data-doi="10.1016/j.cell.2021.07.020" data-id="article-info-crossmark" class="crossmark__link" style="cursor: pointer;"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 290 58" height="22px" role="presentation"><path fill="url(#horizontal_crossmark)" stroke="#948F8F" stroke-miterlimit="10" stroke-width=".75" d="M287 1H3a2 2 0 0 0-2 2v52a2 2 0 0 0 2 2h284a2 2 0 0 0 2-2V3a2 2 0 0 0-2-2Z"></path><path fill="#535353" d="M80.3 23.58a6.395 6.395 0 0 0-.55-1.43 3.92 3.92 0 0 0-2.19-1.86 5.099 5.099 0 0 0-1.71-.29 5 5 0 0 0-2.46.58 4.831 4.831 0 0 0-1.69 1.54 6.921 6.921 0 0 0-1 2.19 10.16 10.16 0 0 0 0 5 6.921 6.921 0 0 0 1 2.19 4.83 4.83 0 0 0 1.69 1.5 5 5 0 0 0 2.46.58 4.44 4.44 0 0 0 1.85-.36 4.12 4.12 0 0 0 1.38-1c.39-.436.695-.942.9-1.49A7.094 7.094 0 0 0 80.4 29h3a8.46 8.46 0 0 1-.69 2.92 7.179 7.179 0 0 1-1.59 2.29 7 7 0 0 1-2.35 1.49 8.14 8.14 0 0 1-3 .52 8.43 8.43 0 0 1-3.59-.74 7.88 7.88 0 0 1-2.69-2 9.001 9.001 0 0 1-1.69-3 11.41 11.41 0 0 1 0-7.23 9.001 9.001 0 0 1 1.69-3 8.001 8.001 0 0 1 2.69-2 8.3 8.3 0 0 1 3.59-.75 9.44 9.44 0 0 1 2.83.41c.866.242 1.68.642 2.4 1.18A6.229 6.229 0 0 1 82.65 21a6.66 6.66 0 0 1 .78 2.58H80.3ZM85.9 17.9h2.85v6.63h.05a4.15 4.15 0 0 1 1.56-1.46 4.61 4.61 0 0 1 2.31-.59 4.83 4.83 0 0 1 3.33 1.1 4.21 4.21 0 0 1 1.22 3.3v8.88H94.4v-8.13a3.51 3.51 0 0 0-.65-2.21 2.36 2.36 0 0 0-1.87-.69 3.1 3.1 0 0 0-1.3.26 2.821 2.821 0 0 0-1 .73A3.41 3.41 0 0 0 89 26.8a3.88 3.88 0 0 0-.23 1.33v7.63H85.9V17.9ZM102.47 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7A5.349 5.349 0 0 1 109.7 35a5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4A5.953 5.953 0 0 1 100 32a8.748 8.748 0 0 1-.41-2.75 7.768 7.768 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.264.905.352 1.852.26 2.79h-9.53Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.594 3.594 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM122.88 27.15a2.666 2.666 0 0 0-1-1.81 3.14 3.14 0 0 0-2-.61c-.4.005-.798.07-1.18.19-.435.136-.83.376-1.15.7a3.92 3.92 0 0 0-.87 1.43 6.783 6.783 0 0 0-.35 2.39c.002.539.065 1.076.19 1.6.113.509.316.993.6 1.43.273.41.635.752 1.06 1a3 3 0 0 0 1.58.39 2.872 2.872 0 0 0 2.06-.77 3.596 3.596 0 0 0 1-2.18h2.85a6.26 6.26 0 0 1-1.91 3.86 5.83 5.83 0 0 1-4 1.34 6.61 6.61 0 0 1-2.69-.51 5.695 5.695 0 0 1-2-1.4 6.001 6.001 0 0 1-1.21-2.11 8.279 8.279 0 0 1-.41-2.65 8.987 8.987 0 0 1 .4-2.72 6.237 6.237 0 0 1 1.2-2.21 5.614 5.614 0 0 1 2-1.47 6.7 6.7 0 0 1 2.79-.54 7.801 7.801 0 0 1 2.14.29 5.634 5.634 0 0 1 1.8.86c.529.386.969.88 1.29 1.45a5 5 0 0 1 .6 2.07h-2.85l.06-.02ZM128.13 17.9H131V28l5.15-5.22h3.5l-5 4.75 5.42 8.17h-3.47l-4-6.27-1.6 1.7v4.63h-2.85V17.9h-.02ZM147.15 22.83h2.13v-1.08a5.505 5.505 0 0 1 .3-2c.161-.456.436-.862.8-1.18.33-.273.721-.462 1.14-.55.44-.094.89-.141 1.34-.14a8.158 8.158 0 0 1 2 .18v2.24a4.113 4.113 0 0 0-.59-.11 6.343 6.343 0 0 0-.74 0 1.74 1.74 0 0 0-1 .27 1.204 1.204 0 0 0-.41 1.08v1.33h2.42V25h-2.42v10.8h-2.85V25h-2.12v-2.17ZM162.23 36.1a6.999 6.999 0 0 1-2.76-.51 5.877 5.877 0 0 1-2-1.41 5.998 5.998 0 0 1-1.33-2.18 8.775 8.775 0 0 1 0-5.48 6.008 6.008 0 0 1 1.27-2.15 5.894 5.894 0 0 1 2-1.41A7.71 7.71 0 0 1 165 23a5.894 5.894 0 0 1 2 1.41 6.003 6.003 0 0 1 1.28 2.15c.585 1.78.585 3.7 0 5.48a5.99 5.99 0 0 1-3.28 3.54 7.002 7.002 0 0 1-2.77.52Zm0-2.25a3.268 3.268 0 0 0 1.65-.4c.447-.262.83-.621 1.12-1.05.304-.444.528-.938.66-1.46a6.581 6.581 0 0 0 0-3.31 4.416 4.416 0 0 0-.66-1.46 3.526 3.526 0 0 0-1.15-1 3.6 3.6 0 0 0-3.3 0 3.526 3.526 0 0 0-1.15 1 4.414 4.414 0 0 0-.66 1.46 6.558 6.558 0 0 0 0 3.31c.132.522.356 1.016.66 1.46a3.47 3.47 0 0 0 1.15 1.05 3.26 3.26 0 0 0 1.68.4ZM171.13 22.83h2.67v2.5c.097-.362.264-.701.49-1 .251-.341.547-.647.88-.91a4.404 4.404 0 0 1 1.14-.66 3.41 3.41 0 0 1 1.28-.25c.23-.013.46-.013.69 0h.39v2.79l-.61-.09a5.173 5.173 0 0 0-.61 0 3.278 3.278 0 0 0-1.36.29 3.131 3.131 0 0 0-1.11.85 4.171 4.171 0 0 0-.75 1.39 6 6 0 0 0-.28 1.9v6.15h-2.85V22.83h.03ZM198.22 35.75h-2.8V34a3.907 3.907 0 0 1-1.56 1.56 4.25 4.25 0 0 1-2.11.59 4.742 4.742 0 0 1-3.75-1.31 5.537 5.537 0 0 1-1.12-3.84v-8.2h2.85v7.92a3.503 3.503 0 0 0 .65 2.4 2.38 2.38 0 0 0 1.83.7 3.599 3.599 0 0 0 1.5-.27 2.66 2.66 0 0 0 1-.74c.259-.326.444-.705.54-1.11a5.79 5.79 0 0 0 .16-1.4v-7.5h2.85v12.95h-.04ZM201.3 22.83h2.7v1.75a3.523 3.523 0 0 1 1.72-1.58 5.568 5.568 0 0 1 2.33-.49 6.17 6.17 0 0 1 2.66.54 5.246 5.246 0 0 1 1.89 1.47c.515.65.899 1.394 1.13 2.19.257.87.385 1.773.38 2.68.001.851-.114 1.7-.34 2.52a6.568 6.568 0 0 1-1 2.16 5.002 5.002 0 0 1-4.21 2.06c-.419 0-.837-.036-1.25-.11a5.39 5.39 0 0 1-1.2-.36A4.737 4.737 0 0 1 205 35a3.567 3.567 0 0 1-.81-.91v6.45h-2.89V22.83Zm10 6.47c0-.574-.078-1.146-.23-1.7a4.606 4.606 0 0 0-.67-1.46 3.475 3.475 0 0 0-1.12-1 3.06 3.06 0 0 0-1.55-.39A3.141 3.141 0 0 0 205 26a5.518 5.518 0 0 0-1 3.3c-.004.611.077 1.22.24 1.81.138.523.38 1.012.71 1.44a3.55 3.55 0 0 0 1.14 1 3.242 3.242 0 0 0 1.54.35 3.18 3.18 0 0 0 1.65-.4c.438-.25.817-.59 1.11-1 .299-.44.513-.931.63-1.45a7.38 7.38 0 0 0 .23-1.75h.05ZM228.67 35.75H226V34a3.38 3.38 0 0 1-1.67 1.61 5.668 5.668 0 0 1-2.33.49 6.17 6.17 0 0 1-2.66-.54 5.307 5.307 0 0 1-1.89-1.46 6.254 6.254 0 0 1-1.12-2.19 9.48 9.48 0 0 1-.37-2.71 8.67 8.67 0 0 1 .47-3 6.058 6.058 0 0 1 1.26-2.1 4.89 4.89 0 0 1 1.8-1.21 5.738 5.738 0 0 1 2.06-.39c.412 0 .824.037 1.23.11.413.073.815.194 1.2.36.38.166.736.381 1.06.64.32.255.594.562.81.91V17.9h2.85v17.85h-.03Zm-10-6.33c-.001.55.069 1.098.21 1.63.13.511.35.996.65 1.43.288.414.668.757 1.11 1a3.241 3.241 0 0 0 1.6.38 3.199 3.199 0 0 0 1.64-.4 3.398 3.398 0 0 0 1.13-1.05c.297-.447.517-.94.65-1.46.14-.542.211-1.1.21-1.66a5.227 5.227 0 0 0-1-3.35 3.175 3.175 0 0 0-2.61-1.2 3.23 3.23 0 0 0-1.69.41 3.478 3.478 0 0 0-1.12 1.07 4.494 4.494 0 0 0-.62 1.5 7.871 7.871 0 0 0-.11 1.7h-.05ZM242.6 32.88c-.018.258.03.516.14.75a.577.577 0 0 0 .54.23h.3c.135-.002.269-.019.4-.05v2l-.39.11-.49.08-.5.08h-.42a2.75 2.75 0 0 1-1.45-.35 1.731 1.731 0 0 1-.75-1.23 4.998 4.998 0 0 1-2.09 1.2 8.224 8.224 0 0 1-2.39.38 5.861 5.861 0 0 1-1.67-.24 4.394 4.394 0 0 1-1.41-.7 3.35 3.35 0 0 1-1-1.18 3.624 3.624 0 0 1-.36-1.66 3.84 3.84 0 0 1 .44-2 3.246 3.246 0 0 1 1.15-1.17 5.195 5.195 0 0 1 1.6-.61c.593-.127 1.19-.223 1.79-.29a14.77 14.77 0 0 1 1.47-.21 6.896 6.896 0 0 0 1.24-.21c.318-.077.611-.236.85-.46a1.286 1.286 0 0 0 .31-.94 1.458 1.458 0 0 0-.26-.9A1.759 1.759 0 0 0 239 25a2.807 2.807 0 0 0-.86-.25 6.941 6.941 0 0 0-.9-.06 3.58 3.58 0 0 0-2 .5 2 2 0 0 0-.87 1.55h-2.85c.021-.73.227-1.442.6-2.07.338-.54.797-.996 1.34-1.33a5.475 5.475 0 0 1 1.84-.7c.692-.134 1.395-.2 2.1-.2.632 0 1.262.067 1.88.2a5.337 5.337 0 0 1 1.66.65 3.6 3.6 0 0 1 1.19 1.16c.314.525.47 1.129.45 1.74v6.65l.02.04Zm-2.85-3.6a3.45 3.45 0 0 1-1.6.51c-.667.06-1.3.147-1.9.26a6.137 6.137 0 0 0-.87.21 2.64 2.64 0 0 0-.75.38c-.22.164-.395.38-.51.63a2.129 2.129 0 0 0-.19.94c-.011.29.085.575.27.8.182.215.407.388.66.51.269.128.555.216.85.26.277.05.558.076.84.08a4.63 4.63 0 0 0 1-.12 3.418 3.418 0 0 0 1-.43 2.73 2.73 0 0 0 .81-.76 1.93 1.93 0 0 0 .32-1.14v-2.14l.07.01ZM244.37 22.83h2.15V19h2.85v3.88h2.58V25h-2.58v6.9a7.064 7.064 0 0 0 0 .77c.016.194.074.381.17.55a.84.84 0 0 0 .41.34 2 2 0 0 0 .75.11h.6c.203-.01.404-.04.6-.09v2.2l-.93.1a8.403 8.403 0 0 1-.92 0 6.33 6.33 0 0 1-1.81-.21 2.421 2.421 0 0 1-1.08-.62 2.15 2.15 0 0 1-.52-1 7.791 7.791 0 0 1-.16-1.42V25h-2.15v-2.17h.04ZM256.22 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7a5.352 5.352 0 0 1-2.1 3.26 5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4 5.947 5.947 0 0 1-1.21-2.18 8.754 8.754 0 0 1-.41-2.75 7.758 7.758 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.243.916.308 1.87.19 2.81h-9.5V30Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.575 3.575 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM270 31.6a2.154 2.154 0 0 0 .95 1.75c.607.35 1.3.524 2 .5.304-.002.608-.022.91-.06a3.943 3.943 0 0 0 1-.24c.286-.105.54-.28.74-.51a1.23 1.23 0 0 0 .26-.89 1.261 1.261 0 0 0-.4-.9 2.779 2.779 0 0 0-1-.56 9.315 9.315 0 0 0-1.34-.36l-1.5-.33a14.219 14.219 0 0 1-1.54-.42 4.937 4.937 0 0 1-1.33-.68 3.12 3.12 0 0 1-.94-1.09 3.472 3.472 0 0 1-.35-1.64 2.94 2.94 0 0 1 .51-1.76 3.913 3.913 0 0 1 1.3-1.15 5.66 5.66 0 0 1 1.75-.61 10.316 10.316 0 0 1 1.84-.17 8.418 8.418 0 0 1 1.91.21 5.19 5.19 0 0 1 1.65.69c.496.318.916.741 1.23 1.24.341.559.55 1.188.61 1.84h-3a1.783 1.783 0 0 0-.94-1.37 3.892 3.892 0 0 0-1.69-.35 6.093 6.093 0 0 0-.71 0 3.327 3.327 0 0 0-.78.19 1.642 1.642 0 0 0-.61.4 1 1 0 0 0-.25.69 1.093 1.093 0 0 0 .36.85c.294.245.634.428 1 .54.437.153.885.274 1.34.36l1.55.33a20.9 20.9 0 0 1 1.53.42c.479.157.931.386 1.34.68.41.277.751.643 1 1.07.255.494.379 1.045.36 1.6a3.48 3.48 0 0 1-.52 2 4.15 4.15 0 0 1-1.36 1.3 6.19 6.19 0 0 1-1.86.73 9.435 9.435 0 0 1-2 .23 8.823 8.823 0 0 1-2.26-.27 5.265 5.265 0 0 1-1.8-.84 4 4 0 0 1-1.2-1.4 4.445 4.445 0 0 1-.46-2h2.7v-.02Z"></path><path fill="#C72914" d="m21.94 38.74 18.12-12.08v-14.5H21.94v26.58Z"></path><path fill="#EF3340" d="M40.06 38.74 21.94 26.66v-14.5h18.12v26.58Z"></path><path fill="#3EB1C8" d="M31 9a20 20 0 1 0 0 40 20 20 0 0 0 0-40Zm0 35.1a15.1 15.1 0 1 1 0-30.2 15.1 15.1 0 0 1 0 30.2Z"></path><path fill="#FFC72C" d="M42.09 39.23A15.09 15.09 0 0 1 17 23.38l-4.2-2.64a20 20 0 0 0 33.49 21.14l-4.2-2.65Z"></path><defs><linearGradient id="horizontal_crossmark" x1="145" x2="145" y1="7.33" y2="56.82" gradientUnits="userSpaceOnUse"><stop stop-color="#fff"></stop><stop offset="1" stop-color="#c4c4c4"></stop></linearGradient></defs></svg></a></div><div class="core-content-info"></div></div></div></div></div></header><div class="core-header-aside">
    

        


    

            

            

            <div class="cover-image cover-image--axel"><div class="cover-image__thumb"><a href="https://www.cell.com/cell/issue?pii=S0092-8674(20)X0019-5"><img src="/cms/asset/015b1f4c-7a6b-4886-863b-51ca91227007/cov200h.gif" alt="Cover Image - Cell, Volume 184, Issue 18"></a></div></div>

            

        
</div></div><div data-core-wrapper="content"><div id="dummy-sticky-observer"></div><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="navigation-menu-pdf">
    

        


    

            

            

            <div data-widget-id="ecff07e8-0bc4-4533-b1f1-49365e2ead20" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><a href="/action/showPdf?pii=S0092-8674%2821%2900879-5" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" role="menuitem" class="article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></div>

            

        
</div><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Outline</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><div class="heading">Outline<button aria-haspopup="true" aria-controls="article_sections_menu" title="Close outline menu"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div><ul><li><a href="#author-highlights-abstract">Highlights</a></li><li><a href="#author-abstract">Summary</a></li><li><a href="#graphical-abstract">Graphical abstract</a></li><li><a href="#keywords">Keywords</a></li><li><a href="#sec-1">Introduction</a></li><li><a href="#sec-2">Results</a></li><li><a href="#sec-3">Discussion</a></li><li><a href="#sec-4">STAR★Methods</a></li><li><a href="#acknowledgments">Acknowledgments</a></li><li><a href="#supplementary-material">Supplemental information (3)</a></li><li><a href="#data-availability">Data and code availability</a></li><li><a href="#references">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div><div class="navigation-menu-share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="5f978446-c80a-450c-a185-94d633df2db2" data-widget-name="UX3share" aria-hidden="false" role="group" class="article-tools__dropblock article-tools__share"><button aria-label="Toggle share menu" aria-expanded="false" aria-haspopup="true" role="menuitem" aria-controls="navigation_menu_share_block" aria-labelledby="share-label" class="article-tools__item__share"><i aria-hidden="true" class="icon-article-share"></i><span id="share-label">Share</span></button><div id="navigation_menu_share_block" role="menu" class="share__block axel-share article-tools__dropblock__holder"><h4 class="axel-share__title heading">Share<button title="Close share menu" aria-expanded="false" aria-haspopup="true" aria-controls="navigation_menu_share_block"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2821%2900879-5" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="f1a208d3-ac5e-4db2-9c3a-40ef97ddfa10" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2021.07.020">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</div><div><button data-id="article-nav-menubar-more" aria-controls="article_more_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle more menu"><i aria-hidden="true" class="icon-more-mobile"></i><span>More</span></button><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__article_tools info-panel__item"><div id="article_more_menu" aria-label="More menu" data-core-nav="more"><div class="heading">More<button title="Close more menu" aria-controls="article_more_menu" aria-haspopup="true"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div>
    

        


    

            

            

            <ul data-widget-id="183a17a2-87b5-4e6f-bb85-6b5cda068c89" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><li class="article-tools__item article-tools__pdf"><a href="/action/showPdf?pii=S0092-8674%2821%2900879-5" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" class="article-tools__ctrl article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></li><li><a href="https://www.cell.com/action/showCitFormats?doi=10.1016%2Fj.cell.2021.07.020&amp;pii=S0092-8674%2821%2900879-5" title="Cite" target="_blank" aria-label="Open Cite in new tab" class="article-tools__item__displayExportCitation"><i aria-hidden="true" class="icon-export-Citation"></i><span>Cite</span></a></li><li id="article_tools_share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" data-widget-name="UX3share" class="dropBlock article-tools__dropblock article-tools__share"><button data-db-target-for="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" aria-expanded="false" title="open Share menu" class="article-tools__ctrl share__ctrl"><i aria-hidden="true" class="icon-article-share"></i><span>Share</span></button><div data-db-target-of="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da_Pop" class="share__block axel-share dropBlock__holder article-tools__dropblock__holder"><h4 class="axel-share__title">Share</h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2821%2900879-5" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>Bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="ae9bf5c5-a2ee-4f5c-8e41-9b21638b1a9f" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2021.07.020">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</li><li><a href="https://www.cell.com/action/addCitationAlert?doi=10.1016%2Fj.cell.2021.07.020" title="Set Alert" target="_blank" aria-label="Open Set Alert in new tab" class="article-tools__item__displayCreateCitationAlert"><i aria-hidden="true" class="icon-set-alert"></i><span>Set Alert</span></a></li><li><a href="https://s100.copyright.com/AppDispatchServlet?publisherName=ELS&amp;contentID=S0092867421008795&amp;orderBeanReset=true&amp;orderSource=Phoenix" title="Get Rights" target="_blank" aria-label="Open Get Rights in new tab" class="article-tools__item__request"><i aria-hidden="true" class="icon-get-rights"></i><span>Get Rights</span></a></li><li><a href="https://www.contentednet.com/salesforce-form/?pii=S0092867421008795&amp;issn=00928674&amp;source=jbs" title="Reprints" target="_blank" aria-label="Open Reprints in new tab" class="article-tools__item__reprints"><i aria-hidden="true" class="icon-article-reprints"></i><span>Reprints</span></a></li></ul>

            

        
</div></div><div class="info-panel__download-issue info-panel__item"><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=184&amp;issue=18&amp;pii=S0092-8674%2820%29X0019-5" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div></div><div class="info-panel__right-content"><div class="info-panel__navigation info-panel__item"><div class="content-navigation"><a href="/cell/fulltext/S0092-8674(21)00945-4" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><i aria-hidden="true" class="icon-arrow_l"></i><span>Previous article</span></a><a href="/cell/fulltext/S0092-8674(21)00883-7" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><span>Next article</span><i aria-hidden="true" class="icon-arrow_r"></i></a></div></div></div></div></div></div></div><div class="core-sections-menu-outer"><div class="core-sections-menu"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-show-outline" aria-hidden="true"></i><span>Show Outline</span></button><nav id="article_sections_menu-desktop" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-hide-outline" aria-hidden="true"></i><span>Hide Outline</span></button><ul><li><a href="#author-highlights-abstract">Highlights</a></li><li><a href="#author-abstract">Summary</a></li><li><a href="#graphical-abstract">Graphical abstract</a></li><li><a href="#keywords">Keywords</a></li><li><a href="#sec-1">Introduction</a></li><li><a href="#sec-2">Results</a></li><li><a href="#sec-3">Discussion</a></li><li><a href="#sec-4">STAR★Methods</a></li><li><a href="#acknowledgments">Acknowledgments</a></li><li><a href="#supplementary-material">Supplemental information (3)</a></li><li><a href="#data-availability">Data and code availability</a></li><li><a href="#references">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div></div><div><div class="core-content-inner"><div class="core-linked-content"></div><div id="abstracts" data-extent="frontmatter"><div class="core-container"><section id="author-highlights-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Highlights</h2><div id="abspara0020" role="paragraph"><div id="ulist0010" role="list"><div id="u0010" role="listitem"><div class="label">•</div><div class="content"><div id="p0010" role="paragraph">Pin1 is overexpressed both in PDAC cells and CAFs and correlates with poor patient survival</div></div></div><div id="u0015" role="listitem"><div class="label">•</div><div class="content"><div id="p0015" role="paragraph">Targeting Pin1 disrupts the desmoplastic and immunosuppressive TME by acting on CAFs</div></div></div><div id="u0020" role="listitem"><div class="label">•</div><div class="content"><div id="p0020" role="paragraph">Targeting Pin1 increases PD-L1 and ENT1 expression in cancer cells by acting on HIP1R</div></div></div><div id="u0025" role="listitem"><div class="label">•</div><div class="content"><div id="p0025" role="paragraph">Targeting Pin1 renders aggressive PDAC eradicable by synergizing with immunochemotherapy</div></div></div></div></div></section><section id="author-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Summary</h2><div id="abspara0010" role="paragraph">Pancreatic ductal adenocarcinoma (PDAC) is characterized by notorious resistance to current therapies attributed to inherent tumor heterogeneity and highly desmoplastic and immunosuppressive tumor microenvironment (TME). Unique proline isomerase Pin1 regulates multiple cancer pathways, but its role in the TME and cancer immunotherapy is unknown. Here, we find that Pin1 is overexpressed both in cancer cells and cancer-associated fibroblasts (CAFs) and correlates with poor survival in PDAC patients. Targeting Pin1 using clinically available drugs induces complete elimination or sustained remissions of aggressive PDAC by synergizing with anti-PD-1 and gemcitabine in diverse model systems. Mechanistically, Pin1 drives the desmoplastic and immunosuppressive TME by acting on CAFs and induces lysosomal degradation of the PD-1 ligand PD-L1 and the gemcitabine transporter ENT1 in cancer cells, besides activating multiple cancer pathways. Thus, Pin1 inhibition simultaneously blocks multiple cancer pathways, disrupts the desmoplastic and immunosuppressive TME, and upregulates PD-L1 and ENT1, rendering PDAC eradicable by immunochemotherapy.</div></section><section id="graphical-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Graphical abstract</h2><div id="abspara0015" role="paragraph"><div class="figure-wrap"><figure id="undfig1" class="graphic" data-figureviewer-ignore="true"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.07.020/asset/34d6f600-258f-4040-a571-b1591bbafc1b/main.assets/fx1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx1" alt="Graphical abstract undfig1" src="/cms/10.1016/j.cell.2021.07.020/asset/537c0936-e5b0-43db-977f-46aacf06de07/main.assets/fx1.jpg" height="375" width="375" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/34d6f600-258f-4040-a571-b1591bbafc1b/main.assets/fx1_lrg.jpg" loading="lazy"></a></figure></div></div></section></div></div><div class="core-linked-content"></div><section id="keywords" property="keywords"><h2>Keywords</h2><ol><li><a href="/action/doSearch?AllField=&quot;Pin1&quot;" alt="Search on this keyword" rel="nofollow">Pin1</a></li><li><a href="/action/doSearch?AllField=&quot;pancreatic+cancer&quot;" alt="Search on this keyword" rel="nofollow">pancreatic cancer</a></li><li><a href="/action/doSearch?AllField=&quot;tumor+microenvironment&quot;" alt="Search on this keyword" rel="nofollow">tumor microenvironment</a></li><li><a href="/action/doSearch?AllField=&quot;tumor+immune+microenvironment&quot;" alt="Search on this keyword" rel="nofollow">tumor immune microenvironment</a></li><li><a href="/action/doSearch?AllField=&quot;cancer-associated+fibroblasts&quot;" alt="Search on this keyword" rel="nofollow">cancer-associated fibroblasts</a></li><li><a href="/action/doSearch?AllField=&quot;immuni+checkpoint+therapy&quot;" alt="Search on this keyword" rel="nofollow">immuni checkpoint therapy</a></li><li><a href="/action/doSearch?AllField=&quot;chemotherapy&quot;" alt="Search on this keyword" rel="nofollow">chemotherapy</a></li><li><a href="/action/doSearch?AllField=&quot;combination+therapy&quot;" alt="Search on this keyword" rel="nofollow">combination therapy</a></li><li><a href="/action/doSearch?AllField=&quot;cancer+immune+evasion&quot;" alt="Search on this keyword" rel="nofollow">cancer immune evasion</a></li><li><a href="/action/doSearch?AllField=&quot;targeted+therapy&quot;" alt="Search on this keyword" rel="nofollow">targeted therapy</a></li></ol></section><div class="core-linked-content"></div><div class="core-linked-content"></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text"><div class="core-container"><section id="sec-1"><h2>Introduction</h2><div id="p0035" role="paragraph">Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive solid malignancies, with near uniform mortality (<span class="dropBlock reference-citations"><a id="body-ref-sref86" href="#" role="doc-biblioref" data-xml-rid="bib86" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref86" aria-controls="sref86">Siegel et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref86"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">88.</div><div>Siegel, R.L. ∙ Miller, K.D. ∙ Fuchs, H.E. ...</div><div><strong>Cancer Statistics, 2021</strong></div><div><em>CA Cancer J. Clin.</em> 2021; <strong>71</strong>:7-33</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3322/caac.21654" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85099242992" target="_blank" aria-label="Open Scopus in new tab">Scopus (1547)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33433946/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3322%2Fcaac.21654&amp;pmid=33433946" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and is projected to be the 2<sup>nd</sup> leading cause of cancer deaths by 2030 (<span class="dropBlock reference-citations"><a id="body-ref-sref76" href="#" role="doc-biblioref" data-xml-rid="bib76" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref76" aria-controls="sref76">Rahib et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref76"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Rahib, L. ∙ Smith, B.D. ∙ Aizenberg, R. ...</div><div><strong>Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States</strong></div><div><em>Cancer Res.</em> 2014; <strong>74</strong>:2913-2921</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-14-0155" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84902147062" target="_blank" aria-label="Open Scopus in new tab">Scopus (3350)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24840647/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-14-0155&amp;pmid=24840647" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). PDAC is notoriously resistant to chemotherapy, targeted therapies, and even immunotherapy (<span class="dropBlock reference-citations"><a id="body-ref-sref11-1" href="#" role="doc-biblioref" data-xml-rid="bib11" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref11-1" aria-controls="sref11-1">Brahmer et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref11-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Brahmer, J.R. ∙ Tykodi, S.S. ∙ Chow, L.Q. ...</div><div><strong>Safety and activity of anti-PD-L1 antibody in patients with advanced cancer</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2012; <strong>366</strong>:2455-2465</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1200694" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84862903106" target="_blank" aria-label="Open Scopus in new tab">Scopus (5190)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22658128/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1200694&amp;pmid=22658128" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref46" href="#" role="doc-biblioref" data-xml-rid="bib46" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref46" aria-controls="sref46">Kleeff et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref46"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">47.</div><div>Kleeff, J. ∙ Korc, M. ∙ Apte, M. ...</div><div><strong>Pancreatic cancer</strong></div><div><em>Nat. Rev. Dis. Primers.</em> 2016; <strong>2</strong>:16022</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrdp.2016.22" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27158978/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrdp.2016.22&amp;pmid=27158978" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), attributed to inherent intratumor heterogeneity and a highly desmoplastic and immunosuppressive tumor microenvironment (TME) (<span class="dropBlock reference-citations"><a id="body-ref-sref8" href="#" role="doc-biblioref" data-xml-rid="bib8" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref8" aria-controls="sref8">Binnewies et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">9.</div><div>Binnewies, M. ∙ Roberts, E.W. ∙ Kersten, K. ...</div><div><strong>Understanding the tumor immune microenvironment (TIME) for effective therapy</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:541-550</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0014-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85045833745" target="_blank" aria-label="Open Scopus in new tab">Scopus (1254)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29686425/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0014-x&amp;pmid=29686425" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref39-1" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-1" aria-controls="sref39-1">Ho et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref39-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Ho, W.J. ∙ Jaffee, E.M. ∙ Zheng, L.</div><div><strong>The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities</strong></div><div><em>Nat. Rev. Clin. Oncol.</em> 2020; <strong>17</strong>:527-540</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41571-020-0363-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85084454263" target="_blank" aria-label="Open Scopus in new tab">Scopus (106)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32398706/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41571-020-0363-5&amp;pmid=32398706" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref66" href="#" role="doc-biblioref" data-xml-rid="bib66" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref66" aria-controls="sref66">McGranahan and Swanton, 2017</a><div class="dropBlock__holder" data-db-target-of="sref66"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">68.</div><div>McGranahan, N. ∙ Swanton, C.</div><div><strong>Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future</strong></div><div><em>Cell.</em> 2017; <strong>168</strong>:613-628</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2017.01.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2017.01.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85012110528" target="_blank" aria-label="Open Scopus in new tab">Scopus (976)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28187284/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.01.018&amp;pmid=28187284" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Tumor heterogeneity renders tumors resistant to targeted therapies aiming at blocking individual pathways because multiple pathways are often activated simultaneously and/or rapidly upregulated as a compensatory mechanism (<span class="dropBlock reference-citations"><a id="body-ref-sref29" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29" aria-controls="sref29">Gerlinger et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref29"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">30.</div><div>Gerlinger, M. ∙ Rowan, A.J. ∙ Horswell, S. ...</div><div><strong>Intratumor heterogeneity and branched evolution revealed by multiregion sequencing</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2012; <strong>366</strong>:883-892</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1113205" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84863393080" target="_blank" aria-label="Open Scopus in new tab">Scopus (5201)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22397650/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1113205&amp;pmid=22397650" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref35" href="#" role="doc-biblioref" data-xml-rid="bib35" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref35" aria-controls="sref35">Hanahan and Weinberg, 2011</a><div class="dropBlock__holder" data-db-target-of="sref35"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">36.</div><div>Hanahan, D. ∙ Weinberg, R.A.</div><div><strong>Hallmarks of cancer: the next generation</strong></div><div><em>Cell.</em> 2011; <strong>144</strong>:646-674</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2011.02.013&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2011.02.013&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-79952284127" target="_blank" aria-label="Open Scopus in new tab">Scopus (36092)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21376230/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2011.02.013&amp;pmid=21376230" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref60" href="#" role="doc-biblioref" data-xml-rid="bib60" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref60" aria-controls="sref60">Luo et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref60"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Luo, J. ∙ Solimini, N.L. ∙ Elledge, S.J.</div><div><strong>Principles of cancer therapy: oncogene and non-oncogene addiction</strong></div><div><em>Cell.</em> 2009; <strong>136</strong>:823-837</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2009.02.024&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2009.02.024&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-61449182121" target="_blank" aria-label="Open Scopus in new tab">Scopus (1258)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19269363/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2009.02.024&amp;pmid=19269363" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), especially in PDAC where they are highly heterogeneous and continuously evolving (<span class="dropBlock reference-citations"><a id="body-ref-sref7" href="#" role="doc-biblioref" data-xml-rid="bib7" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref7" aria-controls="sref7">Biankin et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Biankin, A.V. ∙ Waddell, N. ∙ Kassahn, K.S. ..., Australian Pancreatic Cancer Genome Initiative</div><div><strong>Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes</strong></div><div><em>Nature.</em> 2012; <strong>491</strong>:399-405</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature11547" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84869091997" target="_blank" aria-label="Open Scopus in new tab">Scopus (1343)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23103869/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature11547&amp;pmid=23103869" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref82" href="#" role="doc-biblioref" data-xml-rid="bib82" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref82" aria-controls="sref82">Samuel and Hudson, 2011</a><div class="dropBlock__holder" data-db-target-of="sref82"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">84.</div><div>Samuel, N. ∙ Hudson, T.J.</div><div><strong>The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma</strong></div><div><em>Nat. Rev. Gastroenterol. Hepatol.</em> 2011; <strong>9</strong>:77-87</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrgastro.2011.215" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84856955522" target="_blank" aria-label="Open Scopus in new tab">Scopus (69)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22183185/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrgastro.2011.215&amp;pmid=22183185" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0040" role="paragraph">The PDAC TME is dominated by dense desmoplasia and immunosuppressive cell populations, which limit cytotoxic T&nbsp;cell response (<span class="dropBlock reference-citations"><a id="body-ref-sref3" href="#" role="doc-biblioref" data-xml-rid="bib3" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref3" aria-controls="sref3">Balachandran et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Balachandran, V.P. ∙ Beatty, G.L. ∙ Dougan, S.K.</div><div><strong>Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities</strong></div><div><em>Gastroenterology.</em> 2019; <strong>156</strong>:2056-2072</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2018.12.038&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2018.12.038&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85064567229" target="_blank" aria-label="Open Scopus in new tab">Scopus (98)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30660727/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2018.12.038&amp;pmid=30660727" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref51" href="#" role="doc-biblioref" data-xml-rid="bib51" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref51" aria-controls="sref51">Laklai et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref51"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Laklai, H. ∙ Miroshnikova, Y.A. ∙ Pickup, M.W. ...</div><div><strong>Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression</strong></div><div><em>Nat. Med.</em> 2016; <strong>22</strong>:497-505</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.4082" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84964317478" target="_blank" aria-label="Open Scopus in new tab">Scopus (287)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27089513/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.4082&amp;pmid=27089513" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Cancer-associated fibroblasts (CAFs) play a central role in promoting the desmoplastic and immunosuppressive TME by producing extracellular matrix proteins and cytokines, as well as interacting with cancer cells to promote tumor growth and malignancy (<span class="dropBlock reference-citations"><a id="body-ref-sref81-1" href="#" role="doc-biblioref" data-xml-rid="bib81" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref81-1" aria-controls="sref81-1">Sahai et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref81-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">83.</div><div>Sahai, E. ∙ Astsaturov, I. ∙ Cukierman, E. ...</div><div><strong>A framework for advancing our understanding of cancer-associated fibroblasts</strong></div><div><em>Nat. Rev. Cancer.</em> 2020; <strong>20</strong>:174-186</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41568-019-0238-1" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85078418124" target="_blank" aria-label="Open Scopus in new tab">Scopus (485)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31980749/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41568-019-0238-1&amp;pmid=31980749" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref95-1" href="#" role="doc-biblioref" data-xml-rid="bib95" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref95-1" aria-controls="sref95-1">Whittle and Hingorani, 2019</a><div class="dropBlock__holder" data-db-target-of="sref95-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">97.</div><div>Whittle, M.C. ∙ Hingorani, S.R.</div><div><strong>Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets</strong></div><div><em>Gastroenterology.</em> 2019; <strong>156</strong>:2085-2096</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2018.12.044&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2018.12.044&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85064573516" target="_blank" aria-label="Open Scopus in new tab">Scopus (38)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30721663/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2018.12.044&amp;pmid=30721663" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Recent strategies targeting the stroma reduce tumor growth and increase tumor response to chemo- and/or immunotherapy; however, they rarely lead to obvious tumor regression (<span class="dropBlock reference-citations"><a id="body-ref-sref44-1" href="#" role="doc-biblioref" data-xml-rid="bib44" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref44-1" aria-controls="sref44-1">Jiang et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref44-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">45.</div><div>Jiang, H. ∙ Hegde, S. ∙ Knolhoff, B.L. ...</div><div><strong>Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy</strong></div><div><em>Nat. Med.</em> 2016; <strong>22</strong>:851-860</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.4123" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84976871907" target="_blank" aria-label="Open Scopus in new tab">Scopus (444)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27376576/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.4123&amp;pmid=27376576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref84" href="#" role="doc-biblioref" data-xml-rid="bib84" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref84" aria-controls="sref84">Sherman et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref84"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">86.</div><div>Sherman, M.H. ∙ Yu, R.T. ∙ Engle, D.D. ...</div><div><strong>Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy</strong></div><div><em>Cell.</em> 2014; <strong>159</strong>:80-93</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2014.08.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2014.08.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84907485104" target="_blank" aria-label="Open Scopus in new tab">Scopus (570)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25259922/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2014.08.007&amp;pmid=25259922" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Moreover, some of those approaches even lead to disease acceleration and more aggressive tumors (<span class="dropBlock reference-citations"><a id="body-ref-sref73" href="#" role="doc-biblioref" data-xml-rid="bib73" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref73" aria-controls="sref73">Özdemir et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref73"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">75.</div><div>Özdemir, B.C. ∙ Pentcheva-Hoang, T. ∙ Carstens, J.L. ...</div><div><strong>Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival</strong></div><div><em>Cancer Cell.</em> 2014; <strong>25</strong>:719-734</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2014.04.005&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2014.04.005&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84902469661" target="_blank" aria-label="Open Scopus in new tab">Scopus (1150)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24856586/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2014.04.005&amp;pmid=24856586" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref78" href="#" role="doc-biblioref" data-xml-rid="bib78" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref78" aria-controls="sref78">Rhim et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref78"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">80.</div><div>Rhim, A.D. ∙ Oberstein, P.E. ∙ Thomas, D.H. ...</div><div><strong>Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Cell.</em> 2014; <strong>25</strong>:735-747</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2014.04.021&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2014.04.021&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84902435628" target="_blank" aria-label="Open Scopus in new tab">Scopus (1088)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24856585/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2014.04.021&amp;pmid=24856585" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and clinical trials have not yet produced promising results (<span class="dropBlock reference-citations"><a id="body-ref-sref39-2" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-2" aria-controls="sref39-2">Ho et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref39-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Ho, W.J. ∙ Jaffee, E.M. ∙ Zheng, L.</div><div><strong>The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities</strong></div><div><em>Nat. Rev. Clin. Oncol.</em> 2020; <strong>17</strong>:527-540</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41571-020-0363-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85084454263" target="_blank" aria-label="Open Scopus in new tab">Scopus (106)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32398706/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41571-020-0363-5&amp;pmid=32398706" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref40-1" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40-1" aria-controls="sref40-1">Hosein et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref40-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Hosein, A.N. ∙ Brekken, R.A. ∙ Maitra, A.</div><div><strong>Pancreatic cancer stroma: an update on therapeutic targeting strategies</strong></div><div><em>Nat. Rev. Gastroenterol. Hepatol.</em> 2020; <strong>17</strong>:487-505</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41575-020-0300-1" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85084520894" target="_blank" aria-label="Open Scopus in new tab">Scopus (93)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32393771/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41575-020-0300-1&amp;pmid=32393771" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref81-2" href="#" role="doc-biblioref" data-xml-rid="bib81" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref81-2" aria-controls="sref81-2">Sahai et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref81-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">83.</div><div>Sahai, E. ∙ Astsaturov, I. ∙ Cukierman, E. ...</div><div><strong>A framework for advancing our understanding of cancer-associated fibroblasts</strong></div><div><em>Nat. Rev. Cancer.</em> 2020; <strong>20</strong>:174-186</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41568-019-0238-1" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85078418124" target="_blank" aria-label="Open Scopus in new tab">Scopus (485)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31980749/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41568-019-0238-1&amp;pmid=31980749" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), suggesting that targeting the TME might not be sufficient.</div><div id="p0045" role="paragraph">Targeting immune checkpoints such as the one mediated by programmed cell death protein 1 (PD-1) and its ligand PD-L1 has improved patient survival in various cancers. However, the response rate is very low in PDAC patients (<span class="dropBlock reference-citations"><a id="body-ref-sref11-2" href="#" role="doc-biblioref" data-xml-rid="bib11" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref11-2" aria-controls="sref11-2">Brahmer et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref11-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Brahmer, J.R. ∙ Tykodi, S.S. ∙ Chow, L.Q. ...</div><div><strong>Safety and activity of anti-PD-L1 antibody in patients with advanced cancer</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2012; <strong>366</strong>:2455-2465</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1200694" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84862903106" target="_blank" aria-label="Open Scopus in new tab">Scopus (5190)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22658128/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1200694&amp;pmid=22658128" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), due to diminished tumor immunogenicity, including low PD-L1 expression and immunosuppressive TME, but the underlying mechanisms are not well understood (<span class="dropBlock reference-citations"><a id="body-ref-sref33" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33" aria-controls="sref33">Gotwals et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref33"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Gotwals, P. ∙ Cameron, S. ∙ Cipolletta, D. ...</div><div><strong>Prospects for combining targeted and conventional cancer therapy with immunotherapy</strong></div><div><em>Nat. Rev. Cancer.</em> 2017; <strong>17</strong>:286-301</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc.2017.17" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85015975300" target="_blank" aria-label="Open Scopus in new tab">Scopus (448)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28338065/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc.2017.17&amp;pmid=28338065" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref63" href="#" role="doc-biblioref" data-xml-rid="bib63" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref63" aria-controls="sref63">Mahoney et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref63"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>Mahoney, K.M. ∙ Rennert, P.D. ∙ Freeman, G.J.</div><div><strong>Combination cancer immunotherapy and new immunomodulatory targets</strong></div><div><em>Nat. Rev. Drug Discov.</em> 2015; <strong>14</strong>:561-584</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrd4591" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84938350452" target="_blank" aria-label="Open Scopus in new tab">Scopus (752)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26228759/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrd4591&amp;pmid=26228759" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref83" href="#" role="doc-biblioref" data-xml-rid="bib83" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref83" aria-controls="sref83">Sharma and Allison, 2015</a><div class="dropBlock__holder" data-db-target-of="sref83"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Sharma, P. ∙ Allison, J.P.</div><div><strong>The future of immune checkpoint therapy</strong></div><div><em>Science.</em> 2015; <strong>348</strong>:56-61</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaa8172" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84928774156" target="_blank" aria-label="Open Scopus in new tab">Scopus (2466)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25838373/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaa8172&amp;pmid=25838373" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref101" href="#" role="doc-biblioref" data-xml-rid="bib101" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref101" aria-controls="sref101">Zou et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref101"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">104.</div><div>Zou, W. ∙ Wolchok, J.D. ∙ Chen, L.</div><div><strong>PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations</strong></div><div><em>Sci. Transl. Med.</em> 2016; <strong>8</strong>:328rv4</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.aad7118" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_104_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84959529731" target="_blank" aria-label="Open Scopus in new tab">Scopus (1132)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26936508/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.aad7118&amp;pmid=26936508" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). PD-L1 expression is tightly controlled at the transcriptional and post-translational levels but is aberrantly altered in human cancers (<span class="dropBlock reference-citations"><a id="body-ref-sref12-1" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12-1" aria-controls="sref12-1">Burr et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref12-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Burr, M.L. ∙ Sparbier, C.E. ∙ Chan, Y.C. ...</div><div><strong>CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity</strong></div><div><em>Nature.</em> 2017; <strong>549</strong>:101-105</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature23643" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85029029250" target="_blank" aria-label="Open Scopus in new tab">Scopus (291)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28813417/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature23643&amp;pmid=28813417" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref13-1" href="#" role="doc-biblioref" data-xml-rid="bib13" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref13-1" aria-controls="sref13-1">Cha et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref13-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Cha, J.H. ∙ Chan, L.C. ∙ Li, C.W. ...</div><div><strong>Mechanisms Controlling PD-L1 Expression in Cancer</strong></div><div><em>Mol. Cell.</em> 2019; <strong>76</strong>:359-370</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.molcel.2019.09.030&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.molcel.2019.09.030&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85074248406" target="_blank" aria-label="Open Scopus in new tab">Scopus (88)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31668929/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.molcel.2019.09.030&amp;pmid=31668929" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref19-1" href="#" role="doc-biblioref" data-xml-rid="bib19" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref19-1" aria-controls="sref19-1">Dorand et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref19-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>Dorand, R.D. ∙ Nthale, J. ∙ Myers, J.T. ...</div><div><strong>Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity</strong></div><div><em>Science.</em> 2016; <strong>353</strong>:399-403</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aae0477" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84979502955" target="_blank" aria-label="Open Scopus in new tab">Scopus (237)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27463676/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aae0477&amp;pmid=27463676" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref55-1" href="#" role="doc-biblioref" data-xml-rid="bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55-1" aria-controls="sref55-1">Lim et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref55-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Lim, S.O. ∙ Li, C.W. ∙ Xia, W. ...</div><div><strong>Deubiquitination and Stabilization of PD-L1 by CSN5</strong></div><div><em>Cancer Cell.</em> 2016; <strong>30</strong>:925-939</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccell.2016.10.010&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccell.2016.10.010&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85004025764" target="_blank" aria-label="Open Scopus in new tab">Scopus (284)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27866850/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccell.2016.10.010&amp;pmid=27866850" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref99-1" href="#" role="doc-biblioref" data-xml-rid="bib99" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref99-1" aria-controls="sref99-1">Zhang et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref99-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">102.</div><div>Zhang, J. ∙ Bu, X. ∙ Wang, H. ...</div><div><strong>Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance</strong></div><div><em>Nature.</em> 2018; <strong>553</strong>:91-95</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25015" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_102_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85040189345" target="_blank" aria-label="Open Scopus in new tab">Scopus (306)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29160310/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25015&amp;pmid=29160310" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Importantly, although PD-L1 has been well studied for its engagement with PD-1 on T&nbsp;cells to evade antitumor immunity, recent studies have shown that the presence of PD-L1-expressing cancer cells within tumors is known to be an important predictor of response to immune checkpoint blockade (ICB) therapy in patients (<span class="dropBlock reference-citations"><a id="body-ref-sref36-1" href="#" role="doc-biblioref" data-xml-rid="bib36" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref36-1" aria-controls="sref36-1">Herbst et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref36-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Herbst, R.S. ∙ Soria, J.C. ∙ Kowanetz, M. ...</div><div><strong>Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients</strong></div><div><em>Nature.</em> 2014; <strong>515</strong>:563-567</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature14011" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84920956735" target="_blank" aria-label="Open Scopus in new tab">Scopus (3140)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25428504/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature14011&amp;pmid=25428504" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Moreover, upregulating PD-L1 expression in cancer cells using different approaches improves ICB efficacy in experimental models (<span class="dropBlock reference-citations"><a id="body-ref-sref37-1" href="#" role="doc-biblioref" data-xml-rid="bib37" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref37-1" aria-controls="sref37-1">Herter-Sprie et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref37-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">38.</div><div>Herter-Sprie, G.S. ∙ Koyama, S. ∙ Korideck, H. ...</div><div><strong>Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer</strong></div><div><em>JCI Insight.</em> 2016; <strong>1</strong>:e87415</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/jci.insight.87415" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27699275/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2Fjci.insight.87415&amp;pmid=27699275" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref45-1" href="#" role="doc-biblioref" data-xml-rid="bib45" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref45-1" aria-controls="sref45-1">Jiao et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref45-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">46.</div><div>Jiao, S. ∙ Xia, W. ∙ Yamaguchi, H. ...</div><div><strong>PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression</strong></div><div><em>Clin. Cancer Res.</em> 2017; <strong>23</strong>:3711-3720</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-16-3215" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85021146688" target="_blank" aria-label="Open Scopus in new tab">Scopus (372)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28167507/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-16-3215&amp;pmid=28167507" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref99-2" href="#" role="doc-biblioref" data-xml-rid="bib99" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref99-2" aria-controls="sref99-2">Zhang et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref99-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">102.</div><div>Zhang, J. ∙ Bu, X. ∙ Wang, H. ...</div><div><strong>Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance</strong></div><div><em>Nature.</em> 2018; <strong>553</strong>:91-95</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25015" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_102_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85040189345" target="_blank" aria-label="Open Scopus in new tab">Scopus (306)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29160310/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25015&amp;pmid=29160310" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Since most PDAC tumors are negative for PD-L1 (<span class="dropBlock reference-citations"><a id="body-ref-sref88-1" href="#" role="doc-biblioref" data-xml-rid="bib88" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref88-1" aria-controls="sref88-1">Tessier-Cloutier et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref88-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">90.</div><div>Tessier-Cloutier, B. ∙ Kalloger, S.E. ∙ Al-Kandari, M. ...</div><div><strong>Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma</strong></div><div><em>BMC Cancer.</em> 2017; <strong>17</strong>:618</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s12885-017-3634-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_90_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85028699849" target="_blank" aria-label="Open Scopus in new tab">Scopus (21)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28870260/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs12885-017-3634-5&amp;pmid=28870260" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), it is critical to understand the mechanisms and signaling pathways behind the regulation of PD-L1 levels to improve ICB response and efficacy.</div><div id="p0050" role="paragraph">A central common signaling mechanism in cancer is proline-directed phosphorylation regulating numerous oncoproteins and tumor suppressors (<span class="dropBlock reference-citations"><a id="body-ref-sref10" href="#" role="doc-biblioref" data-xml-rid="bib10" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref10" aria-controls="sref10">Blume-Jensen and Hunter, 2001</a><div class="dropBlock__holder" data-db-target-of="sref10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">11.</div><div>Blume-Jensen, P. ∙ Hunter, T.</div><div><strong>Oncogenic kinase signalling</strong></div><div><em>Nature.</em> 2001; <strong>411</strong>:355-365</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/35077225" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-0035902180" target="_blank" aria-label="Open Scopus in new tab">Scopus (2995)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11357143/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2F35077225&amp;pmid=11357143" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref89" href="#" role="doc-biblioref" data-xml-rid="bib89" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref89" aria-controls="sref89">Ubersax and Ferrell, 2007</a><div class="dropBlock__holder" data-db-target-of="sref89"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">91.</div><div>Ubersax, J.A. ∙ Ferrell, Jr., J.E.</div><div><strong>Mechanisms of specificity in protein phosphorylation</strong></div><div><em>Nat. Rev. Mol. Cell Biol.</em> 2007; <strong>8</strong>:530-541</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrm2203" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_91_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-34250878954" target="_blank" aria-label="Open Scopus in new tab">Scopus (893)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17585314/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrm2203&amp;pmid=17585314" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), many of which are further regulated by a unique proline isomerase, Pin1 (<span class="dropBlock reference-citations"><a id="body-ref-sref59-1" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59-1" aria-controls="sref59-1">Lu and Hunter, 2014</a><div class="dropBlock__holder" data-db-target-of="sref59-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Lu, Z. ∙ Hunter, T.</div><div><strong>Prolyl isomerase Pin1 in cancer</strong></div><div><em>Cell Res.</em> 2014; <strong>24</strong>:1033-1049</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/cr.2014.109" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84905810923" target="_blank" aria-label="Open Scopus in new tab">Scopus (112)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25124924/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fcr.2014.109&amp;pmid=25124924" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref100-1" href="#" role="doc-biblioref" data-xml-rid="bib100" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref100-1" aria-controls="sref100-1">Zhou and Lu, 2016</a><div class="dropBlock__holder" data-db-target-of="sref100-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">103.</div><div>Zhou, X.Z. ∙ Lu, K.P.</div><div><strong>The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target</strong></div><div><em>Nat. Rev. Cancer.</em> 2016; <strong>16</strong>:463-478</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc.2016.49" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_103_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84973128266" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27256007/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc.2016.49&amp;pmid=27256007" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Aberrant Pin1 overactivation promotes tumorigenesis by activating over 60 oncoproteins and inactivating over 30 tumor suppressors in various cancers, including numerous substrates in oncogenic Kras signaling (<span class="dropBlock reference-citations"><a id="body-ref-sref59-2" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59-2" aria-controls="sref59-2">Lu and Hunter, 2014</a><div class="dropBlock__holder" data-db-target-of="sref59-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Lu, Z. ∙ Hunter, T.</div><div><strong>Prolyl isomerase Pin1 in cancer</strong></div><div><em>Cell Res.</em> 2014; <strong>24</strong>:1033-1049</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/cr.2014.109" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84905810923" target="_blank" aria-label="Open Scopus in new tab">Scopus (112)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25124924/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fcr.2014.109&amp;pmid=25124924" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref100-2" href="#" role="doc-biblioref" data-xml-rid="bib100" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref100-2" aria-controls="sref100-2">Zhou and Lu, 2016</a><div class="dropBlock__holder" data-db-target-of="sref100-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">103.</div><div>Zhou, X.Z. ∙ Lu, K.P.</div><div><strong>The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target</strong></div><div><em>Nat. Rev. Cancer.</em> 2016; <strong>16</strong>:463-478</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc.2016.49" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_103_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84973128266" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27256007/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc.2016.49&amp;pmid=27256007" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), which is dominant in PDAC (<span class="dropBlock reference-citations"><a id="body-ref-sref93" href="#" role="doc-biblioref" data-xml-rid="bib93" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref93" aria-controls="sref93">Waters and Der, 2018</a><div class="dropBlock__holder" data-db-target-of="sref93"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">95.</div><div>Waters, A.M. ∙ Der, C.J.</div><div><strong>KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer</strong></div><div><em>Cold Spring Harb. Perspect. Med.</em> 2018; <strong>8</strong>:a031435</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/cshperspect.a031435" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_95_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85053712794" target="_blank" aria-label="Open Scopus in new tab">Scopus (218)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29229669/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fcshperspect.a031435&amp;pmid=29229669" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Furthermore, <i>PIN1</i><sup><i>−/−</i></sup> mice develop normally but are highly resistant to tumorigenesis (<span class="dropBlock reference-citations"><a id="body-ref-sref31" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31" aria-controls="sref31">Girardini et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref31"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">32.</div><div>Girardini, J.E. ∙ Napoli, M. ∙ Piazza, S. ...</div><div><strong>A Pin1/mutant p53 axis promotes aggressiveness in breast cancer</strong></div><div><em>Cancer Cell.</em> 2011; <strong>20</strong>:79-91</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2011.06.004&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2011.06.004&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-79960039752" target="_blank" aria-label="Open Scopus in new tab">Scopus (204)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21741598/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2011.06.004&amp;pmid=21741598" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref57-1" href="#" role="doc-biblioref" data-xml-rid="bib57" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref57-1" aria-controls="sref57-1">Liou et&nbsp;al., 2002</a><div class="dropBlock__holder" data-db-target-of="sref57-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">59.</div><div>Liou, Y.C. ∙ Ryo, A. ∙ Huang, H.K. ...</div><div><strong>Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2002; <strong>99</strong>:1335-1340</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.032404099" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-0037022355" target="_blank" aria-label="Open Scopus in new tab">Scopus (286)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11805292/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.032404099&amp;pmid=11805292" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref96" href="#" role="doc-biblioref" data-xml-rid="bib96" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref96" aria-controls="sref96">Wulf et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref96"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">98.</div><div>Wulf, G. ∙ Garg, P. ∙ Liou, Y.C. ...</div><div><strong>Modeling breast cancer in&nbsp;vivo and ex&nbsp;vivo reveals an essential role of Pin1 in tumorigenesis</strong></div><div><em>EMBO J.</em> 2004; <strong>23</strong>:3397-3407</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/sj.emboj.7600323" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_98_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-4444309643" target="_blank" aria-label="Open Scopus in new tab">Scopus (156)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15257284/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fsj.emboj.7600323&amp;pmid=15257284" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref100-3" href="#" role="doc-biblioref" data-xml-rid="bib100" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref100-3" aria-controls="sref100-3">Zhou and Lu, 2016</a><div class="dropBlock__holder" data-db-target-of="sref100-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">103.</div><div>Zhou, X.Z. ∙ Lu, K.P.</div><div><strong>The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target</strong></div><div><em>Nat. Rev. Cancer.</em> 2016; <strong>16</strong>:463-478</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc.2016.49" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_103_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84973128266" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27256007/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc.2016.49&amp;pmid=27256007" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Moreover, genetic polymorphisms that reduce Pin1 expression are also associated with reduced risk for multiple cancers in humans (<span class="dropBlock reference-citations"><a id="body-ref-sref53" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53" aria-controls="sref53">Li et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref53"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Li, Q. ∙ Dong, Z. ∙ Lin, Y. ...</div><div><strong>The rs2233678 polymorphism in PIN1 promoter region reduced cancer risk: a meta-analysis</strong></div><div><em>PLoS ONE.</em> 2013; <strong>8</strong>:e68148</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pone.0068148" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84879893112" target="_blank" aria-label="Open Scopus in new tab">Scopus (13)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23874525/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pone.0068148&amp;pmid=23874525" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). These data suggest that targeting Pin1 in PDAC might simultaneously block multiple oncogenic signaling pathways without major toxicity (<span class="dropBlock reference-citations"><a id="body-ref-sref59-3" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59-3" aria-controls="sref59-3">Lu and Hunter, 2014</a><div class="dropBlock__holder" data-db-target-of="sref59-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Lu, Z. ∙ Hunter, T.</div><div><strong>Prolyl isomerase Pin1 in cancer</strong></div><div><em>Cell Res.</em> 2014; <strong>24</strong>:1033-1049</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/cr.2014.109" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84905810923" target="_blank" aria-label="Open Scopus in new tab">Scopus (112)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25124924/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fcr.2014.109&amp;pmid=25124924" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref100-4" href="#" role="doc-biblioref" data-xml-rid="bib100" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref100-4" aria-controls="sref100-4">Zhou and Lu, 2016</a><div class="dropBlock__holder" data-db-target-of="sref100-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">103.</div><div>Zhou, X.Z. ∙ Lu, K.P.</div><div><strong>The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target</strong></div><div><em>Nat. Rev. Cancer.</em> 2016; <strong>16</strong>:463-478</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc.2016.49" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_103_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84973128266" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27256007/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc.2016.49&amp;pmid=27256007" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This notion has been corroborated by the recent unexpected identification of all-<i>trans</i> retinoic acid and arsenic trioxide (ATRA&nbsp;+ ATO) as synergistic Pin1 inhibitors that block multiple cancer-driving pathways, eliminate cancer stem cells, and increase response to chemotherapy, targeted therapy, and radiation in various cancers (<span class="dropBlock reference-citations"><a id="body-ref-sref50-1" href="#" role="doc-biblioref" data-xml-rid="bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50-1" aria-controls="sref50-1">Kozono et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref50-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Kozono, S. ∙ Lin, Y.M. ∙ Seo, H.S. ...</div><div><strong>Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells</strong></div><div><em>Nat. Commun.</em> 2018; <strong>9</strong>:3069</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-018-05402-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85051562951" target="_blank" aria-label="Open Scopus in new tab">Scopus (54)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30093655/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-018-05402-2&amp;pmid=30093655" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref58" href="#" role="doc-biblioref" data-xml-rid="bib58" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref58" aria-controls="sref58">Liu et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref58"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">60.</div><div>Liu, P.H. ∙ Shah, R.B. ∙ Li, Y. ...</div><div><strong>An IRAK1-PIN1 signalling axis drives intrinsic tumour resistance to radiation therapy</strong></div><div><em>Nat. Cell Biol.</em> 2019; <strong>21</strong>:203-213</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41556-018-0260-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85060453836" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30664786/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41556-018-0260-7&amp;pmid=30664786" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref61" href="#" role="doc-biblioref" data-xml-rid="bib61" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref61" aria-controls="sref61">Luo et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref61"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Luo, M.L. ∙ Zheng, F. ∙ Chen, W. ...</div><div><strong>Inactivation of the prolyl isomerase Pin1 sensitizes BRCA1-proficient breast cancer to PARP inhibition</strong></div><div><em>Cancer Res.</em> 2020; <strong>80</strong>:3033-3045</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-19-2739" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85088277567" target="_blank" aria-label="Open Scopus in new tab">Scopus (7)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32193285/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-19-2739&amp;pmid=32193285" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref70" href="#" role="doc-biblioref" data-xml-rid="bib70" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref70" aria-controls="sref70">Mugoni et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref70"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">72.</div><div>Mugoni, V. ∙ Panella, R. ∙ Cheloni, G. ...</div><div><strong>Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy</strong></div><div><em>Cell Res.</em> 2019; <strong>29</strong>:446-459</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41422-019-0162-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85064927567" target="_blank" aria-label="Open Scopus in new tab">Scopus (16)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31024166/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41422-019-0162-7&amp;pmid=31024166" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref94-1" href="#" role="doc-biblioref" data-xml-rid="bib94" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref94-1" aria-controls="sref94-1">Wei et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref94-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">96.</div><div>Wei, S. ∙ Kozono, S. ∙ Kats, L. ...</div><div><strong>Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer</strong></div><div><em>Nat. Med.</em> 2015; <strong>21</strong>:457-466</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.3839" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_96_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84937759226" target="_blank" aria-label="Open Scopus in new tab">Scopus (172)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25849135/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.3839&amp;pmid=25849135" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref100-5" href="#" role="doc-biblioref" data-xml-rid="bib100" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref100-5" aria-controls="sref100-5">Zhou and Lu, 2016</a><div class="dropBlock__holder" data-db-target-of="sref100-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">103.</div><div>Zhou, X.Z. ∙ Lu, K.P.</div><div><strong>The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target</strong></div><div><em>Nat. Rev. Cancer.</em> 2016; <strong>16</strong>:463-478</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc.2016.49" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_103_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84973128266" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27256007/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc.2016.49&amp;pmid=27256007" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). These findings identify Pin1 as a major cellular target for ATRA&nbsp;+ ATO to safely cure deadly acute promyelocytic leukemia (APL) (<span class="dropBlock reference-citations"><a id="body-ref-sref17-1" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17-1" aria-controls="sref17-1">de Thé and Chen, 2010</a><div class="dropBlock__holder" data-db-target-of="sref17-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>de Thé, H. ∙ Chen, Z.</div><div><strong>Acute promyelocytic leukaemia: novel insights into the mechanisms of cure</strong></div><div><em>Nat. Rev. Cancer.</em> 2010; <strong>10</strong>:775-783</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc2943" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-77958510339" target="_blank" aria-label="Open Scopus in new tab">Scopus (336)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20966922/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc2943&amp;pmid=20966922" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref50-2" href="#" role="doc-biblioref" data-xml-rid="bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50-2" aria-controls="sref50-2">Kozono et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref50-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Kozono, S. ∙ Lin, Y.M. ∙ Seo, H.S. ...</div><div><strong>Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells</strong></div><div><em>Nat. Commun.</em> 2018; <strong>9</strong>:3069</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-018-05402-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85051562951" target="_blank" aria-label="Open Scopus in new tab">Scopus (54)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30093655/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-018-05402-2&amp;pmid=30093655" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref94-2" href="#" role="doc-biblioref" data-xml-rid="bib94" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref94-2" aria-controls="sref94-2">Wei et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref94-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">96.</div><div>Wei, S. ∙ Kozono, S. ∙ Kats, L. ...</div><div><strong>Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer</strong></div><div><em>Nat. Med.</em> 2015; <strong>21</strong>:457-466</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.3839" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_96_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84937759226" target="_blank" aria-label="Open Scopus in new tab">Scopus (172)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25849135/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.3839&amp;pmid=25849135" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref100-6" href="#" role="doc-biblioref" data-xml-rid="bib100" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref100-6" aria-controls="sref100-6">Zhou and Lu, 2016</a><div class="dropBlock__holder" data-db-target-of="sref100-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">103.</div><div>Zhou, X.Z. ∙ Lu, K.P.</div><div><strong>The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target</strong></div><div><em>Nat. Rev. Cancer.</em> 2016; <strong>16</strong>:463-478</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc.2016.49" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_103_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84973128266" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27256007/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc.2016.49&amp;pmid=27256007" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). However, it is unknown whether Pin1 has any role in the TME and cancer immunotherapy and whether Pin1 inhibitors could render a solid malignancy curable.</div><div id="p0055" role="paragraph">Here, we report that in PDAC, Pin1 drives the desmoplastic and immunosuppressive TME by acting on CAFs and induces PD-L1 and ENT1 endocytosis and lysosomal degradation in cancer cells by acting on HIP1R, in addition to activating multiple oncogenic pathways. Consequently, targeting Pin1 using Pin1 inhibitors including ATRA&nbsp;+ ATO simultaneously blocks multiple cancer pathways, disrupts the desmoplastic and immunosuppressive TME, and upregulates PD-L1 and ENT1, thereby rendering aggressive PDAC eradicable by synergizing with immunochemotherapy. These findings may have immediate therapeutic impact on PDAC patients as some Pin1 inhibitors are approved drugs.</div></section><section id="sec-2"><h2>Results</h2><section id="sec-2-1"><h3>Targeting Pin1 disrupts the desmoplastic and immunosuppressive TME and renders PDAC tumors curable by immunochemotherapy in KPC mouse-derived allografts</h3><div id="p0060" role="paragraph">To evaluate the effects of targeting Pin1 on the TME and tumor growth in PDAC, we used two different Pin1 inhibitors (Pin1i-1 and -2) to treat three different PDAC mouse models. Pin1i-1 is a combination of ATRA&nbsp;+ ATO (<span class="dropBlock reference-citations"><a id="body-ref-sref50-3" href="#" role="doc-biblioref" data-xml-rid="bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50-3" aria-controls="sref50-3">Kozono et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref50-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Kozono, S. ∙ Lin, Y.M. ∙ Seo, H.S. ...</div><div><strong>Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells</strong></div><div><em>Nat. Commun.</em> 2018; <strong>9</strong>:3069</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-018-05402-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85051562951" target="_blank" aria-label="Open Scopus in new tab">Scopus (54)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30093655/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-018-05402-2&amp;pmid=30093655" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and Pin1i-2 is Sulfopin, a highly Pin1-specific covalent inhibitor that targets the ATO-binding pocket and has no detectable side effect (<span class="dropBlock reference-citations"><a id="body-ref-sref21-1" href="#" role="doc-biblioref" data-xml-rid="bib21" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref21-1" aria-controls="sref21-1">Dubiella et al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref21-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Dubiella, C. ∙ Pinch, B.J. ∙ Koikawa, K. ...</div><div><strong>Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo</strong></div><div><em>Nat. Chem. Biol.</em> 2021;</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41589-021-00786-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85105881530" target="_blank" aria-label="Open Scopus in new tab">Scopus (8)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33972797/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41589-021-00786-7&amp;pmid=33972797" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (<a id="crosref0740" href="#mmc1">Tables S1</a> and <a id="crosref0745" href="#mmc2">S2</a>). The three mouse models were patient-derived tumor orthotopic xenograft (PDTX) model (<span class="dropBlock reference-citations"><a id="body-ref-sref16-1" href="#" role="doc-biblioref" data-xml-rid="bib16" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref16-1" aria-controls="sref16-1">Day et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref16-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Day, C.P. ∙ Merlino, G. ∙ Van Dyke, T.</div><div><strong>Preclinical mouse cancer models: a maze of opportunities and challenges</strong></div><div><em>Cell.</em> 2015; <strong>163</strong>:39-53</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2015.08.068&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2015.08.068&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84948464999" target="_blank" aria-label="Open Scopus in new tab">Scopus (301)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26406370/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2015.08.068&amp;pmid=26406370" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref79-1" href="#" role="doc-biblioref" data-xml-rid="bib79" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref79-1" aria-controls="sref79-1">Rubio-Viqueira et&nbsp;al., 2006</a><div class="dropBlock__holder" data-db-target-of="sref79-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">81.</div><div>Rubio-Viqueira, B. ∙ Jimeno, A. ∙ Cusatis, G. ...</div><div><strong>An in&nbsp;vivo platform for translational drug development in pancreatic cancer</strong></div><div><em>Clin. Cancer Res.</em> 2006; <strong>12</strong>:4652-4661</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-06-0113" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-33748088524" target="_blank" aria-label="Open Scopus in new tab">Scopus (343)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16899615/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-06-0113&amp;pmid=16899615" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), patient-derived PDAC organoid and CAFs orthotopic xenograft (PDOX) model (<span class="dropBlock reference-citations"><a id="body-ref-sref48-1" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48-1" aria-controls="sref48-1">Koikawa et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref48-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Koikawa, K. ∙ Ohuchida, K. ∙ Ando, Y. ...</div><div><strong>Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Lett.</em> 2018; <strong>425</strong>:65-77</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2018.03.031" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29580808/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2018.03.031&amp;pmid=29580808" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and the LSL-K-Ras<sup>G12D/+</sup>; LSL-p53<sup>R172H/+</sup>;Pdx1-Cre (KPC) genetically engineered mouse model (GEMM)-derived orthotopic allograft (GDA) model in syngeneic immunocompetent mice (<span class="dropBlock reference-citations"><a id="body-ref-sref16-2" href="#" role="doc-biblioref" data-xml-rid="bib16" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref16-2" aria-controls="sref16-2">Day et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref16-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Day, C.P. ∙ Merlino, G. ∙ Van Dyke, T.</div><div><strong>Preclinical mouse cancer models: a maze of opportunities and challenges</strong></div><div><em>Cell.</em> 2015; <strong>163</strong>:39-53</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2015.08.068&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2015.08.068&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84948464999" target="_blank" aria-label="Open Scopus in new tab">Scopus (301)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26406370/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2015.08.068&amp;pmid=26406370" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref38-1" href="#" role="doc-biblioref" data-xml-rid="bib38" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref38-1" aria-controls="sref38-1">Hingorani et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref38-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Hingorani, S.R. ∙ Wang, L. ∙ Multani, A.S. ...</div><div><strong>Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice</strong></div><div><em>Cancer Cell.</em> 2005; <strong>7</strong>:469-483</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2005.04.023&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2005.04.023&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-19344362405" target="_blank" aria-label="Open Scopus in new tab">Scopus (1497)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15894267/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2005.04.023&amp;pmid=15894267" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref54-1" href="#" role="doc-biblioref" data-xml-rid="bib54" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref54-1" aria-controls="sref54-1">Li et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref54-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">56.</div><div>Li, J. ∙ Qian, W. ∙ Qin, T. ...</div><div><strong>Mouse-Derived Allografts: A Complementary Model to the KPC Mice on Researching Pancreatic Cancer In&nbsp;Vivo</strong></div><div><em>Comput. Struct. Biotechnol. J.</em> 2019; <strong>17</strong>:498-506</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.csbj.2019.03.016" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85064078721" target="_blank" aria-label="Open Scopus in new tab">Scopus (6)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31011408/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.csbj.2019.03.016&amp;pmid=31011408" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Treatment of overt tumor (&gt;0.5&nbsp;cm)-bearing PDTX or GDA mice with Pin1i-1 or -2 significantly reduced tumor growth (<a id="crosref0780" href="#figs1">Figures S1</a>A–S1C and <a id="crosref0785" href="#figs2">S2</a>B), collagen deposition (<a id="crosref0790" href="#fig1">Figures 1</a>A and <a id="crosref0795" href="#figs1">S1</a>D), and CAF activation and proliferation (<a id="crosref0800" href="#fig1">Figures 1</a>B, <a id="crosref0805" href="#figs1">S1</a>F, S1G, and S1J). Compared with vehicle controls, Pin1 inhibitors reduced the proliferation of cancer cells (<a id="crosref0810" href="#figs1">Figure&nbsp;S1</a>E) and resulted in a more differentiated histology (<a id="crosref0815" href="#figs1">Figures S1</a>D and S1I), as evidenced by reduced vimentin and increased E-cadherin, markers for epithelial mesenchymal transition (EMT) (<a id="crosref0820" href="#figs1">Figure&nbsp;S1</a>H). Both Pin1 inhibitors also increased tumor-infiltrating CD8α<sup>+</sup> T&nbsp;cells, specifically CD8α<sup>+</sup>Granzyme B<sup>+</sup> cytotoxic T&nbsp;cells (CTLs) and decreased immunosuppressive CD4<sup>+</sup>FOXP3<sup>+</sup> regulatory T&nbsp;cells (Tregs), Ly6G<sup>+</sup>CD11b<sup>+</sup> myeloid cells, and F4/80<sup>+</sup>CD206<sup>+</sup> tumor associated macrophages (TAMs) in GDA mice (<a id="crosref0825" href="#fig1">Figures 1</a>C and <a id="crosref0830" href="#figs2">S2</a>D–S2G). Thus, Pin1 inhibitors suppress tumor growth and progression and block CAF activation, as well as disrupt the desmoplastic and immunosuppressive TME in PDAC mouse models.</div><div class="figure-wrap"><figure id="fig1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.07.020/asset/6847667b-2bb9-4bc6-b33c-95c265a516e3/main.assets/gr1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr1" src="/cms/10.1016/j.cell.2021.07.020/asset/6eacbe41-ef40-453a-b390-ce3d7b4c5edf/main.assets/gr1.jpg" height="861" width="657" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/6847667b-2bb9-4bc6-b33c-95c265a516e3/main.assets/gr1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;1</span> <span class="figure__title__text">Targeting Pin1 disrupts the desmoplastic and immunosuppressive TME and renders PDAC tumors curable by immunochemotherapy in GDA mice</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0015" role="paragraph">(A–C) Overt tumor-bearing (&gt;0.5&nbsp;cm) GDA mice were treated with Pin1i-1 or -2 for 4&nbsp;weeks, followed by examining collagen deposition using Sirius Red staining (A), CAF proliferation using double immunofluorescence (IF) for αSMA and Ki67 (B), and tumor-infiltrating immune cell populations (CD8α<sup>+</sup> T&nbsp;cells, FOXP3<sup>+</sup> Tregs, and Ly6G<sup>+</sup> CD11b<sup>+</sup> myeloid cells) using IF (C).</div><div id="fspara0020" role="paragraph">(D–G) Tumor-bearing GDA mice were treated with Pin1i, low-dose (10&nbsp;mg/kg, weekly) GEM&nbsp;+ αPD1 (G+P), Pin1i&nbsp;+ αPD1, or Pin1i&nbsp;+ G+P for up to 120&nbsp;days and monitored for tumor growth (D), and overall survival using Kaplan-Meier survival analysis (E) for up to 365&nbsp;days, as well as examining macroscopic tumors (F) or microscopic tumors (G) after autopsy (n&nbsp;= 8–16). Median survival:vehicle, 33&nbsp;days; G+P, 38&nbsp;days; Pin1i-1, 43.5&nbsp;days; and Pin1i-1&nbsp;+ αPD1, 72.4&nbsp;days (E). CR, complete remission.</div><div id="fspara0025" role="paragraph">(H) Tumor-bearing GDA mice were treated with vehicle, Pin1i-2&nbsp;+ αPD1, anti-CD8 α (αCD8α), anti-NK1.1 (αNK1.1) or their combination for 3&nbsp;weeks, followed by assaying tumor volume.</div><div id="fspara0030" role="paragraph">Scale bars, 200&nbsp;μm (A), 50&nbsp;μm (B), 100&nbsp;μm (C), and 2,000 and 100&nbsp;μm (high magnification) (G). Error bars, mean ± SD; <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗</sup>p&nbsp;= 0.0001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001; n.s., not significant; by Student’s t test (A–C), long-rank test (E), or one-way ANOVA (H).</div><div id="fspara0035" role="paragraph">See also <a id="crosref2045" href="#figs1">Figures S1</a> and <a id="crosref2050" href="#figs2">S2</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.07.020/asset/03f284e6-d3f0-46f2-b7cf-ecb8513ded95/main.assets/figs1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs1" src="/cms/10.1016/j.cell.2021.07.020/asset/c18b70c3-ae3b-40fe-bc7c-4bd4bfd359ea/main.assets/figs1.jpg" height="922" width="702" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/03f284e6-d3f0-46f2-b7cf-ecb8513ded95/main.assets/figs1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S1</span> <span class="figure__title__text">Targeting Pin1 disrupts the desmoplastic and/or immunosuppressive TME and inhibits tumor growth and progression in PDTX and GDA mice, related to <a id="crosref2095" href="#fig1">Figure&nbsp;1</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0265" role="paragraph">(A-B) Experimental setup and treatment schedule. Tumor-bearing (&gt; 0.5&nbsp;cm) PDTX, PDOX or GDA mice were treated with Pin1i, GEM and/or αPD1, starting Pin1i 3&nbsp;days before others unless stated otherwise. Tumor sizes were detected by ultrasound or palpation with electronic caliper (A). Representative ultrasound images of the initial tumor on Day −3 (B).</div><div id="fspara0270" role="paragraph">(C-H) Pin1 inhibitors suppress tumor growth and progression, and desmoplastic TME in PDTX mice. Overt tumor-bearing PDTX mice were treated with vehicle or Pin1i-1 for 4&nbsp;weeks, followed by assaying tumor growth and volume (C), collagen deposition and cancer cell differentiation using Sirius Red and H&amp;E staining (D), cancer cell proliferation using Ki67 IHC (E), tumor-associated CAF activation and proliferation using double IF for αSMA and Ki67 (F) or platelet-derived growth factor receptor α (PDGFRα) and Ki67 (G), and EMT using double IF for E-cadherin and Vimentin (H) (n&nbsp;= 5). White arrows indicate αSMA and Ki67 double positive CAFs (F), Ki67 and PDGFRα double positive CAFs (G), or Vimentin positive cancer cell (H).</div><div id="fspara0275" role="paragraph">(I and J) Pin1 inhibitors suppress cancer cell proliferation and tumor progression, and desmoplastic and immunosuppressive TME in GDA mice. Tumor-bearing GDA mice were treated with vehicle, Pin1i-1 or −2 for 4&nbsp;weeks, followed by examining cancer cell differentiation using H&amp;E staining (I), and CAF proliferation using double IF for PDGFRα and Ki67 (J) using IF (n&nbsp;= 5).</div><div id="fspara0280" role="paragraph">(K-N) Pin1 inhibitors render PDAC sensitive to GEM in PDOX and PDTX mice. Patient-derived PDAC1 organoids and CAFs (K; PDOX mice, n&nbsp;= 5) or patient-derived PDAC tumors (L-N; PDTX mice, n&nbsp;= 6) were orthotopically transplanted into NSG mouse pancreas and when tumors reached 0.5&nbsp;cm, mice were treated with vehicle, Pin1i and/or GEM (20&nbsp;mg/kg), followed by measuring tumor volumes (K and L) and liver metastasis (N) after autopsy at 4&nbsp;weeks after treatment, or monitoring overall survival by Kaplan–Meier survival analysis (M). Median survival; vehicle 36&nbsp;days, GEM 42.5&nbsp;days, Pin1i-1 43&nbsp;days, and Pin1i-1&nbsp;+ GEM 71&nbsp;days (M).</div><div id="fspara0285" role="paragraph">Scale bars, 500 and 100&nbsp;μm (right panel) (D), 100 and 25&nbsp;μm (inset) (F, G), 50&nbsp;μm (H, J), and 100&nbsp;μm (I), and 200&nbsp;μm (N). Error bars, mean ± s.d.; <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗</sup>p&nbsp;= 0.0001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001; n.s., not significant; by Student’s t test (C-H, J), one-way ANOVA (K, L, N), or log-rank test (M).</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.07.020/asset/6eb9856b-38d4-43f6-b518-0b9416823e0a/main.assets/figs2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs2" src="/cms/10.1016/j.cell.2021.07.020/asset/386a0819-8edf-4c6e-9649-852bd4bc2763/main.assets/figs2.jpg" height="941" width="713" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/6eb9856b-38d4-43f6-b518-0b9416823e0a/main.assets/figs2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S2</span> <span class="figure__title__text">Targeting Pin1 disrupts the desmoplastic and/or immunosuppressive TME and render PDAC sensitive to GEM and/or anti-PD-1 in PDTX, PDOX, and GDA mice, related to <a id="crosref2100" href="#fig1">Figure&nbsp;1</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0295" role="paragraph">(A) Pin1 inhibitors render PDAC sensitive to GEM in GDA mice. Overt tumor-bearing GDA mice were treated with vehicle, Pin1i and/or GEM (20&nbsp;mg/kg) (n&nbsp;= 6), followed by monitoring overall survival by Kaplan–Meier survival analysis. Median survival; vehicle 34&nbsp;days, GEM 42&nbsp;days, Pin1i-2 56&nbsp;days, GEM&nbsp;+ Pin1i-2 83.5&nbsp;days.</div><div id="fspara0300" role="paragraph">(B-H) Pin1 inhibitors render PDAC sensitive to GEM and αPD1 by disrupting the desmoplastic and immunosuppressive TME in GDA mice. Tumor-bearing GDA mice were treated with vehicle, Pin1i and/or αPD1 or GEM (10mg/kg)&nbsp;+αPD1 (G+P), followed by measuring tumor volumes (B), assaying collagen deposition using Sirius Red staining (C), tumor-infiltrated immune cell profiling using flow cytometry (D, E), and tumor-infiltrating immune cell populations, CD8α<sup>+</sup> T&nbsp;cells, FOXP3<sup>+</sup> Tregs, Ly6G<sup>+</sup>CD11b<sup>+</sup> Myeloid cells (F), and CD8α<sup>+</sup>Granzyme B<sup>+</sup> CTLs (G) using IF after 4&nbsp;weeks treatment (n&nbsp;= 5), or measuring body weight after 120&nbsp;days treatment (Control/No transplantation: n&nbsp;= 3, G+P&nbsp;+ Pin1i-1: n&nbsp;= 7, G+P&nbsp;+ Pin1i-2: n&nbsp;= 6) (H).</div><div id="fspara0305" role="paragraph">(I) Pin1 inhibitors render PDAC curable by immunochemotherapy in GDA mice. Overt tumor-bearing GDA mice were treated with vehicle, Pin1i-2, GEM (10&nbsp;mg/kg)&nbsp;+ αPD1 (G+P), Pin1i-2&nbsp;+ αPD1, or Pin1i-2&nbsp;+ G+P for up to 150&nbsp;days and followed by monitoring overall survival by Kaplan–Meier survival analysis up to 250&nbsp;days (n&nbsp;= 8). Median survival; vehicle 36.5&nbsp;days, G+P 41&nbsp;days, Pin1i-2 54&nbsp;days, αPD1&nbsp;+ Pin1i-2 83.5&nbsp;days, G+P&nbsp;+ Pin1i-2 133.5&nbsp;days (I).</div><div id="fspara0310" role="paragraph">(J) αPD1 renders GDA tumors hyperprogressive in the absence of CD8<sup>+</sup> T&nbsp;cells. Tumor-bearing GDA mice were treated with αCD8α and vehicle, αPD1, Pin1i-2, or αPD1&nbsp;+ Pin1i-2 for 9&nbsp;days, followed by examining tumor volume.</div><div id="fspara0315" role="paragraph">(K) Pin1 inhibition does not significantly potentiate PTX or αCTLA4 therapy in GDA mice. Tumor-bearing GDA mice were treated with vehicle, Pin1i-2, PTX, αCTLA4, or their combination for 4&nbsp;weeks, followed by assaying tumor volume.</div><div id="fspara0320" role="paragraph">Scale bars, 200&nbsp;μm (C), 100&nbsp;μm (F), and 100 and 25&nbsp;μm (inset) (G). Error bars, mean ± s.d.; <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗</sup>p&nbsp;= 0.0001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001; n.s., not significant; by log-rank test (A, I), Student’s t test (D), or one-way ANOVA (B, C, E-H, J, K).</div></div></div></div></figcaption></figure></div><div id="p0065" role="paragraph">The above results suggest that Pin1 inhibitors might increase PDAC responses to chemo- and/or immunotherapy. Thus, we first treated overt tumor-bearing PDTX, PDOX or GDA mice with Pin1i and/or low dose (20&nbsp;mg/kg, weekly) gemcitabine (GEM), with or without starting Pin1i treatment 3&nbsp;days before starting GEM (<a id="crosref0835" href="#figs1">Figure&nbsp;S1</a>A). Pin1i-1 or -2 were only slightly superior to GEM treatment in inhibiting tumor growth and improving survival, but the effects were significantly enhanced by their combination in each of mouse models assessed (<a id="crosref0840" href="#figs1">Figures S1</a>K–S1M and <a id="crosref0845" href="#figs2">S2</a>A). The combination effects were even more profound in a group of tumor-bearing mice with Pin1i treatment started at 3&nbsp;days before GEM (<a id="crosref0850" href="#figs1">Figure&nbsp;S1</a>K). This prompted us to routinely start a Pin1i treatment at 3&nbsp;days before others in combination therapies. In addition, unlike GEM treatment alone, Pin1i also fully prevented liver metastasis of PDAC in PDTX mice (<a id="crosref0855" href="#figs1">Figure&nbsp;S1</a>N).</div><div id="p0070" role="paragraph">Next, we treated tumor-bearing GDA mice with Pin1i, and/or anti-PD-1 (αPD1), or low-dose (10&nbsp;mg/kg, weekly) GEM&nbsp;+ αPD1 (G+P) (<a id="crosref0860" href="#figs1">Figure&nbsp;S1</a>A). Treatment with αPD1 or G+P partially inhibited tumor growth and marginally increased overall survival (<span class="dropBlock reference-citations"><a id="body-ref-sref44-2" href="#" role="doc-biblioref" data-xml-rid="bib44" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref44-2" aria-controls="sref44-2">Jiang et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref44-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">45.</div><div>Jiang, H. ∙ Hegde, S. ∙ Knolhoff, B.L. ...</div><div><strong>Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy</strong></div><div><em>Nat. Med.</em> 2016; <strong>22</strong>:851-860</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.4123" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84976871907" target="_blank" aria-label="Open Scopus in new tab">Scopus (444)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27376576/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.4123&amp;pmid=27376576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and both Pin1i-1 and -2 as single agents were slightly more potent than above treatments (<a id="crosref0870" href="#fig1">Figures 1</a>D, 1E, <a id="crosref0875" href="#figs2">S2</a>B, and S2I). Notably, Pin1i-1&nbsp;+ αPD1 combination dramatically reduced tumor growth and more than doubled median survival, with 12.5% complete regression (<a id="crosref0880" href="#fig1">Figure&nbsp;1</a>E). The most pronounced effect was seen in a group treated with the triple combination. Pin1i-1 and G+P combination markedly disrupted the desmoplastic and immunosuppressive TME (<a id="crosref0885" href="#figs2">Figures S2</a>C, S2F, and S2G) and fundamentally changed overall survival, leading to 87.5% complete regression (<a id="crosref0890" href="#fig1">Figures 1</a>D and 1E). These mice survived without macroscopic (<a id="crosref0895" href="#fig1">Figure&nbsp;1</a>F) or microscopic (<a id="crosref0900" href="#fig1">Figure&nbsp;1</a>G) evidence for residual PDAC at least for 1 year in good health, even though the treatments were stopped at 120&nbsp;days (<a id="crosref0905" href="#fig1">Figures 1</a>E and <a id="crosref0910" href="#figs2">S2</a>H). Similar results were obtained with Pin1i-2 in combination with αPD1 or G+P, although they were less impressive during long-term treatment (<a id="crosref0915" href="#figs2">Figures S2</a>B, S2C, S2E, S2F, S2H, and S2I).</div><div id="p0075" role="paragraph">To examine the relevance of cytotoxic and natural killer cells for the synergy between Pin1 inhibition and immunotherapy, we examined the efficacy of Pin1i-2 and αPD1 combination in the absence or presence of CD8α<sup>+</sup> T&nbsp;cells or NK1.1<sup>+</sup> cells in GDA mice. When CD8α<sup>+</sup> T&nbsp;cells were depleted, PDAC tumor growth accelerated considerably and the synergistic efficacy of Pin1i-2 and αPD1 treatment was completely offset (<a id="crosref0920" href="#fig1">Figure&nbsp;1</a>H). αPD1 treatment alone also accelerated tumor growth in CD8α<sup>+</sup> T&nbsp;cell depleted GDA mice (<a id="crosref0925" href="#figs2">Figure&nbsp;S2</a>J), reminiscent of hyper-progression observed in clinical trials of cancer patients with αPD1 therapy (<span class="dropBlock reference-citations"><a id="body-ref-sref92" href="#" role="doc-biblioref" data-xml-rid="bib92" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref92" aria-controls="sref92">Wang et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref92"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">94.</div><div>Wang, X. ∙ Wang, F. ∙ Zhong, M. ...</div><div><strong>The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy</strong></div><div><em>Mol. Cancer.</em> 2020; <strong>19</strong>:81</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s12943-020-01200-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_94_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85085117338" target="_blank" aria-label="Open Scopus in new tab">Scopus (22)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32359357/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs12943-020-01200-x&amp;pmid=32359357" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Immune cell profiling showed that while Pin1i increased the number of tumor-infiltrating CD8α<sup>+</sup> T&nbsp;cells and their Granzyme B expression, Pin1i alone also increased their expression of the activation/exhaustion markers, PD-1, lymphocyte activation gene-3 (LAG-3), and cytotoxic T-lymphocyte antigen 4 (CTLA-4), but the later effects tended to be reduced by combination with αPD1 (<a id="crosref0935" href="#figs2">Figures S2</a>E and S2G), indicative of reversion of lymphocyte exhaustion (<span class="dropBlock reference-citations"><a id="body-ref-sref80" href="#" role="doc-biblioref" data-xml-rid="bib80" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref80" aria-controls="sref80">Ruscetti et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref80"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">82.</div><div>Ruscetti, M. ∙ Morris, 4th, J.P. ∙ Mezzadra, R. ...</div><div><strong>Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer</strong></div><div><em>Cell.</em> 2020; <strong>181</strong>:424-441</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2020.03.008&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2020.03.008&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85083049781" target="_blank" aria-label="Open Scopus in new tab">Scopus (64)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32234521/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2020.03.008&amp;pmid=32234521" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In contrast, PD-L1 expression on myeloid and dendritic cells (DCs), which contribute to anti-tumor immune response (<span class="dropBlock reference-citations"><a id="body-ref-sref71" href="#" role="doc-biblioref" data-xml-rid="bib71" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref71" aria-controls="sref71">Oh et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref71"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">73.</div><div>Oh, S.A. ∙ Wu, D.C. ∙ Cheung, J. ...</div><div><strong>PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer</strong></div><div><em>Nat. Can.</em> 2021; <strong>1</strong>:681-691</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s43018-020-0075-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs43018-020-0075-x" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), was not changed after Pin1 inhibition (<a id="crosref0950" href="#figs2">Figure&nbsp;S2</a>E). Thus, CD8<sup>+</sup> CTLs are pivotal for the synergy between Pin1 inhibition and immunotherapy.</div><div id="p0080" role="paragraph">To investigate whether the synergy of immunochemotherapy with Pin1 inhibition in PDAC is specific to GEM or αPD1, we tested the microtubule stabilizing paclitaxel (PTX), non-nucleoside-based chemotherapy, and anti-CTLA-4 (αCTLA4), an alternative ICB. Pin1 inhibition did not potentiate PTX anti-tumor activity and tended to increase αCTLA4 anti-tumor effect, but the effect was small and without statistical significance (<a id="crosref0955" href="#figs2">Figure&nbsp;S2</a>K). Thus, although Pin1 inhibitors have moderate single-agent anticancer efficacy, they potently disrupt the desmoplastic and immunosuppressive TME, and remarkably render most aggressive PDAC tumors curable when combined with GEM and αPD1 in GDA mice.</div></section><section id="sec-2-2"><h3>Pin1 is overexpressed both in cancer cells and CAFs in human PDAC and correlates with the desmoplastic and immunosuppressive TME and poor patient survival</h3><div id="p0085" role="paragraph">Given such unexpected and striking potency of Pin1i in rendering PDAC curable, we evaluated Pin1 expression in human tumor tissues surgically resected from 167 PDAC patients and its relationships with TME changes and patient survival using IHC with a validated Pin1 monoclonal antibody (<span class="dropBlock reference-citations"><a id="body-ref-sref4-1" href="#" role="doc-biblioref" data-xml-rid="bib4" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref4-1" aria-controls="sref4-1">Bao et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref4-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Bao, L. ∙ Kimzey, A. ∙ Sauter, G. ...</div><div><strong>Prevalent overexpression of prolyl isomerase Pin1 in human cancers</strong></div><div><em>Am. J. Pathol.</em> 2004; <strong>164</strong>:1727-1737</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2FS0002-9440%2810%2963731-5&amp;cf=fulltext&amp;site=ajpa-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2FS0002-9440%2810%2963731-5&amp;cf=pdf&amp;site=ajpa-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15111319/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0002-9440%2810%2963731-5&amp;pmid=15111319" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Pin1 was overexpressed in cancer cells and correlated positively with cancer progression (<a id="crosref0965" href="#fig2">Figures 2</a>A and <a id="crosref0970" href="#figs3">S3</a>A). Furthermore, Pin1 was overexpressed in tumor stromal CAFs, which expressed various CAF markers, α-smooth muscle actin (αSMA), fibroblast activation protein (FAP), human leukocyte antigen (HLA) class II histocompatibility antigen DP beta 1 (HLA-DPB1), or CD44 (<a id="crosref0975" href="#fig2">Figures 2</a>B–2D, and <a id="crosref0980" href="#figs3">S3</a>B) (<span class="dropBlock reference-citations"><a id="body-ref-sref40-2" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40-2" aria-controls="sref40-2">Hosein et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref40-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Hosein, A.N. ∙ Brekken, R.A. ∙ Maitra, A.</div><div><strong>Pancreatic cancer stroma: an update on therapeutic targeting strategies</strong></div><div><em>Nat. Rev. Gastroenterol. Hepatol.</em> 2020; <strong>17</strong>:487-505</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41575-020-0300-1" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85084520894" target="_blank" aria-label="Open Scopus in new tab">Scopus (93)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32393771/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41575-020-0300-1&amp;pmid=32393771" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). By classifying our cohorts into Pin1-High and Pin1-Low groups based on their IHC intensity and area, we not only found that Pin1 was overexpressed in cancer cells in 71.5% of the patients and correlated with poor survival, as reported (<span class="dropBlock reference-citations"><a id="body-ref-sref14-1" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14-1" aria-controls="sref14-1">Chen et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref14-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">15.</div><div>Chen, L. ∙ Xu, X. ∙ Wen, X. ...</div><div><strong>Targeting PIN1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis</strong></div><div><em>Cancer Sci.</em> 2019; <strong>110</strong>:2442-2455</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/cas.14085" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85070236436" target="_blank" aria-label="Open Scopus in new tab">Scopus (3)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31148345/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fcas.14085&amp;pmid=31148345" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), but also uncovered that Pin1 was overexpressed in CAFs in 51.9% of the patients and correlated with poor survival (<a id="crosref0995" href="#fig2">Figure&nbsp;2</a>E). More impressively, high Pin1 both in cancer cells and CAFs, as compared with low Pin1 group, strongly correlated with reduced median overall survival from 60 to 16&nbsp;months in this cohort (<a id="crosref1000" href="#fig2">Figure&nbsp;2</a>F). To ask whether Pin1 overexpression is relevant to the desmoplastic and immunosuppressive TME, we evaluated collagen deposition and tumor-infiltrating immune cell populations in human PDAC tissues. Pin1 overexpression in CAFs, but not in cancer cells, significantly correlated with collagen deposition (<a id="crosref1005" href="#fig2">Figure&nbsp;2</a>G). Pin1 overexpression in cancer cells and CAFs also correlated with fewer infiltrated CD8<sup>+</sup> T&nbsp;cells and more CD163<sup>+</sup> TAMs (<a id="crosref1010" href="#fig2">Figures 2</a>H and 2I). Thus, Pin1 is overexpressed in cancer cells and CAFs in human PDAC and correlates well with the desmoplastic and immunosuppressive TME and poor survival.</div><div class="figure-wrap"><figure id="fig2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.07.020/asset/858850b1-e141-4e87-a75a-2756ce1af9b8/main.assets/gr2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr2" src="/cms/10.1016/j.cell.2021.07.020/asset/82f67305-8a0a-417a-a8eb-585d89ee7b4b/main.assets/gr2.jpg" height="941" width="737" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/858850b1-e141-4e87-a75a-2756ce1af9b8/main.assets/gr2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;2</span> <span class="figure__title__text">Pin1 is overexpressed in cancer cells and CAFs in human PDAC and strongly correlates with the desmoplastic and immunosuppressive TME and poor patient survival</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0045" role="paragraph">(A) Representative images of Pin1 IHC staining in human PDAC tissues at different stages of cancer progression. Quantification of Pin1 expression is shown in <a id="crosref2055" href="#figs3">Figure&nbsp;S3</a>A.</div><div id="fspara0050" role="paragraph">(B) Pin1, ctokeratin (CK) 19, and αSMA IHC staining in human PDAC tissues. Black arrows indicate Pin1<sup>+</sup>CK19<sup>+</sup>αSMA<sup>−</sup> cancer cell and red arrows indicate Pin1<sup>+</sup>CK19<sup>–</sup>αSMA<sup>+</sup> CAF.</div><div id="fspara0055" role="paragraph">(C and D) Tissue-based cyclic immunofluorescence (t-CyCIF) for Pin1 (white), pan-cytokeratin (Pan-CK) (green), αSMA (red), HLA-DBP1 (yellow), CD44 (cyan), and CD45 (green) in human PDAC tissues (C) and quantification of Pin1 expression (D). Red arrows indicate Pin1<sup>+</sup> and DPB1<sup>+</sup> or CD44<sup>+</sup> CAFs or Pin1<sup>+</sup> and CD45<sup>+</sup> cells (C).</div><div id="fspara0060" role="paragraph">(E and F) Human PDAC tissues were classified into cancer cell Pin1-High or Pin1-Low groups, CAFs Pin1-High or Pin1-Low (E), or cancer Pin1-High and CAF Pin1-High or cancer Pin1-Low and CAF Pin1-Low groups (F) based on Pin1 IHC, followed by examining patient overall survival using Kaplan-Meier survival analysis.</div><div id="fspara0065" role="paragraph">(G) Pin1 IHC and Sirius Red staining in human normal pancreas and PDAC tissues and quantification of collagen deposition using Sirius Red staining (n&nbsp;= 46).</div><div id="fspara0070" role="paragraph">(H and I) Pin1 and CD8 (H) or CD163 (I) IHC staining in human PDAC tissues, and quantification of CD8 or CD163 positive cells area per field (n&nbsp;= 45) (H and I).</div><div id="fspara0075" role="paragraph">Scale bars, 300 and 50&nbsp;μm (inset) (A), 1,000 and 100&nbsp;μm (high magnification) (B), 100 (left panel) and 50&nbsp;μm (C), and 300&nbsp;μm (G–I). Error bars, mean ± SD; <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗</sup>p&nbsp;= 0.0001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001; n.s., not significant; by Student’s t test (G–I) or log-rank test (E and F).</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.07.020/asset/e85a81de-2a9f-4e74-add2-204a59509e86/main.assets/figs3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs3" src="/cms/10.1016/j.cell.2021.07.020/asset/0096feb9-ce8b-4633-8a9b-fc05519694e6/main.assets/figs3.jpg" height="876" width="657" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/e85a81de-2a9f-4e74-add2-204a59509e86/main.assets/figs3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S3</span> <span class="figure__title__text">Pin1 is overexpressed in CAFs, and Pin1 promotes oncogenic signaling pathways, CAF activation, and crosstalk with cancer cells to enhance tumor growth and malignancy in human organoids and PDOXs, related to <a id="crosref2105" href="#fig2">Figures 2</a> and <a id="crosref2110" href="#fig3">3</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0330" role="paragraph">(A-B) Pin1 is overexpressed in cancer cells and CAFs, and correlated with PDAC progression.</div><div id="fspara0335" role="paragraph">Quantification of Pin1 expression at different stages of human PDAC progression by deterring Pin1 IHC score. Normal-Adjacent normal (Normal, n&nbsp;= 12), Low grade PanIN (Low, n&nbsp;= 20), High grade PanIN (High, n&nbsp;= 35), PDAC (n&nbsp;= 167) (A). Representative images of Co-IF for Pin1 (red) and FAP (green) in human PDAC tissue (B).</div><div id="fspara0340" role="paragraph">(C-F) ATRA and ATO synergistically reduce Pin1 and its substrate oncoproteins, suppress cell growth and induce quiescent phenotype in CAFs, like Pin1 KD. CAF1 and CAF2 cells derived from two different human PDAC patients were treated with ATRA, ATO, or their combination (Pin1i-1) for 72&nbsp;hr (C, D, F) or genetically knocked down of Pin1 (E), followed by examining Pin1 and its substrate oncoproteins using IB (C), cell growth using cell proliferation assay (D, E), quiescent phenotype as measured by lipid droplets/CAF cell using BODIPY staining (F). ATRA and ATO were used in 10: 1 ratio as Pin1i-1 and only ATRA concentrations were shown to simplify labeling (C). CAFs were treated with control (DMSO), ATRA (10&nbsp;μM) or Pin1i-1 (10&nbsp;μM) (F).</div><div id="fspara0345" role="paragraph">(G and H) Pin1 inhibitors reduce cytokine production in primary human PDAC cells (G) and CAFs (H). Primary PDAC2 or CAF1 cells were treated with Pin1i-1 or −2 for 72&nbsp;hr, before assaying IL-6, TGFβ, LIF and CXCL12 using ELISA. Pin1i-1 10&nbsp;μM (G). ATRA and ATO were used in 10: 1 ratio as Pin1i-1 and only ATRA concentrations were shown (H).</div><div id="fspara0350" role="paragraph">(I-K) Pin1-inhibited or CRISPR KO CAFs fail to promote PDAC growth and invasion in human 3D PDAC organoid direct co-cultures. Control (DMSO) or Pin1i-treated CAF1 (Pin1i-1 10&nbsp;μM or Pin1i-2 5&nbsp;μM for 72&nbsp;hr), or CRISPER control or Pin KO CAF1, labeled in red using cell tracker red, were cocultured with established human PDAC1 organoids, labeled by GFP (green) (I), followed by time-lapse imaging to visualize their interactions and analyze organoid growth and invasion (J, K).</div><div id="fspara0355" role="paragraph">(L and M) Pin1 KO CAFs fail to promote PDAC tumor progression and proliferation in PDOX mice. Human PDAC1 organoids were orthotopically co-transplanted with or without CRISPER control or Pin1 KO CAF1 into NSG mouse pancreas for 5&nbsp;weeks, followed by examining histology using H&amp;E staining (L) and cell proliferation using Ki67 IHC (M) derived from PDAC1 organoids (n&nbsp;= 5).</div><div id="fspara0360" role="paragraph">Scale bars, 100 and 20&nbsp;μm (inset) (B), 100&nbsp;μm (J), 100 and 50&nbsp;μm (right panels) (L), and 50&nbsp;μm (M). Error bars, mean ± s.d.; <sup>∗∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗</sup>p&nbsp;= 0.0001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001; n.s., not significant; multiple comparisons: by Student’s t test (E, G) or one-way ANOVA (F, H, K, M).</div></div></div></div></figcaption></figure></div></section><section id="sec-2-3"><h3>Pin1 promotes oncogenic signaling pathways, CAF activation, and crosstalk with cancer cells to enhance tumor growth and malignancy in human organoids and PDOXs</h3><div id="p0090" role="paragraph">To determine the functional significance of Pin1 overexpression in CAFs in human PDAC tumors, we derived primary CAFs from two different PDAC patients (<span class="dropBlock reference-citations"><a id="body-ref-sref48-2" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48-2" aria-controls="sref48-2">Koikawa et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref48-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Koikawa, K. ∙ Ohuchida, K. ∙ Ando, Y. ...</div><div><strong>Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Lett.</em> 2018; <strong>425</strong>:65-77</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2018.03.031" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29580808/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2018.03.031&amp;pmid=29580808" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, <span class="dropBlock reference-citations"><a id="body-ref-sref49-1" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49-1" aria-controls="sref49-1">2018b</a><div class="dropBlock__holder" data-db-target-of="sref49-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Koikawa, K. ∙ Ohuchida, K. ∙ Takesue, S. ...</div><div><strong>Pancreatic stellate cells reorganize matrix components and lead pancreatic cancer invasion via the function of Endo180</strong></div><div><em>Cancer Lett.</em> 2018; <strong>412</strong>:143-154</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2017.10.010" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85032707374" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29061505/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2017.10.010&amp;pmid=29061505" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and inhibited their Pin1 function using Pin1i, genetic knockdown (KD) or CRISPR knockout (KO). Both Pin1 inhibitors dose-dependently reduced Pin1 and its many substrate oncoproteins in CAFs (<a id="crosref1025" href="#fig3">Figures 3</a>A and <a id="crosref1030" href="#figs3">S3</a>C), with ATRA and ATO synergistically targeting and degrading Pin1, as shown (<span class="dropBlock reference-citations"><a id="body-ref-sref50-4" href="#" role="doc-biblioref" data-xml-rid="bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50-4" aria-controls="sref50-4">Kozono et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref50-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Kozono, S. ∙ Lin, Y.M. ∙ Seo, H.S. ...</div><div><strong>Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells</strong></div><div><em>Nat. Commun.</em> 2018; <strong>9</strong>:3069</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-018-05402-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85051562951" target="_blank" aria-label="Open Scopus in new tab">Scopus (54)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30093655/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-018-05402-2&amp;pmid=30093655" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref94-3" href="#" role="doc-biblioref" data-xml-rid="bib94" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref94-3" aria-controls="sref94-3">Wei et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref94-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">96.</div><div>Wei, S. ∙ Kozono, S. ∙ Kats, L. ...</div><div><strong>Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer</strong></div><div><em>Nat. Med.</em> 2015; <strong>21</strong>:457-466</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.3839" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_96_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84937759226" target="_blank" aria-label="Open Scopus in new tab">Scopus (172)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25849135/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.3839&amp;pmid=25849135" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We demonstrated that Pin1 inhibition suppressed CAF proliferation (<a id="crosref1045" href="#fig3">Figures 3</a>B, <a id="crosref1050" href="#figs3">S3</a>D, and S3E), induced CAF quiescent phenotype, and inhibited their ability to secrete a wide range of cytokines (<a id="crosref1055" href="#fig3">Figures 3</a>C–3E and <a id="crosref1060" href="#figs3">S3</a>F). Notably, we found suppression of IL-6 and TGF-β release by cancer cells and IL-6, TGF-β, LIF, and CXCL12 secretion by CAFs in response to Pin1 inhibition (<a id="crosref1065" href="#figs3">Figures S3</a>G and S3H). Those factors promote cancer cell progression (<span class="dropBlock reference-citations"><a id="body-ref-sref24-1" href="#" role="doc-biblioref" data-xml-rid="bib24" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref24-1" aria-controls="sref24-1">Erkan et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref24-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Erkan, M. ∙ Adler, G. ∙ Apte, M.V. ...</div><div><strong>StellaTUM: current consensus and discussion on pancreatic stellate cell research</strong></div><div><em>Gut.</em> 2012; <strong>61</strong>:172-178</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/gutjnl-2011-301220" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84855201311" target="_blank" aria-label="Open Scopus in new tab">Scopus (270)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22115911/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1136%2Fgutjnl-2011-301220&amp;pmid=22115911" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref85" href="#" role="doc-biblioref" data-xml-rid="bib85" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref85" aria-controls="sref85">Shi et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref85"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">87.</div><div>Shi, Y. ∙ Gao, W. ∙ Lytle, N.K. ...</div><div><strong>Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring</strong></div><div><em>Nature.</em> 2019; <strong>569</strong>:131-135</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-019-1130-6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85064686834" target="_blank" aria-label="Open Scopus in new tab">Scopus (112)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30996350/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-019-1130-6&amp;pmid=30996350" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), prevent T&nbsp;cell recruitment into the TME (<span class="dropBlock reference-citations"><a id="body-ref-sref28-1" href="#" role="doc-biblioref" data-xml-rid="bib28" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref28-1" aria-controls="sref28-1">Garg et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref28-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Garg, B. ∙ Giri, B. ∙ Modi, S. ...</div><div><strong>NFκB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12</strong></div><div><em>Gastroenterology.</em> 2018; <strong>155</strong>:880-891</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2018.05.051&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2018.05.051&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85051678735" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29909021/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2018.05.051&amp;pmid=29909021" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), induce the desmoplastic and immunosuppressive TME (<span class="dropBlock reference-citations"><a id="body-ref-sref62-1" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-1" aria-controls="sref62-1">Mace et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref62-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Mace, T.A. ∙ Shakya, R. ∙ Pitarresi, J.R. ...</div><div><strong>IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer</strong></div><div><em>Gut.</em> 2018; <strong>67</strong>:320-332</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/gutjnl-2016-311585" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84994516325" target="_blank" aria-label="Open Scopus in new tab">Scopus (212)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27797936/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1136%2Fgutjnl-2016-311585&amp;pmid=27797936" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and suppress response to anti-PD-L1 (αPDL1) (<span class="dropBlock reference-citations"><a id="body-ref-sref26" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26" aria-controls="sref26">Feig et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref26"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">27.</div><div>Feig, C. ∙ Jones, J.O. ∙ Kraman, M. ...</div><div><strong>Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2013; <strong>110</strong>:20212-20217</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1320318110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84890281217" target="_blank" aria-label="Open Scopus in new tab">Scopus (876)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24277834/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1320318110&amp;pmid=24277834" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref65-1" href="#" role="doc-biblioref" data-xml-rid="bib65" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref65-1" aria-controls="sref65-1">Mariathasan et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref65-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">67.</div><div>Mariathasan, S. ∙ Turley, S.J. ∙ Nickles, D. ...</div><div><strong>TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T&nbsp;cells</strong></div><div><em>Nature.</em> 2018; <strong>554</strong>:544-548</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25501" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85042495633" target="_blank" aria-label="Open Scopus in new tab">Scopus (1236)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29443960/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25501&amp;pmid=29443960" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Thus, Pin1 activates CAFs and may contribute to the desmoplastic and immunosuppressive TME.</div><div class="figure-wrap"><figure id="fig3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.07.020/asset/935672f7-ef2b-43a2-9ed5-d8c00c8fa134/main.assets/gr3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr3" src="/cms/10.1016/j.cell.2021.07.020/asset/7925f3ce-1f21-4a29-a264-f16cf591742f/main.assets/gr3.jpg" height="930" width="753" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/935672f7-ef2b-43a2-9ed5-d8c00c8fa134/main.assets/gr3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;3</span> <span class="figure__title__text">Pin1 promotes oncogenic signaling pathways, CAF activation, and crosstalk with cancer cells to enhance tumor growth and malignancy in organoids and PDOXs</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0085" role="paragraph">(A–E) Primary human CAFs derived from two different PDAC patients (CAF1 or CAF2) were treated with Pin1i-1 or -2 for 72 h, or subjected to stable Pin1 KD or KO, followed by examining Pin1 and its substrate oncoproteins using IB (A), cell growth using proliferation assay (B), quiescent phenotype as measured by lipid droplets/CAF cell using BODIPY (C and D), and cytokine production using cytokine array (E). ATRA and ATO were used in 10:1 ratio as Pin1i-1 and only ATRA concentrations were shown (A and B). Pin1i-1 (10&nbsp;μM) or Pin1i-2 (5&nbsp;μM) (C–E).</div><div id="fspara0090" role="paragraph">(F–H) Pin1 KD or vector control CAFs were seeded to the top of Matrigel that contained pre-formed PDAC organoids and co-cultured for 10&nbsp;days (F), followed by examining organoid growth and invasion into Matrigel using microscopic imaging analysis (G and H). Human PDAC organoids were derived from two different PDAC patients (PDAC1 and PDAC2 organoids).</div><div id="fspara0095" role="paragraph">(I and J) Human PDAC organoids were orthotopically transplanted alone or with Pin1 KO CAFs or CRISPR control CAFs into the pancreas of NSG mice for 5&nbsp;weeks, followed by examining tumor growth (l), and fibrosis using Sirius Red staining (J) (n&nbsp;= 5).</div><div id="fspara0100" role="paragraph">Scale bars, 100&nbsp;(top panels) and 50&nbsp;μm (bottom panels) (C), 100&nbsp;μm (G), and 200&nbsp;μm (J). Error bars, mean ± SD; <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗</sup>p&nbsp;= 0.0001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001; n.s., not significant; by one-way ANOVA.</div><div id="fspara0105" role="paragraph">See also <a id="crosref2060" href="#figs3">Figure&nbsp;S3</a>.</div></div></div></div></figcaption></figure></div><div id="p0095" role="paragraph">A continuous crosstalk between cancer cells and CAFs enhances tumor growth and invasion (<span class="dropBlock reference-citations"><a id="body-ref-sref24-2" href="#" role="doc-biblioref" data-xml-rid="bib24" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref24-2" aria-controls="sref24-2">Erkan et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref24-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Erkan, M. ∙ Adler, G. ∙ Apte, M.V. ...</div><div><strong>StellaTUM: current consensus and discussion on pancreatic stellate cell research</strong></div><div><em>Gut.</em> 2012; <strong>61</strong>:172-178</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/gutjnl-2011-301220" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84855201311" target="_blank" aria-label="Open Scopus in new tab">Scopus (270)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22115911/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1136%2Fgutjnl-2011-301220&amp;pmid=22115911" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). To address whether Pin1 inhibition in CAFs affects their ability to act on cancer cells, we first indirectly co-cultured pre-formed human PDAC organoids with CAFs to analyze the effects of CAF-derived humoral factors on PDAC organoid growth and invasion (<a id="crosref1105" href="#fig3">Figure&nbsp;3</a>F). Unlike control CAFs, which promoted PDAC organoid growth and invasion, Pin1 KD CAFs failed to promote PDAC organoid growth and invasion similar to the level of those without added CAFs (<a id="crosref1110" href="#fig3">Figures 3</a>G and 3H). To analyze the effects of cell-cell interactions, we then directly co-cultured PDAC organoids with Pin1i-treated or KO CAFs, followed by assaying organoid growth and invasion using time-lapse imaging (<span class="dropBlock reference-citations"><a id="body-ref-sref48-3" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48-3" aria-controls="sref48-3">Koikawa et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref48-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Koikawa, K. ∙ Ohuchida, K. ∙ Ando, Y. ...</div><div><strong>Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Lett.</em> 2018; <strong>425</strong>:65-77</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2018.03.031" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29580808/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2018.03.031&amp;pmid=29580808" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (<a id="crosref1120" href="#figs3">Figure&nbsp;S3</a>I). The results further confirmed that control CAFs, but neither Pin1i-treated nor Pin1 KO CAFs, promoted PDAC organoid growth and invasion (<a id="crosref1125" href="#figs3">Figures S3</a>J and S3K; <a id="crosref1130" href="#mmc4">Video S1</a>). Finally, to examine whether Pin1 is important for CAFs to promote the TME and tumor growth of PDAC <i>in&nbsp;vivo</i>, we orthotopically co-transplanted human PDAC organoids with Pin1 KO or control CAFs into the mouse pancreas (PDOX model). In contrast to control CAFs, Pin1 KO CAFs completely failed to promote tumor fibrosis, cancer cell proliferation, and tumor growth and progression, similar to those without co-transplanted CAFs (<a id="crosref1135" href="#fig3">Figures 3</a>I, 3J, <a id="crosref1140" href="#figs3">S3</a>L, and S3M). Thus, Pin1 in CAFs is necessary to promote the pro-tumorigenic TME and enhance the growth and malignant phenotype of PDAC in human organoids and mouse tumors.</div><div id="p0100" role="paragraph"><div id="mmc4" class="core-supplementary-material" data-category="video"><div class="core-link"><div class="cloudflare-stream-container" id="mmc4" data-type="mp4"><span id="video_stream_mmc4_src" class="video-stream-source" style="display:none">eyJraWQiOiI4ZjUxYWNhY2IzYjhiNjNlNzFlYmIzYWFmYTU5NmZmYyIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiJjMDNkYWM2OTgzYWM0NmI4MDM0MTRhYmJmMDg0YzgzZSIsImtpZCI6IjhmNTFhY2FjYjNiOGI2M2U3MWViYjNhYWZhNTk2ZmZjIiwiZXhwIjoxNzQ5NjEyOTA3fQ.cCrwiKcfYX3wSxwnSBwFrHOakBlhbRAjqMBSLH14Ydx8zvXf_HXh1LSgD1uxv2hSfL2ID9Qr5beroaiEgzIGIHoIncuLthiDz5C5nPMv8tRgRxtU4kE95eBZlleki0M6SkGzzs9_Hos_Fwft4jYT0d4eWmdgUysoqhFEzPc-tGZYEbVhLU836K6lMQ_APmdnvd6flXZSUBJ6XIFWZifjN6gDIJpRpDUsBvsRM8t3d3iV0GCY2T9Yp7wRFnzioHkZrfnirk5wpN4wqXLtlrKTo0VkRWogo6NnG67_l6sKt29DQP-V8iguGqiHhAIHNUR64p3WA8C704oS1NS5Z-DGxQ</span><stream src="eyJraWQiOiI4ZjUxYWNhY2IzYjhiNjNlNzFlYmIzYWFmYTU5NmZmYyIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiJjMDNkYWM2OTgzYWM0NmI4MDM0MTRhYmJmMDg0YzgzZSIsImtpZCI6IjhmNTFhY2FjYjNiOGI2M2U3MWViYjNhYWZhNTk2ZmZjIiwiZXhwIjoxNzQ5NjEyOTA3fQ.cCrwiKcfYX3wSxwnSBwFrHOakBlhbRAjqMBSLH14Ydx8zvXf_HXh1LSgD1uxv2hSfL2ID9Qr5beroaiEgzIGIHoIncuLthiDz5C5nPMv8tRgRxtU4kE95eBZlleki0M6SkGzzs9_Hos_Fwft4jYT0d4eWmdgUysoqhFEzPc-tGZYEbVhLU836K6lMQ_APmdnvd6flXZSUBJ6XIFWZifjN6gDIJpRpDUsBvsRM8t3d3iV0GCY2T9Yp7wRFnzioHkZrfnirk5wpN4wqXLtlrKTo0VkRWogo6NnG67_l6sKt29DQP-V8iguGqiHhAIHNUR64p3WA8C704oS1NS5Z-DGxQ" class="cloudflare-stream-player ready tracked" id="video_stream_mmc4" controls="true"><div class="player-share-button" title="Share Video"><div class="share-player-icon"></div></div><div class="player-share-container hidden"><span class="player-close-share"></span><div class="social-links-container"><ul class="social-links-list"><li class="html5-share-facebook-icon" data-share-url="https://www.facebook.com/sharer/sharer.php?u=https://www.cell.com/cell/fulltext/S0092-8674(21)00879-5" target="_blank"></li><li class="html5-share-twitter-icon" data-share-url="https://twitter.com/share?url=https://www.cell.com/cell/fulltext/S0092-8674(21)00879-5" target="_blank"></li><li class="html5-share-mail-icon" data-share-url="mailto:?body=https://www.cell.com/cell/fulltext/S0092-8674(21)00879-5" target="_blank"></li></ul><input type="text" value="https://www.cell.com/cell/fulltext/S0092-8674(21)00879-5" readonly="readonly" class="share-input"></div></div><div style="position: relative; height: 0px; width: 100%; padding-top: 56.25%;"><iframe src="https://embed.cloudflarestream.com/embed/iframe.fla9.823df22.html?videoId=eyJraWQiOiI4ZjUxYWNhY2IzYjhiNjNlNzFlYmIzYWFmYTU5NmZmYyIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiJjMDNkYWM2OTgzYWM0NmI4MDM0MTRhYmJmMDg0YzgzZSIsImtpZCI6IjhmNTFhY2FjYjNiOGI2M2U3MWViYjNhYWZhNTk2ZmZjIiwiZXhwIjoxNzQ5NjEyOTA3fQ.cCrwiKcfYX3wSxwnSBwFrHOakBlhbRAjqMBSLH14Ydx8zvXf_HXh1LSgD1uxv2hSfL2ID9Qr5beroaiEgzIGIHoIncuLthiDz5C5nPMv8tRgRxtU4kE95eBZlleki0M6SkGzzs9_Hos_Fwft4jYT0d4eWmdgUysoqhFEzPc-tGZYEbVhLU836K6lMQ_APmdnvd6flXZSUBJ6XIFWZifjN6gDIJpRpDUsBvsRM8t3d3iV0GCY2T9Yp7wRFnzioHkZrfnirk5wpN4wqXLtlrKTo0VkRWogo6NnG67_l6sKt29DQP-V8iguGqiHhAIHNUR64p3WA8C704oS1NS5Z-DGxQ" allowfullscreen="true" allow="autoplay; picture-in-picture" style="height: 100%; width: 100%; position: absolute; top: 0px; left: 0px; border: none;"></iframe></div></stream></div><a href="/cms/10.1016/j.cell.2021.07.020/attachment/7f5fe635-acd3-4c0a-b130-9c9c70afdc9a/mmc4.mp4" download="mmc4.mp4" aria-labelledby="mmc4-heading mmc4-link"><span id="mmc4-link">Video (3.23 MB)</span></a></div><div class="core-description"><div id="mmc4-heading" class="heading">Video S1. Pin1-inhibited or CRISPR KO CAFs fail to promote PDAC growth and invasion in human 3D PDAC organoid direct co-cultures, related to Figure&nbsp;S3</div><div id="espara0010" role="paragraph">Pin1i-treated CAF1 (Pin1i1 10&nbsp;μM or Pin1i-2 5&nbsp;μM for 72&nbsp;hr), or Pin KO CAF1 or control CAF1, labeled in red using cell tracker red, were co-cultured with established PDAC1 organoids, labeled by GFP (green), followed by live-cell time-lapse movies to visualize their interactions and analyze organoid growth and invasion.</div></div></div></div></section><section id="sec-2-4"><h3>Pin1 promotes oncogenic signaling pathways and reduces the expression of PD-L1 and ENT1 at the cell surface of PDAC cells</h3><div id="p0105" role="paragraph">The above results show that targeting Pin1 disrupts the TME and renders PDAC tumors curable by immunochemotherapy, but the previous attempts to target stroma cells in PDAC were only modestly effective (<span class="dropBlock reference-citations"><a id="body-ref-sref39-3" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-3" aria-controls="sref39-3">Ho et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref39-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Ho, W.J. ∙ Jaffee, E.M. ∙ Zheng, L.</div><div><strong>The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities</strong></div><div><em>Nat. Rev. Clin. Oncol.</em> 2020; <strong>17</strong>:527-540</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41571-020-0363-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85084454263" target="_blank" aria-label="Open Scopus in new tab">Scopus (106)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32398706/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41571-020-0363-5&amp;pmid=32398706" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref81-3" href="#" role="doc-biblioref" data-xml-rid="bib81" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref81-3" aria-controls="sref81-3">Sahai et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref81-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">83.</div><div>Sahai, E. ∙ Astsaturov, I. ∙ Cukierman, E. ...</div><div><strong>A framework for advancing our understanding of cancer-associated fibroblasts</strong></div><div><em>Nat. Rev. Cancer.</em> 2020; <strong>20</strong>:174-186</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41568-019-0238-1" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85078418124" target="_blank" aria-label="Open Scopus in new tab">Scopus (485)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31980749/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41568-019-0238-1&amp;pmid=31980749" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref95-2" href="#" role="doc-biblioref" data-xml-rid="bib95" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref95-2" aria-controls="sref95-2">Whittle and Hingorani, 2019</a><div class="dropBlock__holder" data-db-target-of="sref95-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">97.</div><div>Whittle, M.C. ∙ Hingorani, S.R.</div><div><strong>Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets</strong></div><div><em>Gastroenterology.</em> 2019; <strong>156</strong>:2085-2096</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2018.12.044&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2018.12.044&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85064573516" target="_blank" aria-label="Open Scopus in new tab">Scopus (38)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30721663/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2018.12.044&amp;pmid=30721663" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We reasoned that Pin1 inhibitors might also act on cancer cells, given its overexpression in cancer cells (<a id="crosref1160" href="#fig2">Figures 2</a>A–2D). Thus, we examined the effects of Pin1i, Pin1 KD or KO in primary PDAC cells and organoids derived from two different PDAC patients (<span class="dropBlock reference-citations"><a id="body-ref-sref48-4" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48-4" aria-controls="sref48-4">Koikawa et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref48-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Koikawa, K. ∙ Ohuchida, K. ∙ Ando, Y. ...</div><div><strong>Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Lett.</em> 2018; <strong>425</strong>:65-77</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2018.03.031" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29580808/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2018.03.031&amp;pmid=29580808" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Indeed, like Pin1 KD or KO, both Pin1 inhibitors dose-dependently reduced Pin1 and its substrate oncoproteins including those in Kras signaling (<a id="crosref1170" href="#figs4">Figures S4</a>A–S4C and S4E), as well as PDAC cell proliferation (<a id="crosref1175" href="#figs4">Figures S4</a>D, S4F, and S4G), but the effects were largely abolished by Pin1 KO (<a id="crosref1180" href="#figs4">Figure&nbsp;S4</a>H), confirming their specificity. Furthermore, like Pin1 KD, both Pin1 inhibitors also reduced human PDAC organoid growth and enhanced the ability of GEM to inhibit organoid growth and proliferation (<a id="crosref1185" href="#figs4">Figures S4</a>I–S4L). Moreover, when human PDAC organoids were pre-treated with Pin1i-1 or -2, followed by treatment with GEM, both Pin1 inhibitors greatly potentiated GEM-mediated organoid apoptosis, whereas neither Pin1i nor GEM alone had obvious effect (<a id="crosref1190" href="#fig4">Figures 4</a>A and 4B).</div><div class="figure-wrap"><figure id="fig4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.07.020/asset/134b02a3-56ef-4ca9-96c2-c234f806bed2/main.assets/gr4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr4" src="/cms/10.1016/j.cell.2021.07.020/asset/6017156b-7631-48c5-b68b-772566aa1656/main.assets/gr4.jpg" height="875" width="657" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/134b02a3-56ef-4ca9-96c2-c234f806bed2/main.assets/gr4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;4</span> <span class="figure__title__text">Pin1 promotes oncogenic signaling pathways and reduces the expression of PD-L1 and ENT1 at the cell surface of PDAC cells</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0115" role="paragraph">(A and B) Human PDAC2 organoids were pre-treated with control (DMSO), Pin1i-1 (10&nbsp;μM), or Pin1i-2 (5&nbsp;μM) for 72&nbsp;h and then treated with control (PBS) or GEM (25&nbsp;nM) for 24 h, followed by examining organoid apoptosis using caspase 3/7 green fluorescence reagent.</div><div id="fspara0120" role="paragraph">(C) Human PDAC2 cells were treated with Pin1i-1 or -2 at various concentrations for 72 h, followed by IB for different proteins indicated. ATRA and ATO were used in 10:1 ratio as Pin1i-1 and only ATRA concentrations are shown.</div><div id="fspara0125" role="paragraph">(D) PDAC1 or 2 cells were subjected to Pin1 KD or KO, followed by IB for different proteins indicated.</div><div id="fspara0130" role="paragraph">(E and F) PDAC2 cells were treated with control (DMSO), Pin1i-1 (10&nbsp;μM), or Pin1i-2 (5&nbsp;μM), followed by IF for Pin1 (red), DAPI (blue), and PD-L1 (green) (E) or ENT1 (green) (F). White arrows point to PD-L1 (E) and ENT1 (F) at the cell surface.</div><div id="fspara0135" role="paragraph">(G–J) Tumor-bearing GDA mice were treated with vehicle, Pin1i-1 or -2 for 4&nbsp;weeks, followed by IHC for PD-L1 (G) or ENT1 (I), or IF for Pin1 (red), DAPI (blue), and PD-L1 (green) (H) or ENT1 (green) (J) (n&nbsp;= 5). White arrows point to PD-L1 (H) and ENT1 (J) at the cell surface.</div><div id="fspara0140" role="paragraph">Scale bars, 100&nbsp;μm (A), 50&nbsp;μm (E and F), 500 and 100&nbsp;μm (right panels) (G and I), and 50 and 12.5&nbsp;μm (inset) (H and J). Error bars, mean ± SD; <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗</sup>p&nbsp;= 0.0001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001; n.s., not significant; by one-way ANOVA (B, E, and F) or Student’s t test (H and J).</div><div id="fspara0145" role="paragraph">See also <a id="crosref2065" href="#figs4">Figures S4</a> and <a id="crosref2070" href="#figs5">S5</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.07.020/asset/b0f593cd-2871-4c9f-9e59-6be1a357f385/main.assets/figs4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs4" src="/cms/10.1016/j.cell.2021.07.020/asset/77fdf87b-9e0e-4e75-82e6-e4b0445160a8/main.assets/figs4.jpg" height="844" width="657" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/b0f593cd-2871-4c9f-9e59-6be1a357f385/main.assets/figs4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S4</span> <span class="figure__title__text">Pin1 promotes oncogenic signaling pathways and growth of PDAC Cells, related to <a id="crosref2115" href="#fig4">Figure&nbsp;4</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0370" role="paragraph">(A) ATRA and ATO cooperatively reduce Pin1 and its substrate oncoproteins in human PDAC cells. Primary human PDAC cells (PDAC1 and PDAC2) derived from two different PDAC patients were treated with ATRA, ATO, or ATRA&nbsp;+ ATO (Pin1i-1) for 72&nbsp;hr, followed by examining Pin1 and its substrate oncoproteins using IB. ATRA and ATO were used in 10: 1 ratio as Pin1i-1 and only ATRA concentrations were shown.</div><div id="fspara0375" role="paragraph">(B and C) Pin1i-1, Pin1 KD or Pin1 KO reduces many Pin1 substrates in oncogenic Kras signaling networks in PDAC cells. PDAC2 cells were treated with Pin1i-1 for 72&nbsp;hr (B) or subjected to Pin1 KD or KO (C) followed by examining Pin1 and its substrate oncoproteins in Kras signaling using IB. ATRA and ATO were used in 10: 1 ratio as Pin1i-1 and only ATRA concentrations are shown (B).</div><div id="fspara0380" role="paragraph">(D-F) ATRA, ATO, Pin1i-1 and Pin1i-2 dose-dependently suppress cell growth and ablate Pin1. PDAC cells were treated with ATRA, ATO, Pin1i-1 or Pin1i-2 for 72&nbsp;hr, followed by examining cell growth using proliferation assay (D, F) and Pin1 using IB (E). ATRA and ATO were used in 10: 1 ratio as Pin1i-1 and only ATRA concentrations are shown (E).</div><div id="fspara0385" role="paragraph">(G) Pin1 KD inhibits human PDAC organoid growth. Pin1 KD or vector control human PDAC cells were subjected to 3D organoid cultures, followed by assaying organoid growth curve.</div><div id="fspara0390" role="paragraph">(H) Pin1i-2 fails to suppress Pin1 KO cell growth. Pin1 KO or CRISPR control PDAC2 cells were treated with Pin1i-2 for 72&nbsp;hr, followed by examining cell growth using proliferation assay (H).</div><div id="fspara0395" role="paragraph">(I-L) Pin1 inhibitors enhance the ability of GEM to inhibit human PDAC organoid growth. PDAC organoids were treated with Pin1i-1 or −2 and/or GEM at various concentrations for 7&nbsp;days, followed by examining organoid growth using microscope (I, J; PDAC2 organoid) and H&amp;E staining, and organoid proliferation using double IF for Pan-Keratin and Ki67 IF (K, L; PDAC1 organoid, Pin1i-1 10&nbsp;μM and GEM 10&nbsp;nM).</div><div id="fspara0400" role="paragraph">Scale bars, 100&nbsp;μm (G, I) and 100 and 20&nbsp;μm (inset) (K). Error bars, mean ± s.d.; <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗</sup>p&nbsp;= 0.0001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001; n.s., not significant; by Student’s t test (G) or one-way ANOVA (H, J, L).</div></div></div></div></figcaption></figure></div><div id="p0110" role="paragraph">Given the striking ability of Pin1 inhibitor pretreatment to potentiate the GEM sensitivity of PDAC cells, we reasoned that Pin1 inhibitors might affect the expression of some determinants of the GEM sensitivity. Notably, equilibrative nucleoside transporter 1 (ENT1) is required for GEM uptake and is a therapeutic response marker for GEM, deoxycytidine kinase (dCK) is involved in the first phosphorylation cascade in GEM activation, and ribonucleotide reductase subunit 1 (RRM1) is a main nuclear target for GEM (<span class="dropBlock reference-citations"><a id="body-ref-sref1" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1" aria-controls="sref1">Amrutkar and Gladhaug, 2017</a><div class="dropBlock__holder" data-db-target-of="sref1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Amrutkar, M. ∙ Gladhaug, I.P.</div><div><strong>Pancreatic Cancer Chemoresistance to Gemcitabine</strong></div><div><em>Cancers (Basel).</em> 2017; <strong>9</strong>:157</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3390/cancers9110157" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85034791078" target="_blank" aria-label="Open Scopus in new tab">Scopus (171)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29144412/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3390%2Fcancers9110157&amp;pmid=29144412" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref25" href="#" role="doc-biblioref" data-xml-rid="bib25" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref25" aria-controls="sref25">Farrell et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref25"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">26.</div><div>Farrell, J.J. ∙ Elsaleh, H. ∙ Garcia, M. ...</div><div><strong>Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer</strong></div><div><em>Gastroenterology.</em> 2009; <strong>136</strong>:187-195</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2008.09.067&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2008.09.067&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-59849115856" target="_blank" aria-label="Open Scopus in new tab">Scopus (339)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18992248/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2008.09.067&amp;pmid=18992248" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Both Pin1 inhibitors dose-dependently increased the levels of ENT1, but neither dCK nor RRM1 was affected (<a id="crosref1205" href="#fig4">Figure&nbsp;4</a>C). Since Pin1 inhibition potently enhanced αPD1 efficacy against PDAC (<a id="crosref1210" href="#fig1">Figure&nbsp;1</a>E), we hypothesized that Pin1 inhibitors might also affect the expression of ICB response biomarkers, whose upregulation increases ICB efficacy such as PD-L1 (<span class="dropBlock reference-citations"><a id="body-ref-sref45-2" href="#" role="doc-biblioref" data-xml-rid="bib45" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref45-2" aria-controls="sref45-2">Jiao et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref45-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">46.</div><div>Jiao, S. ∙ Xia, W. ∙ Yamaguchi, H. ...</div><div><strong>PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression</strong></div><div><em>Clin. Cancer Res.</em> 2017; <strong>23</strong>:3711-3720</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-16-3215" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85021146688" target="_blank" aria-label="Open Scopus in new tab">Scopus (372)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28167507/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-16-3215&amp;pmid=28167507" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref99-3" href="#" role="doc-biblioref" data-xml-rid="bib99" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref99-3" aria-controls="sref99-3">Zhang et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref99-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">102.</div><div>Zhang, J. ∙ Bu, X. ∙ Wang, H. ...</div><div><strong>Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance</strong></div><div><em>Nature.</em> 2018; <strong>553</strong>:91-95</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25015" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_102_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85040189345" target="_blank" aria-label="Open Scopus in new tab">Scopus (306)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29160310/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25015&amp;pmid=29160310" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and HLA class 1 (<span class="dropBlock reference-citations"><a id="body-ref-sref67" href="#" role="doc-biblioref" data-xml-rid="bib67" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref67" aria-controls="sref67">McGranahan et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref67"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">69.</div><div>McGranahan, N. ∙ Rosenthal, R. ∙ Hiley, C.T. ..., TRACERx Consortium</div><div><strong>Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution</strong></div><div><em>Cell.</em> 2017; <strong>171</strong>:1259-1271</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2017.10.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2017.10.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85032583704" target="_blank" aria-label="Open Scopus in new tab">Scopus (439)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29107330/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.10.001&amp;pmid=29107330" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref98" href="#" role="doc-biblioref" data-xml-rid="bib98" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref98" aria-controls="sref98">Yamamoto et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref98"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">101.</div><div>Yamamoto, K. ∙ Venida, A. ∙ Yano, J. ...</div><div><strong>Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I</strong></div><div><em>Nature.</em> 2020; <strong>581</strong>:100-105</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-020-2229-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_101_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85084050905" target="_blank" aria-label="Open Scopus in new tab">Scopus (178)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32376951/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-020-2229-5&amp;pmid=32376951" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Indeed, both Pin1 inhibitors dose-dependently upregulated PD-L1 but not HLA class 1 level (<a id="crosref1235" href="#fig4">Figure&nbsp;4</a>C). The upregulation of PD-L1 and ENT1 was also confirmed by Pin1 KD or KO (<a id="crosref1240" href="#fig4">Figure&nbsp;4</a>D) and was notable on the cell surface of Pin1i-treated PDAC cells <i>in&nbsp;vitro</i> (<a id="crosref1245" href="#fig4">Figures 4</a>E and 4F) and Pin1i-treated PDTXs and GDAs in mice (<a id="crosref1250" href="#fig4">Figures 4</a>G–4J, <a id="crosref1255" href="#figs5">S5</a>A, and S5B). Moreover, Pin1 expression inversely correlated with that of PD-L1 and ENT1 in human PDAC tissues (<a id="crosref1260" href="#figs5">Figures S5</a>C–S5E). Thus, Pin1 inhibition not only blocks multiple cancer pathways but also induces PD-L1 and ENT1 expression on the surface of PDAC cells <i>in&nbsp;vitro</i> and <i>in&nbsp;vivo</i>.</div><div class="figure-wrap"><figure id="figs5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.07.020/asset/19b005c7-838b-4ef3-8b94-c0c61341f30f/main.assets/figs5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs5" src="/cms/10.1016/j.cell.2021.07.020/asset/53baa9f8-3dde-46e6-aa0c-33ef33a3abe8/main.assets/figs5.jpg" height="862" width="657" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/19b005c7-838b-4ef3-8b94-c0c61341f30f/main.assets/figs5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S5</span> <span class="figure__title__text">Pin1 promotes GEM resistance and reduces the expression of PD-L1 and ENT1 at the cell surface of PDAC cells, related to <a id="crosref2120" href="#fig4">Figures 4</a>, <a id="crosref2125" href="#fig5">5</a>, and <a id="crosref2130" href="#fig6">6</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0410" role="paragraph">(A and B) Pin1 inhibition increases the expression of PD-L1 or ENT1 notably at the cell surface in PDTX mice. PDTX mice were treated with vehicle, Pin1i-1, or Pin1i-2 for 4&nbsp;weeks, followed by IF for Pin1 (red), DAPI (blue), and PD-L1 (green) (A), or ENT1 (green) (B) (n&nbsp;= 5). White arrows point to PD-L1 (A) and ENT1 (B) at the cell surface.</div><div id="fspara0415" role="paragraph">(C-E) Pin1 overexpression is correlated with reduced PD-L1 or ENT1 levels in human PDAC tissues. Human PDAC tissues were subjected to IHC for Pin1 and PD-L1 (n&nbsp;= 53) (C), or for Pin1 and ENT1 (n&nbsp;= 46) (D), followed by semi-quantifying their expression as high or low and examining their correlations by Pearson’s chi-square test (PD-L1: p&nbsp;= 0.013, ENT1: p&nbsp;= 0.008) (E).</div><div id="fspara0420" role="paragraph">(F) Pin1 inhibition suppresses mRNA expression of Pin1, ENT1 and PD-L1 in human PDAC cells. PDAC2 cells were treated with vehicle (DMSO), Pin1i-1 (10&nbsp;μM) or Pin1i-2 (5&nbsp;μM) for 72&nbsp;hr, followed by RT-PCR.</div><div id="fspara0425" role="paragraph">(G) Both PD-L1 and ENT levels are regulated by the lysosome-dependent proteolysis. PDAC2 cells were treated with 3-MA (15&nbsp;mM), Bafilomycin A1 (30&nbsp;nM), Chloroquine (20&nbsp;μM), MLN4929 (1&nbsp;μM), or MG132 (5&nbsp;μM) for 12&nbsp;hr, followed by analyzing PD-L1 and ENT1 levels using IB.</div><div id="fspara0430" role="paragraph">(H) A schematic for the structural domains of HIP1R and the location of only one putative Pin1 recognition Ser929-Pro motif that is identical in humans and mice.</div><div id="fspara0435" role="paragraph">(I) Cycloheximide (CHX) chase assay shows the degradation of HIP1R in HIP1R WT or S929A PDAC2 cells.</div><div id="fspara0440" role="paragraph">(J-K) Pin1 KO or HIP1RS929A synergizes with GEM or αPD1 to induce human PDAC organoid apoptosis as well as Pin1i. Pin1i-2 (5&nbsp;μM) pre-treated PDAC2 organoids or Pin1 KO or HIP1RS929A PDAC2 organoids were treated with GEM (25&nbsp;nM), followed by examining apoptotic organoids using time lapse imaging and green fluorescent caspase 3/7 reagent for 48&nbsp;hr (J). Pin1i-2 (5&nbsp;μM) pre-treated PDAC2 organoids or Pin1 KO or HIP1RS929A PDAC2 organoids were co-cultured with activated human PBMCs, and then treated with αPD1 (200&nbsp;μg/ml), followed by examining apoptotic organoids using time lapse imaging and green fluorescent caspase 3/7 reagent for 40&nbsp;hr (K).</div><div id="fspara0445" role="paragraph">Scale bars, 50&nbsp;μm and 12.5&nbsp;μm (inset) (A, B), 500&nbsp;μm (C, D) and 100&nbsp;μm (J, K). Error bars, mean ± s.d.; <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗</sup>p&nbsp;= 0.0001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001; n.s., not significant; by Student’s t test (A, B) or one-way ANOVA (F, J, K).</div></div></div></div></figcaption></figure></div></section><section id="sec-2-5"><h3>Pin1 promotes endocytosis and lysosomal degradation of PD-L1 and ENT1 by acting on the pS929-Pro motif in HIP1R</h3><div id="p0115" role="paragraph">Our findings that Pin1 inhibition in PDAC cells increased PD-L1 and ENT1 protein levels (<a id="crosref1265" href="#fig4">Figures 4</a>C–4F) but decreased their mRNA levels (<a id="crosref1270" href="#figs5">Figure&nbsp;S5</a>F) suggest that Pin1 inhibition might stabilize ENT1 and PD-L1 proteins. The proteolysis of both PD-L1 (<span class="dropBlock reference-citations"><a id="body-ref-sref12-2" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12-2" aria-controls="sref12-2">Burr et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref12-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Burr, M.L. ∙ Sparbier, C.E. ∙ Chan, Y.C. ...</div><div><strong>CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity</strong></div><div><em>Nature.</em> 2017; <strong>549</strong>:101-105</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature23643" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85029029250" target="_blank" aria-label="Open Scopus in new tab">Scopus (291)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28813417/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature23643&amp;pmid=28813417" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref13-2" href="#" role="doc-biblioref" data-xml-rid="bib13" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref13-2" aria-controls="sref13-2">Cha et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref13-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Cha, J.H. ∙ Chan, L.C. ∙ Li, C.W. ...</div><div><strong>Mechanisms Controlling PD-L1 Expression in Cancer</strong></div><div><em>Mol. Cell.</em> 2019; <strong>76</strong>:359-370</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.molcel.2019.09.030&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.molcel.2019.09.030&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85074248406" target="_blank" aria-label="Open Scopus in new tab">Scopus (88)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31668929/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.molcel.2019.09.030&amp;pmid=31668929" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref19-2" href="#" role="doc-biblioref" data-xml-rid="bib19" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref19-2" aria-controls="sref19-2">Dorand et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref19-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>Dorand, R.D. ∙ Nthale, J. ∙ Myers, J.T. ...</div><div><strong>Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity</strong></div><div><em>Science.</em> 2016; <strong>353</strong>:399-403</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aae0477" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84979502955" target="_blank" aria-label="Open Scopus in new tab">Scopus (237)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27463676/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aae0477&amp;pmid=27463676" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref55-2" href="#" role="doc-biblioref" data-xml-rid="bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55-2" aria-controls="sref55-2">Lim et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref55-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Lim, S.O. ∙ Li, C.W. ∙ Xia, W. ...</div><div><strong>Deubiquitination and Stabilization of PD-L1 by CSN5</strong></div><div><em>Cancer Cell.</em> 2016; <strong>30</strong>:925-939</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccell.2016.10.010&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccell.2016.10.010&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85004025764" target="_blank" aria-label="Open Scopus in new tab">Scopus (284)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27866850/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccell.2016.10.010&amp;pmid=27866850" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref99-4" href="#" role="doc-biblioref" data-xml-rid="bib99" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref99-4" aria-controls="sref99-4">Zhang et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref99-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">102.</div><div>Zhang, J. ∙ Bu, X. ∙ Wang, H. ...</div><div><strong>Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance</strong></div><div><em>Nature.</em> 2018; <strong>553</strong>:91-95</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25015" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_102_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85040189345" target="_blank" aria-label="Open Scopus in new tab">Scopus (306)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29160310/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25015&amp;pmid=29160310" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and ENT1 (<span class="dropBlock reference-citations"><a id="body-ref-sref41-1" href="#" role="doc-biblioref" data-xml-rid="bib41" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref41-1" aria-controls="sref41-1">Hu et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref41-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>Hu, Q. ∙ Qin, Y. ∙ Zhang, B. ...</div><div><strong>FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1</strong></div><div><em>Oncol. Rep.</em> 2017; <strong>38</strong>:2069-2077</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3892/or.2017.5856" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85029784620" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28765935/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3892%2For.2017.5856&amp;pmid=28765935" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) is highly regulated, and to modulate proteolysis is a dominant mechanism for Pin1 to regulate dozens of oncogenic proteins (<span class="dropBlock reference-citations"><a id="body-ref-sref100-7" href="#" role="doc-biblioref" data-xml-rid="bib100" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref100-7" aria-controls="sref100-7">Zhou and Lu, 2016</a><div class="dropBlock__holder" data-db-target-of="sref100-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">103.</div><div>Zhou, X.Z. ∙ Lu, K.P.</div><div><strong>The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target</strong></div><div><em>Nat. Rev. Cancer.</em> 2016; <strong>16</strong>:463-478</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc.2016.49" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_103_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84973128266" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27256007/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc.2016.49&amp;pmid=27256007" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). To assess the mechanisms behind Pin1-mediated effects, we treated PDAC cells with chemical inhibitors for the lysosomal degradation pathway (3-MA, Bafilomycin and Chloroquine) or proteasomal degradation pathway (MG132 and MLN4924). Inhibition of the proteasomal pathway increased PD-L1, but not ENT1, as shown (<span class="dropBlock reference-citations"><a id="body-ref-sref41-2" href="#" role="doc-biblioref" data-xml-rid="bib41" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref41-2" aria-controls="sref41-2">Hu et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref41-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>Hu, Q. ∙ Qin, Y. ∙ Zhang, B. ...</div><div><strong>FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1</strong></div><div><em>Oncol. Rep.</em> 2017; <strong>38</strong>:2069-2077</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3892/or.2017.5856" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85029784620" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28765935/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3892%2For.2017.5856&amp;pmid=28765935" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref99-5" href="#" role="doc-biblioref" data-xml-rid="bib99" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref99-5" aria-controls="sref99-5">Zhang et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref99-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">102.</div><div>Zhang, J. ∙ Bu, X. ∙ Wang, H. ...</div><div><strong>Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance</strong></div><div><em>Nature.</em> 2018; <strong>553</strong>:91-95</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25015" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_102_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85040189345" target="_blank" aria-label="Open Scopus in new tab">Scopus (306)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29160310/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25015&amp;pmid=29160310" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), while inhibition of the lysosomal pathway increased both PD-L1 and ENT1 (<a id="crosref1320" href="#figs5">Figure&nbsp;S5</a>G), suggesting that lysosomal degradation may be a common mechanism for Pin1-mediated regulation of PD-L1 and ENT1.</div><div id="p0120" role="paragraph">To support this possibility, we investigated Huntingtin interacting protein 1-related (HIP1R) (<span class="dropBlock reference-citations"><a id="body-ref-sref91-1" href="#" role="doc-biblioref" data-xml-rid="bib91" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref91-1" aria-controls="sref91-1">Wang et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref91-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">93.</div><div>Wang, H. ∙ Yao, H. ∙ Li, C. ...</div><div><strong>HIP1R targets PD-L1 to lysosomal degradation to alter T&nbsp;cell-mediated cytotoxicity</strong></div><div><em>Nat. Chem. Biol.</em> 2019; <strong>15</strong>:42-50</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41589-018-0161-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_93_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85055997824" target="_blank" aria-label="Open Scopus in new tab">Scopus (69)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30397328/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41589-018-0161-x&amp;pmid=30397328" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and CKLF Like MARVEL Transmembrane Domain Containing 6 (CMTM6) (<span class="dropBlock reference-citations"><a id="body-ref-sref12-3" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12-3" aria-controls="sref12-3">Burr et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref12-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Burr, M.L. ∙ Sparbier, C.E. ∙ Chan, Y.C. ...</div><div><strong>CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity</strong></div><div><em>Nature.</em> 2017; <strong>549</strong>:101-105</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature23643" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85029029250" target="_blank" aria-label="Open Scopus in new tab">Scopus (291)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28813417/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature23643&amp;pmid=28813417" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), which promote and inhibit the endocytosis and lysosomal degradation of PD-L1, respectively, and also contain putative Pin1 substrate recognition sites (pSer/Thr-Pro motifs), whereas such Pin1 recognition sites are not present in PD-L1. Both Pin1 inhibitors dose-dependently increased HIP1R with a slower mobility and presumably in the phosphorylated form, which was also induced by Pin1 KD or KO (<a id="crosref1335" href="#fig5">Figures 5</a>A–5D) but was undetectable after treating cell lysates with calf intestinal phosphatase (CIP) (<a id="crosref1340" href="#fig5">Figure&nbsp;5</a>E). Co-immunoprecipitation (Co-IP) demonstrated that Pin1 bound to phosphorylated HIP1R under endogenous conditions and that this interaction was phosphatase sensitive (<a id="crosref1345" href="#fig5">Figure&nbsp;5</a>E). By contrast, Pin1 inhibitors neither affected the PD-L1 stabilizing CMTM6, nor did Pin1 interact with CMTM6 (<a id="crosref1350" href="#fig5">Figures 5</a>A, 5C, and 5E). To determine the importance of HIP1R in regulating PD-L1 and ENT1 levels, we stably knocked down HIP1R in PDAC cells and found that HIP1R KD increased both PD-L1 and ENT1 levels (<a id="crosref1355" href="#fig5">Figure&nbsp;5</a>F). These results together suggest that Pin1 promotes PD-L1 and ENT1 degradation by acting on phosphorylated HIP1R.</div><div class="figure-wrap"><figure id="fig5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.07.020/asset/c300b707-aa95-4207-8336-9e96595275d7/main.assets/gr5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr5" src="/cms/10.1016/j.cell.2021.07.020/asset/9dcfd7ef-bc1f-4303-a770-021e89ca6122/main.assets/gr5.jpg" height="941" width="746" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/c300b707-aa95-4207-8336-9e96595275d7/main.assets/gr5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;5</span> <span class="figure__title__text">Pin1 promotes the endocytosis and lysosomal degradation of PD-L1 and ENT1 by acting on the pS929-Pro motif in HIP1R</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0155" role="paragraph">(A–D) Human PDAC2 cells were treated with Pin1i-1 or -2 at various concentrations for 72&nbsp;h (A and B) or subjected to Pin1 KD or KO (C and D), followed by IB for different proteins indicated (A and C) and quantifying phosphorylated HIP1R (B and D). A red arrow points to phosphorylated HIP1R and a black arrow to non-phosphorylated HIP1R. ATRA and ATO were used in 10:1 ratio as Pin1i-1 and only ATRA concentrations are shown (A and B).</div><div id="fspara0160" role="paragraph">(E) PDAC2 cell lysates were incubated with CIP (+ CIP) or CIP plus phosphatase inhibitors (– CIP), followed by IB directly (input) or after IP with Pin1 antibodies.</div><div id="fspara0165" role="paragraph">(F) HIP1R in PDAC2 cells was stably knocked down using shRNA or vector control, followed by IB.</div><div id="fspara0170" role="paragraph">(G) Flag-HIP1R WT or its S929A mutant was stably expressed in PDAC2 cells, followed by IB.</div><div id="fspara0175" role="paragraph">(H–J) PDAC2 cells stably expressing Flag-HIP1R WT or S929A mutant were subjected to IB directly (input) or after IP with Pin1 antibody (H) or Flag antibody (I and J). A red arrow points to phosphorylated HIP1R and a black arrow to non-phosphorylated HIP1R.</div><div id="fspara0180" role="paragraph">(K) PDAC2 cells were treated with control (DMSO) or Pin1i-1 (10&nbsp;μM) and then subjected to IF for Pin1 (red), HIP1R (green), and DAPI (blue).</div><div id="fspara0185" role="paragraph">(L–N) HIP1R WT or S929A stably transfected PDAC2 cells were subjected to IF for HIP1R (red), DAPI (blue), and LAMP1 (green) (L), PD-L1 (green) (M), or ENT1 (green) (N), followed by assaying co-localization of Pin1-HIP1R (K), HIP1R-LAMP1 (L), HIP1R-PDL1 (M), and HIP1R-ENT1 (N) using ImageJ program, with R value being Pearson’s coefficient for co-localization.</div><div id="fspara0190" role="paragraph">Scale bars, 50 and 5&nbsp;μm (inset) (K) and 20 and 5&nbsp;μm (inset) (L–N). Error bars, mean ± SD; <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗</sup>p&nbsp;= 0.0001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001; n.s., not significant; by one-way ANOVA (B and D) or Student’s t test (K–N).</div><div id="fspara0195" role="paragraph">See also <a id="crosref2075" href="#figs5">Figure&nbsp;S5</a>.</div></div></div></div></figcaption></figure></div><div id="p0125" role="paragraph">To identify the Pin1-binding site in HIP1R, we generated an Ala substitution (S929A) at the only putative and conserved S/P site, pSer929-Pro motif in HIP1R (<a id="crosref1360" href="#figs5">Figure&nbsp;S5</a>H). Unlike wild-type (WT) HIP1R, when introduced into PDAC cells, the S929A mutant not only failed to interact with Pin1 (<a id="optN0tvBtlUys" href="#fig5">Figures 5</a>H and 5I) but also increased the levels of PD-L1 and ENT1 (<a id="optBcPZ8eujkf" href="#fig5">Figure 5</a>G), similar to Pin1 inhibitors, Pin1 KD or KO, or HIP1R KD (<a id="crosref1370" href="#fig5">Figures 4</a>C, 4D, and <a id="optifnE4TNNiE" href="#fig5">5</a>F). Notably, the pSer929-Pro in HIP1R is located within its actin-binding domain (<a id="crosref1375" href="#figs5">Figure&nbsp;S5</a>H), which is critical for HIP1R-mediated endocytosis and lysosomal degradation (<span class="dropBlock reference-citations"><a id="body-ref-sref32-1" href="#" role="doc-biblioref" data-xml-rid="bib32" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref32-1" aria-controls="sref32-1">Gottfried et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref32-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">33.</div><div>Gottfried, I. ∙ Ehrlich, M. ∙ Ashery, U.</div><div><strong>The Sla2p/HIP1/HIP1R family: similar structure, similar function in endocytosis?</strong></div><div><em>Biochem. Soc. Trans.</em> 2010; <strong>38</strong>:187-191</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1042/BST0380187" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-76449118339" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20074057/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1042%2FBST0380187&amp;pmid=20074057" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref68-1" href="#" role="doc-biblioref" data-xml-rid="bib68" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref68-1" aria-controls="sref68-1">Messa et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref68-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">70.</div><div>Messa, M. ∙ Fernández-Busnadiego, R. ∙ Sun, E.W. ...</div><div><strong>Epsin deficiency impairs endocytosis by stalling the actin-dependent invagination of endocytic clathrin-coated pits</strong></div><div><em>eLife.</em> 2014; <strong>3</strong>:e03311</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.7554/eLife.03311" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25122462/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.7554%2FeLife.03311&amp;pmid=25122462" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). These results suggest that the S929A mutation might impair the ability of HIP1R to bind actin and promote the endocytosis of PD-L1 and ENT1 to lysosomes. Indeed, WT HIP1R, but not its S929A mutant, interacted with actin (<a id="crosref1390" href="#fig5">Figure&nbsp;5</a>J) and colocalized with Pin1, PD-L1 and ENT1 to peri-nuclear lysosomes, as marked by the lysosomal marker LAMP1 (<a id="crosref1395" href="#fig5">Figures 5</a>K–5N). Cycloheximide (CHX) chase assay demonstrated that the HIP1R, but not its S929A mutant, was unstable (<a id="crosref1400" href="#figs5">Figure&nbsp;S5</a>I). Thus, Pin1 promotes the endocytosis and lysosomal degradation of PD-L1 and ENT1 presumably by acting on the pSer929-Pro motif in HIP1R to facilitate actin binding.</div></section><section id="sec-2-6"><h3>Targeting Pin1 synergizes with immunochemotherapy to induce PDAC organoid apoptosis</h3><div id="p0130" role="paragraph">Given that targeting Pin1 robustly induces the cell-surface expression of ENT1 and PD-L1 in PDAC cells, a critical question is whether targeting Pin1 would affect the therapeutic response to GEM and αPD1. Thus, we targeted Pin1 in established human PDAC organoids without any stromal cells to avoid indirect effects (<span class="dropBlock reference-citations"><a id="body-ref-sref48-5" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48-5" aria-controls="sref48-5">Koikawa et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref48-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Koikawa, K. ∙ Ohuchida, K. ∙ Ando, Y. ...</div><div><strong>Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Lett.</em> 2018; <strong>425</strong>:65-77</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2018.03.031" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29580808/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2018.03.031&amp;pmid=29580808" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), followed by the organoid apoptosis assay using time-lapse imaging to visualize and quantify the dynamic changes in organoid apoptosis (<a id="crosref1410" href="#fig6">Figure&nbsp;6</a>A). As expected, both Pin1 inhibitors time-dependently induced ENT1 and PD-L1 levels (<a id="crosref1415" href="#fig6">Figure&nbsp;6</a>B), and time- and dose-dependently sensitized PDAC organoids to GEM-induce apoptosis, with highly synergistic effects (<a id="crosref1420" href="#fig6">Figures 6</a>C–6E and <a id="crosref1425" href="#figs6">S6</a>A). The similar effect was observed in Pin1i with ENT1-dependent 5-FU (<a id="crosref1430" href="#figs6">Figures S6</a>G and S6H). Pin1 KO or introduction of HIP1R929A mutant into the PDAC organoids resulted in similar synergy with GEM treatment (<a id="crosref1435" href="#figs5">Figure&nbsp;S5</a>J), further supporting our model. To examine the importance of ENT expression for modulating GEM responsiveness by Pin1i, we treated Pin1i pre-treated WT or ENT1-KD PDAC organoids with GEM. Pin1i-2 induced apoptosis in WT PDAC organoids but not in ENT1-KD PDAC organoids (<a id="crosref1440" href="#figs6">Figures S6</a>B and S6C), supporting the role of ENT1 in GEM response.</div><div class="figure-wrap"><figure id="fig6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.07.020/asset/aa76fb8f-ae6c-4914-81dc-9715cde48aa0/main.assets/gr6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr6" src="/cms/10.1016/j.cell.2021.07.020/asset/5c0db951-f9f5-4f36-927c-9c1a789b5e02/main.assets/gr6.jpg" height="873" width="657" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/aa76fb8f-ae6c-4914-81dc-9715cde48aa0/main.assets/gr6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;6</span> <span class="figure__title__text">Targeting Pin1 synergizes with immunochemotherapy to induce PDAC organoid apoptosis</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0205" role="paragraph">(A) Experimental setup of PDAC organoid apoptosis assay. Established primary human or KPC mouse PDAC organoids were pre-treated with control or Pin1i for 3&nbsp;days, followed by (1) treating with control, GEM, or 5-FU, or (2) co-culturing with activated human PBMCs or mouse-derived CD8<sup>+</sup> T&nbsp;cells, and treating with control, αPD1, αPDL1, or GEM&nbsp;+ αPD1 (G+P). Apoptosis of PDAC organoid was measured using caspase 3/7 green fluorescent reagent and time-lapse imaging.</div><div id="fspara0210" role="paragraph">(B) Human PDAC2 organoids were treated with control (DMSO), Pin1i-1 (10&nbsp;μM) or Pin1i-2 (5&nbsp;μM) for 3 or 7&nbsp;days, followed by IB.</div><div id="fspara0215" role="paragraph">(C–E) Pin1i-1 pre-treated PDAC2 organoids were treated with GEM, followed by examining PDAC organoid apoptosis at constant concentrations (Pin1i-1 10&nbsp;μM and GEM 25&nbsp;nM) for different times (C and D) or at different concentrations for 24&nbsp;h and analyzing the synergy score of Pin1i and GEM using Synergy finder (E).</div><div id="fspara0220" role="paragraph">(F–H) Pin1i-1 pre-treated PDAC2 organoids were co-cultured with activated human PBMCs and then treated with αPD1, followed by examining PDAC organoid apoptosis at constant concentrations (Pin1i-1 10&nbsp;μM and αPD1 200&nbsp;μg/mL) for different times (F and G) or at different concentrations indicated for 40&nbsp;h and analyzing synergy score of Pin1i and αPD1 using Synergy finder (H).</div><div id="fspara0225" role="paragraph">(I–K) Pin1i pre-treated PDAC2 organoids were co-cultured with activated human PBMCs and then treated with GEM and/or αPD1, followed by assaying PDAC organoid apoptosis at constant concentrations (Pin1i-1 10&nbsp;μM, GEM 10&nbsp;nM and αPD1 100&nbsp;μg/mL) for different times (I and J) or at different concentrations indicated for 40&nbsp;h and analyzing synergy score of Pin1i, GEM and/or αPD1 using Synergy finder (K).</div><div id="fspara0230" role="paragraph">(L–N) KPC organoids derived from KPC mouse PDAC tumors were co-cultured with/without activated CD8<sup>+</sup> T&nbsp;cells derived from the same KPC tumor-bearing mice or their tumor-free littermates that did not have all the three transgenes for 48&nbsp;h (L), or the KPC organoids were pre-treated with control (DMSO) or Pin1i-2 (5&nbsp;μM) for 3&nbsp;days and co-cultured with the same KPC tumor-bearing mouse-derived activated CD8<sup>+</sup> T&nbsp;cells and then treated with αPD1 (200&nbsp;μg/mL) for 24&nbsp;h (M and N), followed by examining PDAC organoid apoptosis.</div><div id="fspara0235" role="paragraph">Scale bars, 100&nbsp;μm. Error bars, mean ± SD; <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗</sup>p&nbsp;= 0.0001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001; n.s., not significant; by one-way ANOVA. See also <a id="crosref2080" href="#figs6">Figure&nbsp;S6</a> and <a id="crosref2085" href="#mmc5">Video S2</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.07.020/asset/e52c368e-2424-42fe-93e8-67df612d845d/main.assets/figs6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs6" src="/cms/10.1016/j.cell.2021.07.020/asset/38e11031-d6a9-4b3f-b878-f37ca7920226/main.assets/figs6.jpg" height="941" width="721" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/e52c368e-2424-42fe-93e8-67df612d845d/main.assets/figs6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S6</span> <span class="figure__title__text">Targeting Pin1 synergizes with immunochemotherapy to induce human/mouse PDAC organoid apoptosis, related to <a id="crosref2135" href="#fig6">Figure&nbsp;6</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0455" role="paragraph">(A) Pin1 inhibitors synergize with GEM to induce human PDAC organoid apoptosis. Pin1i-2 pre-treated PDAC2 organoids were treated with GEM, followed by examining organoid apoptosis at different concentrations for 24&nbsp;hr and analyzing synergy score of Pin1i-2 and GEM using Synergy finder. We have tested 2 different patient-derived PDAC organoids (PDAC1 and PDAC2 organoid) and obtained consistent results. Subsequent experiments were shown with one organoid (PDAC2 organoid) with high expression of PD-L1 and ENT.</div><div id="fspara0460" role="paragraph">(B-C) ENT1 KD impairs the synergic effect of Pin1i and GEM. Control (DMSO) or Pin1i-2 (5&nbsp;μM) pre-treated ENT1 WT or KD PDAC2 organoids were treated with control (PBS) or GEM (25&nbsp;nM), followed by examining apoptotic organoids using time lapse imaging and green fluorescent caspase 3/7 reagent for 24&nbsp;hr.</div><div id="fspara0465" role="paragraph">(D) Pin1 inhibitors synergize with αPD1 to induce human PDAC organoid apoptosis. Pin1i-2 pre-treated PDAC2 organoids were co-cultured with activated human PBMCs, and then treated with αPD1, followed by examining organoid apoptosis at different concentrations for 40&nbsp;hr and analyzing synergy score of Pin1i-2 and αPD1 using Synergy finder.</div><div id="fspara0470" role="paragraph">(E-F) PD-L1 KD impaired the synergic effect of Pin1i and αPD1. Control (DMSO) or Pin1i-2 (5&nbsp;μM) pre-treated PD-L1 WT or KD PDAC2 organoids were co-cultured with activated human PBMCs, and then treated with control (IgG) or αPD1 (200&nbsp;μg/ml), followed by examining apoptotic organoids using time lapse imaging and green fluorescent caspase 3/7 reagent for 40&nbsp;hr.</div><div id="fspara0475" role="paragraph">(G-J) Pin1 inhibitors synergize with 5-FU or αPD1 to induce human PDAC organoid apoptosis. Control (DMSO), Pin1i-1 (10&nbsp;μM) or Pin1i-2 (5&nbsp;μM) pre-treated PDAC2 organoids were treated with control (DMSO) or 5-FU (25&nbsp;nM), followed by examining PDAC organoid apoptosis using time lapse imaging for 24&nbsp;hr (G, H), or were co-cultured with activated human PBMCs, and then treated with control (IgG) or αPD-L1 (200&nbsp;μg/ml), followed by examining PDAC organoid apoptosis using time lapse imaging for 40&nbsp;hr (I, J).</div><div id="fspara0480" role="paragraph">(K and L) Pin1 inhibitors synergize with immunochemotherapy (GEM&nbsp;+ αPD1) to induce human PDAC organoid apoptosis. Control (DMSO) or Pin1i pre-treated PDAC2 organoids were co-cultured with activated human PBMCs, and then treated with control (PBS and/or IgG), GEM and/or αPD1, followed by assaying PDAC organoid apoptosis for different times at constant concentrations (Pin1i-1 10&nbsp;μM, Pin1i-2 5&nbsp;μM, GEM 10&nbsp;nM, and αPD1 100&nbsp;μg/ml).</div><div id="fspara0485" role="paragraph">(M) KPC tumor-bearing mouse derived CD8<sup>+</sup> T&nbsp;cells induce KPC organoid apoptosis. KPC mouse PDAC tumor derived organoids were co-cultured with/without activated CD8<sup>+</sup> T&nbsp;cells derived from KPC tumor-bearing mice or their tumor-free controls, followed by examining apoptotic organoids using time lapse imaging and green fluorescent caspase 3/7 reagent for 40&nbsp;hr.</div><div id="fspara0490" role="paragraph">(N-O) Pin1 inhibitors synergize with GEM and αPD1 to induce KPC PDAC organoid apoptosis. Control (DMSO) or Pin1i-2 pre-treated KPC tumor derived organoids were co-cultured with KPC tumor-bearing mouse derived activated CD8<sup>+</sup> T&nbsp;cells, and then treated with control (PBS&nbsp;+ IgG), or GEM and αPD1, followed by examining apoptotic organoids using time lapse imaging and green fluorescent caspase 3/7 reagent for 24&nbsp;hr at constant concentrations (Pin1i-2 5&nbsp;μM, GEM 10&nbsp;nM, and αPD1 200&nbsp;μg/ml).</div><div id="fspara0495" role="paragraph">Scale bars, 100&nbsp;μm (B, E, G, I, K, M, N). Error bars, mean ± s.d.; <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗</sup>p&nbsp;= 0.0001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001; n.s., not significant; by one-way ANOVA (C, F, H, J, O) or Student’s t test (L).</div></div></div></div></figcaption></figure></div><div id="p0135" role="paragraph">To examine the effects of Pin1 inhibition on the ability of αPD1 to induce PDAC organoid apoptosis, Pin1i pre-treated human PDAC organoids and activated human primary peripheral blood mononuclear cells (PBMCs) were subjected to the organoid apoptosis assay (<a id="crosref1445" href="#fig6">Figure&nbsp;6</a>A) (<span class="dropBlock reference-citations"><a id="body-ref-sref18-1" href="#" role="doc-biblioref" data-xml-rid="bib18" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref18-1" aria-controls="sref18-1">Dijkstra et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref18-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Dijkstra, K.K. ∙ Cattaneo, C.M. ∙ Weeber, F. ...</div><div><strong>Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids</strong></div><div><em>Cell.</em> 2018; <strong>174</strong>:1586-1598</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2018.07.009&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2018.07.009&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85052651284" target="_blank" aria-label="Open Scopus in new tab">Scopus (273)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30100188/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.07.009&amp;pmid=30100188" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref45-3" href="#" role="doc-biblioref" data-xml-rid="bib45" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref45-3" aria-controls="sref45-3">Jiao et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref45-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">46.</div><div>Jiao, S. ∙ Xia, W. ∙ Yamaguchi, H. ...</div><div><strong>PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression</strong></div><div><em>Clin. Cancer Res.</em> 2017; <strong>23</strong>:3711-3720</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-16-3215" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85021146688" target="_blank" aria-label="Open Scopus in new tab">Scopus (372)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28167507/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-16-3215&amp;pmid=28167507" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Both Pin1 inhibitors increased the ability of αPD1 or αPDL1 to induce organoid apoptosis, and the effects were again dose dependent and highly synergistic (<a id="crosref1460" href="#fig6">Figures 6</a>F–6H, <a id="crosref1465" href="#figs6">S6</a>D, S6I, and S6J). To exclude possible off-target effects of Pin1 inhibitors, we conducted the same experiment with Pin1 KO and HIP1R929A PDAC organoids with activated human PBMCs and found a similar enhancement of αPD1 anti-tumor effects (<a id="crosref1470" href="#figs5">Figure&nbsp;S5</a>K). Pin1i-2 also promoted the apoptosis of WT PDAC organoids but not of PD-L1-KD PDAC organoids (<a id="crosref1475" href="#figs6">Figures S6</a>E and S6F), supporting that the effects of Pin1 inhibition and αPD1 are dependent on PD-L1 expression. Moreover, both Pin1 inhibitors time- and dose-dependently enhanced the ability of G+P to induce apoptosis of PDAC organoids, and the effects were also highly synergistic (<a id="crosref1480" href="#fig6">Figures 6</a>I–6K, <a id="crosref1485" href="#figs6">S6</a>K, and S6L; <a id="crosref1490" href="#mmc5">Video S2</a>).</div><div id="p0140" role="paragraph"><div id="mmc5" class="core-supplementary-material" data-category="video"><div class="core-link"><div class="cloudflare-stream-container" id="mmc5" data-type="mp4"><span id="video_stream_mmc5_src" class="video-stream-source" style="display:none">eyJraWQiOiI4ZjUxYWNhY2IzYjhiNjNlNzFlYmIzYWFmYTU5NmZmYyIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiJlMjUzNDI0YzA2ZDQ4YzE1NTM0MDY5MGEyMjExMmFmNyIsImtpZCI6IjhmNTFhY2FjYjNiOGI2M2U3MWViYjNhYWZhNTk2ZmZjIiwiZXhwIjoxNzQ5NjEyOTA3fQ.S3t1YXkkNVSBK5HkOLGY25D1ZpcDeh6w7CTwvE5EGfb-i9KlgJ8lUF8GVttsH_Abiddx_DxeJm3hnmmWo_UCP4V7hCkkw-BYXnIkoHQIhmwHcz4djKWFv_CKX2dPaLtM8xgVlGpHZEUWScKmznmKzW1jql8Udb7iRGFE8LFSKAMRab19TEHrfOD7xFPBlXPN8Fqlxui4SeIoi9k9Bdu9uD4oAFgYJp0thEtGEfQSWNa4bWhSYcZr0799JvG2LwQTYazDrKZUwxQkgscdHCQAWHeixPKv3zNPSi9mmdSXDP-z96PV2wxMmXKFUWOM9C53aZtD_lyE8JoVl9vADW4v0A</span><stream src="eyJraWQiOiI4ZjUxYWNhY2IzYjhiNjNlNzFlYmIzYWFmYTU5NmZmYyIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiJlMjUzNDI0YzA2ZDQ4YzE1NTM0MDY5MGEyMjExMmFmNyIsImtpZCI6IjhmNTFhY2FjYjNiOGI2M2U3MWViYjNhYWZhNTk2ZmZjIiwiZXhwIjoxNzQ5NjEyOTA3fQ.S3t1YXkkNVSBK5HkOLGY25D1ZpcDeh6w7CTwvE5EGfb-i9KlgJ8lUF8GVttsH_Abiddx_DxeJm3hnmmWo_UCP4V7hCkkw-BYXnIkoHQIhmwHcz4djKWFv_CKX2dPaLtM8xgVlGpHZEUWScKmznmKzW1jql8Udb7iRGFE8LFSKAMRab19TEHrfOD7xFPBlXPN8Fqlxui4SeIoi9k9Bdu9uD4oAFgYJp0thEtGEfQSWNa4bWhSYcZr0799JvG2LwQTYazDrKZUwxQkgscdHCQAWHeixPKv3zNPSi9mmdSXDP-z96PV2wxMmXKFUWOM9C53aZtD_lyE8JoVl9vADW4v0A" class="cloudflare-stream-player ready tracked" id="video_stream_mmc5" controls="true"><div class="player-share-button" title="Share Video"><div class="share-player-icon"></div></div><div class="player-share-container hidden"><span class="player-close-share"></span><div class="social-links-container"><ul class="social-links-list"><li class="html5-share-facebook-icon" data-share-url="https://www.facebook.com/sharer/sharer.php?u=https://www.cell.com/cell/fulltext/S0092-8674(21)00879-5" target="_blank"></li><li class="html5-share-twitter-icon" data-share-url="https://twitter.com/share?url=https://www.cell.com/cell/fulltext/S0092-8674(21)00879-5" target="_blank"></li><li class="html5-share-mail-icon" data-share-url="mailto:?body=https://www.cell.com/cell/fulltext/S0092-8674(21)00879-5" target="_blank"></li></ul><input type="text" value="https://www.cell.com/cell/fulltext/S0092-8674(21)00879-5" readonly="readonly" class="share-input"></div></div><div style="position: relative; height: 0px; width: 100%; padding-top: 56.25%;"><iframe src="https://embed.cloudflarestream.com/embed/iframe.fla9.823df22.html?videoId=eyJraWQiOiI4ZjUxYWNhY2IzYjhiNjNlNzFlYmIzYWFmYTU5NmZmYyIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiJlMjUzNDI0YzA2ZDQ4YzE1NTM0MDY5MGEyMjExMmFmNyIsImtpZCI6IjhmNTFhY2FjYjNiOGI2M2U3MWViYjNhYWZhNTk2ZmZjIiwiZXhwIjoxNzQ5NjEyOTA3fQ.S3t1YXkkNVSBK5HkOLGY25D1ZpcDeh6w7CTwvE5EGfb-i9KlgJ8lUF8GVttsH_Abiddx_DxeJm3hnmmWo_UCP4V7hCkkw-BYXnIkoHQIhmwHcz4djKWFv_CKX2dPaLtM8xgVlGpHZEUWScKmznmKzW1jql8Udb7iRGFE8LFSKAMRab19TEHrfOD7xFPBlXPN8Fqlxui4SeIoi9k9Bdu9uD4oAFgYJp0thEtGEfQSWNa4bWhSYcZr0799JvG2LwQTYazDrKZUwxQkgscdHCQAWHeixPKv3zNPSi9mmdSXDP-z96PV2wxMmXKFUWOM9C53aZtD_lyE8JoVl9vADW4v0A" allowfullscreen="true" allow="autoplay; picture-in-picture" style="height: 100%; width: 100%; position: absolute; top: 0px; left: 0px; border: none;"></iframe></div></stream></div><a href="/cms/10.1016/j.cell.2021.07.020/attachment/7331a310-112b-4874-87b7-941d16d8d1a0/mmc5.mp4" download="mmc5.mp4" aria-labelledby="mmc5-heading mmc5-link"><span id="mmc5-link">Video (4.88 MB)</span></a></div><div class="core-description"><div id="mmc5-heading" class="heading">Video S2. Pin1 inhibitors synergize with immunochemotherapy (GEM&nbsp;+ αPD1) to induce human PDAC organoid apoptosis, related Figures 6 and S6</div><div id="espara0015" role="paragraph">Pin1i pre-treated human PDAC2 organoids were co-cultured with activated human PBMCs, and then then treated with GEM and/or αPD1, followed by assaying PDAC organoid apoptosis using green fluorescent Caspase 3/7 reagent and live-cell time-lapse imaging for 40&nbsp;hr (Pin1i-1 10&nbsp;μM, Pin1i-2 5&nbsp;μM, GEM 10&nbsp;nM, and αPD1 100&nbsp;μg/ml).</div></div></div></div><div id="p0145" role="paragraph">To use an autologous organoid model to confirm the above findings that CD8<sup>+</sup> cytotoxic T&nbsp;cells are important factor for the response of Pin1i&nbsp;+ αPD1 therapy in GDA mice (<a id="crosref1495" href="#fig1">Figures 1</a>H and <a id="crosref1500" href="#figs2">S2</a>E–S2G), we co-cultured KPC mouse PDAC organoids with activated CD8<sup>+</sup> T&nbsp;cells derived from the same KPC tumor-bearing mice or their tumor-free littermates. As expected, the CD8<sup>+</sup> T&nbsp;cells derived from tumor-bearing mice were significantly more effective in inducing organoid apoptosis than those from non-tumor-bearing controls (<a id="crosref1505" href="#fig6">Figures 6</a>L and <a id="crosref1510" href="#figs6">S6</a>M). More importantly, Pin1i synergized with αPD1 to induce PDAC organoid apoptosis (<a id="crosref1515" href="#fig6">Figures 6</a>M and 6N), and the synergistic effects were also upheld when GEM was used (<a id="crosref1520" href="#figs6">Figures S6</a>N and S6O), as in GDA mice (<a id="crosref1525" href="#fig1">Figure&nbsp;1</a>E), confirming the critical role of CD8<sup>+</sup> CTLs for Pin1 inhibitors to potentiate immunotherapy response. Thus, targeting Pin1 acts on PDAC cells not only to inhibit multiple cancer pathways and induce the cell-surface expression of PD-L1 and ENT1 but also to synergize with immunochemotherapy to induce apoptosis of human and mouse PDAC organoids.</div></section><section id="sec-2-7"><h3>Targeting Pin1 renders primary PDAC tumors eradicable by immunochemotherapy in KPC GEMM</h3><div id="p0150" role="paragraph">To determine whether Pin1 inhibitors are able to disrupt the highly desmoplastic and immunosuppressive TME and render primary PDAC tumors eradicable by immunochemotherapy in a GEMM of PDAC, we used KPC mice expressing commonly occurring Kras<sup>G12D</sup> and p53<sup>R172H</sup> mutations in the pancreas. These mice developed the spectrum of aggressive PDAC with 100% penetrance, which recapitulate tumor heterogeneity, desmoplastic and immunosuppressive TME, poor immunogenicity, and rapid progression typical of human disease (<span class="dropBlock reference-citations"><a id="body-ref-sref5" href="#" role="doc-biblioref" data-xml-rid="bib5" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref5" aria-controls="sref5">Bayne et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">6.</div><div>Bayne, L.J. ∙ Beatty, G.L. ∙ Jhala, N. ...</div><div><strong>Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T&nbsp;cell immunity in pancreatic cancer</strong></div><div><em>Cancer Cell.</em> 2012; <strong>21</strong>:822-835</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2012.04.025&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2012.04.025&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84862150896" target="_blank" aria-label="Open Scopus in new tab">Scopus (580)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22698406/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2012.04.025&amp;pmid=22698406" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref38-2" href="#" role="doc-biblioref" data-xml-rid="bib38" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref38-2" aria-controls="sref38-2">Hingorani et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref38-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Hingorani, S.R. ∙ Wang, L. ∙ Multani, A.S. ...</div><div><strong>Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice</strong></div><div><em>Cancer Cell.</em> 2005; <strong>7</strong>:469-483</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2005.04.023&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2005.04.023&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-19344362405" target="_blank" aria-label="Open Scopus in new tab">Scopus (1497)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15894267/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2005.04.023&amp;pmid=15894267" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We treated overt tumor-bearing KPC mice with Pin1i, G+P or their combination. As shown (<span class="dropBlock reference-citations"><a id="body-ref-sref44-3" href="#" role="doc-biblioref" data-xml-rid="bib44" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref44-3" aria-controls="sref44-3">Jiang et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref44-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">45.</div><div>Jiang, H. ∙ Hegde, S. ∙ Knolhoff, B.L. ...</div><div><strong>Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy</strong></div><div><em>Nat. Med.</em> 2016; <strong>22</strong>:851-860</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.4123" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84976871907" target="_blank" aria-label="Open Scopus in new tab">Scopus (444)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27376576/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.4123&amp;pmid=27376576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), G+P neither affected the desmoplastic and immunosuppressive TME, nor increased survival, with most mice succumbing to the disease within 3&nbsp;months (<a id="crosref1545" href="#fig7">Figures 7</a>B and 7D–7F). However, Pin1i-1 or -2 and G+P combination suppressed cancer cell proliferation, and CAF activation and proliferation (<a id="crosref1550" href="#fig7">Figures 7</a>A, 7C, <a id="crosref1555" href="#figs7">S7</a>A, and S7B), disrupted the desmoplastic and immunosuppressive TME, increased tumor-infiltrating CD8α<sup>+</sup>Granzyme B<sup>+</sup> CTLs (<a id="crosref1560" href="#fig7">Figures 7</a>B, 7D, and 7E) and induced PD-L1 and ENT1 expression in cancer cells (<a id="crosref1565" href="#figs7">Figures S7</a>C and S7D). Importantly, Pin1i-1 or -2 and G+P combination drastically increased survival, with 60%–70% of treated mice surviving for at least 6&nbsp;months after treatment (<a id="crosref1570" href="#fig7">Figure&nbsp;7</a>F). Upon necropsy, these surviving mice had no obvious macroscopic tumors, and only residual microscopic tumors were notable (<a id="crosref1575" href="#fig7">Figures 7</a>G and <a id="crosref1580" href="#figs7">S7</a>E), without any liver metastases (<a id="crosref1585" href="#figs7">Figure&nbsp;S7</a>F), indicating that tumors are disappearing despite continuous expression of oncogenic mutant Kras and p53 in the pancreas. In conclusion, Pin1 inhibitors not only block multiple cancer pathways, disrupt the desmoplastic and immunosuppressive TME, and induce PD-L1 and ENT1 expression but also render PDAC tumors eradicable by immunochemotherapy in GDA and KPC mice (<a id="crosref1590" href="#figs7">Figure&nbsp;S7</a>G).</div><div class="figure-wrap"><figure id="fig7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.07.020/asset/b6d84c85-749c-4ba9-abc8-affc8393d4d9/main.assets/gr7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr7" src="/cms/10.1016/j.cell.2021.07.020/asset/6da4ec50-fb8f-4e8b-ba78-6fd0ce8a004f/main.assets/gr7.jpg" height="836" width="657" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/b6d84c85-749c-4ba9-abc8-affc8393d4d9/main.assets/gr7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;7</span> <span class="figure__title__text">Targeting Pin1 renders primary PDAC tumors eradicable by immunochemotherapy in KPC GEMM</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0245" role="paragraph">(A–E) Overt tumor-bearing KPC mice were treated with vehicle or low dose (10&nbsp;mg/kg, weekly) GEM&nbsp;+ αPD1 (G+P) with/without Pin1i-1 or -2 for a month, followed by assaying CAF activation using IF for αSMA and CAF proliferation using double IF for αSMA and Ki67 (A), cancer cell proliferation using double IF for Pan-Keratin and Ki67 (C), collagen deposition using Sirius Red staining (B) and tumor-infiltrating immune cell populations, CD8α<sup>+</sup> T&nbsp;cells, FOXP3<sup>+</sup> Tregs, and Ly6G<sup>+</sup>CD11b<sup>+</sup> myeloid cells (D) and CD8α<sup>+</sup>Granzyme B<sup>+</sup> CTLs (E) using IF (n&nbsp;= 5).</div><div id="fspara0250" role="paragraph">(F and G) Tumor-bearing KPC mice were treated with vehicle or G+P with/without Pin1i-1 or -2 for up to 180&nbsp;days, followed by monitoring overall survival (n&nbsp;= 10) (F), as well as detecting macroscopic and microscopic tumors with H&amp;E staining (G) after autopsy.</div><div id="fspara0255" role="paragraph">Scale bars, 100 and 25&nbsp;μm (inset) (A, C, and E), 500&nbsp;μm (B), 100&nbsp;μm (D), and 200&nbsp;μm (G). Error bars, mean ± SD; <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗</sup>p&nbsp;= 0.0001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001; n.s., not significant; by one-way ANOVA (A–E) or log-rank test (F). See also <a id="crosref2090" href="#figs7">Figure&nbsp;S7</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.07.020/asset/8634e906-a887-4a61-8f41-87241ff8aab4/main.assets/figs7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs7" src="/cms/10.1016/j.cell.2021.07.020/asset/7c086884-6109-48a6-aa09-639c272e01e1/main.assets/figs7.jpg" height="824" width="657" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/8634e906-a887-4a61-8f41-87241ff8aab4/main.assets/figs7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S7</span> <span class="figure__title__text">Targeting Pin1 renders primary PDAC tumors eradicable by immunochemotherapy in KPC GEMM, related to <a id="crosref2140" href="#fig7">Figure&nbsp;7</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0505" role="paragraph">(A-B) Pin1 inhibitors disrupt the desmoplastic and immunosuppressive TME in KPC mice. Overt tumor-bearing KPC mice were treated with vehicle or G+P with/without Pin1i-1 or −2, followed by assaying CAF activation using αSMA IF (A) or PDGFRα IF (B) and CAF proliferation using double IF for PDGFRα and Ki67 (B) (n&nbsp;= 5).</div><div id="fspara0510" role="paragraph">(C-D) Pin1 inhibitors increased PD-L1 and ENT1 expression in KPC mice. Overt tumor-bearing KPC mice were treated with vehicle or G+P with/without Pin1i-1 or −2, followed by assaying PDL1 (C) and ENT1 (D) expression using IF after autopsy (n&nbsp;= 5).</div><div id="fspara0515" role="paragraph">(E-F) Pin1 inhibitors render PDAC tumors eradicable by immunochemotherapy in KPC mice. Overt tumor-bearing KPC mice were treated with vehicle or G+P with/without Pin1i-1 or −2, for up to 180&nbsp;days, followed by detecting macroscopic and microscopic tumors (E) and liver metastasis (F) after autopsy (n&nbsp;= 10).</div><div id="fspara0520" role="paragraph">(G) Left, in PDAC, Pin1 acts on cancer cells to induce HIP1R-mediated endocytosis and lysosomal degradation of PD-L1 and ENT1, and on stromal cells such as CAFs to drive the desmoplastic and immunosuppressive TME, as well as activating multiple oncogenic pathways, including many in oncogenic Kras signaling in both cells, thereby inducing drug resistance to immunochemotherapy. Right, Pin1 inhibitors suppress multiple oncogenic pathways, increase the cell surface expression of PD-L1 and ENT1 in cancer and disrupt the desmoplastic and immunosuppressive TME, together rendering aggressive PDAC tumors eradicable by immunochemotherapy (GEM&nbsp;+ αPD1) in a synergistic manner.</div><div id="fspara0525" role="paragraph">Scale bars, 100 and 50&nbsp;μm (B), 100&nbsp;μm (C, D), 5000 and 200&nbsp;μm (E), and 200&nbsp;μm (F). Error bars, mean ± s.d.; <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗</sup>p&nbsp;= 0.0001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001; n.s., not significant; by one-way ANOVA (A-D).</div></div></div></div></figcaption></figure></div></section></section><section id="sec-3"><h2>Discussion</h2><div id="p0155" role="paragraph">PDAC is notoriously resistant to current therapies due to inherent tumor heterogeneity and highly desmoplastic and immunosuppressive TME. Here, we find that Pin1 is overexpressed both in cancer cells and CAFs in PDAC patients and highly correlates with the desmoplastic and immunosuppressive TME and poor patient survival. Functionally, besides activating multiple cancer pathways, Pin1 drives the desmoplastic and immunosuppressive TME and promotes tumor malignancy and drug resistance by acting on stromal cells such as CAFs and inducing endocytosis and degradation PD-L1 and ENT1 in cancer cells by acting on pS929-HIP1R. Consequently, targeting Pin1 offers a unique and promising approach to render this deadly cancer eradicable. These findings support a possible design of future clinical trials using Pin1 inhibitors in combination with immunochemotherapy for PDAC patients given that the ATRA+ATO therapy is a safe modality to cure most APL patients.</div><div id="p0160" role="paragraph">In PDAC, stromal CAFs play a vital role in promoting the desmoplastic and immunosuppressive TME, as well as tumor growth and malignancy, and have emerged as cancer targets (<span class="dropBlock reference-citations"><a id="body-ref-sref81-4" href="#" role="doc-biblioref" data-xml-rid="bib81" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref81-4" aria-controls="sref81-4">Sahai et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref81-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">83.</div><div>Sahai, E. ∙ Astsaturov, I. ∙ Cukierman, E. ...</div><div><strong>A framework for advancing our understanding of cancer-associated fibroblasts</strong></div><div><em>Nat. Rev. Cancer.</em> 2020; <strong>20</strong>:174-186</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41568-019-0238-1" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85078418124" target="_blank" aria-label="Open Scopus in new tab">Scopus (485)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31980749/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41568-019-0238-1&amp;pmid=31980749" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref95-3" href="#" role="doc-biblioref" data-xml-rid="bib95" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref95-3" aria-controls="sref95-3">Whittle and Hingorani, 2019</a><div class="dropBlock__holder" data-db-target-of="sref95-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">97.</div><div>Whittle, M.C. ∙ Hingorani, S.R.</div><div><strong>Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets</strong></div><div><em>Gastroenterology.</em> 2019; <strong>156</strong>:2085-2096</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2018.12.044&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2018.12.044&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85064573516" target="_blank" aria-label="Open Scopus in new tab">Scopus (38)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30721663/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2018.12.044&amp;pmid=30721663" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). However, the mechanisms controlling CAF activation and function are still not fully understood. We show that Pin1 is overexpressed in CAFs and correlates with the desmoplastic and immunosuppressive TME and poor survival. Targeting Pin1 not only inhibits multiple oncogenic pathways in CAFs but also suppresses their growth, activation, and production of cytokines implicated in immunosuppression (<span class="dropBlock reference-citations"><a id="body-ref-sref24-3" href="#" role="doc-biblioref" data-xml-rid="bib24" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref24-3" aria-controls="sref24-3">Erkan et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref24-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Erkan, M. ∙ Adler, G. ∙ Apte, M.V. ...</div><div><strong>StellaTUM: current consensus and discussion on pancreatic stellate cell research</strong></div><div><em>Gut.</em> 2012; <strong>61</strong>:172-178</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/gutjnl-2011-301220" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84855201311" target="_blank" aria-label="Open Scopus in new tab">Scopus (270)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22115911/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1136%2Fgutjnl-2011-301220&amp;pmid=22115911" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref62-2" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-2" aria-controls="sref62-2">Mace et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref62-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Mace, T.A. ∙ Shakya, R. ∙ Pitarresi, J.R. ...</div><div><strong>IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer</strong></div><div><em>Gut.</em> 2018; <strong>67</strong>:320-332</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/gutjnl-2016-311585" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84994516325" target="_blank" aria-label="Open Scopus in new tab">Scopus (212)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27797936/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1136%2Fgutjnl-2016-311585&amp;pmid=27797936" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref65-2" href="#" role="doc-biblioref" data-xml-rid="bib65" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref65-2" aria-controls="sref65-2">Mariathasan et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref65-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">67.</div><div>Mariathasan, S. ∙ Turley, S.J. ∙ Nickles, D. ...</div><div><strong>TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T&nbsp;cells</strong></div><div><em>Nature.</em> 2018; <strong>554</strong>:544-548</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25501" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85042495633" target="_blank" aria-label="Open Scopus in new tab">Scopus (1236)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29443960/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25501&amp;pmid=29443960" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Furthermore, targeting Pin1 eliminates the ability of CAFs to promote the desmoplastic TME, tumor growth, and malignancy in human PDAC organoids and/or PDOX mice. Moreover, Pin1 inhibitors also potently increase tumor-infiltrating CD8<sup>+</sup> CTLs and decrease immunosuppressive cells in GDA and KPC mice. These results are consistent with the reports that ATRA reduces the desmoplastic and immunosuppressive TME, and tumor growth and malignancy via multiple cancer and CAF-related pathways (<span class="dropBlock reference-citations"><a id="body-ref-sref14-2" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14-2" aria-controls="sref14-2">Chen et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref14-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">15.</div><div>Chen, L. ∙ Xu, X. ∙ Wen, X. ...</div><div><strong>Targeting PIN1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis</strong></div><div><em>Cancer Sci.</em> 2019; <strong>110</strong>:2442-2455</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/cas.14085" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85070236436" target="_blank" aria-label="Open Scopus in new tab">Scopus (3)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31148345/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fcas.14085&amp;pmid=31148345" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref23" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23" aria-controls="sref23">Ene-Obong et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref23"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Ene-Obong, A. ∙ Clear, A.J. ∙ Watt, J. ...</div><div><strong>Activated pancreatic stellate cells sequester CD8+ T&nbsp;cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma</strong></div><div><em>Gastroenterology.</em> 2013; <strong>145</strong>:1121-1132</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2013.07.025&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2013.07.025&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84886780808" target="_blank" aria-label="Open Scopus in new tab">Scopus (271)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23891972/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2013.07.025&amp;pmid=23891972" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref27" href="#" role="doc-biblioref" data-xml-rid="bib27" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref27" aria-controls="sref27">Froeling et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref27"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">28.</div><div>Froeling, F.E. ∙ Feig, C. ∙ Chelala, C. ...</div><div><strong>Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-beta-catenin signaling to slow tumor progression</strong></div><div><em>Gastroenterology.</em> 2011; <strong>141</strong>:1486-1497</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2011.06.047&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2011.06.047&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-80053577336" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21704588/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2011.06.047&amp;pmid=21704588" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref34" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34" aria-controls="sref34">Guan et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref34"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">35.</div><div>Guan, J. ∙ Zhang, H. ∙ Wen, Z. ...</div><div><strong>Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells</strong></div><div><em>Cancer Lett.</em> 2014; <strong>345</strong>:132-139</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2013.12.006" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84893736743" target="_blank" aria-label="Open Scopus in new tab">Scopus (64)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24334138/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2013.12.006&amp;pmid=24334138" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref47-1" href="#" role="doc-biblioref" data-xml-rid="bib47" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref47-1" aria-controls="sref47-1">Kocher et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref47-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">48.</div><div>Kocher, H.M. ∙ Basu, B. ∙ Froeling, F.E.M. ...</div><div><strong>Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer</strong></div><div><em>Nat. Commun.</em> 2020; <strong>11</strong>:4841</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-020-18636-w" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85091458810" target="_blank" aria-label="Open Scopus in new tab">Scopus (22)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32973176/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-020-18636-w&amp;pmid=32973176" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), because many ATRA-mediated effects might be at least partially due to Pin1 inhibition (<span class="dropBlock reference-citations"><a id="body-ref-sref94-4" href="#" role="doc-biblioref" data-xml-rid="bib94" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref94-4" aria-controls="sref94-4">Wei et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref94-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">96.</div><div>Wei, S. ∙ Kozono, S. ∙ Kats, L. ...</div><div><strong>Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer</strong></div><div><em>Nat. Med.</em> 2015; <strong>21</strong>:457-466</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.3839" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_96_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84937759226" target="_blank" aria-label="Open Scopus in new tab">Scopus (172)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25849135/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.3839&amp;pmid=25849135" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref100-8" href="#" role="doc-biblioref" data-xml-rid="bib100" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref100-8" aria-controls="sref100-8">Zhou and Lu, 2016</a><div class="dropBlock__holder" data-db-target-of="sref100-8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">103.</div><div>Zhou, X.Z. ∙ Lu, K.P.</div><div><strong>The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target</strong></div><div><em>Nat. Rev. Cancer.</em> 2016; <strong>16</strong>:463-478</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc.2016.49" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_103_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84973128266" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27256007/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc.2016.49&amp;pmid=27256007" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Of note, CAFs are heterogenous and their functions are complex in PDAC. Our results suggest that Pin1 inhibition might target αSMA<sup>+</sup> CAFs (myCAFs) and PDGFRα<sup>+</sup> CAFs (iCAFs), with the latter contributing to desmoplastic immune suppressive TME by secreting collagens and cytokines (<span class="dropBlock reference-citations"><a id="body-ref-sref28-2" href="#" role="doc-biblioref" data-xml-rid="bib28" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref28-2" aria-controls="sref28-2">Garg et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref28-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Garg, B. ∙ Giri, B. ∙ Modi, S. ...</div><div><strong>NFκB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12</strong></div><div><em>Gastroenterology.</em> 2018; <strong>155</strong>:880-891</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2018.05.051&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2018.05.051&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85051678735" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29909021/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2018.05.051&amp;pmid=29909021" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref40-3" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40-3" aria-controls="sref40-3">Hosein et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref40-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Hosein, A.N. ∙ Brekken, R.A. ∙ Maitra, A.</div><div><strong>Pancreatic cancer stroma: an update on therapeutic targeting strategies</strong></div><div><em>Nat. Rev. Gastroenterol. Hepatol.</em> 2020; <strong>17</strong>:487-505</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41575-020-0300-1" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85084520894" target="_blank" aria-label="Open Scopus in new tab">Scopus (93)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32393771/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41575-020-0300-1&amp;pmid=32393771" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), but further work needs to define the role of Pin1 in various types of CAFs.</div><div id="p0165" role="paragraph">Protein degradation is a key mechanism to regulate not only numerous oncogenic proteins (<span class="dropBlock reference-citations"><a id="body-ref-sref59-4" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59-4" aria-controls="sref59-4">Lu and Hunter, 2014</a><div class="dropBlock__holder" data-db-target-of="sref59-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Lu, Z. ∙ Hunter, T.</div><div><strong>Prolyl isomerase Pin1 in cancer</strong></div><div><em>Cell Res.</em> 2014; <strong>24</strong>:1033-1049</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/cr.2014.109" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84905810923" target="_blank" aria-label="Open Scopus in new tab">Scopus (112)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25124924/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fcr.2014.109&amp;pmid=25124924" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref100-9" href="#" role="doc-biblioref" data-xml-rid="bib100" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref100-9" aria-controls="sref100-9">Zhou and Lu, 2016</a><div class="dropBlock__holder" data-db-target-of="sref100-9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">103.</div><div>Zhou, X.Z. ∙ Lu, K.P.</div><div><strong>The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target</strong></div><div><em>Nat. Rev. Cancer.</em> 2016; <strong>16</strong>:463-478</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc.2016.49" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_103_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84973128266" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27256007/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc.2016.49&amp;pmid=27256007" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), but also many cancer therapeutic targets/receptors biomarkers, including PD-L1 (<span class="dropBlock reference-citations"><a id="body-ref-sref12-4" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12-4" aria-controls="sref12-4">Burr et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref12-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Burr, M.L. ∙ Sparbier, C.E. ∙ Chan, Y.C. ...</div><div><strong>CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity</strong></div><div><em>Nature.</em> 2017; <strong>549</strong>:101-105</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature23643" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85029029250" target="_blank" aria-label="Open Scopus in new tab">Scopus (291)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28813417/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature23643&amp;pmid=28813417" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref91-2" href="#" role="doc-biblioref" data-xml-rid="bib91" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref91-2" aria-controls="sref91-2">Wang et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref91-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">93.</div><div>Wang, H. ∙ Yao, H. ∙ Li, C. ...</div><div><strong>HIP1R targets PD-L1 to lysosomal degradation to alter T&nbsp;cell-mediated cytotoxicity</strong></div><div><em>Nat. Chem. Biol.</em> 2019; <strong>15</strong>:42-50</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41589-018-0161-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_93_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85055997824" target="_blank" aria-label="Open Scopus in new tab">Scopus (69)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30397328/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41589-018-0161-x&amp;pmid=30397328" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref99-6" href="#" role="doc-biblioref" data-xml-rid="bib99" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref99-6" aria-controls="sref99-6">Zhang et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref99-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">102.</div><div>Zhang, J. ∙ Bu, X. ∙ Wang, H. ...</div><div><strong>Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance</strong></div><div><em>Nature.</em> 2018; <strong>553</strong>:91-95</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25015" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_102_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85040189345" target="_blank" aria-label="Open Scopus in new tab">Scopus (306)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29160310/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25015&amp;pmid=29160310" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and ENT1 (<span class="dropBlock reference-citations"><a id="body-ref-sref41-3" href="#" role="doc-biblioref" data-xml-rid="bib41" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref41-3" aria-controls="sref41-3">Hu et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref41-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>Hu, Q. ∙ Qin, Y. ∙ Zhang, B. ...</div><div><strong>FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1</strong></div><div><em>Oncol. Rep.</em> 2017; <strong>38</strong>:2069-2077</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3892/or.2017.5856" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85029784620" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28765935/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3892%2For.2017.5856&amp;pmid=28765935" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Notably, HIP1R is a key protein in lysosomal proteolysis by binding with a membrane protein such as PD-L1 and cytoplasmic actin for endocytosis (<span class="dropBlock reference-citations"><a id="body-ref-sref32-2" href="#" role="doc-biblioref" data-xml-rid="bib32" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref32-2" aria-controls="sref32-2">Gottfried et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref32-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">33.</div><div>Gottfried, I. ∙ Ehrlich, M. ∙ Ashery, U.</div><div><strong>The Sla2p/HIP1/HIP1R family: similar structure, similar function in endocytosis?</strong></div><div><em>Biochem. Soc. Trans.</em> 2010; <strong>38</strong>:187-191</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1042/BST0380187" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-76449118339" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20074057/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1042%2FBST0380187&amp;pmid=20074057" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref68-2" href="#" role="doc-biblioref" data-xml-rid="bib68" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref68-2" aria-controls="sref68-2">Messa et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref68-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">70.</div><div>Messa, M. ∙ Fernández-Busnadiego, R. ∙ Sun, E.W. ...</div><div><strong>Epsin deficiency impairs endocytosis by stalling the actin-dependent invagination of endocytic clathrin-coated pits</strong></div><div><em>eLife.</em> 2014; <strong>3</strong>:e03311</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.7554/eLife.03311" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25122462/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.7554%2FeLife.03311&amp;pmid=25122462" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref91-3" href="#" role="doc-biblioref" data-xml-rid="bib91" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref91-3" aria-controls="sref91-3">Wang et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref91-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">93.</div><div>Wang, H. ∙ Yao, H. ∙ Li, C. ...</div><div><strong>HIP1R targets PD-L1 to lysosomal degradation to alter T&nbsp;cell-mediated cytotoxicity</strong></div><div><em>Nat. Chem. Biol.</em> 2019; <strong>15</strong>:42-50</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41589-018-0161-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_93_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85055997824" target="_blank" aria-label="Open Scopus in new tab">Scopus (69)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30397328/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41589-018-0161-x&amp;pmid=30397328" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). However, whether this PD-L1 degradation is further regulated is not known, which is especially important for PDAC because most PDAC patients have very low PD-L1 (<span class="dropBlock reference-citations"><a id="body-ref-sref88-2" href="#" role="doc-biblioref" data-xml-rid="bib88" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref88-2" aria-controls="sref88-2">Tessier-Cloutier et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref88-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">90.</div><div>Tessier-Cloutier, B. ∙ Kalloger, S.E. ∙ Al-Kandari, M. ...</div><div><strong>Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma</strong></div><div><em>BMC Cancer.</em> 2017; <strong>17</strong>:618</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s12885-017-3634-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_90_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85028699849" target="_blank" aria-label="Open Scopus in new tab">Scopus (21)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28870260/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs12885-017-3634-5&amp;pmid=28870260" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We demonstrated that Pin1 binds to the pSer929-Pro motif in HIP1R and also promotes the HIP1R-actin interaction and HIP1R-mediated endocytosis and lysosomal degradation of PD-L1 and ENT1 in PDAC cells. Moreover, Pin1 inhibition highly synergizes with αPD1 to promote the ability of activated lymphocytes to induce human and KPC PDAC organoid apoptosis and to dramatically reduce tumor growth and increase overall survival of GDA mice. These results are consistent with the recent findings that human cancer patients with elevated PD-L1 levels tend to respond better to PD-1 blockade (<span class="dropBlock reference-citations"><a id="body-ref-sref36-2" href="#" role="doc-biblioref" data-xml-rid="bib36" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref36-2" aria-controls="sref36-2">Herbst et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref36-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Herbst, R.S. ∙ Soria, J.C. ∙ Kowanetz, M. ...</div><div><strong>Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients</strong></div><div><em>Nature.</em> 2014; <strong>515</strong>:563-567</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature14011" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84920956735" target="_blank" aria-label="Open Scopus in new tab">Scopus (3140)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25428504/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature14011&amp;pmid=25428504" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Moreover, induction of PD-L1 expression in cancer cells in response to radiation (<span class="dropBlock reference-citations"><a id="body-ref-sref37-2" href="#" role="doc-biblioref" data-xml-rid="bib37" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref37-2" aria-controls="sref37-2">Herter-Sprie et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref37-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">38.</div><div>Herter-Sprie, G.S. ∙ Koyama, S. ∙ Korideck, H. ...</div><div><strong>Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer</strong></div><div><em>JCI Insight.</em> 2016; <strong>1</strong>:e87415</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/jci.insight.87415" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27699275/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2Fjci.insight.87415&amp;pmid=27699275" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), PARP inhibitors (<span class="dropBlock reference-citations"><a id="body-ref-sref45-4" href="#" role="doc-biblioref" data-xml-rid="bib45" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref45-4" aria-controls="sref45-4">Jiao et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref45-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">46.</div><div>Jiao, S. ∙ Xia, W. ∙ Yamaguchi, H. ...</div><div><strong>PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression</strong></div><div><em>Clin. Cancer Res.</em> 2017; <strong>23</strong>:3711-3720</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-16-3215" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85021146688" target="_blank" aria-label="Open Scopus in new tab">Scopus (372)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28167507/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-16-3215&amp;pmid=28167507" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), or inhibition of PD-L1 proteasomal proteolysis using CDK4/6 inhibitors (<span class="dropBlock reference-citations"><a id="body-ref-sref99-7" href="#" role="doc-biblioref" data-xml-rid="bib99" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref99-7" aria-controls="sref99-7">Zhang et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref99-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">102.</div><div>Zhang, J. ∙ Bu, X. ∙ Wang, H. ...</div><div><strong>Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance</strong></div><div><em>Nature.</em> 2018; <strong>553</strong>:91-95</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25015" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_102_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85040189345" target="_blank" aria-label="Open Scopus in new tab">Scopus (306)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29160310/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25015&amp;pmid=29160310" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) also potentiates ICB efficacy.</div><div id="p0170" role="paragraph">It is likely that without or before ICB therapy, tumors with high PD-L1 will gain an advantage by avoiding immune surveillance resulting in poor outcomes. However, in response to αPD1 therapy, immune cells might be activated as well as protected from exhaustion to recognize and kill cancer cells expressing high PD-L1 at the cell surface. This might be especially true if cancer cells sensitize to the therapy by Pin1 inhibitors, which block multiple cancer pathways and disrupt the desmoplastic and immunosuppressive TME, are combined with GEM, which is cytotoxic to cancer cells, as suggested by our results in human organoids, GDA mice, and KPC mice. However, more experiments are needed to define the mechanisms by which high PD-L1 levels in cancer cells improve αPD1 response, and whether Pin1 in immune cells including CD8<sup>+</sup> CTLs contributes to their function and tumor killing response. Notably, our results also indicate that combination treatment with Pin1 inhibitor and αPD1 induces only a small minority of tumors (12.5%) to complete regression, but leads to the complete regressions in the vast majority (87.5%) of tumors when given in combination with low-dose GEM in GDA mice, underscoring the importance of cytotoxic damage to cancer cells.</div><div id="p0175" role="paragraph">Our results together suggest a potential new treatment strategy using Pin1 inhibitors in combination with αPD1 and GEM to render aggressive PDAC eradicable. Our experimental design with a Pin1 inhibitor treatment for 3&nbsp;days before addition of the combination of GEM and αPD1 treatment is consistent with the ability of Pin1 inhibitors to reduce multiple cancer pathways in cancer cells and CAFs, to induce the cell-surface expression of PD-L1 and ENT in cancer cells, to synergize with GEM and αPD1 to induce organoid apoptosis, and to have better efficacy in various PDAC mice models. We believe, prior to GEM and αPD1 treatments, it may be important to “prime” the tumor with Pin1 inhibition to reduce multiple cancer pathways in cancer cells and CAFs and to induce the cell-surface expression of PD-L1 and ENT in cancer cells, to prepare the tumor and its microenvironment for immunochemotherapy, but further work needs to define the exact impact and timing for such additional Pin1 inhibitor treatment.</div><div id="p0180" role="paragraph">We speculate that the Pin1 inhibitor-immunochemotherapy combination would add little and/or non-overlapping toxicity to immunochemotherapy. ATRA+ATO are well tolerated and render APL curable with an acceptable safety profile even in children (<span class="dropBlock reference-citations"><a id="body-ref-sref17-2" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17-2" aria-controls="sref17-2">de Thé and Chen, 2010</a><div class="dropBlock__holder" data-db-target-of="sref17-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>de Thé, H. ∙ Chen, Z.</div><div><strong>Acute promyelocytic leukaemia: novel insights into the mechanisms of cure</strong></div><div><em>Nat. Rev. Cancer.</em> 2010; <strong>10</strong>:775-783</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc2943" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-77958510339" target="_blank" aria-label="Open Scopus in new tab">Scopus (336)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20966922/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc2943&amp;pmid=20966922" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and <i>PIN1</i><sup>−/−</sup> mice develop normally (<span class="dropBlock reference-citations"><a id="body-ref-sref57-2" href="#" role="doc-biblioref" data-xml-rid="bib57" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref57-2" aria-controls="sref57-2">Liou et&nbsp;al., 2002</a><div class="dropBlock__holder" data-db-target-of="sref57-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">59.</div><div>Liou, Y.C. ∙ Ryo, A. ∙ Huang, H.K. ...</div><div><strong>Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2002; <strong>99</strong>:1335-1340</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.032404099" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-0037022355" target="_blank" aria-label="Open Scopus in new tab">Scopus (286)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11805292/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.032404099&amp;pmid=11805292" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref100-10" href="#" role="doc-biblioref" data-xml-rid="bib100" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref100-10" aria-controls="sref100-10">Zhou and Lu, 2016</a><div class="dropBlock__holder" data-db-target-of="sref100-10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">103.</div><div>Zhou, X.Z. ∙ Lu, K.P.</div><div><strong>The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target</strong></div><div><em>Nat. Rev. Cancer.</em> 2016; <strong>16</strong>:463-478</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc.2016.49" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_103_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84973128266" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27256007/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc.2016.49&amp;pmid=27256007" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). A recent phase I study found that adding ATRA to GEM and nab-paclitaxel in the treatment of advanced PDAC is safe and tolerable and results in an encouraging progression-free survival for over 11&nbsp;months, as well as reprograms the TME (<span class="dropBlock reference-citations"><a id="body-ref-sref47-2" href="#" role="doc-biblioref" data-xml-rid="bib47" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref47-2" aria-controls="sref47-2">Kocher et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref47-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">48.</div><div>Kocher, H.M. ∙ Basu, B. ∙ Froeling, F.E.M. ...</div><div><strong>Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer</strong></div><div><em>Nat. Commun.</em> 2020; <strong>11</strong>:4841</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-020-18636-w" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85091458810" target="_blank" aria-label="Open Scopus in new tab">Scopus (22)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32973176/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-020-18636-w&amp;pmid=32973176" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), consistent with our findings. The efficacy of ATRA is limited by a short half-life of 45&nbsp;min in humans (<span class="dropBlock reference-citations"><a id="body-ref-sref52" href="#" role="doc-biblioref" data-xml-rid="bib52" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref52" aria-controls="sref52">Lefebvre et&nbsp;al., 1991</a><div class="dropBlock__holder" data-db-target-of="sref52"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Lefebvre, P. ∙ Thomas, G. ∙ Gourmel, B. ...</div><div><strong>Pharmacokinetics of oral all-trans retinoic acid in patients with acute promyelocytic leukemia</strong></div><div><em>Leukemia.</em> 1991; <strong>5</strong>:1054-1058</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/1774953/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=1774953" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and requires addition of ATO to cure APL (<span class="dropBlock reference-citations"><a id="body-ref-sref17-3" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17-3" aria-controls="sref17-3">de Thé and Chen, 2010</a><div class="dropBlock__holder" data-db-target-of="sref17-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>de Thé, H. ∙ Chen, Z.</div><div><strong>Acute promyelocytic leukaemia: novel insights into the mechanisms of cure</strong></div><div><em>Nat. Rev. Cancer.</em> 2010; <strong>10</strong>:775-783</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc2943" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-77958510339" target="_blank" aria-label="Open Scopus in new tab">Scopus (336)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20966922/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc2943&amp;pmid=20966922" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). However, liposomal ATRA has a longer half-life with significant efficacy in APL patients as monotherapy (<span class="dropBlock reference-citations"><a id="body-ref-sref43" href="#" role="doc-biblioref" data-xml-rid="bib43" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref43" aria-controls="sref43">Jain et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref43"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Jain, P. ∙ Kantarjian, H. ∙ Estey, E. ...</div><div><strong>Single-agent liposomal all-trans-retinoic Acid as initial therapy for acute promyelocytic leukemia: 13-year follow-up data</strong></div><div><em>Clin. Lymphoma Myeloma Leuk.</em> 2014; <strong>14</strong>:e47-e49</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.clml.2013.08.004&amp;cf=fulltext&amp;site=clml-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.clml.2013.08.004&amp;cf=pdf&amp;site=clml-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24128595/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.clml.2013.08.004&amp;pmid=24128595" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In this context, our data show that the covalent Pin1 inhibitor Sulfopin, which targets the ATO-binding site (<span class="dropBlock reference-citations"><a id="body-ref-sref21-2" href="#" role="doc-biblioref" data-xml-rid="bib21" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref21-2" aria-controls="sref21-2">Dubiella et al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref21-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Dubiella, C. ∙ Pinch, B.J. ∙ Koikawa, K. ...</div><div><strong>Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo</strong></div><div><em>Nat. Chem. Biol.</em> 2021;</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41589-021-00786-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85105881530" target="_blank" aria-label="Open Scopus in new tab">Scopus (8)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33972797/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41589-021-00786-7&amp;pmid=33972797" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), matches ATRA+ATO with regard to efficacy in PDAC.</div><div id="p0185" role="paragraph">In summary, we uncover a unique therapeutic strategy and elucidate the underlying mechanisms by which targeting Pin1 renders aggressive PDAC eradicable by synergizing with immunochemotherapy, paving the way for clinical trials and further development of new Pin1 inhibitors to evaluate their clinical impact on patients with PDAC.</div><section id="sec-3-1"><h3>Limitations of the study</h3><div id="p0190" role="paragraph">Our studies present pre-clinical data that justify further development of Pin1 inhibitors in preparation for first-in-human trials, but they have some limitations. A potential concern is that PD-L1 expression induced by Pin1 inhibition might aid immune evasion of cancer cells, and hence combination of a Pin1 inhibitor with a ICB might be preferable to capitalize on increased PD-L1 expression to increase the synergy. Although we found complete resolution of a majority of PDAC tumors in the GDA model, and long sustained reemission in the majority of the spontaneous PDAC tumors in the genetic KPC mouse model, the KPC mice have a minimal residual disease and some KPC mice showed a resistance to Pin1i after long treatment.</div></section></section><section id="sec-4"><h2>STAR★Methods</h2><section id="sec-4-1"><h3>Key resources table</h3><div id="p0195" role="paragraph"><div class="figure-wrap"><figure id="undtbl1" class="table" data-figureviewer-ignore="true"><div class="table-wrap"><table data-figureviewer-ignore="true" tabindex="0"><thead><tr class="rowsep"><th>Reagent or resource</th><th>Source</th><th>Identifier</th></tr></thead><tbody><tr class="rowsep"><td colspan="3"><b>Antibodies</b></td></tr><tr><td>Mouse monoclonal anti-Pin1</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref4-2" href="#" role="doc-biblioref" data-xml-rid="bib4" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref4-2" aria-controls="sref4-2">Bao et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref4-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Bao, L. ∙ Kimzey, A. ∙ Sauter, G. ...</div><div><strong>Prevalent overexpression of prolyl isomerase Pin1 in human cancers</strong></div><div><em>Am. J. Pathol.</em> 2004; <strong>164</strong>:1727-1737</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2FS0002-9440%2810%2963731-5&amp;cf=fulltext&amp;site=ajpa-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2FS0002-9440%2810%2963731-5&amp;cf=pdf&amp;site=ajpa-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15111319/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0002-9440%2810%2963731-5&amp;pmid=15111319" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Rabbit polyclonal anti-Pin1</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref105" href="#" role="doc-biblioref" data-xml-rid="bib106 bib105" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref105" aria-controls="sref105">Ayala et al., 2003; Wulf et al., 2001</a><div class="dropBlock__holder" data-db-target-of="sref105"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Ayala, G. ∙ Wang, D. ∙ Wulf, G. ...</div><div><strong>Pin1 is a novel prognostic marker in prostate cancer</strong></div><div><em>Cancer Research.</em> 2003; <strong>63</strong>:6244-6251</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/14559810/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=14559810" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">99.</div><div>Wulf, G.M. ∙ Ryo, A. ∙ Wulf, G.G. ...</div><div><strong>Pin1 is overexpressed in breast cancer and potentiates the transcriptional activity of phosphorylated c-Jun towards the cyclin D1 gene</strong></div><div><em>EMBO J.</em> 2001; <strong>20</strong>:3459-3472</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/emboj/20.13.3459" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_99_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-0035796405" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11432833/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Femboj%2F20.13.3459&amp;pmid=11432833" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Mouse monoclonal anti-Pin1 (clone G-8)</td><td>Santa Cruz</td><td>Cat# sc-46660; RRID: <a id="intref0010" href="https://antibodyregistry.org/AB_628132" target="_blank">AB_628132</a></td></tr><tr><td>Mouse monoclonal Alexa Fluor 647 anti-Pin1 (clone G-8)</td><td>Santa Cruz</td><td>Cat# sc-46660 AF647; RRID: <a id="intref0015" href="https://antibodyregistry.org/AB_628132" target="_blank">AB_628132</a></td></tr><tr><td>Rabbit polyclonal anti-Pin1</td><td>Cell Signaling Technology</td><td>Cat# 3722; RRID: <a id="intref0020" href="https://antibodyregistry.org/AB_10692654" target="_blank">AB_10692654</a></td></tr><tr><td>Mouse monoclonal anti-CD8 alpha</td><td>Abcam</td><td>Cat# ab17147; RRID: <a id="intref0025" href="https://antibodyregistry.org/AB_443686" target="_blank">AB_443686</a></td></tr><tr><td>Rabbit monoclonal anti-CD3 (clone SP7)</td><td>Abcam</td><td>Cat# ab16669; RRID: <a id="intref0030" href="https://antibodyregistry.org/AB_443425" target="_blank">AB_443425</a></td></tr><tr><td>Rabbit monoclonal anti-CD45 (clone EP322Y)</td><td>Abcam</td><td>Cat# ab40763; RRID: <a id="intref0035" href="https://antibodyregistry.org/AB_726545" target="_blank">AB_726545</a></td></tr><tr><td>Rabbit monoclonal anti-CD163</td><td>Abcam</td><td>Cat# ab182422; RRID: <a id="intref0040" href="https://antibodyregistry.org/AB_2753196" target="_blank">AB_2753196</a></td></tr><tr><td>Rabbit monoclonal anti-Cytokeratin 19</td><td>Abcam</td><td>Cat# ab52625; RRID: <a id="intref0045" href="https://antibodyregistry.org/AB_2281020" target="_blank">AB_2281020</a></td></tr><tr><td>Rabbit monoclonal anti-Fibroblast activation protein</td><td>Abcam</td><td>Cat# ab207178; RRID: <a id="intref0050" href="https://antibodyregistry.org/AB_2864720" target="_blank">AB_2864720</a></td></tr><tr><td>Rabbit polyclonal anti-Ki67</td><td>Abcam</td><td>Cat# ab15580; RRID: <a id="intref0055" href="https://antibodyregistry.org/AB_443209" target="_blank">AB_443209</a></td></tr><tr><td>Rabbit polyclonal anti-Granzyme B</td><td>Abcam</td><td>Cat# ab4059; RRID: <a id="intref0060" href="https://antibodyregistry.org/AB_304251" target="_blank">AB_304251</a></td></tr><tr><td>Recombinant Alexa Fluor 488 Anti-HLA-DPB1 antibody (clone EPR11226)</td><td>Abcam</td><td>Cat#ab201527; RRID: <a id="intref0065" href="https://antibodyregistry.org/AB_2890211" target="_blank">AB_2890211</a></td></tr><tr><td>Recombinant Alexa Fluor 555 Anti-alpha smooth muscle Actin antibody (clone EPR5368)</td><td>Abcam</td><td>Cat# ab202509; RRID: <a id="intref0070" href="https://antibodyregistry.org/AB_2868435" target="_blank">AB_2868435</a></td></tr><tr><td>Goat F(ab) Anti-Mouse IgG H&amp;L</td><td>Abcam</td><td>Cat# ab6668; RRID: <a id="intref0075" href="https://antibodyregistry.org/AB_955960" target="_blank">AB_955960</a></td></tr><tr><td>Rabbit polyclonal anti-FBW7</td><td>Bethyl</td><td>Cat# A301-720A; RRID: <a id="intref0080" href="https://antibodyregistry.org/AB_1210897" target="_blank">AB_1210897</a></td></tr><tr><td>Rat monoclonal anti-Mouse FOXP3, Alexa Fluor 647</td><td>BioLegend</td><td>Cat# 126408; RRID: <a id="intref0085" href="https://antibodyregistry.org/AB_1089115" target="_blank">AB_1089115</a></td></tr><tr><td>Rat monoclonal anti-Mouse Ly-6G, Alexa Fluor 647</td><td>BioLegend</td><td>Cat# 127610; RRID: <a id="intref0090" href="https://antibodyregistry.org/AB_1134159" target="_blank">AB_1134159</a></td></tr><tr><td>Rat monoclonal anti-Mouse CD11c, Alexa Fluor 647</td><td>BioLegend</td><td>Cat# 117312; RRID: <a id="intref0095" href="https://antibodyregistry.org/AB_389328" target="_blank">AB_389328</a></td></tr><tr><td>Rat monoclonal anti-Mouse CD8α, Alexa Fluor 647</td><td>BioLegend</td><td>Cat# 100724; RRID: <a id="interref465" href="https://antibodyregistry.org/AB_389326" target="_blank">AB_389326</a></td></tr><tr><td>Rabbit polyclonal anti-Akt</td><td>Cell Signaling Technology</td><td>Cat# 9272; RRID: <a id="intref0100" href="https://antibodyregistry.org/AB_329827" target="_blank">AB_329827</a></td></tr><tr><td>Rabbit monoclonal anti-c-Jun (clone 60A8)</td><td>Cell Signaling Technology</td><td>Cat# 9165; RRID: <a id="intref0105" href="https://antibodyregistry.org/AB_2130165" target="_blank">AB_2130165</a></td></tr><tr><td>Mouse monoclonal anti-E-Cadherin (clone 4A2)</td><td>Cell Signaling Technology</td><td>Cat# 14472; RRID: <a id="intref0110" href="https://antibodyregistry.org/AB_2728770" target="_blank">AB_2728770</a></td></tr><tr><td>Mouse monoclonal anti-Pan Keratin (clone C11)</td><td>Cell Signaling Technology</td><td>Cat# 4523S; RRID: <a id="interref470" href="https://antibodyregistry.org/AB_836889" target="_blank">AB_836889</a></td></tr><tr><td>Rabbit monoclonal anti-NF-kappaB p65 (clone D14E12)</td><td>Cell Signaling Technology</td><td>Cat# 8242; RRID: <a id="intref0115" href="https://antibodyregistry.org/AB_10859369" target="_blank">AB_10859369</a></td></tr><tr><td>Rabbit monoclonal anti-LAMP1 (clone D2D11)</td><td>Cell Signaling Technology</td><td>Cat# 9091; RRID: <a id="intref0120" href="https://antibodyregistry.org/AB_2687579" target="_blank">AB_2687579</a></td></tr><tr><td>Rabbit monoclonal anti-PD-L1 (clone E1L3N)</td><td>Cell Signaling Technology</td><td>Cat# 13684; RRID: <a id="intref0125" href="https://antibodyregistry.org/AB_2687655" target="_blank">AB_2687655</a></td></tr><tr><td>Rabbit monoclonal anti-SQSTM1/p62 (clone D1Q5S)</td><td>Cell Signaling Technology</td><td>Cat# 39749; RRID: <a id="intref0130" href="https://antibodyregistry.org/AB_2799160" target="_blank">AB_2799160</a></td></tr><tr><td>Rabbit monoclonal anti-RRM1 (clone D12F12)</td><td>Cell Signaling Technology</td><td>Cat# 8637; RRID: <a id="intref0135" href="https://antibodyregistry.org/AB_11217623" target="_blank">AB_11217623</a></td></tr><tr><td>Rabbit monoclonal anti-Vimentin (clone D21H3)</td><td>Cell Signaling Technology</td><td>Cat# 5741; RRID: <a id="intref0140" href="https://antibodyregistry.org/AB_10695459" target="_blank">AB_10695459</a></td></tr><tr><td>Rabbit monoclonal anti-β-Catenin (clone D10A8)</td><td>Cell Signaling Technology</td><td>Cat# 8480; RRID: <a id="intref0145" href="https://antibodyregistry.org/AB_11127855" target="_blank">AB_11127855</a></td></tr><tr><td>Rabbit monoclonal anti-Cleaved Caspase3 (clone 5A1E)</td><td>Cell Signaling Technology</td><td>Cat# 9664S; RRID: <a id="intref0150" href="https://antibodyregistry.org/AB_2070042" target="_blank">AB_2070042</a></td></tr><tr><td>Rabbit monoclonal anti-STING</td><td>Cell Signaling Technology</td><td>Cat# 13647S; RRID: <a id="intref0155" href="https://antibodyregistry.org/AB_2732796" target="_blank">AB_2732796</a></td></tr><tr><td>Mouse monoclonal PE anti-CD44 (clone 156-3C11)</td><td>Cell Signaling Technology</td><td>Cat# 8724; RRID: <a id="intref0160" href="https://antibodyregistry.org/AB_10829611" target="_blank">AB_10829611</a></td></tr><tr><td>Rabbit monoclonal Alexa Fluor 555 anti-PDGF Receptor α (D13C6) XP</td><td>Cell Signaling Technology</td><td>Cat# 8893; RRID: <a id="intref0165" href="https://antibodyregistry.org/AB_2797679" target="_blank">AB_2797679</a></td></tr><tr><td>Mouse monoclonal anti-Human Smooth Muscle Actin (clone 1A4)</td><td>Dako</td><td>Cat# M0851; RRID: <a id="intref0170" href="https://antibodyregistry.org/AB_2223500" target="_blank">AB_2223500</a></td></tr><tr><td>Rat monoclonal Super Bright 600 anti-CD8α (clone 53-6.7)</td><td>eBioscience</td><td>Cat# 63-0081-82; RRID: <a id="intref0175" href="https://antibodyregistry.org/AB_2637163" target="_blank">AB_2637163</a></td></tr><tr><td>Mouse monoclonal eFluor 660 anti-CD8α (clone AMC908)</td><td>eBioscience</td><td>Cat# 50-0008-80; RRID: <a id="intref0180" href="https://antibodyregistry.org/AB_2574148" target="_blank">AB_2574148</a></td></tr><tr><td>Goat Polyclonal Alexa Fluor 488 anti-CD4</td><td>R&amp;D Systems</td><td>Cat# FAB8165G; RRID: <a id="intref0185" href="https://antibodyregistry.org/AB_2728839" target="_blank">AB_2728839</a></td></tr><tr><td>Rabbit polyclonal anti-PD-L1</td><td>Novus</td><td>Cat# NBP1-76769; RRID: <a id="intref0190" href="https://antibodyregistry.org/AB_11024101" target="_blank">AB_11024101</a></td></tr><tr><td>Mouse monoclonal anti-AQP9 (clone G-3)</td><td>Santa Cruz</td><td>Cat# sc-74409; RRID: <a id="intref0195" href="https://antibodyregistry.org/AB_1119055" target="_blank">AB_1119055</a></td></tr><tr><td>Mouse monoclonal anti-Cytokeratin 19 (clone A-3)</td><td>Santa Cruz</td><td>Cat# sc-376126; RRID: <a id="intref0200" href="https://antibodyregistry.org/AB_10988034" target="_blank">AB_10988034</a></td></tr><tr><td>Mouse monoclonal anti-cyclin D1 (clone DCS-6)</td><td>Santa Cruz</td><td>Cat# sc-20044; RRID: <a id="intref0205" href="https://antibodyregistry.org/AB_627346" target="_blank">AB_627346</a></td></tr><tr><td>Mouse monoclonal anti-dCK (clone H-3)</td><td>Santa Cruz</td><td>Cat# sc-393099; RRID: <a id="intref0210" href="https://antibodyregistry.org/AB_2864729" target="_blank">AB_2864729</a></td></tr><tr><td>Mouse monoclonal FITC anti-ENT1 (clone F12)</td><td>Santa Cruz</td><td>Cat#sc-377283FITC; RRID: N/A</td></tr><tr><td>Rabbit polyclonal anti-CMTM6</td><td>Sigma-Aldrich</td><td>Cat# HPA026980; RRID: <a id="intref0215" href="https://antibodyregistry.org/AB_10602801" target="_blank">AB_10602801</a></td></tr><tr><td>Mouse monoclonal anti-FLAG (clone M2)</td><td>Sigma-Aldrich</td><td>Cat# F1804; RRID: <a id="intref0220" href="https://antibodyregistry.org/AB_262044" target="_blank">AB_262044</a></td></tr><tr><td>Mouse monoclonal anti-β-Actin</td><td>Sigma-Aldrich</td><td>Cat# A5441; RRID: <a id="intref0225" href="https://antibodyregistry.org/AB_476744" target="_blank">AB_476744</a></td></tr><tr><td>Rabbit polyclonal anti-ENT1</td><td>Proteintech</td><td>Cat# 11337-1-AP; RRID: <a id="intref0230" href="https://antibodyregistry.org/AB_2190784" target="_blank">AB_2190784</a></td></tr><tr><td>Rabbit polyclonal anti-HLA class I ABC</td><td>Proteintech</td><td>Cat# 15240-1-AP; RRID: <a id="intref0235" href="https://antibodyregistry.org/AB_1557426" target="_blank">AB_1557426</a></td></tr><tr><td>Rabbit polyclonal anti-HIP1R</td><td>Proteintech</td><td>Cat# 16814-1-AP; RRID: <a id="intref0240" href="https://antibodyregistry.org/AB_2117572" target="_blank">AB_2117572</a></td></tr><tr><td>Rat monoclonal PE-Cyanine7 anti-mouse CD45</td><td>Invitrogen</td><td>Cat# 25-0451-82; RRID: <a id="intref0245" href="https://antibodyregistry.org/AB_2734986" target="_blank">AB_2734986</a></td></tr><tr><td>Mouse monoclonal Pan Cytokeratin Alexa Fluor 488 (clone AE1/AE3)</td><td>Invitrogen</td><td>Cat# 53-9003-82; RRID: <a id="intref0250" href="https://antibodyregistry.org/AB_1834350" target="_blank">AB_1834350</a></td></tr><tr><td>Rat monoclonal Pacific blue anti-mouse CD3</td><td>BioLegend</td><td>Cat# 100214; RRID:<a id="intref0255" href="https://antibodyregistry.org/AB_493645" target="_blank">AB_493645</a></td></tr><tr><td>Rat monoclonal APC anti-mouse CD4</td><td>BioLegend</td><td>Cat# 100516; RRID: <a id="intref0260" href="https://antibodyregistry.org/AB_312719" target="_blank">AB_312719</a></td></tr><tr><td>Rat monoclonal PE anti-CD8α</td><td>BioLegend</td><td>Cat# 553033; RRID: <a id="intref0265" href="https://antibodyregistry.org/AB_394571" target="_blank">AB_394571</a></td></tr><tr><td>Rat monoclonal PE anti-mouse/human CD11b</td><td>BioLegend</td><td>Cat# 101208; RRID: <a id="intref0270" href="https://antibodyregistry.org/AB_312791" target="_blank">AB_312791</a></td></tr><tr><td>Armenian Hamster monoclonal PE anti-mouse CD11c</td><td>BioLegend</td><td>Cat# ;117308; RRID: <a id="intref0275" href="https://antibodyregistry.org/AB_313777" target="_blank">AB_313777</a></td></tr><tr><td>Rat monoclonal PE anti-mouse NK1.1</td><td>BioLegend</td><td>Cat# 108708; RRID: <a id="intref0280" href="https://antibodyregistry.org/AB_313395" target="_blank">AB_313395</a></td></tr><tr><td>Rat monoclonal APC anti-mouse CD206</td><td>BioLegend</td><td>Cat# 141708; RRID: <a id="intref0285" href="https://antibodyregistry.org/AB_10900231" target="_blank">AB_10900231</a></td></tr><tr><td>Rat monoclonal FITC anti-mouse F4/80</td><td>BioLegend</td><td>Cat# 123108; RRID:<a id="intref0290" href="https://antibodyregistry.org/AB_893502" target="_blank">AB_893502</a></td></tr><tr><td>Rat monoclonal APC anti-mouse CD279 (PD-1)</td><td>BioLegend</td><td>Cat# 135210; RRID: <a id="intref0295" href="https://antibodyregistry.org/AB_2159183" target="_blank">AB_2159183</a></td></tr><tr><td>Rat monoclonal APC anti-mouse CD274 (PD-L1)</td><td>BioLegend</td><td>Cat# 124312; RRID: <a id="intref0300" href="https://antibodyregistry.org/AB_10612741" target="_blank">AB_10612741</a></td></tr><tr><td>Rat monoclonal FITC anti-mouse H-2Kb (MHC-ClassI)</td><td>BioLegend</td><td>Cat#116506; RRID: <a id="intref0305" href="https://antibodyregistry.org/AB_313733" target="_blank">AB_313733</a></td></tr><tr><td>Rat monoclonal FITC anti-mouse 1-A/1-E (MHC-ClassII)</td><td>BioLegend</td><td>Cat# 107606; RRID: <a id="intref0310" href="https://antibodyregistry.org/AB_313321" target="_blank">AB_313321</a></td></tr><tr><td>Rat monoclonal FITC anti-human/mouse Granzyme B</td><td>BioLegend</td><td>Cat# 515403; RRID: <a id="intref0315" href="https://antibodyregistry.org/AB_2114575" target="_blank">AB_2114575</a></td></tr><tr><td>Rat monoclonal APC anti-mouse CD152 (CTLA4)</td><td>BioLegend</td><td>Cat# 106310; RRID: <a id="intref0320" href="https://antibodyregistry.org/AB_2087653" target="_blank">AB_2087653</a></td></tr><tr><td>Mouse monoclonal Alexa Fluor 647 anti-human CD45</td><td>BioLegend</td><td>Cat# 304056; RRID: <a id="intref0325" href="https://antibodyregistry.org/AB_2564155" target="_blank">AB_2564155</a></td></tr><tr><td>Rat monoclonal FITC anti-FOXP3</td><td>Invitrogen</td><td>Cat# 11-5773-82; RRID:<a id="intref0330" href="https://antibodyregistry.org/AB_465243" target="_blank">AB_465243</a></td></tr><tr><td>Rat monoclonal FITC anti-CD223 (Lag-3)</td><td>Invitrogen</td><td>Cat# 11-2231-82; RRID: <a id="intref0335" href="https://antibodyregistry.org/AB_2572484" target="_blank">AB_2572484</a></td></tr><tr><td>Goat polyclonal anti-Mouse IgG, IgM (H+L), Alexa Fluor 488</td><td>Invitrogen</td><td>Cat# A-10680; RRID: <a id="intref0340" href="https://antibodyregistry.org/AB_2534062" target="_blank">AB_2534062</a></td></tr><tr><td>Goat polyclonal anti-Rabbit IgG (H+L), Alexa Fluor 488</td><td>Invitrogen</td><td>Cat# A-11008; RRID: <a id="intref0345" href="https://antibodyregistry.org/AB_143165" target="_blank">AB_143165</a></td></tr><tr><td>Goat polyclonal anti-Mouse IgG (H+L), Alexa Fluor 594</td><td>Invitrogen</td><td>Cat# A-11005; RRID: <a id="intref0350" href="https://antibodyregistry.org/AB_2534073" target="_blank">AB_2534073</a></td></tr><tr><td>Goat polyclonal anti-Rabbit IgG (H+L), Alexa Fluor 594</td><td>Invitrogen</td><td>Cat# A-11012; RRID: <a id="intref0355" href="https://antibodyregistry.org/AB_2534079" target="_blank">AB_2534079</a></td></tr><tr><td>Goat polyclonal anti-Rat IgG (H+L), Alexa Fluor 594</td><td>Invitrogen</td><td>Cat# A-11007; RRID: <a id="intref0360" href="https://antibodyregistry.org/AB_10561522" target="_blank">AB_10561522</a></td></tr><tr><td>Goat polyclonal anti-Mouse IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 647</td><td>Invitrogen</td><td>Cat# A-21235; RRID: <a id="intref0365" href="https://antibodyregistry.org/AB_2535804" target="_blank">AB_2535804</a></td></tr><tr><td>Goat polyclonal anti-Rabbit IgG IRDye 800CW</td><td>LI-COR</td><td>Cat# 926-32211; RRID: <a id="intref0370" href="https://antibodyregistry.org/AB_621843" target="_blank">AB_621843</a></td></tr><tr><td>Horse anti-Mouse IgG (H+L)</td><td>Vector Laboratories</td><td>Cat# PI-2000; RRID: <a id="intref0375" href="https://antibodyregistry.org/AB_2336177" target="_blank">AB_2336177</a></td></tr><tr class="rowsep"><td>Goat anti-Rabbit IgG (H+L)</td><td>Vector Laboratories</td><td>Cat# PI-1000; RRID: <a id="intref0380" href="https://antibodyregistry.org/AB_2336198" target="_blank">AB_2336198</a></td></tr><tr class="rowsep"><td colspan="3"><b>Bacterial and virus strains</b></td></tr><tr><td>Pin1 shRNA lentiviral particles</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref102" href="#" role="doc-biblioref" data-xml-rid="bib102" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref102" aria-controls="sref102">Kondo et al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref102"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">51.</div><div>Kondo, A. ∙ Shahpasand, K. ∙ Mannix, R. ...</div><div><strong>Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy</strong></div><div><em>Nature.</em> 2015; <strong>523</strong>:431-436</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature14658" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84937849044" target="_blank" aria-label="Open Scopus in new tab">Scopus (245)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26176913/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature14658&amp;pmid=26176913" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>CRISPR Pin1 lentiviral particles</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref50-5" href="#" role="doc-biblioref" data-xml-rid="bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50-5" aria-controls="sref50-5">Kozono et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref50-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Kozono, S. ∙ Lin, Y.M. ∙ Seo, H.S. ...</div><div><strong>Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells</strong></div><div><em>Nat. Commun.</em> 2018; <strong>9</strong>:3069</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-018-05402-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85051562951" target="_blank" aria-label="Open Scopus in new tab">Scopus (54)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30093655/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-018-05402-2&amp;pmid=30093655" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr class="rowsep"><td>GFP (CMV Bsd) lentiviral particles</td><td>GeneTarge</td><td>Cat# LVP001</td></tr><tr class="rowsep"><td colspan="3"><b>Biological samples</b></td></tr><tr><td>Tissue specimens of patients with PDAC</td><td>Kyushu University Hospital, Fukuoka, Japan</td><td>Ethics board approval #28-189</td></tr><tr><td>Archival tissue specimens of patients with PDAC</td><td>Brigham and Women’s Hospital, Boston, MA</td><td>IRB approval #1627</td></tr><tr class="rowsep"><td>PDAC patient derived xenograft (PDX) tumor</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref30-1" href="#" role="doc-biblioref" data-xml-rid="bib30" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref30-1" aria-controls="sref30-1">Gilles et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref30-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gilles, M.E. ∙ Hao, L. ∙ Huang, L. ...</div><div><strong>Personalized RNA Medicine for Pancreatic Cancer</strong></div><div><em>Clin. Cancer Res.</em> 2018; <strong>24</strong>:1734-1747</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-17-2733" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85047864333" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29330203/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-17-2733&amp;pmid=29330203" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Chemicals, peptides, and recombinant proteins</b></td></tr><tr><td>All-trans retinoic acid (ATRA)</td><td>Sigma</td><td>Cat. #R2625</td></tr><tr><td>Arsenic trioxide (ATO)</td><td>Sigma-Aldrich</td><td>Cat# A1010</td></tr><tr><td>ATRA-releasing pellet</td><td>Innovative Research of America</td><td>Cat# V-111</td></tr><tr><td>Placebo pellet</td><td>Innovative Research of America</td><td>Cat# C-111</td></tr><tr><td>Sulfopin</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref21-3" href="#" role="doc-biblioref" data-xml-rid="bib21" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref21-3" aria-controls="sref21-3">Dubiella et al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref21-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Dubiella, C. ∙ Pinch, B.J. ∙ Koikawa, K. ...</div><div><strong>Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo</strong></div><div><em>Nat. Chem. Biol.</em> 2021;</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41589-021-00786-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85105881530" target="_blank" aria-label="Open Scopus in new tab">Scopus (8)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33972797/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41589-021-00786-7&amp;pmid=33972797" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>NMP</td><td>Sigma-Aldrich</td><td>Cat# 328634</td></tr><tr><td>Kolliphor HS 15 (Solutol)</td><td>Sigma-Aldrich</td><td>Cat# 42966</td></tr><tr><td>DMSO</td><td>Corning</td><td>Cat# 25-950-CQC</td></tr><tr><td>Gemcitabine</td><td>FRESENIUS KABI</td><td>NDC 63323-102-13</td></tr><tr><td>5-FU</td><td>Sigma</td><td>Cat# F6627</td></tr><tr><td>InVivoMAb anti-PD-1</td><td>BioXcell</td><td>Cat# BE0146</td></tr><tr><td>InVivoMAb anti-PD-L1</td><td>BioXcell</td><td>Cat# BE0285</td></tr><tr><td>InVivoMAb anti-CD8a</td><td>BioXcell</td><td>Cat# BE0117</td></tr><tr><td>InVivoMAb anti-Nk1.1</td><td>BioXcell</td><td>Cat# BE0036</td></tr><tr><td>InVivoMAb anti-CTLA4</td><td>BioXcell</td><td>Cat# BE0032</td></tr><tr><td>InVivoMAb rat IgG2a isotype control</td><td>BioXcell</td><td>Cat# BE0089</td></tr><tr><td>InVivo ph7.0 Dilution Buffer</td><td>BioXcell</td><td>Cat# IP0070</td></tr><tr><td>Paclitaxel</td><td>MedChemExpress</td><td>Cat# HY-B0015</td></tr><tr><td>PEG 300</td><td>MedChemExpress</td><td>Cat# HY-Y0873</td></tr><tr><td>Tween 80</td><td>MedChemExpress</td><td>Cat# HY-Y1891</td></tr><tr><td>Growth Factor reduced (GFR) Matrigel</td><td>Corning</td><td>Cat# 356231</td></tr><tr><td>RPMI 1640 without L-glutamine and phenol red</td><td>Corning</td><td>Cat# 17-105-CV</td></tr><tr><td>AdDMEM/F12</td><td>Invitrogen</td><td>Cat# 12634-010</td></tr><tr><td>HEPES</td><td>Invitrogen</td><td>Cat# H4034</td></tr><tr><td>GlutaMax</td><td>Invitrogen</td><td>Cat# 35050-061</td></tr><tr><td>Penicillin/Streptomycin</td><td>Invitrogen</td><td>Cat# 15140122</td></tr><tr><td>B27</td><td>Invitrogen</td><td>Cat# 17504044</td></tr><tr><td>N-acetyl-L-cysteine</td><td>Sigma-Aldrich</td><td>Cat# 9165</td></tr><tr><td>Wnt-3a</td><td>R&amp;D Systems</td><td>Cat# 5036-WN-010</td></tr><tr><td>R-Spondin 1</td><td>Peprotech</td><td>Cat# 120-38</td></tr><tr><td>Noggin</td><td>Invitrogen</td><td>Cat# 120-10C</td></tr><tr><td>EGF</td><td>Peprotech</td><td>Cat# AF-100-15</td></tr><tr><td>FGF</td><td>Peprotech</td><td>Cat# C100-26</td></tr><tr><td>Nicotinamide</td><td>Sigma-Aldrich</td><td>Cat# N0636</td></tr><tr><td>Y- 27263</td><td>Sigma-Aldrich</td><td>Cat# Y0503</td></tr><tr><td>A83-01</td><td>R&amp;D Systems</td><td>Cat# 2939/10</td></tr><tr><td>Cell Tracker Green</td><td>Life Technologies</td><td>Cat# C7025</td></tr><tr><td>Cell Tracker Red</td><td>Life Technologies</td><td>Cat# C34552</td></tr><tr><td>Matrigel</td><td>Corning</td><td>Cat# 356231</td></tr><tr><td>Collagen</td><td>BD Biosciences</td><td>Cat# 354249</td></tr><tr><td>Collagenase/dispase</td><td>Sigma-Aldrich</td><td>Cat# 11097113001</td></tr><tr><td>TrypLE Express</td><td>GIBCO</td><td>Cat# 12604-021</td></tr><tr><td>Defined K-SFM</td><td>GIBCO</td><td>Cat# 10744019</td></tr><tr><td>Dynabeads Human T-Activator CD3/CD28 for T Cell Expansion and Activation</td><td>GIBCO</td><td>Cat# 11161D</td></tr><tr><td>Dynabeads Mouse T-Activator CD3/CD28 for T Cell Expansion and Activation</td><td>GIBCO</td><td>Cat# 11456D</td></tr><tr><td>Recombinant IL-2</td><td>Peprotech</td><td>Cat# 200-02</td></tr><tr><td>Recombinant IL-2</td><td>Peprotech</td><td>Cat# 212-12</td></tr><tr><td>Green-fluorescent caspase 3/7 probe reagent</td><td>Invitrogen</td><td>Cat# R37111</td></tr><tr><td>Image-iT LIVE Red Caspase-3 and −7 Detection Kit, for microscopy</td><td>Invitrogen</td><td>Cat# I35101</td></tr><tr><td>Cell Staining Buffer</td><td>BioLegend</td><td>Cat. #420201</td></tr><tr><td>Foxp3 / Transcription Factor Staining Buffer Set</td><td>eBioscience</td><td>Cat# 00-5523-00</td></tr><tr><td>Intracellular Fixation &amp; Permeabilization Kit</td><td>eBioscience</td><td>Cat# 88-8824-00</td></tr><tr><td>RIPA Lysis and Extraction Buffer</td><td>Thermo Scientific</td><td>Cat# 89901</td></tr><tr><td>NaF</td><td>Sigma-Aldrich</td><td>Cat# S1504</td></tr><tr><td>NA<sub>3</sub>VO<sub>4</sub></td><td>Sigma-Aldrich</td><td>Cat# S6508</td></tr><tr><td>Aprotinin</td><td>Sigma-Aldrich</td><td>Cat# A1153</td></tr><tr><td>Leupeptin</td><td>Sigma-Aldrich</td><td>Cat# 62070</td></tr><tr><td>Pepstatin</td><td>Sigma-Aldrich</td><td>Cat# P5318</td></tr><tr><td>DTT</td><td>Fisher Scientific</td><td>Cat# BP172-25</td></tr><tr><td>AEBSF</td><td>Sigma-Aldrich</td><td>Cat# A8456</td></tr><tr><td>Chymotrypsin</td><td>Sigma-Aldrich</td><td>Cat# C7268</td></tr><tr><td>Tween 20</td><td>VWR LIFE SCIENCE</td><td>Cat# M147</td></tr><tr><td>HEPES</td><td>Sigma-Aldrich</td><td>Cat# H3375</td></tr><tr><td>Triton X-100</td><td>Sigma-Aldrich</td><td>Cat# T9284</td></tr><tr><td>Cycloheximide</td><td>Sigma-Aldrich</td><td>Cat# C104450</td></tr><tr><td>Glycerol</td><td>Fisher Chemical</td><td>Cat# G33-4</td></tr><tr><td>Protein A Sepahrose beads</td><td>GeneScript</td><td>Cat# L00210</td></tr><tr><td>β-mercaptoethanol</td><td>Millipore</td><td>Cat# ES-007-E</td></tr><tr><td>4,4-difluoro-1,3,5,7,8-pentamethyl-4-bora-3a,4a-diaza-s-indacene</td><td>Life Technologies</td><td>Cat# D-3922</td></tr><tr><td>Hematoxylin</td><td>Fisher Chemical</td><td>Cat# CS401-1D</td></tr><tr><td>Picrosirius Red Staining Kit</td><td>Polysciences</td><td>Cat# 24901</td></tr><tr><td>Blasticidin</td><td>InvivoGen</td><td>Cat# ant-bl-05</td></tr><tr><td>Puromycin</td><td>Sigma</td><td>Cat#P8833</td></tr><tr><td>MG132</td><td>Sigma</td><td>Cat#1211877-36-9</td></tr><tr><td>NAE inhibitor, MLN4929</td><td>Calbiochem</td><td>Cat# 5.05477.000</td></tr><tr><td>3-MA</td><td>Sigma</td><td>Cat# M9281</td></tr><tr><td>Bafilomycin A1</td><td>Sigma</td><td>Cat# 19-148</td></tr><tr><td>Chloroquine</td><td>CAYMAN CHEMICAL COMPANY</td><td>Cat# 14194</td></tr><tr><td>EasySep Mouse CD8+ T Cell Isolation Kit</td><td>STEM CELL</td><td>Cat# 19853</td></tr><tr><td>EasySep Buffer</td><td>STEM CELL</td><td>Cat# 20144</td></tr><tr><td>Tumor dissociation Kit Mouse</td><td>Miltenyi Biotec</td><td>Cat# 130-960-730</td></tr><tr><td>RNeasy Mini Kit</td><td>QIAGEN</td><td>Cat# 74104</td></tr><tr class="rowsep"><td>SYBR Green PCR Master Mix</td><td>Applied Biosystems</td><td>Cat# 4309155</td></tr><tr class="rowsep"><td colspan="3"><b>Critical commercial assays</b></td></tr><tr><td>CellTiter-Glo 2.0 Assay</td><td>Promega</td><td>Cat# G9242</td></tr><tr><td>Human IL-6 uncoated ELISA Kit</td><td>Invitrogen</td><td>Cat# 88-7066-88</td></tr><tr><td>Human TGF-β uncoated ELISA Kit</td><td>Invitrogen</td><td>Cat# 88-50390-88</td></tr><tr><td>Human SDF1α (CXCL12) ELISA Kit</td><td>Invitrogen</td><td>Cat# EHCXCL12A</td></tr><tr><td>Human LIF ELISA Kit</td><td>Invitrogen</td><td>Cat# BMS242</td></tr><tr><td>Human IFNα ELISA kit</td><td>R&amp;D Systems</td><td>Cat# 41100-1</td></tr><tr class="rowsep"><td>Human cytokine ELISA plate array I</td><td>Signosis</td><td>Cat# EA-4001</td></tr><tr class="rowsep"><td colspan="3"><b>Experimental models: Cell lines</b></td></tr><tr><td>Human: Patient derived PDAC organoid</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref48-6" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48-6" aria-controls="sref48-6">Koikawa et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref48-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Koikawa, K. ∙ Ohuchida, K. ∙ Ando, Y. ...</div><div><strong>Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Lett.</em> 2018; <strong>425</strong>:65-77</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2018.03.031" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29580808/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2018.03.031&amp;pmid=29580808" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Human: Patient derived PDAC cell</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref48-7" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48-7" aria-controls="sref48-7">Koikawa et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref48-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Koikawa, K. ∙ Ohuchida, K. ∙ Ando, Y. ...</div><div><strong>Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Lett.</em> 2018; <strong>425</strong>:65-77</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2018.03.031" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29580808/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2018.03.031&amp;pmid=29580808" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Human: Patient derived PSC cell</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref22-1" href="#" role="doc-biblioref" data-xml-rid="bib22" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref22-1" aria-controls="sref22-1">Endo et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref22-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">23.</div><div>Endo, S. ∙ Nakata, K. ∙ Ohuchida, K. ...</div><div><strong>Autophagy Is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mice</strong></div><div><em>Gastroenterology.</em> 2017; <strong>152</strong>:1492-1506</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2017.01.010&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2017.01.010&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85018835771" target="_blank" aria-label="Open Scopus in new tab">Scopus (100)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28126348/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2017.01.010&amp;pmid=28126348" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref49-2" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49-2" aria-controls="sref49-2">Koikawa et&nbsp;al., 2018b</a><div class="dropBlock__holder" data-db-target-of="sref49-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Koikawa, K. ∙ Ohuchida, K. ∙ Takesue, S. ...</div><div><strong>Pancreatic stellate cells reorganize matrix components and lead pancreatic cancer invasion via the function of Endo180</strong></div><div><em>Cancer Lett.</em> 2018; <strong>412</strong>:143-154</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2017.10.010" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85032707374" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29061505/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2017.10.010&amp;pmid=29061505" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr><td>Human: PBMC</td><td>Precision for Medicine</td><td>Lot# 2010113876</td></tr><tr><td>Mouse: KPC derived PDAC organoid</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref48-8" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48-8" aria-controls="sref48-8">Koikawa et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref48-8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Koikawa, K. ∙ Ohuchida, K. ∙ Ando, Y. ...</div><div><strong>Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Lett.</em> 2018; <strong>425</strong>:65-77</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2018.03.031" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29580808/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2018.03.031&amp;pmid=29580808" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr class="rowsep"><td>Mouse: KPC derived PDAC cell</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref72-1" href="#" role="doc-biblioref" data-xml-rid="bib72" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref72-1" aria-controls="sref72-1">Okumura et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref72-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Okumura, T. ∙ Ohuchida, K. ∙ Kibe, S. ...</div><div><strong>Adipose tissue-derived stromal cells are sources of cancer-associated fibroblasts and enhance tumor progression by dense collagen matrix</strong></div><div><em>Int. J. Cancer.</em> 2019; <strong>144</strong>:1401-1413</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/ijc.31775" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85054665338" target="_blank" aria-label="Open Scopus in new tab">Scopus (7)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30152542/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fijc.31775&amp;pmid=30152542" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Experimental models: Organisms/strains</b></td></tr><tr><td>Mouse: C57BL/6</td><td>Jackson Laboratories</td><td>Stock # 000664 IMSR_JAX:000664</td></tr><tr><td>Mouse: NOD.Cg- prkdc<sup>scid</sup>ll2rg<sup>tm1Wjl</sup>/Szj</td><td>Jackson Laboratories</td><td>Stock # 005557 IMSR_JAX:005557</td></tr><tr><td>Mouse: LSL-KRas<sup>LSLG12D/+</sup></td><td>Jackson Laboratories</td><td>Stock # 008179 IMSR_JAX:008179</td></tr><tr><td>Mouse: LSL-p53<sup>R172H/+</sup></td><td>Jackson Laboratories</td><td>Stock # 008652 IMSR_JAX:008652</td></tr><tr class="rowsep"><td>Mouse: Pdx1-Cre</td><td>Jackson Laboratories</td><td>Stock # 014647 IMSR_JAX:014647</td></tr><tr class="rowsep"><td colspan="3"><b>Oligonucleotides</b></td></tr><tr><td>MISSION shRNA clone for human HIP1R</td><td>Sigma-Aldrich</td><td><a id="crosref1800" href="#mmc3">Table S3</a></td></tr><tr><td>MISSION shRNA clone for human CD274 (PD-L1)</td><td>Sigma-Aldrich</td><td><a id="crosref1805" href="#mmc3">Table S3</a></td></tr><tr class="rowsep"><td>MISSION shRNA clone for human SLC29A1 (ENT1)</td><td>Sigma-Aldrich</td><td><a id="crosref1810" href="#mmc3">Table S3</a></td></tr><tr class="rowsep"><td colspan="3"><b>Software and algorithms</b></td></tr><tr><td>BZ-X 800 analyzer software ver. 1.1.1.8</td><td>KEYENCE</td><td><a id="intref0385" href="https://www.keyence.com/ss/products/microscope/bz-x800_long/" target="_blank">https://www.keyence.com/ss/products/microscope/bz-x800_long/</a></td></tr><tr><td>Synergyfinder ver. 2</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref42-1" href="#" role="doc-biblioref" data-xml-rid="bib42" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref42-1" aria-controls="sref42-1">Ianevski et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref42-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">43.</div><div>Ianevski, A. ∙ Giri, A.K. ∙ Aittokallio, T.</div><div><strong>SynergyFinder 2.0: visual analytics of multi-drug combination synergies</strong></div><div><em>Nucleic Acids Res.</em> 2020; <strong>48</strong>:W488-W493</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkaa216" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85086923971" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32246720/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkaa216&amp;pmid=32246720" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0390" href="https://synergyfinder.fimm.fi" target="_blank">https://synergyfinder.fimm.fi</a></td></tr><tr><td>CRISPR design tool</td><td>ZHANG LAB</td><td><a id="intref0395" href="http://CRISPR.mit.edu/" target="_blank">http://CRISPR.mit.edu/</a></td></tr><tr><td>Guide Design Resources</td><td>ZHANG LAB</td><td><a id="intref0400" href="https://zlab.bio/guide-design-resources" target="_blank">https://zlab.bio/guide-design-resources</a></td></tr><tr><td>CytExpert software</td><td>Beckman Coulter</td><td>Model #B90883</td></tr><tr><td>ImageJ</td><td>NIH</td><td><a id="intref0405" href="https://imagej.nih.gov/ij/" target="_blank">https://imagej.nih.gov/ij/</a></td></tr><tr><td>Prism 8</td><td>GraphPad Software</td><td><a id="intref0410" href="https://www.graphpad.com/scientific-software/prism/" target="_blank">https://www.graphpad.com/scientific-software/prism/</a></td></tr><tr><td>BioRender</td><td>BioRender.com.</td><td><a id="intref0415" href="https://app.biorender.com" target="_blank">https://app.biorender.com</a></td></tr></tbody></table></div><figcaption><div class="core-table-tools"><ul><li><a class="core-table-show-action" href="/action/showFullTableHTML?isHtml=true&amp;tableId=undtbl1&amp;pii=S0092-8674%2821%2900879-5" target="_blank">Open table in a new tab</a></li></ul></div></figcaption></figure></div></div></section><section id="sec-4-2"><h3>Resource availability</h3><section id="sec-4-2-1"><h4>Lead contact</h4><div id="p0200" role="paragraph">Further information and requests for resources and reagents should be directed to and will be fulfilled Lead Contact, Kazuhiro Koikawa (<a id="intref0420" href="mailto:kkoikawa@bidmc.harvard.edu">kkoikawa@bidmc.harvard.edu</a>).</div></section><section id="sec-4-2-2"><h4>Materials availability</h4><div id="p0205" role="paragraph">Any other unique/stable reagents generated in this study are available from the Lead Contact with a completed Materials Transfer Agreement.</div></section></section><section id="sec-4-3"><h3>Experimental model and subject details</h3><section id="sec-4-3-1"><h4>Human PDAC tissue samples</h4><div id="p0210" role="paragraph">Human PDAC tissue samples used in this study came from 167 patients who underwent surgical resections for pancreatic cancer at Kyushu University Hospital (Fukuoka, Japan). The study was approved by the Ethics Committee of Kyushu University and conducted by the Ethical Guidelines for Human Genome/Gene Research enacted by the Japanese Government and Helsinki Declaration.</div></section><section id="sec-4-3-2"><h4>Mouse models of PDAC</h4><div id="p0215" role="paragraph">We used the following 4 different commonly used mouse models of human PDAC (<span class="dropBlock reference-citations"><a id="body-ref-sref9" href="#" role="doc-biblioref" data-xml-rid="bib9" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref9" aria-controls="sref9">Bleijs et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">10.</div><div>Bleijs, M. ∙ van de Wetering, M. ∙ Clevers, H. ...</div><div><strong>Xenograft and organoid model systems in cancer research</strong></div><div><em>EMBO J.</em> 2019; <strong>38</strong>:e101654</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.15252/embj.2019101654" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85068678747" target="_blank" aria-label="Open Scopus in new tab">Scopus (86)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31282586/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.15252%2Fembj.2019101654&amp;pmid=31282586" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref16-3" href="#" role="doc-biblioref" data-xml-rid="bib16" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref16-3" aria-controls="sref16-3">Day et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref16-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Day, C.P. ∙ Merlino, G. ∙ Van Dyke, T.</div><div><strong>Preclinical mouse cancer models: a maze of opportunities and challenges</strong></div><div><em>Cell.</em> 2015; <strong>163</strong>:39-53</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2015.08.068&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2015.08.068&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84948464999" target="_blank" aria-label="Open Scopus in new tab">Scopus (301)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26406370/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2015.08.068&amp;pmid=26406370" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). <b>1) The KPC (LSL-K-Ras</b><sup><b>LSLG12D/+</b></sup><b>; LSL-p53</b><sup><b>R172H/+</b></sup><b>;Pdx1-Cre) genetically engineered mouse model</b> (<span class="dropBlock reference-citations"><a id="body-ref-sref38-3" href="#" role="doc-biblioref" data-xml-rid="bib38" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref38-3" aria-controls="sref38-3">Hingorani et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref38-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Hingorani, S.R. ∙ Wang, L. ∙ Multani, A.S. ...</div><div><strong>Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice</strong></div><div><em>Cancer Cell.</em> 2005; <strong>7</strong>:469-483</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2005.04.023&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2005.04.023&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-19344362405" target="_blank" aria-label="Open Scopus in new tab">Scopus (1497)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15894267/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2005.04.023&amp;pmid=15894267" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). KPC mice were generated by crossbreeding LSL-KrasG12D (B6.129S4-Krastm4Tyj/J Stock No: 008179, a congenic C57BL/6J genetic background, Jackson Laboratories), LSL-p53 (129S-Trp53tm2Tyj/J, Stock No: 008652, a 129S4/SvJae background, Jackson Laboratories, also known As:p53LSL.R172H 129svj), and Pdx1-Cre (B6.FVB-Tg (Pdx1-cre) 6Tuv/J Stock No: 014647, a C57BL/6 genetic background. Allelic profiling of resulting KPC mice by the B6 panel (Jackson Laboratories) confirmed 129S1/SvImJ with average match of 84.2%, 129S4SvJae with average match of 83.8%, B6N with average match of 65.7% and B6J, with average match of 65.1%. <b>2) the KPC Genetically engineered mouse-derived orthotopic allografts (GDA) mouse model</b> (<span class="dropBlock reference-citations"><a id="body-ref-sref38-4" href="#" role="doc-biblioref" data-xml-rid="bib38" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref38-4" aria-controls="sref38-4">Hingorani et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref38-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Hingorani, S.R. ∙ Wang, L. ∙ Multani, A.S. ...</div><div><strong>Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice</strong></div><div><em>Cancer Cell.</em> 2005; <strong>7</strong>:469-483</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2005.04.023&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2005.04.023&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-19344362405" target="_blank" aria-label="Open Scopus in new tab">Scopus (1497)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15894267/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2005.04.023&amp;pmid=15894267" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref54-2" href="#" role="doc-biblioref" data-xml-rid="bib54" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref54-2" aria-controls="sref54-2">Li et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref54-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">56.</div><div>Li, J. ∙ Qian, W. ∙ Qin, T. ...</div><div><strong>Mouse-Derived Allografts: A Complementary Model to the KPC Mice on Researching Pancreatic Cancer In&nbsp;Vivo</strong></div><div><em>Comput. Struct. Biotechnol. J.</em> 2019; <strong>17</strong>:498-506</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.csbj.2019.03.016" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85064078721" target="_blank" aria-label="Open Scopus in new tab">Scopus (6)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31011408/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.csbj.2019.03.016&amp;pmid=31011408" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Mouse PDAC cells were established from KPC mouse pancreatic tumor tissues, followed by orthotopically injecting 1 x10<sup>6</sup> mouse PDAC cells in 50&nbsp;μL Matrigel (356231, Coaning) into the pancreas of female 8&nbsp;week-old syngeneic immunocompetent C57BL/6 mice (Jackson Laboratories). <b>3) PDAC Patient-derived Tumor orthotopic xenografted (PDTX) mouse model</b> (<span class="dropBlock reference-citations"><a id="body-ref-sref30-2" href="#" role="doc-biblioref" data-xml-rid="bib30" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref30-2" aria-controls="sref30-2">Gilles et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref30-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Gilles, M.E. ∙ Hao, L. ∙ Huang, L. ...</div><div><strong>Personalized RNA Medicine for Pancreatic Cancer</strong></div><div><em>Clin. Cancer Res.</em> 2018; <strong>24</strong>:1734-1747</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-17-2733" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85047864333" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29330203/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-17-2733&amp;pmid=29330203" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref79-2" href="#" role="doc-biblioref" data-xml-rid="bib79" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref79-2" aria-controls="sref79-2">Rubio-Viqueira et&nbsp;al., 2006</a><div class="dropBlock__holder" data-db-target-of="sref79-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">81.</div><div>Rubio-Viqueira, B. ∙ Jimeno, A. ∙ Cusatis, G. ...</div><div><strong>An in&nbsp;vivo platform for translational drug development in pancreatic cancer</strong></div><div><em>Clin. Cancer Res.</em> 2006; <strong>12</strong>:4652-4661</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-06-0113" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-33748088524" target="_blank" aria-label="Open Scopus in new tab">Scopus (343)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16899615/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-06-0113&amp;pmid=16899615" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). PDAC PDX tumors were obtained from Dr. Muthuswamy and Dr. Hidalgo and divided into 4&nbsp;× 2&nbsp;mm pieces, followed by xenografting orthotopically into the pancreas of female 8-week-old immunodeficient NOD.Cg-<i>Prkdc</i><sup><i>scid</i></sup> <i>Il2rg</i><sup><i>tm1Wjl</i></sup>/SzJ (NOD scid gamma; NSG) mice (Jackson Laboratories). <b>4) PDAC Patient-derived Organoid and CAFs orthotopic xenograft (PDOX) mouse model</b> (<span class="dropBlock reference-citations"><a id="body-ref-sref15" href="#" role="doc-biblioref" data-xml-rid="bib15" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref15" aria-controls="sref15">Dantes et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref15"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">16.</div><div>Dantes, Z. ∙ Yen, H.Y. ∙ Pfarr, N. ...</div><div><strong>Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology</strong></div><div><em>JCI Insight.</em> 2020; <strong>5</strong>:137809</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/jci.insight.137809" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85089206125" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32614802/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2Fjci.insight.137809&amp;pmid=32614802" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref48-9" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48-9" aria-controls="sref48-9">Koikawa et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref48-9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Koikawa, K. ∙ Ohuchida, K. ∙ Ando, Y. ...</div><div><strong>Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Lett.</em> 2018; <strong>425</strong>:65-77</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2018.03.031" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29580808/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2018.03.031&amp;pmid=29580808" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). 5&nbsp;× 10<sup>4</sup> patient derived PDAC organoids and 5 x10<sup>4</sup> patient derived CAFs in 50&nbsp;μL of Matrigel were injected orthotopically into the pancreas of female 8&nbsp;week-old immunodeficient NSG mice (Jackson Laboratories).</div></section><section id="sec-4-3-3"><h4>Human and mouse PDAC organoids</h4><div id="p0220" role="paragraph">Primary human PDAC organoids (PDAC1 and PDAC2 organoid) were established form fresh surgically resected human PDAC tissues from two different patients in Kyushu University, and mouse PDAC organoids were established form KPC mice pancreatic tumor as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref48-10" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48-10" aria-controls="sref48-10">Koikawa et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref48-10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Koikawa, K. ∙ Ohuchida, K. ∙ Ando, Y. ...</div><div><strong>Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Lett.</em> 2018; <strong>425</strong>:65-77</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2018.03.031" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29580808/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2018.03.031&amp;pmid=29580808" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref49-3" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49-3" aria-controls="sref49-3">Koikawa et&nbsp;al., 2018b</a><div class="dropBlock__holder" data-db-target-of="sref49-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Koikawa, K. ∙ Ohuchida, K. ∙ Takesue, S. ...</div><div><strong>Pancreatic stellate cells reorganize matrix components and lead pancreatic cancer invasion via the function of Endo180</strong></div><div><em>Cancer Lett.</em> 2018; <strong>412</strong>:143-154</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2017.10.010" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85032707374" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29061505/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2017.10.010&amp;pmid=29061505" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref72-2" href="#" role="doc-biblioref" data-xml-rid="bib72" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref72-2" aria-controls="sref72-2">Okumura et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref72-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Okumura, T. ∙ Ohuchida, K. ∙ Kibe, S. ...</div><div><strong>Adipose tissue-derived stromal cells are sources of cancer-associated fibroblasts and enhance tumor progression by dense collagen matrix</strong></div><div><em>Int. J. Cancer.</em> 2019; <strong>144</strong>:1401-1413</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/ijc.31775" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85054665338" target="_blank" aria-label="Open Scopus in new tab">Scopus (7)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30152542/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fijc.31775&amp;pmid=30152542" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). These organoids were 3D cultured in Growth Factor reduced (GFR) Matrigel (356231, Corning) with complete organoid media, containing AdDMEM/F12 (12634-010, Invitrogen, CA, USA), medium supplemented with 1M HEPES (Invitrogen), GlutaMax (35050-061, Invitrogen), penicillin/streptomycin (15140122, Invitrogen), B27 (17504044, Invitrogen), N-acetyl-L-cysteine (9165, Sigma-Aldrich Co.), Wnt-3a (5036-WN-010, R&amp;D Systems), R-Spondin 1 (120-38, Peprotech), Noggin (120-10C, Invitrogen), epidermal growth factor (EGF, AF-100-15, Peprotech), fibroblast growth factor (FGF, C100-26, Peprotech), Nicotinamide (N0636, Sigma-Aldrich Co.), Y- 27263 (Y0503, Sigma-Aldrich Co.) and A83-01 (2939/10, R&amp;D Systems). To distinguish and visualize PDAC organoids and CAFs in live-cell imaging fluorescence microscopy, PDAC organoids were labeled with green fluorescent protein (GFP) or Cell Tracker™ Green (C7025, Life Technologies).</div></section><section id="sec-4-3-4"><h4>Human CAFs and human/mouse PDAC cells</h4><div id="p0225" role="paragraph">The human CAFs (CAF1 and CAF2) were established in Kyushu University from fresh surgically resected PDAC tissues from two different patients using the outgrowth method, as described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref2" href="#" role="doc-biblioref" data-xml-rid="bib2" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref2" aria-controls="sref2">Bachem et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">3.</div><div>Bachem, M.G. ∙ Schünemann, M. ∙ Ramadani, M. ...</div><div><strong>Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells</strong></div><div><em>Gastroenterology.</em> 2005; <strong>128</strong>:907-921</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2004.12.036&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2004.12.036&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-17144404527" target="_blank" aria-label="Open Scopus in new tab">Scopus (463)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15825074/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2004.12.036&amp;pmid=15825074" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref49-4" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49-4" aria-controls="sref49-4">Koikawa et&nbsp;al., 2018b</a><div class="dropBlock__holder" data-db-target-of="sref49-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Koikawa, K. ∙ Ohuchida, K. ∙ Takesue, S. ...</div><div><strong>Pancreatic stellate cells reorganize matrix components and lead pancreatic cancer invasion via the function of Endo180</strong></div><div><em>Cancer Lett.</em> 2018; <strong>412</strong>:143-154</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2017.10.010" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85032707374" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29061505/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2017.10.010&amp;pmid=29061505" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The isolated cells were confirmed to be CAFs by their spindle-shaped morphology, and immunofluorescence staining for αSMA-, vimentin-, CD90-, glial fibrillary acidic protein-, and nestin-positive, and CK19-negative (<span class="dropBlock reference-citations"><a id="body-ref-sref22-2" href="#" role="doc-biblioref" data-xml-rid="bib22" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref22-2" aria-controls="sref22-2">Endo et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref22-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">23.</div><div>Endo, S. ∙ Nakata, K. ∙ Ohuchida, K. ...</div><div><strong>Autophagy Is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mice</strong></div><div><em>Gastroenterology.</em> 2017; <strong>152</strong>:1492-1506</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2017.01.010&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2017.01.010&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85018835771" target="_blank" aria-label="Open Scopus in new tab">Scopus (100)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28126348/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2017.01.010&amp;pmid=28126348" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref49-5" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49-5" aria-controls="sref49-5">Koikawa et&nbsp;al., 2018b</a><div class="dropBlock__holder" data-db-target-of="sref49-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Koikawa, K. ∙ Ohuchida, K. ∙ Takesue, S. ...</div><div><strong>Pancreatic stellate cells reorganize matrix components and lead pancreatic cancer invasion via the function of Endo180</strong></div><div><em>Cancer Lett.</em> 2018; <strong>412</strong>:143-154</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2017.10.010" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85032707374" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29061505/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2017.10.010&amp;pmid=29061505" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and used within 6 passages. Human PDAC cells (PDAC1 and PDAC2) were isolated form PDAC organoids, which were established surgically resected human PDAC tissues from two different patients in Kyushu University (<span class="dropBlock reference-citations"><a id="body-ref-sref49-6" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49-6" aria-controls="sref49-6">Koikawa et&nbsp;al., 2018b</a><div class="dropBlock__holder" data-db-target-of="sref49-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Koikawa, K. ∙ Ohuchida, K. ∙ Takesue, S. ...</div><div><strong>Pancreatic stellate cells reorganize matrix components and lead pancreatic cancer invasion via the function of Endo180</strong></div><div><em>Cancer Lett.</em> 2018; <strong>412</strong>:143-154</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2017.10.010" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85032707374" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29061505/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2017.10.010&amp;pmid=29061505" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and Mouse PDAC cells were established from pancreatic tumors of KPC mice using the outgrowth method described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref72-3" href="#" role="doc-biblioref" data-xml-rid="bib72" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref72-3" aria-controls="sref72-3">Okumura et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref72-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Okumura, T. ∙ Ohuchida, K. ∙ Kibe, S. ...</div><div><strong>Adipose tissue-derived stromal cells are sources of cancer-associated fibroblasts and enhance tumor progression by dense collagen matrix</strong></div><div><em>Int. J. Cancer.</em> 2019; <strong>144</strong>:1401-1413</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/ijc.31775" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85054665338" target="_blank" aria-label="Open Scopus in new tab">Scopus (7)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30152542/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fijc.31775&amp;pmid=30152542" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and the cells were tested for CK19, SMA, Vimentin and CD45 to verify their identity and purity, and used within 8 passages for all experiments. Cell lines were maintained in Dulbecco’s modified Eagle’s medium (Sigma-Aldrich Co.) supplemented with 5%–10% fetal bovine serum, streptomycin (100&nbsp;mg/ml), and penicillin (100&nbsp;mg/ml) at 37°C in a humidified atmosphere containing 10% CO2. All cell lines were tested negative for mycoplasma contamination. To distinguish and visualize PDAC cells and CAFs in live-cell imaging fluorescence microscopy, PDAC cells were labeled with green fluorescent protein (GFP) or Cell Tracker™ Green (C7025, Life Technologies), whereas CAFs were labeled with Cell Tracker™ Red (C34552, Life Technologies).</div></section></section><section id="sec-4-4"><h3>Method details</h3><section id="sec-4-4-1"><h4>Mouse experiments</h4><div id="p0230" role="paragraph">Pin1i-1 (ATRA+ATO) treatment was described as previously (<span class="dropBlock reference-citations"><a id="body-ref-sref50-6" href="#" role="doc-biblioref" data-xml-rid="bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50-6" aria-controls="sref50-6">Kozono et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref50-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Kozono, S. ∙ Lin, Y.M. ∙ Seo, H.S. ...</div><div><strong>Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells</strong></div><div><em>Nat. Commun.</em> 2018; <strong>9</strong>:3069</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-018-05402-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85051562951" target="_blank" aria-label="Open Scopus in new tab">Scopus (54)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30093655/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-018-05402-2&amp;pmid=30093655" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref94-5" href="#" role="doc-biblioref" data-xml-rid="bib94" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref94-5" aria-controls="sref94-5">Wei et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref94-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">96.</div><div>Wei, S. ∙ Kozono, S. ∙ Kats, L. ...</div><div><strong>Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer</strong></div><div><em>Nat. Med.</em> 2015; <strong>21</strong>:457-466</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.3839" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_96_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84937759226" target="_blank" aria-label="Open Scopus in new tab">Scopus (172)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25849135/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.3839&amp;pmid=25849135" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), so did Pin1i-2 (Sulfopin) treatment (<span class="dropBlock reference-citations"><a id="body-ref-sref21-4" href="#" role="doc-biblioref" data-xml-rid="bib21" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref21-4" aria-controls="sref21-4">Dubiella et al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref21-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Dubiella, C. ∙ Pinch, B.J. ∙ Koikawa, K. ...</div><div><strong>Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo</strong></div><div><em>Nat. Chem. Biol.</em> 2021;</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41589-021-00786-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85105881530" target="_blank" aria-label="Open Scopus in new tab">Scopus (8)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33972797/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41589-021-00786-7&amp;pmid=33972797" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, all mice were randomly selected to receive treatments groups. Tumor sizes were measured by weekly palpation with electronic caliper or ultrasound, and when tumors were reached &gt; 0.5cm, the treatment was started. Briefly, animals were placed under general anesthesia with 2%–3% isoflurane once a week. Under general anesthesia, the abdominal wall became very flaccid, and the muscle tone of the mouse was very low. The mouse was scuffed with the left hand to allow for palpation and measurement with the right hand. This allowed to detect the firm pancreatic mass by palpation, and to determine its size by electronic caliper measurements. Mice in our hands did not develop ascites, and the firm upper abdominal mass was easily identified below the rib cage in the left abdomen. In the GDA model and PDX models, palpable tumors predictably were detectable within 4-7&nbsp;days post implantation. Hence electronic caliper measurements under general anesthesia were our routine method, and confirmatory ultrasound was conducted in some cases (<a id="crosref1905" href="#figs1">Figure&nbsp;S1</a>B). In the transgenic KPC mice, where we expected spontaneous tumor development, we started weekly palpation from age 8&nbsp;weeks. When we could not clearly detect the tumor by palpation after age 12&nbsp;weeks, we monitored mice by ultrasound. Once we detected the maximum length &gt; 0.5&nbsp;cm tumor, we randomized the mice to treatment, and then followed tumor growth by electronic caliper measurement. To validate the external caliper measurements, we measured the tumor size prior to euthanization of the mice and then measured the actual tumor size upon necropsy to ascertain concordance. Mice were treated with ATO (2&nbsp;mg/kg, i.p., 3 times/week, Sigma) and subcutaneous implantation of 5&nbsp;mg 21-day slow-releasing ATRA pellets (Innovative Research of America) (Pin1i-1) or placebo pellets (Innovative Research of America), or Sulfopin (40&nbsp;mg/kg, i.p., every day) (Pin1i-2) or vehicle (Sulfopin diluted solution; 5% NMP, 5% Solutol, 20% DMSO), and/or Gemcitabine (10mg/kg or 20mg/kg, i.p., weekly) or vehicle (PBS), and/or anti-PD1 (200&nbsp;μg, i.p., every 3-4&nbsp;days, BE0146, BioXcell) or vehicle (IgG isotype control, BE0090, BioXcell). To evaluate the effects of CD8<sup>+</sup> T&nbsp;cell or NK1.1<sup>+</sup> cell depletion in GDA mice, mice were treated with anti-CD8 (200&nbsp;μg, i.p., twice a week, BE0117, BioXcell) (<span class="dropBlock reference-citations"><a id="body-ref-sref74" href="#" role="doc-biblioref" data-xml-rid="bib74" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref74" aria-controls="sref74">Pantelidou et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref74"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">76.</div><div>Pantelidou, C. ∙ Sonzogni, O. ∙ De Oliveria Taveira, M. ...</div><div><strong>PARP Inhibitor Efficacy Depends on CD8<sup>+</sup> T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer</strong></div><div><em>Cancer Discov.</em> 2019; <strong>9</strong>:722-737</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-18-1218" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_76_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85066844107" target="_blank" aria-label="Open Scopus in new tab">Scopus (155)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31015319/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-18-1218&amp;pmid=31015319" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) or anti-NK1.1 (25&nbsp;μg, i.p., twice a week, BE0036, BioXcell) (<span class="dropBlock reference-citations"><a id="body-ref-sref90" href="#" role="doc-biblioref" data-xml-rid="bib90" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref90" aria-controls="sref90">Waggoner et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref90"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">92.</div><div>Waggoner, S.N. ∙ Cornberg, M. ∙ Selin, L.K. ...</div><div><strong>Natural killer cells act as rheostats modulating antiviral T&nbsp;cells</strong></div><div><em>Nature.</em> 2011; <strong>481</strong>:394-398</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature10624" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_92_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84855999478" target="_blank" aria-label="Open Scopus in new tab">Scopus (386)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22101430/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature10624&amp;pmid=22101430" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), or vehicle (IgG isotype control), and/or Sulfopin (40&nbsp;mg/kg, i.p., every day) (Pin1i-2) or vehicle (Sulfopin diluted solution; 5% NMP, 5% Solutol, 20% DMSO), and/or anti-PD1 (200&nbsp;μg, i.p., every 3-4&nbsp;days, BE0146, BioXcell) or vehicle (IgG isotype control). To test Sulfopin and/or PTX and/or anti-CTLA4 combination treatment in GDA mice, mice were treated with Sulfopin (40&nbsp;mg/kg, i.p., every day) (Pin1i-2) or vehicle (Sulfopin diluted solution; 5% NMP, 5% Solutol, 20% DMSO), and/or PTX (10mg/kg i.p., weekly) or vehicle (PTX diluted solution; 10% DMSO, 40% PEG300, 5% Tween 80, 45% Saline), and/or anti-CTLA-4 (250&nbsp;μg, i.p., every 3-4&nbsp;days, BE0032, BioXcell) or vehicle (IgG isotype control). Tumor volumes were calculated using the formula L x W<sup>2</sup> × 0.52, where L and W represent length and width, respectively (<span class="dropBlock reference-citations"><a id="body-ref-sref50-7" href="#" role="doc-biblioref" data-xml-rid="bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50-7" aria-controls="sref50-7">Kozono et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref50-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Kozono, S. ∙ Lin, Y.M. ∙ Seo, H.S. ...</div><div><strong>Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells</strong></div><div><em>Nat. Commun.</em> 2018; <strong>9</strong>:3069</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-018-05402-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85051562951" target="_blank" aria-label="Open Scopus in new tab">Scopus (54)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30093655/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-018-05402-2&amp;pmid=30093655" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Survival events were scored when mice lost over 10% body weight, tumor burden reached 2.0&nbsp;cm in diameter or per absolute survival events. All animal experiments were approved by the IACUC of the Beth Israel Deaconess Medical Center, Boston, MA, USA.</div></section><section id="sec-4-4-2"><h4>PDAC organoid and CAF co-culture model</h4><div id="p0235" role="paragraph">For indirect co-culture model, 5&nbsp;× 10<sup>3</sup> primary human PDAC organoids were cultured in 50&nbsp;μL GFR Matrigel (356231, Corning) with Organoid Media and 5&nbsp;× 10<sup>4</sup> primary human CAFs, which were stably transfected with Pin1 shRNA or control vector, were then seeded on the top of Matrigel for 10&nbsp;days, followed by monitoring organoid growth using Cyntellect Celigo (Cyntellect) and analyzing the organoid size using Cyntellect Celigo software (version 1.3, Cyntellect). Direct co-culture model of PDAC organoids and CAFs was as described (<span class="dropBlock reference-citations"><a id="body-ref-sref48-11" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48-11" aria-controls="sref48-11">Koikawa et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref48-11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Koikawa, K. ∙ Ohuchida, K. ∙ Ando, Y. ...</div><div><strong>Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Lett.</em> 2018; <strong>425</strong>:65-77</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2018.03.031" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29580808/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2018.03.031&amp;pmid=29580808" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref49-7" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49-7" aria-controls="sref49-7">Koikawa et&nbsp;al., 2018b</a><div class="dropBlock__holder" data-db-target-of="sref49-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Koikawa, K. ∙ Ohuchida, K. ∙ Takesue, S. ...</div><div><strong>Pancreatic stellate cells reorganize matrix components and lead pancreatic cancer invasion via the function of Endo180</strong></div><div><em>Cancer Lett.</em> 2018; <strong>412</strong>:143-154</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2017.10.010" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85032707374" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29061505/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2017.10.010&amp;pmid=29061505" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, primary human PDAC organoid cells were transfected with GFP and subjected to organoid culture. Human primary CAFs were pre-treated with Pin1 inhibitor (Pin1i-1 or Pin1i-2), or stably transfected with Pin1 CRISPR KO or vector control. Before the start of co-culture, CAFs were stained in red with cell tracker red (C34452, Invitrogen) for visualization. 1&nbsp;× 10<sup>4</sup> Organoids were co-cultured with 1&nbsp;× 10<sup>5</sup> human primary CAFs on the Matrigel and collagen (354249, BD Biosciences) mixed gel coated 6 well plate, followed by observing time lapse images using BZ-X800 fluorescence microscope (KEYENCE) and examining the organoid area using BZ-X 800 analyzer software (KEYENCE).</div></section><section id="sec-4-4-3"><h4>Organoid apoptosis assay</h4><div id="p0240" role="paragraph"><div id="olist0010" role="list"><div id="o0010" role="listitem"><div class="label">1)</div><div class="content"><div id="p0245" role="paragraph">For assaying the effects of Pin1 inhibition on GEM sensitivity, 5&nbsp;× 10<sup>3</sup> primary human PDAC organoids were cultured in 50&nbsp;μL GFR Matrigel (356231, Corning) for 7&nbsp;days and then the organoids were treated with control (DMSO) or Pin1 inhibitors (Pin1i-1, or Pin1i-2) for 3&nbsp;days. The organoids were isolated from Matrigel using collagenase, and seed Matrigel coated 96 well plate, and then treated with control (PBS) or GEM, or control (DMSO) or 5-FU, followed by assaying organoid apoptosis using fluorescent caspase 3/7 and live-cell time lapse imaging for 24&nbsp;hr. At the start of coculture, a green-fluorescent caspase 3/7 probe reagent (R37111, Invitrogen) and Hoechst (135102, Invitrogen) was added to visualize cells undergoing apoptosis. Apoptotic organoids were monitored by time lapse imaging using BZ-X800 fluorescence microscope (KEYENCE) and quantified using BZ-X800 analyzer (ver. 1.1.1.8, KEYENCE).</div></div></div><div id="o0015" role="listitem"><div class="label">2)</div><div class="content"><div id="p0250" role="paragraph">For assaying the effects of Pin1 inhibition on anti-PD1 or PDL1 sensitivity, organoids and PBMCs were co-culture as described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref18-2" href="#" role="doc-biblioref" data-xml-rid="bib18" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref18-2" aria-controls="sref18-2">Dijkstra et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref18-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Dijkstra, K.K. ∙ Cattaneo, C.M. ∙ Weeber, F. ...</div><div><strong>Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids</strong></div><div><em>Cell.</em> 2018; <strong>174</strong>:1586-1598</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2018.07.009&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2018.07.009&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85052651284" target="_blank" aria-label="Open Scopus in new tab">Scopus (273)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30100188/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.07.009&amp;pmid=30100188" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref45-5" href="#" role="doc-biblioref" data-xml-rid="bib45" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref45-5" aria-controls="sref45-5">Jiao et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref45-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">46.</div><div>Jiao, S. ∙ Xia, W. ∙ Yamaguchi, H. ...</div><div><strong>PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression</strong></div><div><em>Clin. Cancer Res.</em> 2017; <strong>23</strong>:3711-3720</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-16-3215" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85021146688" target="_blank" aria-label="Open Scopus in new tab">Scopus (372)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28167507/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-16-3215&amp;pmid=28167507" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Human PDAC organoids were treated with control (DMSO) or Pin1 inhibitors (Pin1i-1, or Pin1i-2) for 3&nbsp;days, and then co-cultured with human PBMCs. Human PBMCs (Precision for Medicine) were stimulated by PDAC organoid culture media, and 8.0&nbsp;× 10<sup>4</sup> PBMCs were incubated with 2&nbsp;μl CD3/28 beads (11161D, GIBCO) and 30&nbsp;U recombinant IL-2 (200-02, Peprotech) per well in 96-well plates for 24 hours before starting co-culture. PDAC organoids and activated PBMCs were directly co-cultured at 5:1 ratio on Matrigel (356231, Coaning) coated 96 well plate and treated with control (IgG), anti-PD1, or anti-PDL1, or control (PBS&nbsp;+ IgG) or GEM&nbsp;+ anti-PD1. At the start of co-culture, a green-fluorescent caspase 3/7 probe reagent (R37111, Invitrogen) and Hoechst (135102, Invitrogen) were added to visualize cells undergoing apoptosis. Apoptotic organoids were monitored by live-cell time lapse imaging was started 2 hours after the start of co-culture using BZ-X800 fluorescence microscope (KEYENCE) and quantified using BZ-X800 analyzer (ver. 1.1.1.8, KEYENCE).</div></div></div><div id="o0020" role="listitem"><div class="label">3)</div><div class="content"><div id="p0255" role="paragraph">For assaying the effects of Pin1 inhibition on GEM and anti-PD1 sensitivity in mouse PDAC organoids, mouse PDAC organoids (KPC organoids) were established from KPC mouse PDAC tumors, and 1x 10<sup>6</sup> KPC organoid cells were orthotopically transplanted into their tumor-free littermates that did not have all the three transgene or female C57BL/6 WT (8&nbsp;weeks of age, Jackson) mouse pancreas. 4&nbsp;weeks after transplantation, mouse CD8<sup>+</sup> T&nbsp;cells were isolated from the KPC tumor-bearing mouse, or tumor-free littermate mouse or C57BL/6 WT mouse spleens using CD8<sup>+</sup> T&nbsp;cell Isolation Kit (19853, STEM CELL) according to the manufacturer’s instructions, and then 8.0&nbsp;× 10<sup>4</sup> CD8<sup>+</sup> T&nbsp;cells were activated with 2&nbsp;μl CD3/28 beads (11453D, GIBCO) and 30&nbsp;U recombinant IL-2 (212-12, Peprotech) per well in 96-well plate for 24 hours before the start of co-culture. At the start of co-culture, a green-fluorescent caspase 3/7 probe reagent (R37111, Invitrogen) and Hoechst (135102, Invitrogen) were added to visualize cells undergoing apoptosis. KPC organoids were treated with control (DMSO) or Pin1 inhibitors (Pin1i-1 or Pin1i-2) for 3&nbsp;days, and KPC organoids and activated CD8<sup>+</sup> T&nbsp;cells were directly co-cultured 5:1 ratio on Matrigel (356231, Corning) coated 96 well plate, and then treated with control (IgG) or anti-PD1, or control (PBS&nbsp;+ IgG) or GEM&nbsp;+ anti-PD1. Apoptotic organoids were again monitored by time lapse imaging using BZ-X800 fluorescence microscope (KEYENCE) and quantified using BZ-X800 analyzer (ver. 1.1.1.8, KEYENCE).</div></div></div></div></div></section><section id="sec-4-4-4"><h4>Synergy score analysis</h4><div id="p0260" role="paragraph">To analyze the synergistic effects of the combination therapy between Pin1i and chemotherapies (GEM or 5-FU) or checkpoint immunotherapies (anti-PD-1 or anti-PD-L1), using Organoid apoptosis assay (see Organoid apoptosis assay). Synergy scores were calculated by Synergyfinder ver 2 (<a id="intref0425" href="https://synergyfinder.fimm.fi/" target="_blank">https://synergyfinder.fimm.fi/</a>) (<span class="dropBlock reference-citations"><a id="body-ref-sref42-2" href="#" role="doc-biblioref" data-xml-rid="bib42" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref42-2" aria-controls="sref42-2">Ianevski et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref42-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">43.</div><div>Ianevski, A. ∙ Giri, A.K. ∙ Aittokallio, T.</div><div><strong>SynergyFinder 2.0: visual analytics of multi-drug combination synergies</strong></div><div><em>Nucleic Acids Res.</em> 2020; <strong>48</strong>:W488-W493</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkaa216" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85086923971" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32246720/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkaa216&amp;pmid=32246720" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-4-5"><h4>Production of stable Pin1 KD or KO cell lines</h4><div id="p0265" role="paragraph">Establishment of Pin1 KD and CRISPR KO cells were as descried previously (<span class="dropBlock reference-citations"><a id="body-ref-sref50-8" href="#" role="doc-biblioref" data-xml-rid="bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50-8" aria-controls="sref50-8">Kozono et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref50-8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Kozono, S. ∙ Lin, Y.M. ∙ Seo, H.S. ...</div><div><strong>Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells</strong></div><div><em>Nat. Commun.</em> 2018; <strong>9</strong>:3069</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-018-05402-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85051562951" target="_blank" aria-label="Open Scopus in new tab">Scopus (54)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30093655/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-018-05402-2&amp;pmid=30093655" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref94-6" href="#" role="doc-biblioref" data-xml-rid="bib94" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref94-6" aria-controls="sref94-6">Wei et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref94-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">96.</div><div>Wei, S. ∙ Kozono, S. ∙ Kats, L. ...</div><div><strong>Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer</strong></div><div><em>Nat. Med.</em> 2015; <strong>21</strong>:457-466</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.3839" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_96_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84937759226" target="_blank" aria-label="Open Scopus in new tab">Scopus (172)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25849135/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.3839&amp;pmid=25849135" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Pin1 guide RNAs (gRNAs) were designed using the online CRISPR design tool (http:// CRISPR.mit.edu/). The gRNA sequences were gRNA-1 AGTCACGGCGGCCCTCGTCC TGG, gRNA-2 CAGTGGTGGCAAAAACGGGC AGG. The pLentiCRISPR construction was performed according to the protocol provided by the Zhang Lab (<a id="PC_linkiYK72SwDSe" href="https://zlab.bio/guide-design-resources" target="_blank">https://zlab.bio/guide-design-resources</a>). Oligos, (F)— 5′-CACCC-gRNA and (R) AAAC-gRNA-C, were cloned into the gRNA Cloning Vector (Addgene, plasmid #49536). To obtain single clones of Pin1 KO cells, cells were transfected with the pLenti CRISPR plasmid containing each target gRNA sequence or empty vector, selected with puromycin for 3&nbsp;days and isolated by colony formation assay or single cell culture. The single clones were validated by immunoblotting analysis and DNA sequencing.</div></section><section id="sec-4-4-6"><h4>Construct of HIP1R point mutant</h4><div id="p0270" role="paragraph">Human HIP1R (Huntingtin Interacting Protein 1 Related) (GenBank: <a id="intref0435" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=NM_003959.3" target="_blank">NM_003959.3</a>; 3,204&nbsp;bp ORF sequence) in pcDNA3.1+/C-(K)-DYK was purchased from GenScript (NJ, USA). For constructing the point mutants of the putative Pin1 binding serine929-proline site, Ser929 was substituted by alanine (S929A) using inverse PCR method with primer sets, as described before (<span class="dropBlock reference-citations"><a id="body-ref-sref87-1" href="#" role="doc-biblioref" data-xml-rid="bib87" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref87-1" aria-controls="sref87-1">Suizu et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref87-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">89.</div><div>Suizu, F. ∙ Hirata, N. ∙ Kimura, K. ...</div><div><strong>Phosphorylation-dependent Akt-Inversin interaction at the basal body of primary cilia</strong></div><div><em>EMBO J.</em> 2016; <strong>35</strong>:1346-1363</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.15252/embj.201593003" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_89_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84971268766" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27220846/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.15252%2Fembj.201593003&amp;pmid=27220846" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In brief, whole plasmid DNA was amplified by the polymerase chain reaction of 16 cycles with primer sets described below in Universe Hot Start High-Fidelity 2x PCR Master mix (Biotool). After the reaction, template plasmid DNAs (wild-type) were digested by DpnI enzyme (NEB). The amplified mutated linear DNA fragments were self-ligated and circulized in the presence of T4 Polynucleotide kinase (NEB) and T4 DNA ligase (NEB). The mutation site of plasmid DNA was confirmed by sanger DNA sequencing analysis in DF/HCC DNA resource core facility. Protein expression was analyzed by immunoblotting with anti-FLAG (M2) antibody (Sigma). Primer sets for S929A, sense primer; 5′-CCCCCCACCTGAGCCGC-3′, anti-sense primer5′-; CGTGCTTGTTGGCCTTCACCTTGG-3′, Primer sets for S1017A, sense primer; 5′-cCCCTGGAGAGGAGGTGGCC −3′, anti-sense primer; 5′-cGCCTGATGCCCCAGCCAG-3′</div></section><section id="sec-4-4-7"><h4>Production of stable HIP1R expressing cell lines</h4><div id="p0275" role="paragraph">To subclone human HIP1R into a lentivirus vector, wild-type or point mutated HIP1R ORF including DYK tag sequence was amplified by the polymerase chain reaction of 20 cycles with primer sets described below in Q5 High-Fidelity DNA Polymerase reaction mix (NEB). The digested PCR fragments with restriction enzymes XhoI and NotI were ligated into lentivirus backbone plasmid vector pCSII-EF1α-MCS-IRES2-Blasticidin (<span class="dropBlock reference-citations"><a id="body-ref-sref87-2" href="#" role="doc-biblioref" data-xml-rid="bib87" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref87-2" aria-controls="sref87-2">Suizu et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref87-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">89.</div><div>Suizu, F. ∙ Hirata, N. ∙ Kimura, K. ...</div><div><strong>Phosphorylation-dependent Akt-Inversin interaction at the basal body of primary cilia</strong></div><div><em>EMBO J.</em> 2016; <strong>35</strong>:1346-1363</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.15252/embj.201593003" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_89_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84971268766" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27220846/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.15252%2Fembj.201593003&amp;pmid=27220846" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). For lentivirus production, 293FT packaging cells were transfected with lentiviral plasmid (pCSII), packaging plasmid (pcDNA-ΔR8.91), and envelope plasmid (VSV-G/pMD2.G) by PEI (Polyscience) transfection method. After transfection for 24hrs, the transfection reagent was replaced by fresh medium. After incubation at 35°C, 5% CO<sub>2</sub> for 48&nbsp;hr, the resulting lentivirus supernatant was collected and filtrated with 0.45&nbsp;μm disc filter. Patient-derived PDAC cells were infected with the lentivirus supernatant and fresh media at 1:1 ratio with 8&nbsp;μg/mL polybrene. After infection for 48&nbsp;hr, the virus particles are replaced by fresh media and the stably HIP1R-expressing cells were selected in the presence of 2&nbsp;μg/ml of Blasticidin for at least 4&nbsp;days. Protein expression was analyzed by immunoblotting with anti-FLAG (M2) antibody (Sigma). Primer sets for subcloning Hs HIP1R into pCSII lentivirus vector, sense primer with XhoI enzyme site; 5′-ATCATCCTCGAGCCACCATGAACAGCATCAAG-3′, anti-sense primer including DYK with NotI enzyme site; 5′-ATCGCGGCCGCTCACTTATCGTCGTCATCCTTGTAATCG-3′</div></section><section id="sec-4-4-8"><h4>Production of stable HIP1R KD, ENT KD, and PD-L1 KD cell lines</h4><div id="p0280" role="paragraph">For silencing endogenous HIP1, ENT1 or PD-L1 expression, lentivirus producing shRNA targeting human HIP1R, ENT1 or PD-L1 mRNA was utilized. Five individual clones from MISSION® shRNA target set (Sigma) HIP1R (GenBank:&nbsp;NM_003959.1), ENT1 (GenBank:&nbsp;NM_004955.1), PD-L1 (GenBank:&nbsp;NM_014143.2) (<a id="crosref1965" href="#mmc3">Table S3</a>) or pLKO.1 empty vector was co-transfected with a lentivirus packaging and envelope plasmid into 293FT cells as described above. The resulting lentiviral particles were used to infect PDAC by the mix of lentivirus supernatant and fresh media at 1:1 ratio with 8 g/mL polybrene. After infection for 48&nbsp;hr., the virus particles are replaced by fresh media and the stably shRNA-expressing cells were selected in the presence of 2&nbsp;μg/ml of Puromycin for at least 4&nbsp;days. Protein expression was analyzed by immunoblotting with anti-HIP1R (16814-1-AP, Proteintech), ENT1 (11337-1-AP, Proteintech) or PD-L1 (13684, Cell Signaling Technology) antibody.</div></section><section id="sec-4-4-9"><h4>Cell proliferation assay</h4><div id="p0285" role="paragraph">Cells were seeded at a density of 5000 cells (PDAC1 and PDAC2), or 3000 cells (CAF1 and CAF2) per well in 96-well flat-bottomed plates and incubated for 24&nbsp;h in culture medium. At 24 h, cells were treated with ATO, ATRA, their combination (Pin1i-1), or Sulfopin (Pin1i-2). Control cells received dimethyl sulfoxide (DMSO) at a concentration equal to that of drug- treated cells for 72 hours. The cell viability was determined by CellTiter-Glo® 2.0 Assay (Promega) following the manufacturer’s instructions.</div></section><section id="sec-4-4-10"><h4>ELISA assay and cytokine array</h4><div id="p0290" role="paragraph">The concentrations of cytokines in culture media were evaluated using human IL-6 uncoated ELISA (88-7066), human TGF-β uncoated ELISA (88-50390), human SDF-1 (CXCL12) ELISA (EHCXCL12A), and human LIF ELISA (BMS242) from Invitrogen, human IFNα ELISA (41100-1, R&amp;D Systems) and using human cytokine ELISA plate array I (EA-4001, Signosis), according to the manufacturer’s instructions.</div></section><section id="sec-4-4-11"><h4>Flow cytometric analysis</h4><div id="p0295" role="paragraph">PDAC tumor tissues were finely sliced into 0.5-1.0&nbsp;mm fragments and dissolved by collagenase/dispase (11097113001, Sigma) for 30&nbsp;min at 37°C or by Tumor dissociation Kit (130-960-730, Miltenyi Biotec) according to the manufacturer’s instructions. After filtered, cell lysate was collected. To assess cell surface expressions, cells were harvested by non-enzymatic cell dissociation solution, and resuspend in blocking solution (Cell Staining Buffer, BioLegend). Cells were incubated with following antibodies; CD45-Cy7 (25-0451-82, Invitrogen), CD3-Pacific blue (100214, BioLegend), CD4-APC (100516, BioLegend), CD8α-PE (553033, BioLegend), CD11b-PE (101208, BioLegend), CD11c-PE (117308, BioLegend), CD206-APC (141708, BioLegend), F4/80-FITC (123108, BioLegend), CD279-APC (PD-1,135210, BioLegend), CD274-APC (PD-L1, 124312, BioLegend), H-2Kb-FITC (MHC-ClassI, 116506, BioLegend), 1-A/1-E-FITC (MHC-ClassII, 107606, BioLegend), NK1.1-PE (10870, BioLegend), anti-CD223-FITC (Lag-3, 11-2231-82, Invitrogen) for 60&nbsp;min on ice. For FOXP3 staining, cells were fixed and permeabilized using Foxp3 / Transcription Factor Staining Buffer Set (00-5523, eBioscience), and incubated with FOXP3-FITC (11-5773-82, Invitrogen) for 30&nbsp;mins at RT. For Granzyme B staining, cells were fixed and permeabilized using Intracellular Fixation &amp; Permeabilization Kit (88-8824-00, eBioscience), and incubated with Granzyme B-FITC (515403, BioLegend) for 30&nbsp;mins at RT. All antibodies were diluted according to manufacture instruction. Cells were analyzed using CytoFLEX flow cytometer and CytExpert software (Beckman Coulter, IN, USA).</div></section><section id="sec-4-4-12"><h4>Immunoblotting analysis (IB)</h4><div id="p0300" role="paragraph">Cultured cells were lysed in RIPA buffer (50&nbsp;mM Tris-HCl, pH 7.2, 150&nbsp;mM NaCl, 1% NP40, 0.1% sodium dodecyl sulfate (SDS), 0.25% Na-deoxycholate) with freshly added phosphatase inhibitors containing 5&nbsp;mM NaF and 0.2&nbsp;mM sodium orthovanadate (NA<sub>3</sub>VO<sub>4</sub>), and proteinase inhibitors containing 2&nbsp;μg/ml Aprotinin, 2&nbsp;μg/ml Leupeptin, 2&nbsp;μg/ml Pepstatin A, 1&nbsp;mM DTT (dithiothreitol), 0.5&nbsp;mM 4-(2-aminoethyl)-benzenesulfonyl fluoride (AEBSF), and 20&nbsp;μM Chymotrypsin, and then mixed with the SDS sample buffer and loaded onto a gel after boiling for 10&nbsp;minutes at 95°C. The proteins were resolved by polyacrylamide gel electrophoresis and transferred to PVDF membrane. The transferred membrane was washed three times with Tris-buffered saline containing 0.1% Tween 20 (TBST). After blocking with TBST containing 5% milk or 3% bovine serum albumin (BSA) for 1&nbsp;h room temperature, the membrane was incubated with the appropriate primary antibody (diluted 1:500 - 1:10000) in 5% milk or 3% BSA-containing TBST at 4°C overnight. After incubation with the primary antibody, the membrane was washed three times with TBST for a total of 30&nbsp;min followed by incubation with horseradish peroxidase conjugated goat anti-rabbit or anti-mouse IgG (diluted 1:5000) for 1&nbsp;h at room temperature. After three extensive washes with TBST for a total of 30&nbsp;min, the immunoblots were visualized by enhanced chemi-luminescence. Immunoblotting results were quantified using ImageJ (NIH).</div></section><section id="sec-4-4-13"><h4>Immunoprecipitation analysis (IP)</h4><div id="p0305" role="paragraph">Cells were lysed in IP lysis buffer (50&nbsp;mM HEPES, pH 7.4, 150&nbsp;mM NaCl, 1% Triton X-100 and 10% glycerol) or NP-40 IP lysis buffer (10&nbsp;mM Tris HCl, pH7.5, 100mM NaCl, 0.5% NP-40) with freshly added phosphatase and protease inhibitors. After centrifugation at 13,000&nbsp;g for 15&nbsp;min, the supernatant was pre-cleaned with Protein A Sepahrose beads (L00210, GeneScript) for 60&nbsp;min at 4°C, one-tenth of the supernatant was stored as input, and the remainder was incubated for 12&nbsp;h with 2&nbsp;μg anti-Pin1 or M2 Flag agarose (Sigma) at 4°C. The supernatants were incubated with Protein A Sepahrose beads for 60&nbsp;min at 4°C, and then washed three times with the aforementioned lysis buffer. After brief centrifugation, immunoprecipitates were collected, suspended in 2&nbsp;× SDS sample buffer (100&nbsp;mM Tris-HCl, pH 6.8, 4% SDS, 5% β-mercaptoethanol, 20% glycerol, and 0.1% bromophenol blue), boiled for 10&nbsp;min at 95°C, and subjected to immunoblotting analysis.</div></section><section id="sec-4-4-14"><h4>HIP1R protein stability assay</h4><div id="p0310" role="paragraph">HIP1R WT or HIP1R S929A transfected PDAC cells were incubated with 300&nbsp;μg/mL cycloheximide (C104450, Sigma) under existing culture conditions. Cells were harvested at the indicated time points with RIPA buffer (50&nbsp;mM Tris-HCl, pH 7.2, 150&nbsp;mM NaCl, 1% NP40, 0.1% sodium dodecyl sulfate (SDS), 0.25% Na-deoxycholate) and a proteinase and phosphatase inhibitors (5&nbsp;mM NaF and 0.2&nbsp;mM sodium orthovanadate (NA<sub>3</sub>VO<sub>4</sub>), 2&nbsp;μg/ml Aprotinin, 2&nbsp;μg/ml Leupeptin, 2&nbsp;μg/ml Pepstatin A, 1&nbsp;mM DTT (dithiothreitol), 0.5&nbsp;mM 4-(2-aminoethyl)-benzenesulfonyl fluoride (AEBSF), and 20&nbsp;μM Chymotrypsin). The supernatant was collected and subjected to western blot analysis using antibody for HIP1R.</div></section><section id="sec-4-4-15"><h4>Quantitative real-time PCR analysis</h4><div id="p0315" role="paragraph">The purification of high-quality RNA from cells was performed using The RNeasy Mini Kit (74104, QIAGEN) in accordance with the manufacturer’s protocols. Samples were performed in triplicates. SYBR Green PCR Master Mix (4309155, Applied Biosystems) was used for two-step real-time RT-PCR analysis on an Applied Biosystems StepOnePlus Real Time PCR instrument.</div><div id="p0320" role="paragraph">Expression value of the targeted gene in a given sample was normalized to the corresponding expression of GAPDH. The 2<sup>-ΔΔCt</sup> method was used to calculate relative expression of the targeted genes. The primers were: GAPDH-F, 5′- AGCCTCAAGATCATCAGCAATG’, GAPDH-R 5′- TGATGGCATGGACTGTGGTCAT −3′, hPin1-F, 5′-GCCTCACAGTTCAGCGACT-3′, hPin1-R, 5′-ACTCAGTGCGGAGGATGATGT-3′, hENT1-F, 5′-CAGAAAGTGCCTTCGGCTAC-3′, hENT1-R, 5′-TGGGCTGAGAGAGTTGGAGACT-3′, hPD-L1-F, 5′-TGGCATTTGCTGAACGCATTT-3, hPD-L1-R, 5′-TGCAGCCAGGTCTAATTGTTTT-3′ (<span class="dropBlock reference-citations"><a id="body-ref-sref99-8" href="#" role="doc-biblioref" data-xml-rid="bib99" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref99-8" aria-controls="sref99-8">Zhang et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref99-8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">102.</div><div>Zhang, J. ∙ Bu, X. ∙ Wang, H. ...</div><div><strong>Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance</strong></div><div><em>Nature.</em> 2018; <strong>553</strong>:91-95</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25015" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_102_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85040189345" target="_blank" aria-label="Open Scopus in new tab">Scopus (306)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29160310/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25015&amp;pmid=29160310" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), hPD-L1-2F, 5′-GGTGCCGACTACAAGCGAAT-3′, hPD-L1-2R, 5′-AGCCCTCAGCCTGACATGTC-3′ (<span class="dropBlock reference-citations"><a id="body-ref-sref12-5" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12-5" aria-controls="sref12-5">Burr et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref12-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Burr, M.L. ∙ Sparbier, C.E. ∙ Chan, Y.C. ...</div><div><strong>CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity</strong></div><div><em>Nature.</em> 2017; <strong>549</strong>:101-105</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature23643" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85029029250" target="_blank" aria-label="Open Scopus in new tab">Scopus (291)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28813417/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature23643&amp;pmid=28813417" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), hPD-L1-3F, 5′-ATTTGGAGGATGTGCCAGAG-3′, hPD-L1-3R, 5′-CCAGCACACTGAGAATCAACA-3′ (<span class="dropBlock reference-citations"><a id="body-ref-sref69" href="#" role="doc-biblioref" data-xml-rid="bib69" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref69" aria-controls="sref69">Mezzadra et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref69"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">71.</div><div>Mezzadra, R. ∙ Sun, C. ∙ Jae, L.T. ...</div><div><strong>Identification of CMTM6 and CMTM4 as PD-L1 protein regulators</strong></div><div><em>Nature.</em> 2017; <strong>549</strong>:106-110</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature23669" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85029041186" target="_blank" aria-label="Open Scopus in new tab">Scopus (251)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28813410/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature23669&amp;pmid=28813410" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), hPD-L1-4 F, 5′- CCTACTGGCATTTGCTGAACGCAT-3′, hPD-L1-4 R, 5′- ACCATAGCTGATCATGCAGCGGTA-3′</div></section><section id="sec-4-4-16"><h4>Lipid droplet accumulation assay</h4><div id="p0325" role="paragraph">Lipid droplet accumulation assay was performed as described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref22-3" href="#" role="doc-biblioref" data-xml-rid="bib22" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref22-3" aria-controls="sref22-3">Endo et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref22-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">23.</div><div>Endo, S. ∙ Nakata, K. ∙ Ohuchida, K. ...</div><div><strong>Autophagy Is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mice</strong></div><div><em>Gastroenterology.</em> 2017; <strong>152</strong>:1492-1506</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2017.01.010&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2017.01.010&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85018835771" target="_blank" aria-label="Open Scopus in new tab">Scopus (100)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28126348/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2017.01.010&amp;pmid=28126348" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Cells were stained with 1&nbsp;mg/mL 4,4-difluoro-1,3,5,7,8-pentamethyl-4-bora-3a,4a-diaza-s-indacene (bodipy 493/503; #D-3922; Life Technologies, Carlsbad, CA), and the number of bodipy-positive punctures per cell in 20 cells was counted.</div></section><section id="sec-4-4-17"><h4>Immunohistochemistry analysis (IHC)</h4><div id="p0330" role="paragraph"><i>In&nbsp;vitro</i> PDAC organoids or <i>in&nbsp;vivo</i> mouse pancreas tissues were cut into 4-μm-thick sections from paraffin-embedded samples, deparaffinized in Histoclear, and rehydrated through an ethanol gradient. Antigen retrieval was achieved by microwaving or autoclaving the sections in sodium citrate buffer (pH 6.0) or Tris-EDTA (pH 8.0). Endogenous peroxidase activity was blocked by incubation with 3% hydrogen for 15&nbsp;min. After blocking with 5% Goat serum for 30&nbsp;min at room temperature (RT), the sections were incubated with antibodies in 1% Goat serum buffer (1:1000) overnight at 4°C. Then the sections were incubated with HRP-conjugate secondary antibodies (1:1000, Mouse IgG; PI-2000 or Rabbit IgG; PI-1000, VECTOR) for 60&nbsp;min at RT. Counterstaining was performed with hematoxylin. Sirius red staining was conducted using a Picrosirius Red Staining Kit (24901, Polysciences, Inc.), according to the manufacturer’s instructions. Whole-tissue slide scans at 4&nbsp;× magnification was performed on BZ-X800 fluorescence microscope (KEYENCE), and scanned at least three different representative areas at 10x magnification. Image analysis was performed by thresholding for positive staining and normalizing to total tissue area, using ImageJ (NIH) and BZ-X800 analyzer (KEYENCE). IHC intensity was semi-quantified manually in a double-blind manner as a 3-tier scale (0; negative to weak, 1; moderate, 2; strong) based on previous reports (<span class="dropBlock reference-citations"><a id="body-ref-sref50-9" href="#" role="doc-biblioref" data-xml-rid="bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50-9" aria-controls="sref50-9">Kozono et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref50-9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Kozono, S. ∙ Lin, Y.M. ∙ Seo, H.S. ...</div><div><strong>Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells</strong></div><div><em>Nat. Commun.</em> 2018; <strong>9</strong>:3069</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-018-05402-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85051562951" target="_blank" aria-label="Open Scopus in new tab">Scopus (54)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30093655/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-018-05402-2&amp;pmid=30093655" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref64" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64" aria-controls="sref64">Maréchal et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref64"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">66.</div><div>Maréchal, R. ∙ Bachet, J.B. ∙ Mackey, J.R. ...</div><div><strong>Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma</strong></div><div><em>Gastroenterology.</em> 2012; <strong>143</strong>:664-674</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2012.06.006&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2012.06.006&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84865474189" target="_blank" aria-label="Open Scopus in new tab">Scopus (190)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22705007/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2012.06.006&amp;pmid=22705007" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref94-7" href="#" role="doc-biblioref" data-xml-rid="bib94" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref94-7" aria-controls="sref94-7">Wei et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref94-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">96.</div><div>Wei, S. ∙ Kozono, S. ∙ Kats, L. ...</div><div><strong>Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer</strong></div><div><em>Nat. Med.</em> 2015; <strong>21</strong>:457-466</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.3839" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_96_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84937759226" target="_blank" aria-label="Open Scopus in new tab">Scopus (172)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25849135/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.3839&amp;pmid=25849135" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref97" href="#" role="doc-biblioref" data-xml-rid="bib97" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref97" aria-controls="sref97">Yamaki et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref97"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">100.</div><div>Yamaki, S. ∙ Yanagimoto, H. ∙ Tsuta, K. ...</div><div><strong>PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8<sup>+</sup> tumor-infiltrating lymphocytes: highly sensitive detection using phosphor-integrated dot staining</strong></div><div><em>Int. J. Clin. Oncol.</em> 2017; <strong>22</strong>:726-733</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s10147-017-1112-3" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_100_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85015679284" target="_blank" aria-label="Open Scopus in new tab">Scopus (27)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28314962/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs10147-017-1112-3&amp;pmid=28314962" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). For Pin1 analysis, Low staining was defined as a staining intensity of “0” or “1 in under 50% of cancer or CAF cells,” and high staining was defined as a staining intensity of “2” and “1 in &gt;50% cancer or CAF cells.”</div></section><section id="sec-4-4-18"><h4>Immunofluorescence analysis (IF)</h4><div id="p0335" role="paragraph">Cells were seeded on cover glass (#12-542A Fisher Scientific) at approximately 60% confluence and subsequently treated with Pin1i-1 or Pin1i-2 for 72 hours. At 72 hours, cells were fixed by 4% PFA for 20&nbsp;min, and washed three times with PBS, each time for 5&nbsp;min. Cells were then permeabilized with 0%–0.1% Triton X-100 and blocked in 3% BSA in PBS for 1 hour at RT. Human PDAC or mouse tumor tissue sections were boiled in 10&nbsp;mM sodium citrate (pH 6.0), for antigen retrieval after deparaffinization. The sections were permeabilized with PBS containing 0.1%–0.5% Triton X-100 and blocked with PBS containing 5% Goat serum for 30&nbsp;min RT. The primary antibodies were diluted in PBS containing 1% Goat serum (1:100) and incubated in slides for overnight at 4°C. The cells were rinsed by PBS three times, each time for 5&nbsp;min. Secondary antibodies were diluted in PBS (1:200) and incubated for 20&nbsp;min at room temperature. 20&nbsp;μg/ml DAPI was used to label nuclear of cells. Whole-tissue slide scans at 4&nbsp;× magnification was performed on BZ-X800 fluorescence microscope (KEYENCE), and scanned at least three different representative areas at 10x magnification (for tissue analysis) or 20x magnification (for cell analysis). Image analysis was performed by thresholding for positive staining and normalizing to total tissue area, using ImageJ (NIH) and BZ-X800 analyzer (KEYENCE).</div></section><section id="sec-4-4-19"><h4>t-CyCIF experimental protocol</h4><div id="p0340" role="paragraph">t-CyCIF imaging consisted of multiple cycles of antibody incubation, imaging, and fluorophore inactivation. The t-CyCIF experimental protocol was conducted as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref20" href="#" role="doc-biblioref" data-xml-rid="bib20" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref20" aria-controls="sref20">Du et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref20"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">21.</div><div>Du, Z. ∙ Lin, J.R. ∙ Rashid, R. ...</div><div><strong>Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging</strong></div><div><em>Nat. Protoc.</em> 2019; <strong>14</strong>:2900-2930</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41596-019-0206-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85072716410" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31534232/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41596-019-0206-y&amp;pmid=31534232" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref56-1" href="#" role="doc-biblioref" data-xml-rid="bib56" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref56-1" aria-controls="sref56-1">Lin et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref56-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">58.</div><div>Lin, J.R. ∙ Izar, B. ∙ Wang, S. ...</div><div><strong>Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes</strong></div><div><em>eLife.</em> 2018; <strong>7</strong>:e31657</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.7554/eLife.31657" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85052091363" target="_blank" aria-label="Open Scopus in new tab">Scopus (131)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29993362/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.7554%2FeLife.31657&amp;pmid=29993362" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In brief, 5 micron sections from 9 FFPE pancreatic adenocarcinoma specimens were baked at 60°C for 30&nbsp;min, dewaxed using Bond Dewax Solution (Leica Biosystems) at 72°C, and antigen retrieval was performed with Epitope Retrieval 1 Solution (Leica Biosystems) at 100°C for 20&nbsp;minutes using the BOND RX Automated IHC/ISH Stainer (Leica Biosystems). All antibodies were diluted in Odyssey Intercept Buffer (plus Hoechst 33342 0.25&nbsp;μg/mL; LI-COR Biosciences) and incubated overnight at 4°C in the dark. See the <a id="crosref2020" href="#sec-4-1">Key Resources Table</a> for the complete list of antibodies (note that&nbsp;PDGFRα staining was non-specific and inadequate to detect iCAFs). Slides were coverslipped using 20%–50% glycerol solution&nbsp;(Sigma-Aldrich) in PBS. Images were taken using DAPI, FITC, Cy3, and Cy5 channels on the RareCyte CyteFinder Instrument (20x/0.75NA objective lens, RareCyte Inc. Seattle WA). After imaging, the fluorophores were inactivated by incubating with photobleaching solution (4.5% H2O2 and 20&nbsp;mM NaOH in PBS) for 30&nbsp;minutes under LED lights (this step was repeated twice).</div></section><section id="sec-4-4-20"><h4>t-CyCIF image processing</h4><div id="p0345" role="paragraph">The image processing of tissue cyclic immunofluorescence is organized in the following steps, each of which is described in detail below: i) the software ASHLAR is used to stitch, register, and correct for image acquisition artifacts (using the BaSiC algorithm). The output of ASHLAR is a single pyramid ome.tiff file for each region imaged; ii) the ome.tiff file is re-cut into tiles (typically 5000x5000 pixels) containing only the highest resolution image for all channels. One random cropped image (250x250 pixels) per tile is outputted for segmentation training (using ImageJ/Fiji); iii) using the ilastik software the labeling of nuclear, cytoplasmic and background areas are trained on the cropped images. Based on the user training the Ilastik software outputs a 3-color RGB image with label probabilities; iv) the RBG probability images are thresholded and watershed in MATLAB to segment the nuclear area. The cytoplasmic measurements are derived by dilating the nuclear mask; v) single-cell measurements are extracted for each channel (cell pixel median and mean for both nuclear and cytoplasmic area) as well as morphological measurements of area, solidity, and cell coordinates location.</div></section><section id="sec-4-4-21"><h4>BaSiC</h4><div id="p0350" role="paragraph">The BaSiC ImageJ plugin tool was used to perform background and shading correction of the original images (<span class="dropBlock reference-citations"><a id="body-ref-sref75" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75" aria-controls="sref75">Peng et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref75"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">77.</div><div>Peng, T. ∙ Thorn, K. ∙ Schroeder, T. ...</div><div><strong>A BaSiC tool for background and shading correction of optical microscopy images</strong></div><div><em>Nat. Commun.</em> 2017; <strong>8</strong>:14836</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncomms14836" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_77_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85020638067" target="_blank" aria-label="Open Scopus in new tab">Scopus (60)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28594001/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncomms14836&amp;pmid=28594001" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The BaSiC algorithm calculates the flatfield, the change in effective illumination across an image, and the darkfield, which captures the camera offset and thermal noise. The dark field correction image is subtracted from the original image, and the result is divided by the flatfield image correction to obtain the final image.</div></section><section id="sec-4-4-22"><h4>ASHLAR</h4><div id="p0355" role="paragraph">Alignment by Simultaneous Harmonization of Layer/Adjacency Registration (ASHLAR) is used to stitch together image tiles and register image tiles in subsequent layers to those in the first layer (<span class="dropBlock reference-citations"><a id="body-ref-sref56-2" href="#" role="doc-biblioref" data-xml-rid="bib56" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref56-2" aria-controls="sref56-2">Lin et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref56-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">58.</div><div>Lin, J.R. ∙ Izar, B. ∙ Wang, S. ...</div><div><strong>Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes</strong></div><div><em>eLife.</em> 2018; <strong>7</strong>:e31657</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.7554/eLife.31657" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85052091363" target="_blank" aria-label="Open Scopus in new tab">Scopus (131)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29993362/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.7554%2FeLife.31657&amp;pmid=29993362" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref77" href="#" role="doc-biblioref" data-xml-rid="bib77" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref77" aria-controls="sref77">Rashid et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref77"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">79.</div><div>Rashid, R. ∙ Gaglia, G. ∙ Chen, Y.A. ...</div><div><strong>Highly multiplexed immunofluorescence images and single-cell data of immune markers in tonsil and lung cancer</strong></div><div><em>Sci. Data.</em> 2019; <strong>6</strong>:323</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41597-019-0332-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85076825816" target="_blank" aria-label="Open Scopus in new tab">Scopus (14)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31848351/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41597-019-0332-y&amp;pmid=31848351" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). For the first image layer, neighboring image tiles are aligned to one another via a phase correlation algorithm that corrects for local state positioning error. A similar method is applied for subsequent layers to align tiles to their corresponding tile in the first layer. ASHLAR outputs an OME-TIFF file containing a multi-channel mosaic of the full image across all imaging cycles. Full codes available at: <a id="intref0440" href="https://github.com/labsyspharm/ashlar" target="_blank">https://github.com/labsyspharm/ashlar</a>.</div></section><section id="sec-4-4-23"><h4>Ilastik</h4><div id="p0360" role="paragraph">ilastik is a machine learning based bioimage analysis tool that is used to obtain nuclear and cytoplasmic segmentation masks from OME-TIFF files (<span class="dropBlock reference-citations"><a id="body-ref-sref6" href="#" role="doc-biblioref" data-xml-rid="bib6" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref6" aria-controls="sref6">Berg et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">7.</div><div>Berg, S. ∙ Kutra, D. ∙ Kroeger, T. ...</div><div><strong>ilastik: interactive machine learning for (bio)image analysis</strong></div><div><em>Nat. Methods.</em> 2019; <strong>16</strong>:1226-1232</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41592-019-0582-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85075429634" target="_blank" aria-label="Open Scopus in new tab">Scopus (332)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31570887/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41592-019-0582-9&amp;pmid=31570887" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). For increased processing speed, randomly selected 250&nbsp;× 250 pixel regions from the original OME-TIFF are used as training data. ilastik’s interactive user interface allows the user to provide training annotations on the cropped regions. Users are presented with a subset of the channels stacked images and label pixels as either nuclear area, cytoplasmic area, or background area. The annotations are used to train non-linear classifiers that are applied to the entire image to obtain probability masks describing the probabilities of each pixel belonging to the nuclear, cytoplasmic, or background area. A MATLAB (version 2018a) script uses these masks to construct binary masks for nuclear and cytoplasmic area.</div></section><section id="sec-4-4-24"><h4>t-CyCIF data analysis workflow</h4><div id="p0365" role="paragraph">The data analysis is divided in a set of pre-processing steps in which data from different tissues is i) log2-transformed and aggregated together, ii) filtered for image analysis errors, and iii) normalized on a channel-by-channel basis across the entire data from a single experiment. All the steps are performed in MATLAB.</div></section><section id="sec-4-4-25"><h4>Data aggregation</h4><div id="p0370" role="paragraph">The image processing workflow outputs one ome.tiff image and one data file (.mat) for each tissue area imaged. The data matrices from each .mat file are concatenated into a single matrix for each metric measured (median/mean, nuclear/cytoplasmic) into a single structure (“AggrResults”). The morphological data (i.e., area, solidity, and centroid coordinates) is concatenated into a single structure (“MorpResults”), which also contains the indexing vector to keep track of the tissue of origin within the dataset.</div></section><section id="sec-4-4-26"><h4>Data filtering</h4><div id="p0375" role="paragraph">Single cells are filtered to identify and potentially exclude from subsequent analysis errors in segmentation and cells lost through the rounds of imaging. Two types of criteria are used to filter cells: morphological criteria based on cell object segmented area, which are applied to all the rounds for the cell object, and DAPI-based criteria which are applied to the DAPI measurement for each imaging round. The latter corrects for cell loss during cycling and computational misalignment, which are both round specific.</div><div id="p0380" role="paragraph">Morphological filtering criteria are: 1) nuclear area within a user-input range; 2) cytoplasmic area within a user-input range; 3) nuclear object solidity above a user-input threshold. DAPI-based criteria are: 1) nuclear DAPI measurement above a user-input threshold; 2) ratio between nuclear and cytoplasmic DAPI measurement above a user-input threshold. The filter information for the criteria is allocated to a logical (0-1) structure ‘Filter’, which is used to select the cells to analyze in the further analysis by indexing. The threshold selection is dataset dependent and is performed by data inspection. The values used in each dataset are available with the codes used for data analysis in the github repository</div><div id="p0385" role="paragraph"><a id="intref0445" href="https://github.com/santagatalab/2021_Koikawa_et_al_CyCIF_codes" target="_blank">https://github.com/santagatalab/2021_Koikawa_et_al_CyCIF_codes</a>.</div></section><section id="sec-4-4-27"><h4>Data normalization</h4><div id="p0390" role="paragraph">Each channel distribution is normalized by probability density function (pdf) centering and rescaling. The aim is to center the distribution of the log2 fluorescent signal at 0 and rescale the width of the distribution to be able to compare across channels. The data is first log-transformed (base 2). The standard normalization is performed using a 2-component Gaussian mixture model, each model capturing the negative and the positive cell population. If the 2-component model fails to approximate the channel distribution, two other strategies are attempted: i) a 3-component model is used assuming the components with the two highest means are the negative and positive distribution (i.e., discarding the lowest component) or ii) the user selects a percentage ‘x’ of assumed positive cells and a single Gaussian distribution fit is performed on the remainder of the data to capture the negative distribution. The single Gaussian fit is then used as the lower component in a 2-component model to estimate the distribution of the positive population. The strategy chosen for each channel in each dataset is available in the github repository <a id="intref0450" href="https://github.com/santagatalab/2021_Koikawa_et_al_CyCIF_codes" target="_blank">https://github.com/santagatalab/2021_Koikawa_et_al_CyCIF_codes</a>. The “add_coeff” is defined as the intersection of the negative and positive distributions. The “mult_coeff” is defined as the difference between the mean of the negative and positive distributions. The full distribution is normalized by subtracting the add_coeff and dividing by the mult_coeff. The normalization is performed on the nuclear and cytoplasmic single-cell, single-channel distributions individually. The data preprocessing workflow is performed on all datasets. The individual analyses used in the paper are performed only in select datasets as follows.</div></section><section id="sec-4-4-28"><h4>Isolation of CAF subsets</h4><div id="p0395" role="paragraph">Cells from tissue-based experiments are classified into lineage compartments by cell type markers, by gating on the sign of the normalized values of cell type markers. Stromal cells were defined as double negatives for pan-cytokeratin and CD45. Stromal cells were subtyped by k-means clustering based on normalized values of alpha smooth muscle actin, CD44 and DPB1.</div></section></section><section id="sec-4-5"><h3>Quantification and statistical analysis</h3><div id="p0400" role="paragraph">Biochemical experiments <i>in&nbsp;vitro</i> were routinely repeated at least three times, and the repeat number was increased according to effect size or sample variation. We estimated the sample size considering the variation and mean of the samples. No statistical method was used to predetermine sample size. No animals or samples were excluded from any analysis. Animals were randomly assigned groups for <i>in&nbsp;vivo</i> studies; no formal randomization method was applied when assigning animals for treatment. Group allocation and outcome assessment was not done in a blinded manner, including for animal studies. A computer program Prism 8 (GraphPad Software, CA, USA) was used for statistical analysis. All data are presented as the means ± s.d., followed by determining significant differences using the unpaired Student’s t test or one-way analysis of variance (ANOVA) test or Pearson’s chi-square test. Kaplan-Meier survival analysis was used for all survival studies, and the groups were compared using the log-rank test. Differences of <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;= 0.001, and <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.001 were considered statistically significant.</div></section></section><section id="acknowledgments" role="doc-acknowledgments"><h2>Acknowledgments</h2><div id="p0405" role="paragraph">We are grateful to Stephanie K. Dougan for her expert advice, Terri Woo for her assistance with t-CyCIF, and animal facility staffs at Beth Israel Deaconess Medical Center (BIDMC) for mouse experiments. The graphical abstract and schemas were created with <a id="intref0455" href="http://BioRender.com" target="_blank">BioRender.com</a>. F.S. was supported by JSPS KAKENHI JP18KK0445 and AMED grant JP20gm5910024 in Japan. C.Q. is Alzheimer’s Association Research Fellow in the United States. B.W. was funded by NIH R21 CA256720. S.K.M. was supported by NIH CA224193. The work is supported by the funding from the Ludwig Center at Harvard and NIH grants U54-CA225088 to S.S.; T32-HL007627 to G.G.; the Breast Cancer Research Foundation (BCRF) and NIH SPORE grants 1P50CA168504 and 5R01CA226776 to G.M.W.; NIH R01CA205153 to K.P.L., N.S.G., and X.Z.Z.; NIH R01AG055559 to K.P.L., E.H.L., and X.Z.Z.; and NIH U01NS096835 to K.P.L.; as well as gift donations from the Owens Family Foundation to X.Z.Z. and K.P.L in the United States.</div><section id="sec-5"><h3>Author contributions</h3><div id="p0410" role="paragraph">Conceptualization, K.K., X.Z.Z., and K.P.L.; methodology, K.K., X.Z.Z., and K.P.L.; investigation, K.K., S.K., F.S., N.S., N.K., T.D.M., P.J.B., Y.N., T.H.L., S.K., C.Q., A.V., G.G., and S.S.; writing – original draft, K.K., X.Z.Z., and K.P.L.; writing – review &amp; editing, K.K., B.W., G.M.W., G.S.N., X.Z.Z., and K.P.L.; resources, D.A., K.O., Y.O., B.W., J.C., N.L., M.H., S.K.M., M.N., and G.S.N.; project administration, G.M.W., X.Z.Z., and K.P.L; funding acquisition, X.Z.Z., G.S.N., and K.P.L.; supervision, X.Z.Z. and K.P.L.</div></section><section id="sec-6"><h3>Declaration of interests</h3><div id="p0415" role="paragraph">K.K., G.M.W., T.D.M., B.J.P., N.L., N.S.G., X.Z.Z., and/or K.P.L. are inventors of a number of issued patents and/or pending patent applications on Pin1, Pin1 biomarkers, Pin1 inhibitors, and Pin1 inhibitor combination to treat human diseases; X.Z.Z. and K.P.L. are inventors of <i>cis</i> P-tau antibody technology, which was licensed by BIDMC to the startup Pinteon Therapeutics. X.Z.Z. and K.P.L. are the scientific founders and former scientific advisors of and own equity in Pinteon. Their interests were reviewed and are managed by BIDMC in accordance with its conflict of interest policy. G.M.W. reports research funding from Glaxo Smith Kline (institutional funding). N.S.G. is a founder, science advisory board member (SAB), and equity holder in Gatekeeper, Syros, C4, Allorion, Jengu, Inception, B2S, EoCys, Larkspur, and Soltego (board member). The Gray lab receives or has received research funding from Novartis, Takeda, Astellas, Taiho, Jansen, Kinogen, Arbella, Deerfield, and Sanofi. All other authors do not have any competing interests.</div></section></section><section id="supplementary-material" data-type="supplementary-materials"><h2>Supplemental information (3)</h2><div id="p0425" role="paragraph"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div id="mmc1" class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="/cms/10.1016/j.cell.2021.07.020/attachment/0a4db698-96b7-4439-a89a-8c0a6082890f/mmc1.xlsx" download="mmc1.xlsx" aria-labelledby="mmc1-heading mmc1-link"><span id="mmc1-link">Spreadsheet (10.93 KB)</span></a></div><div class="core-description"><div id="mmc1-heading" class="heading">Table S1. Blood test results and body-weight change of Pin1i-2 treated non-tumor-bearing B6 mice, related to Figure&nbsp;1, S1, and S2</div><div id="espara0020" role="paragraph">WT B6 mice (non-tumor-bearing mice) were treated with vehicle or Pin1i-2 (20, 40, or 60&nbsp;mg/kg, i.p., daily) for 5&nbsp;weeks, followed by examining the hematopoietic (RBC, Hb, Plate, and kidney and live function) using blood test, and body weight at 3&nbsp;weeks and 5&nbsp;weeks (n&nbsp;= 5).</div></div></div><div id="mmc2" class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="/cms/10.1016/j.cell.2021.07.020/attachment/be749941-ce13-45e7-8c00-04c5fd6a24b9/mmc2.xlsx" download="mmc2.xlsx" aria-labelledby="mmc2-heading mmc2-link"><span id="mmc2-link">Spreadsheet (10.17 KB)</span></a></div><div class="core-description"><div id="mmc2-heading" class="heading">Table S2. Immune profiling of splenocytes from Pin1i-2 treated non-tumor-bearing B6 mice, related to Figures 1, S1, and S2</div><div id="espara0025" role="paragraph">WT B6 mice (non-tumor-bearing mice) were treated with vehicle or Pin1i-2 (40&nbsp;mg/kg, i.p., daily) for 5&nbsp;weeks, followed by examining the immune profile of splenocytes using flow cytometry (n&nbsp;= 5).</div></div></div><div id="mmc3" class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="/cms/10.1016/j.cell.2021.07.020/attachment/bdac5f13-5589-49be-9e4c-415f5ba86280/mmc3.xlsx" download="mmc3.xlsx" aria-labelledby="mmc3-heading mmc3-link"><span id="mmc3-link">Spreadsheet (10.33 KB)</span></a></div><div class="core-description"><div id="mmc3-heading" class="heading">Table S3. shRNA sequence information, related to STAR Methods</div></div></div></div></section></div></section><div class="core-linked-content">
    

        

</div><section id="backmatter" data-extent="backmatter"><div class="core-container"><section id="data-availability" class="core-data-availability"><h2>Data and code availability</h2><div id="p0030" role="paragraph">This study did not generate/analyze unique datasets or code.</div></section><section id="references"><h2>References</h2><div id="bibliography" role="doc-bibliography"><div role="list"><div role="listitem" data-has="label"><div id="bib1" class="citations"><div id="sref1" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref1" title="View in article">1.</a></div><div>Amrutkar, M. ∙ Gladhaug, I.P.</div><div><strong>Pancreatic Cancer Chemoresistance to Gemcitabine</strong></div><div><em>Cancers (Basel).</em> 2017; <strong>9</strong>:157</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3390/cancers9110157" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85034791078" target="_blank" aria-label="Open Scopus in new tab">Scopus (171)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29144412/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3390%2Fcancers9110157&amp;pmid=29144412" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib106" class="citations"><div id="sref106" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref105" title="View in article">2.</a></div><div>Ayala, G. ∙ Wang, D. ∙ Wulf, G. ...</div><div><strong>Pin1 is a novel prognostic marker in prostate cancer</strong></div><div><em>Cancer Research.</em> 2003; <strong>63</strong>:6244-6251</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/14559810/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=14559810" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib2" class="citations"><div id="sref2" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref2" title="View in article">3.</a></div><div>Bachem, M.G. ∙ Schünemann, M. ∙ Ramadani, M. ...</div><div><strong>Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells</strong></div><div><em>Gastroenterology.</em> 2005; <strong>128</strong>:907-921</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2004.12.036&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2004.12.036&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-17144404527" target="_blank" aria-label="Open Scopus in new tab">Scopus (463)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15825074/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2004.12.036&amp;pmid=15825074" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib3" class="citations"><div id="sref3" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref3" title="View in article">4.</a></div><div>Balachandran, V.P. ∙ Beatty, G.L. ∙ Dougan, S.K.</div><div><strong>Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities</strong></div><div><em>Gastroenterology.</em> 2019; <strong>156</strong>:2056-2072</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2018.12.038&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2018.12.038&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85064567229" target="_blank" aria-label="Open Scopus in new tab">Scopus (98)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30660727/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2018.12.038&amp;pmid=30660727" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib4" class="citations"><div id="sref4" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref4-1" title="View in article">5.</a></div><div>Bao, L. ∙ Kimzey, A. ∙ Sauter, G. ...</div><div><strong>Prevalent overexpression of prolyl isomerase Pin1 in human cancers</strong></div><div><em>Am. J. Pathol.</em> 2004; <strong>164</strong>:1727-1737</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2FS0002-9440%2810%2963731-5&amp;cf=fulltext&amp;site=ajpa-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2FS0002-9440%2810%2963731-5&amp;cf=pdf&amp;site=ajpa-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15111319/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0002-9440%2810%2963731-5&amp;pmid=15111319" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib5" class="citations"><div id="sref5" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref5" title="View in article">6.</a></div><div>Bayne, L.J. ∙ Beatty, G.L. ∙ Jhala, N. ...</div><div><strong>Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T&nbsp;cell immunity in pancreatic cancer</strong></div><div><em>Cancer Cell.</em> 2012; <strong>21</strong>:822-835</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2012.04.025&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2012.04.025&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84862150896" target="_blank" aria-label="Open Scopus in new tab">Scopus (580)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22698406/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2012.04.025&amp;pmid=22698406" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib6" class="citations"><div id="sref6" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref6" title="View in article">7.</a></div><div>Berg, S. ∙ Kutra, D. ∙ Kroeger, T. ...</div><div><strong>ilastik: interactive machine learning for (bio)image analysis</strong></div><div><em>Nat. Methods.</em> 2019; <strong>16</strong>:1226-1232</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41592-019-0582-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85075429634" target="_blank" aria-label="Open Scopus in new tab">Scopus (332)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31570887/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41592-019-0582-9&amp;pmid=31570887" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib7" class="citations"><div id="sref7" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref7" title="View in article">8.</a></div><div>Biankin, A.V. ∙ Waddell, N. ∙ Kassahn, K.S. ..., Australian Pancreatic Cancer Genome Initiative</div><div><strong>Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes</strong></div><div><em>Nature.</em> 2012; <strong>491</strong>:399-405</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature11547" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84869091997" target="_blank" aria-label="Open Scopus in new tab">Scopus (1343)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23103869/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature11547&amp;pmid=23103869" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib8" class="citations"><div id="sref8" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref8" title="View in article">9.</a></div><div>Binnewies, M. ∙ Roberts, E.W. ∙ Kersten, K. ...</div><div><strong>Understanding the tumor immune microenvironment (TIME) for effective therapy</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:541-550</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0014-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85045833745" target="_blank" aria-label="Open Scopus in new tab">Scopus (1254)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29686425/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0014-x&amp;pmid=29686425" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib9" class="citations"><div id="sref9" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref9" title="View in article">10.</a></div><div>Bleijs, M. ∙ van de Wetering, M. ∙ Clevers, H. ...</div><div><strong>Xenograft and organoid model systems in cancer research</strong></div><div><em>EMBO J.</em> 2019; <strong>38</strong>:e101654</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.15252/embj.2019101654" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85068678747" target="_blank" aria-label="Open Scopus in new tab">Scopus (86)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31282586/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.15252%2Fembj.2019101654&amp;pmid=31282586" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib10" class="citations"><div id="sref10" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref10" title="View in article">11.</a></div><div>Blume-Jensen, P. ∙ Hunter, T.</div><div><strong>Oncogenic kinase signalling</strong></div><div><em>Nature.</em> 2001; <strong>411</strong>:355-365</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/35077225" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-0035902180" target="_blank" aria-label="Open Scopus in new tab">Scopus (2995)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11357143/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2F35077225&amp;pmid=11357143" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib11" class="citations"><div id="sref11" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref11-1" title="View in article">12.</a></div><div>Brahmer, J.R. ∙ Tykodi, S.S. ∙ Chow, L.Q. ...</div><div><strong>Safety and activity of anti-PD-L1 antibody in patients with advanced cancer</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2012; <strong>366</strong>:2455-2465</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1200694" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84862903106" target="_blank" aria-label="Open Scopus in new tab">Scopus (5190)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22658128/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1200694&amp;pmid=22658128" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib12" class="citations"><div id="sref12" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref12-1" title="View in article">13.</a></div><div>Burr, M.L. ∙ Sparbier, C.E. ∙ Chan, Y.C. ...</div><div><strong>CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity</strong></div><div><em>Nature.</em> 2017; <strong>549</strong>:101-105</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature23643" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85029029250" target="_blank" aria-label="Open Scopus in new tab">Scopus (291)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28813417/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature23643&amp;pmid=28813417" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib13" class="citations"><div id="sref13" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref13-1" title="View in article">14.</a></div><div>Cha, J.H. ∙ Chan, L.C. ∙ Li, C.W. ...</div><div><strong>Mechanisms Controlling PD-L1 Expression in Cancer</strong></div><div><em>Mol. Cell.</em> 2019; <strong>76</strong>:359-370</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.molcel.2019.09.030&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.molcel.2019.09.030&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85074248406" target="_blank" aria-label="Open Scopus in new tab">Scopus (88)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31668929/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.molcel.2019.09.030&amp;pmid=31668929" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib14" class="citations"><div id="sref14" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref14-1" title="View in article">15.</a></div><div>Chen, L. ∙ Xu, X. ∙ Wen, X. ...</div><div><strong>Targeting PIN1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis</strong></div><div><em>Cancer Sci.</em> 2019; <strong>110</strong>:2442-2455</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/cas.14085" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85070236436" target="_blank" aria-label="Open Scopus in new tab">Scopus (3)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31148345/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fcas.14085&amp;pmid=31148345" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib15" class="citations"><div id="sref15" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref15" title="View in article">16.</a></div><div>Dantes, Z. ∙ Yen, H.Y. ∙ Pfarr, N. ...</div><div><strong>Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology</strong></div><div><em>JCI Insight.</em> 2020; <strong>5</strong>:137809</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/jci.insight.137809" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85089206125" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32614802/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2Fjci.insight.137809&amp;pmid=32614802" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib16" class="citations"><div id="sref16" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref16-1" title="View in article">17.</a></div><div>Day, C.P. ∙ Merlino, G. ∙ Van Dyke, T.</div><div><strong>Preclinical mouse cancer models: a maze of opportunities and challenges</strong></div><div><em>Cell.</em> 2015; <strong>163</strong>:39-53</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2015.08.068&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2015.08.068&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84948464999" target="_blank" aria-label="Open Scopus in new tab">Scopus (301)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26406370/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2015.08.068&amp;pmid=26406370" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib17" class="citations"><div id="sref17" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref17-1" title="View in article">18.</a></div><div>de Thé, H. ∙ Chen, Z.</div><div><strong>Acute promyelocytic leukaemia: novel insights into the mechanisms of cure</strong></div><div><em>Nat. Rev. Cancer.</em> 2010; <strong>10</strong>:775-783</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc2943" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-77958510339" target="_blank" aria-label="Open Scopus in new tab">Scopus (336)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20966922/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc2943&amp;pmid=20966922" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib18" class="citations"><div id="sref18" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref18-1" title="View in article">19.</a></div><div>Dijkstra, K.K. ∙ Cattaneo, C.M. ∙ Weeber, F. ...</div><div><strong>Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids</strong></div><div><em>Cell.</em> 2018; <strong>174</strong>:1586-1598</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2018.07.009&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2018.07.009&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85052651284" target="_blank" aria-label="Open Scopus in new tab">Scopus (273)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30100188/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.07.009&amp;pmid=30100188" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib19" class="citations"><div id="sref19" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref19-1" title="View in article">20.</a></div><div>Dorand, R.D. ∙ Nthale, J. ∙ Myers, J.T. ...</div><div><strong>Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity</strong></div><div><em>Science.</em> 2016; <strong>353</strong>:399-403</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aae0477" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84979502955" target="_blank" aria-label="Open Scopus in new tab">Scopus (237)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27463676/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aae0477&amp;pmid=27463676" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib20" class="citations"><div id="sref20" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref20" title="View in article">21.</a></div><div>Du, Z. ∙ Lin, J.R. ∙ Rashid, R. ...</div><div><strong>Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging</strong></div><div><em>Nat. Protoc.</em> 2019; <strong>14</strong>:2900-2930</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41596-019-0206-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85072716410" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31534232/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41596-019-0206-y&amp;pmid=31534232" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib21" class="citations"><div id="sref21" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref21-1" title="View in article">22.</a></div><div>Dubiella, C. ∙ Pinch, B.J. ∙ Koikawa, K. ...</div><div><strong>Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo</strong></div><div><em>Nat. Chem. Biol.</em> 2021;</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41589-021-00786-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85105881530" target="_blank" aria-label="Open Scopus in new tab">Scopus (8)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33972797/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41589-021-00786-7&amp;pmid=33972797" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib22" class="citations"><div id="sref22" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref22-1" title="View in article">23.</a></div><div>Endo, S. ∙ Nakata, K. ∙ Ohuchida, K. ...</div><div><strong>Autophagy Is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mice</strong></div><div><em>Gastroenterology.</em> 2017; <strong>152</strong>:1492-1506</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2017.01.010&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2017.01.010&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85018835771" target="_blank" aria-label="Open Scopus in new tab">Scopus (100)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28126348/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2017.01.010&amp;pmid=28126348" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib23" class="citations"><div id="sref23" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref23" title="View in article">24.</a></div><div>Ene-Obong, A. ∙ Clear, A.J. ∙ Watt, J. ...</div><div><strong>Activated pancreatic stellate cells sequester CD8+ T&nbsp;cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma</strong></div><div><em>Gastroenterology.</em> 2013; <strong>145</strong>:1121-1132</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2013.07.025&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2013.07.025&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84886780808" target="_blank" aria-label="Open Scopus in new tab">Scopus (271)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23891972/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2013.07.025&amp;pmid=23891972" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib24" class="citations"><div id="sref24" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref24-1" title="View in article">25.</a></div><div>Erkan, M. ∙ Adler, G. ∙ Apte, M.V. ...</div><div><strong>StellaTUM: current consensus and discussion on pancreatic stellate cell research</strong></div><div><em>Gut.</em> 2012; <strong>61</strong>:172-178</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/gutjnl-2011-301220" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84855201311" target="_blank" aria-label="Open Scopus in new tab">Scopus (270)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22115911/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1136%2Fgutjnl-2011-301220&amp;pmid=22115911" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib25" class="citations"><div id="sref25" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref25" title="View in article">26.</a></div><div>Farrell, J.J. ∙ Elsaleh, H. ∙ Garcia, M. ...</div><div><strong>Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer</strong></div><div><em>Gastroenterology.</em> 2009; <strong>136</strong>:187-195</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2008.09.067&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2008.09.067&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-59849115856" target="_blank" aria-label="Open Scopus in new tab">Scopus (339)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18992248/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2008.09.067&amp;pmid=18992248" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib26" class="citations"><div id="sref26" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref26" title="View in article">27.</a></div><div>Feig, C. ∙ Jones, J.O. ∙ Kraman, M. ...</div><div><strong>Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2013; <strong>110</strong>:20212-20217</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1320318110" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84890281217" target="_blank" aria-label="Open Scopus in new tab">Scopus (876)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24277834/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1320318110&amp;pmid=24277834" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib27" class="citations"><div id="sref27" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref27" title="View in article">28.</a></div><div>Froeling, F.E. ∙ Feig, C. ∙ Chelala, C. ...</div><div><strong>Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-beta-catenin signaling to slow tumor progression</strong></div><div><em>Gastroenterology.</em> 2011; <strong>141</strong>:1486-1497</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2011.06.047&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2011.06.047&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-80053577336" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21704588/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2011.06.047&amp;pmid=21704588" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib28" class="citations"><div id="sref28" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref28-1" title="View in article">29.</a></div><div>Garg, B. ∙ Giri, B. ∙ Modi, S. ...</div><div><strong>NFκB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12</strong></div><div><em>Gastroenterology.</em> 2018; <strong>155</strong>:880-891</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2018.05.051&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2018.05.051&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85051678735" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29909021/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2018.05.051&amp;pmid=29909021" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib29" class="citations"><div id="sref29" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref29" title="View in article">30.</a></div><div>Gerlinger, M. ∙ Rowan, A.J. ∙ Horswell, S. ...</div><div><strong>Intratumor heterogeneity and branched evolution revealed by multiregion sequencing</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2012; <strong>366</strong>:883-892</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1113205" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84863393080" target="_blank" aria-label="Open Scopus in new tab">Scopus (5201)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22397650/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1113205&amp;pmid=22397650" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib30" class="citations"><div id="sref30" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref30-1" title="View in article">31.</a></div><div>Gilles, M.E. ∙ Hao, L. ∙ Huang, L. ...</div><div><strong>Personalized RNA Medicine for Pancreatic Cancer</strong></div><div><em>Clin. Cancer Res.</em> 2018; <strong>24</strong>:1734-1747</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-17-2733" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85047864333" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29330203/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-17-2733&amp;pmid=29330203" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib31" class="citations"><div id="sref31" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref31" title="View in article">32.</a></div><div>Girardini, J.E. ∙ Napoli, M. ∙ Piazza, S. ...</div><div><strong>A Pin1/mutant p53 axis promotes aggressiveness in breast cancer</strong></div><div><em>Cancer Cell.</em> 2011; <strong>20</strong>:79-91</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2011.06.004&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2011.06.004&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-79960039752" target="_blank" aria-label="Open Scopus in new tab">Scopus (204)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21741598/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2011.06.004&amp;pmid=21741598" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib32" class="citations"><div id="sref32" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref32-1" title="View in article">33.</a></div><div>Gottfried, I. ∙ Ehrlich, M. ∙ Ashery, U.</div><div><strong>The Sla2p/HIP1/HIP1R family: similar structure, similar function in endocytosis?</strong></div><div><em>Biochem. Soc. Trans.</em> 2010; <strong>38</strong>:187-191</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1042/BST0380187" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-76449118339" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20074057/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1042%2FBST0380187&amp;pmid=20074057" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib33" class="citations"><div id="sref33" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref33" title="View in article">34.</a></div><div>Gotwals, P. ∙ Cameron, S. ∙ Cipolletta, D. ...</div><div><strong>Prospects for combining targeted and conventional cancer therapy with immunotherapy</strong></div><div><em>Nat. Rev. Cancer.</em> 2017; <strong>17</strong>:286-301</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc.2017.17" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85015975300" target="_blank" aria-label="Open Scopus in new tab">Scopus (448)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28338065/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc.2017.17&amp;pmid=28338065" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib34" class="citations"><div id="sref34" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref34" title="View in article">35.</a></div><div>Guan, J. ∙ Zhang, H. ∙ Wen, Z. ...</div><div><strong>Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells</strong></div><div><em>Cancer Lett.</em> 2014; <strong>345</strong>:132-139</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2013.12.006" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84893736743" target="_blank" aria-label="Open Scopus in new tab">Scopus (64)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24334138/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2013.12.006&amp;pmid=24334138" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib35" class="citations"><div id="sref35" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref35" title="View in article">36.</a></div><div>Hanahan, D. ∙ Weinberg, R.A.</div><div><strong>Hallmarks of cancer: the next generation</strong></div><div><em>Cell.</em> 2011; <strong>144</strong>:646-674</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2011.02.013&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2011.02.013&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-79952284127" target="_blank" aria-label="Open Scopus in new tab">Scopus (36092)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21376230/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2011.02.013&amp;pmid=21376230" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib36" class="citations"><div id="sref36" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref36-1" title="View in article">37.</a></div><div>Herbst, R.S. ∙ Soria, J.C. ∙ Kowanetz, M. ...</div><div><strong>Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients</strong></div><div><em>Nature.</em> 2014; <strong>515</strong>:563-567</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature14011" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84920956735" target="_blank" aria-label="Open Scopus in new tab">Scopus (3140)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25428504/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature14011&amp;pmid=25428504" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib37" class="citations"><div id="sref37" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref37-1" title="View in article">38.</a></div><div>Herter-Sprie, G.S. ∙ Koyama, S. ∙ Korideck, H. ...</div><div><strong>Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer</strong></div><div><em>JCI Insight.</em> 2016; <strong>1</strong>:e87415</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/jci.insight.87415" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27699275/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2Fjci.insight.87415&amp;pmid=27699275" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib38" class="citations"><div id="sref38" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref38-1" title="View in article">39.</a></div><div>Hingorani, S.R. ∙ Wang, L. ∙ Multani, A.S. ...</div><div><strong>Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice</strong></div><div><em>Cancer Cell.</em> 2005; <strong>7</strong>:469-483</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2005.04.023&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2005.04.023&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-19344362405" target="_blank" aria-label="Open Scopus in new tab">Scopus (1497)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15894267/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2005.04.023&amp;pmid=15894267" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib39" class="citations"><div id="sref39" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref39-1" title="View in article">40.</a></div><div>Ho, W.J. ∙ Jaffee, E.M. ∙ Zheng, L.</div><div><strong>The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities</strong></div><div><em>Nat. Rev. Clin. Oncol.</em> 2020; <strong>17</strong>:527-540</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41571-020-0363-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85084454263" target="_blank" aria-label="Open Scopus in new tab">Scopus (106)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32398706/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41571-020-0363-5&amp;pmid=32398706" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib40" class="citations"><div id="sref40" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref40-1" title="View in article">41.</a></div><div>Hosein, A.N. ∙ Brekken, R.A. ∙ Maitra, A.</div><div><strong>Pancreatic cancer stroma: an update on therapeutic targeting strategies</strong></div><div><em>Nat. Rev. Gastroenterol. Hepatol.</em> 2020; <strong>17</strong>:487-505</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41575-020-0300-1" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85084520894" target="_blank" aria-label="Open Scopus in new tab">Scopus (93)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32393771/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41575-020-0300-1&amp;pmid=32393771" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib41" class="citations"><div id="sref41" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref41-1" title="View in article">42.</a></div><div>Hu, Q. ∙ Qin, Y. ∙ Zhang, B. ...</div><div><strong>FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1</strong></div><div><em>Oncol. Rep.</em> 2017; <strong>38</strong>:2069-2077</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3892/or.2017.5856" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85029784620" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28765935/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3892%2For.2017.5856&amp;pmid=28765935" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib42" class="citations"><div id="sref42" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref42-1" title="View in article">43.</a></div><div>Ianevski, A. ∙ Giri, A.K. ∙ Aittokallio, T.</div><div><strong>SynergyFinder 2.0: visual analytics of multi-drug combination synergies</strong></div><div><em>Nucleic Acids Res.</em> 2020; <strong>48</strong>:W488-W493</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkaa216" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85086923971" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32246720/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkaa216&amp;pmid=32246720" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib43" class="citations"><div id="sref43" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref43" title="View in article">44.</a></div><div>Jain, P. ∙ Kantarjian, H. ∙ Estey, E. ...</div><div><strong>Single-agent liposomal all-trans-retinoic Acid as initial therapy for acute promyelocytic leukemia: 13-year follow-up data</strong></div><div><em>Clin. Lymphoma Myeloma Leuk.</em> 2014; <strong>14</strong>:e47-e49</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.clml.2013.08.004&amp;cf=fulltext&amp;site=clml-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.clml.2013.08.004&amp;cf=pdf&amp;site=clml-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24128595/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.clml.2013.08.004&amp;pmid=24128595" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib44" class="citations"><div id="sref44" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref44-1" title="View in article">45.</a></div><div>Jiang, H. ∙ Hegde, S. ∙ Knolhoff, B.L. ...</div><div><strong>Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy</strong></div><div><em>Nat. Med.</em> 2016; <strong>22</strong>:851-860</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.4123" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84976871907" target="_blank" aria-label="Open Scopus in new tab">Scopus (444)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27376576/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.4123&amp;pmid=27376576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib45" class="citations"><div id="sref45" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref45-1" title="View in article">46.</a></div><div>Jiao, S. ∙ Xia, W. ∙ Yamaguchi, H. ...</div><div><strong>PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression</strong></div><div><em>Clin. Cancer Res.</em> 2017; <strong>23</strong>:3711-3720</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-16-3215" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85021146688" target="_blank" aria-label="Open Scopus in new tab">Scopus (372)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28167507/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-16-3215&amp;pmid=28167507" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib46" class="citations"><div id="sref46" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref46" title="View in article">47.</a></div><div>Kleeff, J. ∙ Korc, M. ∙ Apte, M. ...</div><div><strong>Pancreatic cancer</strong></div><div><em>Nat. Rev. Dis. Primers.</em> 2016; <strong>2</strong>:16022</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrdp.2016.22" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27158978/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrdp.2016.22&amp;pmid=27158978" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib47" class="citations"><div id="sref47" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref47-1" title="View in article">48.</a></div><div>Kocher, H.M. ∙ Basu, B. ∙ Froeling, F.E.M. ...</div><div><strong>Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer</strong></div><div><em>Nat. Commun.</em> 2020; <strong>11</strong>:4841</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-020-18636-w" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85091458810" target="_blank" aria-label="Open Scopus in new tab">Scopus (22)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32973176/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-020-18636-w&amp;pmid=32973176" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib48" class="citations"><div id="sref48" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref48-1" title="View in article">49.</a></div><div>Koikawa, K. ∙ Ohuchida, K. ∙ Ando, Y. ...</div><div><strong>Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Lett.</em> 2018; <strong>425</strong>:65-77</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2018.03.031" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29580808/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2018.03.031&amp;pmid=29580808" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib49" class="citations"><div id="sref49" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref49-1" title="View in article">50.</a></div><div>Koikawa, K. ∙ Ohuchida, K. ∙ Takesue, S. ...</div><div><strong>Pancreatic stellate cells reorganize matrix components and lead pancreatic cancer invasion via the function of Endo180</strong></div><div><em>Cancer Lett.</em> 2018; <strong>412</strong>:143-154</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canlet.2017.10.010" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85032707374" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29061505/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canlet.2017.10.010&amp;pmid=29061505" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib102" class="citations"><div id="sref102" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref102" title="View in article">51.</a></div><div>Kondo, A. ∙ Shahpasand, K. ∙ Mannix, R. ...</div><div><strong>Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy</strong></div><div><em>Nature.</em> 2015; <strong>523</strong>:431-436</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature14658" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84937849044" target="_blank" aria-label="Open Scopus in new tab">Scopus (245)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26176913/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature14658&amp;pmid=26176913" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib50" class="citations"><div id="sref50" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref50-1" title="View in article">52.</a></div><div>Kozono, S. ∙ Lin, Y.M. ∙ Seo, H.S. ...</div><div><strong>Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells</strong></div><div><em>Nat. Commun.</em> 2018; <strong>9</strong>:3069</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-018-05402-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85051562951" target="_blank" aria-label="Open Scopus in new tab">Scopus (54)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30093655/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-018-05402-2&amp;pmid=30093655" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib51" class="citations"><div id="sref51" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref51" title="View in article">53.</a></div><div>Laklai, H. ∙ Miroshnikova, Y.A. ∙ Pickup, M.W. ...</div><div><strong>Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression</strong></div><div><em>Nat. Med.</em> 2016; <strong>22</strong>:497-505</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.4082" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84964317478" target="_blank" aria-label="Open Scopus in new tab">Scopus (287)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27089513/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.4082&amp;pmid=27089513" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib52" class="citations"><div id="sref52" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref52" title="View in article">54.</a></div><div>Lefebvre, P. ∙ Thomas, G. ∙ Gourmel, B. ...</div><div><strong>Pharmacokinetics of oral all-trans retinoic acid in patients with acute promyelocytic leukemia</strong></div><div><em>Leukemia.</em> 1991; <strong>5</strong>:1054-1058</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/1774953/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=1774953" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib53" class="citations"><div id="sref53" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref53" title="View in article">55.</a></div><div>Li, Q. ∙ Dong, Z. ∙ Lin, Y. ...</div><div><strong>The rs2233678 polymorphism in PIN1 promoter region reduced cancer risk: a meta-analysis</strong></div><div><em>PLoS ONE.</em> 2013; <strong>8</strong>:e68148</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pone.0068148" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84879893112" target="_blank" aria-label="Open Scopus in new tab">Scopus (13)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23874525/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pone.0068148&amp;pmid=23874525" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib54" class="citations"><div id="sref54" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref54-1" title="View in article">56.</a></div><div>Li, J. ∙ Qian, W. ∙ Qin, T. ...</div><div><strong>Mouse-Derived Allografts: A Complementary Model to the KPC Mice on Researching Pancreatic Cancer In&nbsp;Vivo</strong></div><div><em>Comput. Struct. Biotechnol. J.</em> 2019; <strong>17</strong>:498-506</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.csbj.2019.03.016" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85064078721" target="_blank" aria-label="Open Scopus in new tab">Scopus (6)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31011408/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.csbj.2019.03.016&amp;pmid=31011408" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib55" class="citations"><div id="sref55" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref55-1" title="View in article">57.</a></div><div>Lim, S.O. ∙ Li, C.W. ∙ Xia, W. ...</div><div><strong>Deubiquitination and Stabilization of PD-L1 by CSN5</strong></div><div><em>Cancer Cell.</em> 2016; <strong>30</strong>:925-939</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccell.2016.10.010&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccell.2016.10.010&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85004025764" target="_blank" aria-label="Open Scopus in new tab">Scopus (284)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27866850/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccell.2016.10.010&amp;pmid=27866850" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib56" class="citations"><div id="sref56" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref56-1" title="View in article">58.</a></div><div>Lin, J.R. ∙ Izar, B. ∙ Wang, S. ...</div><div><strong>Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes</strong></div><div><em>eLife.</em> 2018; <strong>7</strong>:e31657</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.7554/eLife.31657" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85052091363" target="_blank" aria-label="Open Scopus in new tab">Scopus (131)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29993362/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.7554%2FeLife.31657&amp;pmid=29993362" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib57" class="citations"><div id="sref57" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref57-1" title="View in article">59.</a></div><div>Liou, Y.C. ∙ Ryo, A. ∙ Huang, H.K. ...</div><div><strong>Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2002; <strong>99</strong>:1335-1340</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.032404099" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-0037022355" target="_blank" aria-label="Open Scopus in new tab">Scopus (286)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11805292/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.032404099&amp;pmid=11805292" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib58" class="citations"><div id="sref58" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref58" title="View in article">60.</a></div><div>Liu, P.H. ∙ Shah, R.B. ∙ Li, Y. ...</div><div><strong>An IRAK1-PIN1 signalling axis drives intrinsic tumour resistance to radiation therapy</strong></div><div><em>Nat. Cell Biol.</em> 2019; <strong>21</strong>:203-213</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41556-018-0260-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85060453836" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30664786/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41556-018-0260-7&amp;pmid=30664786" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib59" class="citations"><div id="sref59" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref59-1" title="View in article">61.</a></div><div>Lu, Z. ∙ Hunter, T.</div><div><strong>Prolyl isomerase Pin1 in cancer</strong></div><div><em>Cell Res.</em> 2014; <strong>24</strong>:1033-1049</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/cr.2014.109" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84905810923" target="_blank" aria-label="Open Scopus in new tab">Scopus (112)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25124924/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fcr.2014.109&amp;pmid=25124924" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib60" class="citations"><div id="sref60" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref60" title="View in article">62.</a></div><div>Luo, J. ∙ Solimini, N.L. ∙ Elledge, S.J.</div><div><strong>Principles of cancer therapy: oncogene and non-oncogene addiction</strong></div><div><em>Cell.</em> 2009; <strong>136</strong>:823-837</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2009.02.024&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2009.02.024&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-61449182121" target="_blank" aria-label="Open Scopus in new tab">Scopus (1258)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19269363/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2009.02.024&amp;pmid=19269363" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib61" class="citations"><div id="sref61" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref61" title="View in article">63.</a></div><div>Luo, M.L. ∙ Zheng, F. ∙ Chen, W. ...</div><div><strong>Inactivation of the prolyl isomerase Pin1 sensitizes BRCA1-proficient breast cancer to PARP inhibition</strong></div><div><em>Cancer Res.</em> 2020; <strong>80</strong>:3033-3045</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-19-2739" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85088277567" target="_blank" aria-label="Open Scopus in new tab">Scopus (7)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32193285/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-19-2739&amp;pmid=32193285" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib62" class="citations"><div id="sref62" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref62-1" title="View in article">64.</a></div><div>Mace, T.A. ∙ Shakya, R. ∙ Pitarresi, J.R. ...</div><div><strong>IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer</strong></div><div><em>Gut.</em> 2018; <strong>67</strong>:320-332</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/gutjnl-2016-311585" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84994516325" target="_blank" aria-label="Open Scopus in new tab">Scopus (212)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27797936/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1136%2Fgutjnl-2016-311585&amp;pmid=27797936" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib63" class="citations"><div id="sref63" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref63" title="View in article">65.</a></div><div>Mahoney, K.M. ∙ Rennert, P.D. ∙ Freeman, G.J.</div><div><strong>Combination cancer immunotherapy and new immunomodulatory targets</strong></div><div><em>Nat. Rev. Drug Discov.</em> 2015; <strong>14</strong>:561-584</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrd4591" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84938350452" target="_blank" aria-label="Open Scopus in new tab">Scopus (752)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26228759/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrd4591&amp;pmid=26228759" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib64" class="citations"><div id="sref64" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref64" title="View in article">66.</a></div><div>Maréchal, R. ∙ Bachet, J.B. ∙ Mackey, J.R. ...</div><div><strong>Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma</strong></div><div><em>Gastroenterology.</em> 2012; <strong>143</strong>:664-674</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2012.06.006&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2012.06.006&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84865474189" target="_blank" aria-label="Open Scopus in new tab">Scopus (190)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22705007/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2012.06.006&amp;pmid=22705007" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib65" class="citations"><div id="sref65" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref65-1" title="View in article">67.</a></div><div>Mariathasan, S. ∙ Turley, S.J. ∙ Nickles, D. ...</div><div><strong>TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T&nbsp;cells</strong></div><div><em>Nature.</em> 2018; <strong>554</strong>:544-548</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25501" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85042495633" target="_blank" aria-label="Open Scopus in new tab">Scopus (1236)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29443960/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25501&amp;pmid=29443960" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib66" class="citations"><div id="sref66" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref66" title="View in article">68.</a></div><div>McGranahan, N. ∙ Swanton, C.</div><div><strong>Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future</strong></div><div><em>Cell.</em> 2017; <strong>168</strong>:613-628</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2017.01.018&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2017.01.018&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85012110528" target="_blank" aria-label="Open Scopus in new tab">Scopus (976)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28187284/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.01.018&amp;pmid=28187284" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib67" class="citations"><div id="sref67" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref67" title="View in article">69.</a></div><div>McGranahan, N. ∙ Rosenthal, R. ∙ Hiley, C.T. ..., TRACERx Consortium</div><div><strong>Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution</strong></div><div><em>Cell.</em> 2017; <strong>171</strong>:1259-1271</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2017.10.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2017.10.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85032583704" target="_blank" aria-label="Open Scopus in new tab">Scopus (439)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29107330/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.10.001&amp;pmid=29107330" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib68" class="citations"><div id="sref68" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref68-1" title="View in article">70.</a></div><div>Messa, M. ∙ Fernández-Busnadiego, R. ∙ Sun, E.W. ...</div><div><strong>Epsin deficiency impairs endocytosis by stalling the actin-dependent invagination of endocytic clathrin-coated pits</strong></div><div><em>eLife.</em> 2014; <strong>3</strong>:e03311</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.7554/eLife.03311" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25122462/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.7554%2FeLife.03311&amp;pmid=25122462" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib69" class="citations"><div id="sref69" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref69" title="View in article">71.</a></div><div>Mezzadra, R. ∙ Sun, C. ∙ Jae, L.T. ...</div><div><strong>Identification of CMTM6 and CMTM4 as PD-L1 protein regulators</strong></div><div><em>Nature.</em> 2017; <strong>549</strong>:106-110</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature23669" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85029041186" target="_blank" aria-label="Open Scopus in new tab">Scopus (251)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28813410/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature23669&amp;pmid=28813410" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib70" class="citations"><div id="sref70" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref70" title="View in article">72.</a></div><div>Mugoni, V. ∙ Panella, R. ∙ Cheloni, G. ...</div><div><strong>Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy</strong></div><div><em>Cell Res.</em> 2019; <strong>29</strong>:446-459</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41422-019-0162-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85064927567" target="_blank" aria-label="Open Scopus in new tab">Scopus (16)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31024166/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41422-019-0162-7&amp;pmid=31024166" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib71" class="citations"><div id="sref71" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref71" title="View in article">73.</a></div><div>Oh, S.A. ∙ Wu, D.C. ∙ Cheung, J. ...</div><div><strong>PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer</strong></div><div><em>Nat. Can.</em> 2021; <strong>1</strong>:681-691</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s43018-020-0075-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs43018-020-0075-x" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib72" class="citations"><div id="sref72" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref72-1" title="View in article">74.</a></div><div>Okumura, T. ∙ Ohuchida, K. ∙ Kibe, S. ...</div><div><strong>Adipose tissue-derived stromal cells are sources of cancer-associated fibroblasts and enhance tumor progression by dense collagen matrix</strong></div><div><em>Int. J. Cancer.</em> 2019; <strong>144</strong>:1401-1413</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/ijc.31775" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85054665338" target="_blank" aria-label="Open Scopus in new tab">Scopus (7)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30152542/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fijc.31775&amp;pmid=30152542" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib73" class="citations"><div id="sref73" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref73" title="View in article">75.</a></div><div>Özdemir, B.C. ∙ Pentcheva-Hoang, T. ∙ Carstens, J.L. ...</div><div><strong>Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival</strong></div><div><em>Cancer Cell.</em> 2014; <strong>25</strong>:719-734</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2014.04.005&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2014.04.005&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84902469661" target="_blank" aria-label="Open Scopus in new tab">Scopus (1150)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24856586/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2014.04.005&amp;pmid=24856586" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib74" class="citations"><div id="sref74" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref74" title="View in article">76.</a></div><div>Pantelidou, C. ∙ Sonzogni, O. ∙ De Oliveria Taveira, M. ...</div><div><strong>PARP Inhibitor Efficacy Depends on CD8<sup>+</sup> T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer</strong></div><div><em>Cancer Discov.</em> 2019; <strong>9</strong>:722-737</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-18-1218" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_76_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85066844107" target="_blank" aria-label="Open Scopus in new tab">Scopus (155)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31015319/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-18-1218&amp;pmid=31015319" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib75" class="citations"><div id="sref75" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref75" title="View in article">77.</a></div><div>Peng, T. ∙ Thorn, K. ∙ Schroeder, T. ...</div><div><strong>A BaSiC tool for background and shading correction of optical microscopy images</strong></div><div><em>Nat. Commun.</em> 2017; <strong>8</strong>:14836</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncomms14836" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_77_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85020638067" target="_blank" aria-label="Open Scopus in new tab">Scopus (60)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28594001/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncomms14836&amp;pmid=28594001" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib76" class="citations"><div id="sref76" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref76" title="View in article">78.</a></div><div>Rahib, L. ∙ Smith, B.D. ∙ Aizenberg, R. ...</div><div><strong>Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States</strong></div><div><em>Cancer Res.</em> 2014; <strong>74</strong>:2913-2921</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-14-0155" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84902147062" target="_blank" aria-label="Open Scopus in new tab">Scopus (3350)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24840647/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-14-0155&amp;pmid=24840647" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib77" class="citations"><div id="sref77" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref77" title="View in article">79.</a></div><div>Rashid, R. ∙ Gaglia, G. ∙ Chen, Y.A. ...</div><div><strong>Highly multiplexed immunofluorescence images and single-cell data of immune markers in tonsil and lung cancer</strong></div><div><em>Sci. Data.</em> 2019; <strong>6</strong>:323</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41597-019-0332-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85076825816" target="_blank" aria-label="Open Scopus in new tab">Scopus (14)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31848351/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41597-019-0332-y&amp;pmid=31848351" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib78" class="citations"><div id="sref78" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref78" title="View in article">80.</a></div><div>Rhim, A.D. ∙ Oberstein, P.E. ∙ Thomas, D.H. ...</div><div><strong>Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma</strong></div><div><em>Cancer Cell.</em> 2014; <strong>25</strong>:735-747</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2014.04.021&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.ccr.2014.04.021&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84902435628" target="_blank" aria-label="Open Scopus in new tab">Scopus (1088)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24856585/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2014.04.021&amp;pmid=24856585" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib79" class="citations"><div id="sref79" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref79-1" title="View in article">81.</a></div><div>Rubio-Viqueira, B. ∙ Jimeno, A. ∙ Cusatis, G. ...</div><div><strong>An in&nbsp;vivo platform for translational drug development in pancreatic cancer</strong></div><div><em>Clin. Cancer Res.</em> 2006; <strong>12</strong>:4652-4661</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-06-0113" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-33748088524" target="_blank" aria-label="Open Scopus in new tab">Scopus (343)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16899615/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-06-0113&amp;pmid=16899615" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib80" class="citations"><div id="sref80" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref80" title="View in article">82.</a></div><div>Ruscetti, M. ∙ Morris, 4th, J.P. ∙ Mezzadra, R. ...</div><div><strong>Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer</strong></div><div><em>Cell.</em> 2020; <strong>181</strong>:424-441</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2020.03.008&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2020.03.008&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85083049781" target="_blank" aria-label="Open Scopus in new tab">Scopus (64)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32234521/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2020.03.008&amp;pmid=32234521" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib81" class="citations"><div id="sref81" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref81-1" title="View in article">83.</a></div><div>Sahai, E. ∙ Astsaturov, I. ∙ Cukierman, E. ...</div><div><strong>A framework for advancing our understanding of cancer-associated fibroblasts</strong></div><div><em>Nat. Rev. Cancer.</em> 2020; <strong>20</strong>:174-186</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41568-019-0238-1" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85078418124" target="_blank" aria-label="Open Scopus in new tab">Scopus (485)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31980749/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41568-019-0238-1&amp;pmid=31980749" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib82" class="citations"><div id="sref82" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref82" title="View in article">84.</a></div><div>Samuel, N. ∙ Hudson, T.J.</div><div><strong>The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma</strong></div><div><em>Nat. Rev. Gastroenterol. Hepatol.</em> 2011; <strong>9</strong>:77-87</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrgastro.2011.215" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84856955522" target="_blank" aria-label="Open Scopus in new tab">Scopus (69)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22183185/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrgastro.2011.215&amp;pmid=22183185" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib83" class="citations"><div id="sref83" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref83" title="View in article">85.</a></div><div>Sharma, P. ∙ Allison, J.P.</div><div><strong>The future of immune checkpoint therapy</strong></div><div><em>Science.</em> 2015; <strong>348</strong>:56-61</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aaa8172" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84928774156" target="_blank" aria-label="Open Scopus in new tab">Scopus (2466)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25838373/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aaa8172&amp;pmid=25838373" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib84" class="citations"><div id="sref84" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref84" title="View in article">86.</a></div><div>Sherman, M.H. ∙ Yu, R.T. ∙ Engle, D.D. ...</div><div><strong>Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy</strong></div><div><em>Cell.</em> 2014; <strong>159</strong>:80-93</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2014.08.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1016%2Fj.cell.2014.08.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84907485104" target="_blank" aria-label="Open Scopus in new tab">Scopus (570)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25259922/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2014.08.007&amp;pmid=25259922" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib85" class="citations"><div id="sref85" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref85" title="View in article">87.</a></div><div>Shi, Y. ∙ Gao, W. ∙ Lytle, N.K. ...</div><div><strong>Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring</strong></div><div><em>Nature.</em> 2019; <strong>569</strong>:131-135</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-019-1130-6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85064686834" target="_blank" aria-label="Open Scopus in new tab">Scopus (112)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30996350/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-019-1130-6&amp;pmid=30996350" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib86" class="citations"><div id="sref86" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref86" title="View in article">88.</a></div><div>Siegel, R.L. ∙ Miller, K.D. ∙ Fuchs, H.E. ...</div><div><strong>Cancer Statistics, 2021</strong></div><div><em>CA Cancer J. Clin.</em> 2021; <strong>71</strong>:7-33</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3322/caac.21654" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85099242992" target="_blank" aria-label="Open Scopus in new tab">Scopus (1547)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33433946/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3322%2Fcaac.21654&amp;pmid=33433946" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib87" class="citations"><div id="sref87" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref87-1" title="View in article">89.</a></div><div>Suizu, F. ∙ Hirata, N. ∙ Kimura, K. ...</div><div><strong>Phosphorylation-dependent Akt-Inversin interaction at the basal body of primary cilia</strong></div><div><em>EMBO J.</em> 2016; <strong>35</strong>:1346-1363</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.15252/embj.201593003" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_89_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84971268766" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27220846/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.15252%2Fembj.201593003&amp;pmid=27220846" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib88" class="citations"><div id="sref88" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref88-1" title="View in article">90.</a></div><div>Tessier-Cloutier, B. ∙ Kalloger, S.E. ∙ Al-Kandari, M. ...</div><div><strong>Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma</strong></div><div><em>BMC Cancer.</em> 2017; <strong>17</strong>:618</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s12885-017-3634-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_90_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85028699849" target="_blank" aria-label="Open Scopus in new tab">Scopus (21)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28870260/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs12885-017-3634-5&amp;pmid=28870260" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib89" class="citations"><div id="sref89" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89" title="View in article">91.</a></div><div>Ubersax, J.A. ∙ Ferrell, Jr., J.E.</div><div><strong>Mechanisms of specificity in protein phosphorylation</strong></div><div><em>Nat. Rev. Mol. Cell Biol.</em> 2007; <strong>8</strong>:530-541</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrm2203" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_91_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-34250878954" target="_blank" aria-label="Open Scopus in new tab">Scopus (893)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17585314/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrm2203&amp;pmid=17585314" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib90" class="citations"><div id="sref90" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref90" title="View in article">92.</a></div><div>Waggoner, S.N. ∙ Cornberg, M. ∙ Selin, L.K. ...</div><div><strong>Natural killer cells act as rheostats modulating antiviral T&nbsp;cells</strong></div><div><em>Nature.</em> 2011; <strong>481</strong>:394-398</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature10624" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_92_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84855999478" target="_blank" aria-label="Open Scopus in new tab">Scopus (386)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22101430/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature10624&amp;pmid=22101430" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib91" class="citations"><div id="sref91" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref91-1" title="View in article">93.</a></div><div>Wang, H. ∙ Yao, H. ∙ Li, C. ...</div><div><strong>HIP1R targets PD-L1 to lysosomal degradation to alter T&nbsp;cell-mediated cytotoxicity</strong></div><div><em>Nat. Chem. Biol.</em> 2019; <strong>15</strong>:42-50</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41589-018-0161-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_93_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85055997824" target="_blank" aria-label="Open Scopus in new tab">Scopus (69)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30397328/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41589-018-0161-x&amp;pmid=30397328" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib92" class="citations"><div id="sref92" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref92" title="View in article">94.</a></div><div>Wang, X. ∙ Wang, F. ∙ Zhong, M. ...</div><div><strong>The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy</strong></div><div><em>Mol. Cancer.</em> 2020; <strong>19</strong>:81</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s12943-020-01200-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_94_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85085117338" target="_blank" aria-label="Open Scopus in new tab">Scopus (22)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32359357/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs12943-020-01200-x&amp;pmid=32359357" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib93" class="citations"><div id="sref93" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref93" title="View in article">95.</a></div><div>Waters, A.M. ∙ Der, C.J.</div><div><strong>KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer</strong></div><div><em>Cold Spring Harb. Perspect. Med.</em> 2018; <strong>8</strong>:a031435</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1101/cshperspect.a031435" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_95_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85053712794" target="_blank" aria-label="Open Scopus in new tab">Scopus (218)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29229669/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1101%2Fcshperspect.a031435&amp;pmid=29229669" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib94" class="citations"><div id="sref94" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref94-1" title="View in article">96.</a></div><div>Wei, S. ∙ Kozono, S. ∙ Kats, L. ...</div><div><strong>Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer</strong></div><div><em>Nat. Med.</em> 2015; <strong>21</strong>:457-466</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.3839" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_96_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84937759226" target="_blank" aria-label="Open Scopus in new tab">Scopus (172)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25849135/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.3839&amp;pmid=25849135" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib95" class="citations"><div id="sref95" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref95-1" title="View in article">97.</a></div><div>Whittle, M.C. ∙ Hingorani, S.R.</div><div><strong>Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets</strong></div><div><em>Gastroenterology.</em> 2019; <strong>156</strong>:2085-2096</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2018.12.044&amp;cf=fulltext&amp;site=ygast-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=10.1053%2Fj.gastro.2018.12.044&amp;cf=pdf&amp;site=ygast-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_97_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85064573516" target="_blank" aria-label="Open Scopus in new tab">Scopus (38)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30721663/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fj.gastro.2018.12.044&amp;pmid=30721663" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib96" class="citations"><div id="sref96" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref96" title="View in article">98.</a></div><div>Wulf, G. ∙ Garg, P. ∙ Liou, Y.C. ...</div><div><strong>Modeling breast cancer in&nbsp;vivo and ex&nbsp;vivo reveals an essential role of Pin1 in tumorigenesis</strong></div><div><em>EMBO J.</em> 2004; <strong>23</strong>:3397-3407</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/sj.emboj.7600323" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_98_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-4444309643" target="_blank" aria-label="Open Scopus in new tab">Scopus (156)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15257284/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fsj.emboj.7600323&amp;pmid=15257284" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib105" class="citations"><div id="sref105" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref105" title="View in article">99.</a></div><div>Wulf, G.M. ∙ Ryo, A. ∙ Wulf, G.G. ...</div><div><strong>Pin1 is overexpressed in breast cancer and potentiates the transcriptional activity of phosphorylated c-Jun towards the cyclin D1 gene</strong></div><div><em>EMBO J.</em> 2001; <strong>20</strong>:3459-3472</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/emboj/20.13.3459" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_99_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-0035796405" target="_blank" aria-label="Open Scopus in new tab">Scopus (0)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11432833/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Femboj%2F20.13.3459&amp;pmid=11432833" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib97" class="citations"><div id="sref97" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref97" title="View in article">100.</a></div><div>Yamaki, S. ∙ Yanagimoto, H. ∙ Tsuta, K. ...</div><div><strong>PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8<sup>+</sup> tumor-infiltrating lymphocytes: highly sensitive detection using phosphor-integrated dot staining</strong></div><div><em>Int. J. Clin. Oncol.</em> 2017; <strong>22</strong>:726-733</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s10147-017-1112-3" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_100_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85015679284" target="_blank" aria-label="Open Scopus in new tab">Scopus (27)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28314962/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs10147-017-1112-3&amp;pmid=28314962" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib98" class="citations"><div id="sref98" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref98" title="View in article">101.</a></div><div>Yamamoto, K. ∙ Venida, A. ∙ Yano, J. ...</div><div><strong>Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I</strong></div><div><em>Nature.</em> 2020; <strong>581</strong>:100-105</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-020-2229-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_101_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85084050905" target="_blank" aria-label="Open Scopus in new tab">Scopus (178)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32376951/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-020-2229-5&amp;pmid=32376951" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib99" class="citations"><div id="sref99" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref99-1" title="View in article">102.</a></div><div>Zhang, J. ∙ Bu, X. ∙ Wang, H. ...</div><div><strong>Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance</strong></div><div><em>Nature.</em> 2018; <strong>553</strong>:91-95</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature25015" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_102_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-85040189345" target="_blank" aria-label="Open Scopus in new tab">Scopus (306)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29160310/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature25015&amp;pmid=29160310" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib100" class="citations"><div id="sref100" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref100-1" title="View in article">103.</a></div><div>Zhou, X.Z. ∙ Lu, K.P.</div><div><strong>The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target</strong></div><div><em>Nat. Rev. Cancer.</em> 2016; <strong>16</strong>:463-478</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrc.2016.49" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_103_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84973128266" target="_blank" aria-label="Open Scopus in new tab">Scopus (127)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27256007/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrc.2016.49&amp;pmid=27256007" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib101" class="citations"><div id="sref101" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref101" title="View in article">104.</a></div><div>Zou, W. ∙ Wolchok, J.D. ∙ Chen, L.</div><div><strong>PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations</strong></div><div><em>Sci. Transl. Med.</em> 2016; <strong>8</strong>:328rv4</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.aad7118" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_104_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.07.020&amp;key=2-s2.0-84959529731" target="_blank" aria-label="Open Scopus in new tab">Scopus (1132)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26936508/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.aad7118&amp;pmid=26936508" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div></div></div></section></div></section><div class="core-linked-content">
    

        


    

            

            

            <div data-widget-id="8633d695-b258-4908-b86f-e2c268ec3c6b" data-widget-name="UX3HTMLWidget"><script type="text/javascript">
if($('.content-navigation__body__title').length){
$('.content-navigation__body__title').each(function(){
var html=this.innerHTML;
var div = document.createElement("div");
div.innerHTML = html;
var text = div.textContent || div.innerText || "";
this.innerHTML=text;
});
}
</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="393effff-5b44-4681-a9b4-4f029b3540b7" data-widget-name="UX3HTMLWidget"><style>
.linkback-ad .pb-ad {
    display: block;
   height: auto;
    margin-left: 0px;
    margin-right: auto;
}
</style></div>

            

        

    

        

</div></div></div><div class="core-collateral-aside"><section id="core-collateral-figures"><h2>Figures (14)<button class="js--openFigureViewer"><span>Figure Viewer</span></button></h2><div class="core-collateral-aside-wrapper"><div class="grid"><a class="figure__open__ctrl" href="#fig1" aria-label="Go to Figure&amp;nbsp;1"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.07.020/asset/6eacbe41-ef40-453a-b390-ce3d7b4c5edf/main.assets/gr1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs1" aria-label="Go to Figure&amp;nbsp;S1"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.07.020/asset/c18b70c3-ae3b-40fe-bc7c-4bd4bfd359ea/main.assets/figs1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs2" aria-label="Go to Figure&amp;nbsp;S2"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.07.020/asset/386a0819-8edf-4c6e-9649-852bd4bc2763/main.assets/figs2.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig2" aria-label="Go to Figure&amp;nbsp;2"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.07.020/asset/82f67305-8a0a-417a-a8eb-585d89ee7b4b/main.assets/gr2.jpg" aria-hidden="true"></a></div><div id="collapsible-figures" data-expandable="item"><div class="content grid" style="display:none;" role="region" id="collapsible-figures_content"><a class="figure__open__ctrl" href="#figs3" aria-label="Go to Figure&amp;nbsp;S3"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.07.020/asset/0096feb9-ce8b-4633-8a9b-fc05519694e6/main.assets/figs3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig3" aria-label="Go to Figure&amp;nbsp;3"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.07.020/asset/7925f3ce-1f21-4a29-a264-f16cf591742f/main.assets/gr3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig4" aria-label="Go to Figure&amp;nbsp;4"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.07.020/asset/6017156b-7631-48c5-b68b-772566aa1656/main.assets/gr4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs4" aria-label="Go to Figure&amp;nbsp;S4"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.07.020/asset/77fdf87b-9e0e-4e75-82e6-e4b0445160a8/main.assets/figs4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs5" aria-label="Go to Figure&amp;nbsp;S5"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.07.020/asset/53baa9f8-3dde-46e6-aa0c-33ef33a3abe8/main.assets/figs5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig5" aria-label="Go to Figure&amp;nbsp;5"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.07.020/asset/9dcfd7ef-bc1f-4303-a770-021e89ca6122/main.assets/gr5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig6" aria-label="Go to Figure&amp;nbsp;6"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.07.020/asset/5c0db951-f9f5-4f36-927c-9c1a789b5e02/main.assets/gr6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs6" aria-label="Go to Figure&amp;nbsp;S6"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.07.020/asset/38e11031-d6a9-4b3f-b878-f37ca7920226/main.assets/figs6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig7" aria-label="Go to Figure&amp;nbsp;7"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.07.020/asset/6da4ec50-fb8f-4e8b-ba78-6fd0ce8a004f/main.assets/gr7.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs7" aria-label="Go to Figure&amp;nbsp;S7"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.07.020/asset/7c086884-6109-48a6-aa09-639c272e01e1/main.assets/figs7.jpg" aria-hidden="true"></a></div><button class="trigger" aria-controls="collapsible-figures_content" aria-expanded="false" tabindex="0" role="button"><span class="expand">Show all figures</span><span class="collapse">Hide figures</span><i class="icon-section_arrow_d" aria-hidden="true"></i></button></div></div></section>
    

        


    

            

            

            <section id="core-collateral-metrics" class="publication-list__axel-section"><h2>Article metrics</h2><div><ul class="publication-list rlist publication-list--list plum-x--lazy-load publication-list--axel" data-plum-x-url="/pb/widgets/ux3/publicationList/plumx?widgetId=66dd7e11-7768-4006-93d8-a72b60e2a264&amp;pbContext=%3Bproduct%3Aproduct%3Aelsevier%5C%3Aproduct%5C%3Acell%3Bwebsite%3Awebsite%3Acell-site%3Bctype%3Astring%3AJournal+Content%3Bjournal%3Ajournal%3Acell%3BpageGroup%3Astring%3AArticle+View%3Barticle%3Aarticle%3Apii%5C%3AS0092867421008795%3Bpage%3Astring%3AShow+Full+Text%3BrequestedJournal%3Ajournal%3Acell%3Bissue%3Aissue%3Apii%5C%3AS0092867420X00195%3Bwgroup%3Astring%3ADefault+Website+Group%3BsubPage%3Astring%3AFull+Text" data-pb-mode-enabled="false"><li aria-label="loading articles" role="alert" class="js--loading plum-x--spinner hidden"></li></ul></div></section>

            

        
<section id="core-collateral-supplementary"><h2>Supplemental information (3)</h2><div class="core-collateral-aside-wrapper"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2021.07.020/attachment/0a4db698-96b7-4439-a89a-8c0a6082890f/mmc1.xlsx" download="mmc1.xlsx"><span id="mmc1-link">Spreadsheet (10.93 KB)</span></a><div class="core-description">Table S1. Blood test results and body-weight change of Pin1i-2 treated non-tumor-bearing B6 mice, related to Figure&nbsp;1, S1, and S2</div></div></div><div class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2021.07.020/attachment/be749941-ce13-45e7-8c00-04c5fd6a24b9/mmc2.xlsx" download="mmc2.xlsx"><span id="mmc2-link">Spreadsheet (10.17 KB)</span></a><div class="core-description">Table S2. Immune profiling of splenocytes from Pin1i-2 treated non-tumor-bearing B6 mice, related to Figures 1, S1, and S2</div></div></div><div class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2021.07.020/attachment/bdac5f13-5589-49be-9e4c-415f5ba86280/mmc3.xlsx" download="mmc3.xlsx"><span id="mmc3-link">Spreadsheet (10.33 KB)</span></a><div class="core-description">Table S3. shRNA sequence information, related to STAR Methods</div></div></div></div></section>
    

        


    

            

            

            <section id="core-collateral-relatedArticles" class="axel-related-articles"><h2 id="relatedArticles" class="top axel-related-articles__title" data-title="Related articles">Related Articles</h2><div data-pb-widget-type="ux3-relatedArticles" data-widget-id="8d3844d1-450e-497c-ab75-a63fc41750ac" data-widget-name="AtyponTempUX3RelatedArticlesWidget" data-article-pii="S0092867421008795" class="ux3DeferredOnScrollWidget axel-related-articles__body ux3DeferredLoaded" data-show-more="true">We haven't found any related articles.</div></section>

            

        
</div></div><aside data-core-aside="right-rail"><div class="inner-wrapper">

    

        


    

            

            

            <div data-widget-id="dca7470d-9085-4d21-a6f4-a66397718146" data-widget-name="UX3HTMLWidget"><input type="hidden" id="gptPage" value="cell-videos"></div>

            

        











        <div data-widget-def="literatumAd" data-widget-id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc" class="adplaceholders" style="right: 0px; position: static;">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd alignCenter  widget-verticalAd" id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc">
                
                
                    
                

                <div class="wrapped " id="Marketplace-Recs">
                    
                    <div class="widget-body body body-verticalAd "><div class="verticalAdContainer">
    <div class="verticalAdLabelContainer">
        <div class="verticalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adVert.gif" alt="Advertisement">
        </div>
    </div>
    <div class="verticalAd">
        





        <div class="pb-ad">
            <script src="//cdn.pbgrd.com/core-cell.js" async=""></script>
<div id="pbgrd-skyr-c"><div id="pbgrd-skyr" style="width: inherit; position: relative; background: transparent;"></div></div>
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

        </div>
    

</div></aside><div class="core-authors-details" style="display:none"><section class="core-authors"></section></div></article><div data-extent="article-wrapper"><div class="core-container"></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1016/j.cell.2021.07.020","data-is-retraction":false,"data-is-retired":false}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="https://static.addtoany.com/menu/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><template id="figure_nav_template"><a href="#" class="open-in-viewer btn btn-dark figure-pop-btn"><i aria-hidden="true" class="icon-export_citation"></i><span>Open in viewer</span></a></template><div id="figure-viewer" role="dialog" aria-modal="true" aria-label="Figure Viewer" class="showCaption showThumbstrip figure-viewer"><nav class="nav-bar figure-viewer__top"><a href="#" title="Close Figure Viewer" role="button" class="figure-viewer__close"><i aria-hidden="true" class="icon-tools_close"></i></a><div class="figure-viewer__title">Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy</div></nav><div class="frames"><ul class="frames__list"><li><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2021.07.020/asset/6eacbe41-ef40-453a-b390-ce3d7b4c5edf/main.assets/gr1.jpg" height="861" width="657" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/6847667b-2bb9-4bc6-b33c-95c265a516e3/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2021.07.020/asset/c18b70c3-ae3b-40fe-bc7c-4bd4bfd359ea/main.assets/figs1.jpg" height="922" width="702" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/03f284e6-d3f0-46f2-b7cf-ecb8513ded95/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2021.07.020/asset/386a0819-8edf-4c6e-9649-852bd4bc2763/main.assets/figs2.jpg" height="941" width="713" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/6eb9856b-38d4-43f6-b518-0b9416823e0a/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2021.07.020/asset/82f67305-8a0a-417a-a8eb-585d89ee7b4b/main.assets/gr2.jpg" height="941" width="737" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/858850b1-e141-4e87-a75a-2756ce1af9b8/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2021.07.020/asset/0096feb9-ce8b-4633-8a9b-fc05519694e6/main.assets/figs3.jpg" height="876" width="657" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/e85a81de-2a9f-4e74-add2-204a59509e86/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2021.07.020/asset/7925f3ce-1f21-4a29-a264-f16cf591742f/main.assets/gr3.jpg" height="930" width="753" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/935672f7-ef2b-43a2-9ed5-d8c00c8fa134/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2021.07.020/asset/6017156b-7631-48c5-b68b-772566aa1656/main.assets/gr4.jpg" height="875" width="657" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/134b02a3-56ef-4ca9-96c2-c234f806bed2/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2021.07.020/asset/77fdf87b-9e0e-4e75-82e6-e4b0445160a8/main.assets/figs4.jpg" height="844" width="657" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/b0f593cd-2871-4c9f-9e59-6be1a357f385/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2021.07.020/asset/53baa9f8-3dde-46e6-aa0c-33ef33a3abe8/main.assets/figs5.jpg" height="862" width="657" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/19b005c7-838b-4ef3-8b94-c0c61341f30f/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2021.07.020/asset/9dcfd7ef-bc1f-4303-a770-021e89ca6122/main.assets/gr5.jpg" height="941" width="746" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/c300b707-aa95-4207-8336-9e96595275d7/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2021.07.020/asset/5c0db951-f9f5-4f36-927c-9c1a789b5e02/main.assets/gr6.jpg" height="873" width="657" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/aa76fb8f-ae6c-4914-81dc-9715cde48aa0/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2021.07.020/asset/38e11031-d6a9-4b3f-b878-f37ca7920226/main.assets/figs6.jpg" height="941" width="721" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/e52c368e-2424-42fe-93e8-67df612d845d/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2021.07.020/asset/6da4ec50-fb8f-4e8b-ba78-6fd0ce8a004f/main.assets/gr7.jpg" height="836" width="657" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/b6d84c85-749c-4ba9-abc8-affc8393d4d9/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2021.07.020/asset/7c086884-6109-48a6-aa09-639c272e01e1/main.assets/figs7.jpg" height="824" width="657" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/8634e906-a887-4a61-8f41-87241ff8aab4/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li></ul><a href="#" title="Previous Frame" class="frameButton previousFrameButton frames__prev"><!--span Previous Frame--><i class="icon-arrow_l"></i></a><a href="#" title="Next Frame" class="frameButton nextFrameButton frames__next"><!--span Next Frame--><i class="icon-arrow_r"></i></a></div><div class="caption"><div class="figure-viewer__caption-body"></div></div><div class="toolbar figure-viewer__toolbar"><span class="figure-viewer__counter"></span><a href="#" class="button toggle-caption-button figure-viewer__caption__ctrl"><i aria-hidden="true" class="icon icon-info"></i><span class="label">Hide Caption</span></a><a href="#" class="button download-options-button"><i aria-hidden="true" class="icon icon-gizmo-folder-in download-size-icon"></i><span class="label">Download</span></a><a href="#figures" class="button see-figures figure-viewer__see-figure__ctrl"><i aria-hidden="true" class="icon icon-gizmo-image_figure viewer-size-icon"></i><span class="label">See figure in Article</span></a></div><div class="thumbstrip"><a href="#" class="toggleButton thumbstrip__ctrl"><span>Toggle Thumbstrip</span></a><a href="#" title="Previous Thumbnails" class="thumbstripButton previousThumbstripButton thumbstrip__prev"><i aria-hidden="true" class="icon-arrow_l"></i></a><a href="#" title="Next Thumbnails" class="thumbstripButton nextThumbstripButton thumbstrip__next"><i aria-hidden="true" class="icon-arrow_r"></i></a><div class="thumbstrip__wrapper"><ul class="rlist figure-viewer__thumbslist"><li><div class="thumbnail__label">Figure&nbsp;1</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2021.07.020/asset/6eacbe41-ef40-453a-b390-ce3d7b4c5edf/main.assets/gr1.jpg" height="861" width="657" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/6847667b-2bb9-4bc6-b33c-95c265a516e3/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S1</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2021.07.020/asset/c18b70c3-ae3b-40fe-bc7c-4bd4bfd359ea/main.assets/figs1.jpg" height="922" width="702" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/03f284e6-d3f0-46f2-b7cf-ecb8513ded95/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S2</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2021.07.020/asset/386a0819-8edf-4c6e-9649-852bd4bc2763/main.assets/figs2.jpg" height="941" width="713" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/6eb9856b-38d4-43f6-b518-0b9416823e0a/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;2</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2021.07.020/asset/82f67305-8a0a-417a-a8eb-585d89ee7b4b/main.assets/gr2.jpg" height="941" width="737" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/858850b1-e141-4e87-a75a-2756ce1af9b8/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S3</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2021.07.020/asset/0096feb9-ce8b-4633-8a9b-fc05519694e6/main.assets/figs3.jpg" height="876" width="657" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/e85a81de-2a9f-4e74-add2-204a59509e86/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;3</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2021.07.020/asset/7925f3ce-1f21-4a29-a264-f16cf591742f/main.assets/gr3.jpg" height="930" width="753" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/935672f7-ef2b-43a2-9ed5-d8c00c8fa134/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;4</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2021.07.020/asset/6017156b-7631-48c5-b68b-772566aa1656/main.assets/gr4.jpg" height="875" width="657" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/134b02a3-56ef-4ca9-96c2-c234f806bed2/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S4</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2021.07.020/asset/77fdf87b-9e0e-4e75-82e6-e4b0445160a8/main.assets/figs4.jpg" height="844" width="657" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/b0f593cd-2871-4c9f-9e59-6be1a357f385/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S5</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2021.07.020/asset/53baa9f8-3dde-46e6-aa0c-33ef33a3abe8/main.assets/figs5.jpg" height="862" width="657" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/19b005c7-838b-4ef3-8b94-c0c61341f30f/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;5</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2021.07.020/asset/9dcfd7ef-bc1f-4303-a770-021e89ca6122/main.assets/gr5.jpg" height="941" width="746" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/c300b707-aa95-4207-8336-9e96595275d7/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;6</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2021.07.020/asset/5c0db951-f9f5-4f36-927c-9c1a789b5e02/main.assets/gr6.jpg" height="873" width="657" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/aa76fb8f-ae6c-4914-81dc-9715cde48aa0/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S6</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2021.07.020/asset/38e11031-d6a9-4b3f-b878-f37ca7920226/main.assets/figs6.jpg" height="941" width="721" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/e52c368e-2424-42fe-93e8-67df612d845d/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;7</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2021.07.020/asset/6da4ec50-fb8f-4e8b-ba78-6fd0ce8a004f/main.assets/gr7.jpg" height="836" width="657" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/b6d84c85-749c-4ba9-abc8-affc8393d4d9/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S7</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2021.07.020/asset/7c086884-6109-48a6-aa09-639c272e01e1/main.assets/figs7.jpg" height="824" width="657" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2021.07.020/asset/8634e906-a887-4a61-8f41-87241ff8aab4/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li></ul></div></div><div class="download figure-viewer__download"><div class="pointer"></div><ul class="rlist downlad__wrapper"><li class="hidden-xs hidden-sm"><a href="/action/downloadFigures?pii=e00489&amp;id=" class="downloadAllButton"><i class="icon icon-gizmo-ppt figure-viewer__download__viewer-size-icon figure-viewer__download__viewer-size-icon--ppt"></i><span class="figure-viewer__download__text"> Download .PPT</span></a></li></ul></div></div><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></a></div></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><button class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></button></div></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion no-separator"><ul></ul></div></div></template><template id="toCitationAccordionItem"><li><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span></span></a></li></template><template id="citations_truncate_template"><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--inverse"><span>Show all references</span></button></div></template><template id="collateral_texts_template" data-do="Digital Object" data-figures="Figures" data-metrics="Article Metrics" data-related="Related articles" data-supplementary="Supplemental information"></template><template id="collapsible_authors_template"><button aria-expanded="false" data-expandable="all" data-label-expand="Expand All" data-label-collapse="Collapse All" class="collateral-contributors-control"><span>Expand All</span></button></template>
<template id="collapsible_tables_collapse_template"><div class="collapsible-figure-btn__wrapper expanded"><button aria-expanded="true" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id="collapsible_tables_expand_template"><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="false" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template><template id="authorsAffiliationsLink"><a href="#tab-contributors" class="to-authors-affiliations">Authors Info &amp; Affiliations</a></template></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-  widget-compact-all" id="756cf18d-e910-4468-936c-0225ae7c669f">
                
                
                    
                

                <div class="wrapped " id="ad for nucleus-single-molecule-technologies">
                    
                    <div class="widget-body body body-  body-compact-all"><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(21)00879-5';

if(URL_var.indexOf("S0165-6147(17)30205-5") > -1
|| URL_var.indexOf("S0167-7799(18)30204-X") > -1 
|| URL_var.indexOf("S0092-8674(18)31649-0") > -1 
|| URL_var.indexOf("S0092-8674(19)30404-0") > -1 
|| URL_var.indexOf("S1097-2765(18)30756-1") > -1 
|| URL_var.indexOf("S0092-8674(18)31452-1") > -1 
|| URL_var.indexOf("S1097-2765(19)30175-3") > -1 
|| URL_var.indexOf("S0092-8674(18)30852-3") > -1 
|| URL_var.indexOf("S0006-3495(18)30295-9") > -1 
|| URL_var.indexOf("S1097-2765(19)30063-2") > -1 
|| URL_var.indexOf("S0006-3495(17)33208-3") > -1 
|| URL_var.indexOf("S2211-1247(18)31639-5") > -1 
|| URL_var.indexOf("S1097-2765(18)30978-X") > -1 
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-single-molecule-technologies" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-" id="754b1780-1117-4371-9285-9cd7020963d5">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body- "><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(21)00879-5';

if(URL_var.indexOf("S1535-6108(19)30104-7") > -1
|| URL_var.indexOf("S0092-8674(18)31394-1") > -1
|| URL_var.indexOf("S1074-7613(19)30033-0") > -1
|| URL_var.indexOf("S1535-6108(18)30473-2") > -1
|| URL_var.indexOf("S0092-8674(19)30154-0") > -1
|| URL_var.indexOf("S1550-4131(18)30178-5") > -1
|| URL_var.indexOf("S1535-6108(19)30242-9") > -1
|| URL_var.indexOf("S1074-7613(18)30431-X") > -1
|| URL_var.indexOf("S0092-8674(19)30618-X") > -1
|| URL_var.indexOf("S1535-6108(18)30472-0") > -1
|| URL_var.indexOf("S1535-6108(18)30120-X") > -1
|| URL_var.indexOf("S0092-8674(18)31247-9") > -1
|| URL_var.indexOf("S1074-7613(18)30085-2") > -1
|| URL_var.indexOf("S1074-7613(18)30080-3") > -1
|| URL_var.indexOf("S1471-4906(18)30210-2") > -1
|| URL_var.indexOf("S1550-4131(19)30304-3") > -1
|| URL_var.indexOf("S1934-5909(18)30599-X") > -1
|| URL_var.indexOf("S2405-8033(19)30024-X") > -1
|| URL_var.indexOf("S1535-6108(18)30109-0") > -1
|| URL_var.indexOf("S0962-8924(18)30127-2") > -1
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-tumor-immune-microenvironment" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="9c9ff7a1-a035-49f6-a336-600c9419c518" data-widget-name="UX3HTMLWidget"><!-- Start of HubSpot Embed Code --> 

<script type="text/plain" class="optanon-category-4" id="hs-script-loader" async="" defer="" src="//js.hs-scripts.com/519224.js"></script> 

<!-- End of HubSpot Embed Code --></div>

            

        

    

        


    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget sessionValidationWidget none  widget-none  widget-compact-all" id="0257aef7-6074-4898-a989-1c3f693225a2">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><script>
    $.ajax({
        url: "https://www.cell.com/ssoSessionCheck",
        type: "GET",
        dataType: "jsonp",
        success: function (data) {
            if(data.RefreshSession) {
                location.reload();
            }
        },
        error : function (){
            console.warn("can't validate CSAS session.");
        }
    });
</script></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasSsoUrls none  widget-none  widget-compact-all" id="948bc5c4-8b0d-47be-b5ad-6570559802d1">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><!-- clear SSO URLs after all iFrames are rendered or after passing a time out-->
<script>
    setTimeout(clearSsoUrlsFun,10000);
    var iFramesList = document.getElementById("sso-urls-div").getElementsByTagName("iframe");
    var renderedIFramesCount = 0;
    var numberOfIFrames = iFramesList.length;
    var skipRefresh = false;
    for (var i = 0; i < iFramesList.length; i++) {
        var iFrame = iFramesList[i];
        iFrame.addEventListener("load", function() {
            renderedIFramesCount = renderedIFramesCount + 1;
            if (renderedIFramesCount >= numberOfIFrames)
            {
                clearSsoUrlsFun();
            }
        });
    }

    function clearSsoUrlsFun() {
        if (skipRefresh == false && numberOfIFrames > 0)
        {
            skipRefresh = true;
            $.ajax({
                url: "https://www.cell.com/action/clearSsoUrls",
                type: "GET",
                dataType: "jsonp",
                error : errorCallingAjx
            });
        }
    }

    function errorCallingAjx(){
        console.log("can't delete sso urls .")
    }
</script></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" class="ux3 ">
        
    

        


    

            

            

            <div data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" data-widget-name="ux3-layout-widget" class="fonts-loaded"><div class="footer clearfix">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header widget-horizontalAd" id="a07ee92b-3942-49f8-9186-a2a08fc3fc56">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 4 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="4"></div>
<!-- End AdSlot 4 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="23703bbc-af46-4f3f-a5bb-dd52891ff0ff" data-widget-name="UX3HTMLWidget"><div class="footer__top">
    <div class="footer__logo centered"><a href="/home" title="Cell Press"><!-- Generator: Adobe Illustrator 25.2.1, SVG Export Plug-In . SVG Version: 6.00 Build 0)  -->
<svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 300 72" style="enable-background:new 0 0 300 72;" xml:space="preserve">
<style type="text/css">
	.st0{fill:#007DBC;}
</style>
<g>
	<path class="st0" d="M39.4,7.5c-2.3-0.3-4.4,1.1-4.9,3.3l-1.8,7.4c-0.4,1.8-1.9,3.1-3.8,3.3l-10.5,1.2C7.1,24-1,34.3,0.7,45.6
		c1.3,9,8.6,15.7,17.2,17c2.3,0.3,4.4-1.1,4.9-3.3l1.8-7.4c0.4-1.8,1.9-3.1,3.8-3.3l10.5-1.2c11.3-1.2,19.4-11.6,17.8-22.9
		C55.3,15.4,48.1,8.8,39.4,7.5z M37.1,34l-6.6,0.8c-1.1,0.1-2,0.9-2.3,2l-1.9,8.1c-0.6,2.4-2.5,4.2-5,4.5c-3.8,0.4-7.1-2.4-7.4-6.2
		c-0.3-3.7,2.6-6.8,6.3-7.2l6.6-0.8c1.1-0.1,2-0.9,2.3-2l1.9-8.1c0.6-2.4,2.5-4.2,5-4.5c3.8-0.4,7.1,2.4,7.4,6.2
		C43.7,30.5,40.8,33.6,37.1,34z"></path>
	<rect x="153.1" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M90.2,20.4c7.3,0,8.6,4.8,9.4,7.3h8.8c-0.5-6.2-5.6-14.9-18.2-14.9c-10.9,0-19.4,7.5-19.4,22.3
		c0,14.6,8.1,22.2,19.3,22.2c10.6,0,16.6-6.4,18.4-15.6h-8.8c-1.1,5.2-4.5,7.9-9.4,7.9c-7.5,0-10.5-6.8-10.5-14.4
		C79.7,23.3,85.9,20.4,90.2,20.4z"></path>
	<path class="st0" d="M125.2,24c-13.7,0-15,12.1-15,15.8c0,12.9,6.8,17.1,15.6,17.1c5.4,0,11.6-2.5,13.8-10H131
		c-0.7,2.2-3,3.4-5.3,3.4c-6.6,0-7.1-5.3-7.3-7.7h21.5v-1.5C139.9,27,131.3,24,125.2,24z M118.6,37.4c0.5-4.1,2.5-6.6,6.4-6.6
		c2.6,0,5.9,1.5,6.4,6.6H118.6z"></path>
	<rect x="142" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M174,13.8h-9.8V21h7.2c4.3,0,8.2,0.9,8.2,6.4c0,5.4-3.9,6.4-8.2,6.4h-7.2V41h9.8c10.6,0,14.7-6.7,14.7-13.6
		C188.7,20.5,184.6,13.8,174,13.8z"></path>
	<path class="st0" d="M210.5,24.9c-0.5-0.2-1.2-0.3-1.8-0.3c-4.1,0-8.3,2.7-9.8,6.5h-0.1v-5.7h-8v30.7h8.4V42.3
		c0-5.4,2.1-9.9,8.3-9.9c1,0,2.3,0.1,3,0.3V24.9z"></path>
	<path class="st0" d="M225.6,24.6c-9.3,0-15.7,7-15.7,16.2c0,9.5,6,16.1,15.7,16.1c6.9,0,12-3.1,14.4-10.3h-7.4
		c-0.5,1.9-3.3,4-6.6,4c-4.7,0-7.3-2.4-7.5-7.8h22.1C241.1,33.4,236,24.6,225.6,24.6z M218.4,37.5c0.1-2.4,1.7-6.5,7-6.5
		c4.1,0,5.9,2.3,6.7,6.5H218.4z"></path>
	<path class="st0" d="M260.3,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		C242,54.3,248.9,57,256,57c7,0,14-2.6,14-10.7C270.1,40.6,265.2,38.8,260.3,37.7z"></path>
	<path class="st0" d="M289.8,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		c0.4,8.1,7.3,10.8,14.4,10.8c7,0,14-2.6,14-10.7C299.6,40.6,294.7,38.8,289.8,37.7z"></path>
	<path class="st0" d="M34.1,57.6c0.3-0.2,0.4-0.6,0.4-1c0-0.5-0.2-0.9-0.5-1.1c-0.3-0.2-0.8-0.3-1.4-0.3h-1.9v5.1h0.8V58h0.8
		l1.3,2.2h0.9l-1.4-2.2C33.6,57.9,33.9,57.8,34.1,57.6z M32.5,57.3h-0.9v-1.5h1c0.1,0,0.3,0,0.4,0c0.1,0,0.3,0,0.4,0.1
		c0.1,0,0.2,0.1,0.3,0.2c0.1,0.1,0.1,0.2,0.1,0.4c0,0.2,0,0.3-0.1,0.4c-0.1,0.1-0.2,0.2-0.3,0.2c-0.1,0.1-0.2,0.1-0.4,0.1
		C32.8,57.3,32.6,57.3,32.5,57.3z"></path>
	<path class="st0" d="M35.6,54.2c-0.4-0.4-0.9-0.7-1.4-0.9c-0.5-0.2-1.1-0.3-1.7-0.3c-0.6,0-1.2,0.1-1.7,0.3c-0.6,0.2-1,0.5-1.4,0.9
		c-0.4,0.4-0.7,0.9-1,1.5c-0.2,0.6-0.4,1.2-0.4,1.9c0,0.7,0.1,1.3,0.3,1.8c0.2,0.6,0.5,1,0.9,1.5c0.4,0.4,0.9,0.7,1.4,1
		c0.6,0.2,1.2,0.4,1.8,0.4c0.6,0,1.2-0.1,1.7-0.3c0.5-0.2,1-0.5,1.4-0.9c0.4-0.4,0.7-0.9,1-1.5c0.2-0.6,0.4-1.2,0.4-1.9
		c0-0.7-0.1-1.3-0.4-1.9C36.4,55.1,36,54.6,35.6,54.2z M35.7,59.1c-0.2,0.5-0.4,0.9-0.8,1.2c-0.3,0.3-0.7,0.6-1.1,0.8
		c-0.4,0.2-0.9,0.3-1.4,0.3c-0.6,0-1-0.1-1.5-0.3c-0.4-0.2-0.8-0.5-1.1-0.8c-0.3-0.3-0.5-0.7-0.7-1.2c-0.2-0.5-0.2-1-0.2-1.5
		c0-0.6,0.1-1.1,0.3-1.5c0.2-0.5,0.4-0.9,0.8-1.2c0.3-0.3,0.7-0.6,1.1-0.8c0.4-0.2,0.9-0.3,1.4-0.3c0.5,0,1,0.1,1.4,0.3
		c0.4,0.2,0.8,0.4,1.1,0.8c0.3,0.3,0.6,0.7,0.8,1.2c0.2,0.5,0.3,1,0.3,1.5C36,58.1,35.9,58.6,35.7,59.1z"></path>
</g>
</svg></a></div>
    <div class="footer__social-links">
        <ul class="rlist rlist--inline centered">
            <li><a href="http://on.fb.me/1tgHakh" title="Facebook" target="_blank"><i aria-hidden="true" class="icon-Icon_Facebook"></i></a></li>

            <li><a href="https://www.instagram.com/cellpress/" title="Instagram" target="_blank"><svg width="18px" height="18px" viewBox="0 0 18 18" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-147.000000, -16.000000)" fill-rule="nonzero" fill="#969696"> <g id="Instagram-Logo" transform="translate(147.000000, 16.000000)"> <path d="M9,1.62580645 C11.4096774,1.62580645 11.7,1.62580645 12.6290323,1.68387097 C13.5,1.71290323 13.9935484,1.85806452 14.3129032,2.00322581 C14.7193548,2.17741935 15.0387097,2.3516129 15.3580645,2.67096774 C15.6774194,2.99032258 15.8806452,3.28064516 16.0258065,3.71612903 C16.1419355,4.03548387 16.2870968,4.5 16.3451613,5.4 C16.3741935,6.35806452 16.4032258,6.61935484 16.4032258,9.02903226 C16.4032258,11.4387097 16.4032258,11.7290323 16.3451613,12.6580645 C16.316129,13.5290323 16.1709677,14.0225806 16.0258065,14.3419355 C15.8516129,14.7483871 15.6774194,15.0677419 15.3580645,15.3870968 C15.0387097,15.7064516 14.7483871,15.9096774 14.3129032,16.0548387 C13.9935484,16.1709677 13.5290323,16.316129 12.6290323,16.3741935 C11.6709677,16.4032258 11.4096774,16.4322581 9,16.4322581 C6.59032258,16.4322581 6.3,16.4322581 5.37096774,16.3741935 C4.5,16.3451613 4.00645161,16.2 3.68709677,16.0548387 C3.28064516,15.8806452 2.96129032,15.7064516 2.64193548,15.3870968 C2.32258065,15.0677419 2.11935484,14.7774194 1.97419355,14.3419355 C1.85806452,14.0225806 1.71290323,13.5580645 1.65483871,12.6580645 C1.62580645,11.7 1.62580645,11.4096774 1.62580645,9 C1.62580645,6.59032258 1.62580645,6.3 1.68387097,5.37096774 C1.71290323,4.5 1.85806452,4.00645161 2.00322581,3.68709677 C2.17741935,3.28064516 2.3516129,2.96129032 2.67096774,2.64193548 C2.99032258,2.32258065 3.28064516,2.11935484 3.71612903,1.97419355 C4.03548387,1.85806452 4.5,1.71290323 5.4,1.65483871 C6.3,1.62580645 6.59032258,1.62580645 9,1.62580645 L9,1.62580645 Z M9,0 C6.56129032,0 6.24193548,0 5.28387097,0.0580645161 C4.32580645,0.116129032 3.65806452,0.261290323 3.10645161,0.464516129 C2.52580645,0.696774194 2.00322581,1.01612903 1.50967742,1.50967742 C1.01612903,2.00322581 0.696774194,2.52580645 0.464516129,3.10645161 C0.232258065,3.68709677 0.0870967742,4.32580645 0.0580645161,5.28387097 C0,6.24193548 0,6.56129032 0,9 C0,11.4387097 0,11.7580645 0.0580645161,12.716129 C0.116129032,13.6741935 0.261290323,14.3419355 0.464516129,14.8935484 C0.696774194,15.4741935 1.01612903,15.9967742 1.50967742,16.4903226 C2.00322581,16.983871 2.52580645,17.3032258 3.10645161,17.5354839 C3.68709677,17.7677419 4.32580645,17.9129032 5.28387097,17.9419355 C6.24193548,18 6.56129032,18 9,18 C11.4387097,18 11.7580645,18 12.716129,17.9419355 C13.6741935,17.883871 14.3419355,17.7387097 14.8935484,17.5354839 C15.4741935,17.3032258 15.9967742,16.983871 16.4903226,16.4903226 C16.983871,15.9967742 17.3032258,15.4741935 17.5354839,14.8935484 C17.7677419,14.3129032 17.9129032,13.6741935 17.9419355,12.716129 C18,11.7580645 18,11.4387097 18,9 C18,6.56129032 18,6.24193548 17.9419355,5.28387097 C17.883871,4.32580645 17.7387097,3.65806452 17.5354839,3.10645161 C17.3032258,2.52580645 16.983871,2.00322581 16.4903226,1.50967742 C15.9967742,1.01612903 15.4741935,0.696774194 14.8935484,0.464516129 C14.3129032,0.232258065 13.6741935,0.0870967742 12.716129,0.0580645161 C11.7580645,0 11.4387097,0 9,0 L9,0 Z"></path> <path d="M9,4.38387097 C6.44516129,4.38387097 4.38387097,6.44516129 4.38387097,9 C4.38387097,11.5548387 6.44516129,13.616129 9,13.616129 C11.5548387,13.616129 13.616129,11.5548387 13.616129,9 C13.616129,6.44516129 11.5548387,4.38387097 9,4.38387097 Z M9,11.9903226 C7.34516129,11.9903226 6.00967742,10.6548387 6.00967742,9 C6.00967742,7.34516129 7.34516129,6.00967742 9,6.00967742 C10.6548387,6.00967742 11.9903226,7.34516129 11.9903226,9 C11.9903226,10.6548387 10.6548387,11.9903226 9,11.9903226 Z"></path> <circle id="Oval" cx="13.7903226" cy="4.20967742" r="1.07419355"></circle> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.linkedin.com/company/cell-press/" title="LinkedIn" target="_blank"><i aria-hidden="true" class="icon-linkedin"></i></a></li>
            
                        <li><a href="http://bit.ly/1zq7Q5T" title="Twitter" target="_blank">
                <!--<i aria-hidden="true" class="icon-Icon_Twitter"></i></a>-->
                
                <svg id="xicon" viewBox="0 0 1200 1227" xmlns="http://www.w3.org/2000/svg" aria-hidden="true" role="none"><path fill="#969696" d="M714.163 519.284L1160.89 0H1055.03L667.137 450.887L357.328 0H0L468.492 681.821L0 1226.37H105.866L515.491 750.218L842.672 1226.37H1200L714.137 519.284H714.163ZM569.165 687.828L521.697 619.934L144.011 79.6944H306.615L611.412 515.685L658.88 583.579L1055.08 1150.3H892.476L569.165 687.854V687.828Z"></path></svg> 

                    <style>
                    .footer svg#xicon {
                      height: 16px;
                    }
                    </style>
            </a></li>

            
            <li><a href="/pb-assets/marketing/WeChat/WeChat-1557753222727.jpg" title="WeChat" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-122.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="wechat" transform="translate(122.000000, 17.000000)"> <path d="M12.375,4.5 L12.375,4.5 L12.4875,4.5 L12.4875,4.5 C12.6898579,4.48604473 12.8520408,4.32704187 12.87,4.125 C12.8705905,4.04725572 12.8470025,3.9712499 12.8025,3.9075 C11.94,1.5675 9.4425,0 6.5625,0 C2.9475,0 0,2.52 0,5.625 C0.0313772094,7.34410122 0.895513317,8.94093526 2.3175,9.9075 L1.5675,11.46 C1.49009368,11.6087816 1.52088865,11.7908702 1.64291494,11.9059236 C1.76494122,12.0209769 1.94852501,12.0410168 2.0925,11.955 L4.08,10.8225 C4.61861992,11.0129999 5.17724298,11.1413322 5.745,11.205 C5.86564124,11.2178337 5.98503738,11.1715098 6.06545426,11.0806685 C6.14587113,10.9898272 6.17737153,10.865694 6.15,10.7475 C6.06148727,10.4219419 6.01114891,10.0871918 6,9.75 C6,6.855 8.8575,4.5 12.375,4.5 Z M8.25,3 C8.66421356,3 9,3.33578644 9,3.75 C9,4.16421356 8.66421356,4.5 8.25,4.5 C7.83578644,4.5 7.5,4.16421356 7.5,3.75 C7.5,3.33578644 7.83578644,3 8.25,3 Z M4.5,4.5 C4.08578644,4.5 3.75,4.16421356 3.75,3.75 C3.75,3.33578644 4.08578644,3 4.5,3 C4.91421356,3 5.25,3.33578644 5.25,3.75 C5.25,4.16421356 4.91421356,4.5 4.5,4.5 Z"></path> <path d="M18,9.75 C18,7.2675 15.48,5.25 12.375,5.25 C9.27,5.25 6.75,7.2675 6.75,9.75 C6.75,12.2325 9.27,14.25 12.375,14.25 C12.9568557,14.2502837 13.5364258,14.1772075 14.1,14.0325 L15.96,14.9625 C16.0114248,14.9874074 16.0678613,15.0002339 16.125,15 C16.2497193,14.9993787 16.3659682,14.9367912 16.4351508,14.8330172 C16.5043335,14.7292432 16.5173955,14.5978644 16.47,14.4825 L15.96,13.2075 C17.1784092,12.4716325 17.9450305,11.1723221 18,9.75 L18,9.75 Z M10.5,9 C10.0857864,9 9.75,8.66421356 9.75,8.25 C9.75,7.83578644 10.0857864,7.5 10.5,7.5 C10.9142136,7.5 11.25,7.83578644 11.25,8.25 C11.25,8.66421356 10.9142136,9 10.5,9 Z M14.25,9 C13.8357864,9 13.5,8.66421356 13.5,8.25 C13.5,7.83578644 13.8357864,7.5 14.25,7.5 C14.6642136,7.5 15,7.83578644 15,8.25 C15,8.66421356 14.6642136,9 14.25,9 Z" opacity="0.959999979"></path> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.weibo.com/CellPress" title="Weibo" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-99.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="weibo" transform="translate(99.000000, 14.000000)"> <g transform="translate(0.000000, 3.000000)"> <path d="M13.2402211,7.47054172 C12.9918392,7.39866484 12.821608,7.34902326 12.9514975,7.03290287 C13.232804,6.34602189 13.2622915,5.75359781 12.9571055,5.33095486 C12.3847236,4.5380684 10.8191759,4.58064295 9.02514573,5.30975376 C9.02514573,5.30889193 8.46144724,5.54882627 8.60544724,5.11515185 C8.88150754,4.25435294 8.83953769,3.53386047 8.41043216,3.11759508 C7.43716583,2.17285363 4.84824121,3.15344733 2.62745729,5.3059617 C0.964944724,6.9186238 0,8.62798358 0,10.105855 C0,12.9324952 3.73748744,14.8235294 7.39429146,14.8235294 C12.1877186,14.8235294 15.3768844,11.9501778 15.3768844,9.80576471 C15.3768844,8.50974008 14.2514774,7.77442408 13.2402211,7.47054172 Z M7.40424121,13.5561176 C4.48625126,13.8315595 1.9678794,12.5686293 1.77811055,10.7327524 C1.58870352,8.89773735 3.80098492,7.18579207 6.71861307,6.90948837 C9.63678392,6.63266758 12.1556985,7.89663201 12.3447437,9.73164706 C12.533608,11.5675239 10.3227739,13.2796416 7.40424121,13.5561176 Z M18,5.16875787 C17.9985528,2.31402189 15.5695477,0 12.5728643,0 C12.222995,0 11.9396985,0.270098495 11.9396985,0.603283174 C11.9396985,0.936640219 12.222995,1.20656635 12.5728643,1.20656635 C14.8708945,1.20656635 16.7336683,2.98159781 16.7336683,5.17099863 C16.7336683,5.50435568 17.0173266,5.77428181 17.3668342,5.77428181 C17.7167035,5.77428181 18,5.50435568 18,5.17099863 C18,5.17099863 18,5.1696197 18,5.16875787 Z M15.4841608,5.08016142 C15.1948945,3.73415048 14.0812462,2.67323393 12.6683819,2.39744733 C12.3262915,2.33039672 11.9914372,2.54051163 11.9212462,2.86680164 C11.8506935,3.19309166 12.0712161,3.51179754 12.4133065,3.57919289 C13.3319397,3.75845417 14.0559196,4.44774829 14.2438794,5.32302599 C14.3146131,5.64931601 14.6491055,5.85925855 14.9915578,5.7923803 C15.3338291,5.72498495 15.5541709,5.40627907 15.4841608,5.08016142 Z M5.90761809,8.7069275 C4.7321005,8.9320383 3.93901508,9.87126402 4.1358392,10.8044569 C4.33248241,11.7378222 5.44504523,12.311803 6.62056281,12.0865198 C7.79571859,11.861409 8.58916583,10.922528 8.3921608,9.98899042 C8.19569849,9.0559699 7.08277387,8.48181669 5.90761809,8.7069275 Z"></path> </g> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.youtube.com/user/cellvideoabstracts" title="YouTube" target="_blank"><svg width="18px" height="13px" viewBox="0 0 18 13" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-76.000000, -19.000000)" fill-rule="nonzero" fill="#969696"> <g id="youtube" transform="translate(76.000000, 14.000000)"> <path d="M17.2984219,6.41974219 C16.6486641,5.64735937 15.4490625,5.33232422 13.1580703,5.33232422 L4.84175391,5.33232422 C2.49834375,5.33232422 1.27838672,5.66771484 0.631089844,6.49001953 C0,7.29172266 0,8.47304297 0,10.1080547 L0,13.2243047 C0,16.3917773 0.748792969,18 4.84175391,18 L13.1581055,18 C15.1448555,18 16.2457383,17.7219844 16.9579688,17.040375 C17.688375,16.3413984 18,15.2001211 18,13.2243047 L18,10.1080547 C18,8.38381641 17.951168,7.19553516 17.2984219,6.41974219 Z M11.5560703,12.0963867 L7.77965625,14.0700586 C7.69524609,14.1141797 7.60289062,14.136082 7.51071094,14.136082 C7.40629687,14.136082 7.30212891,14.1079922 7.20987891,14.0521289 C7.03613672,13.9468711 6.93007031,13.7585391 6.93007031,13.5554414 L6.93007031,9.62075391 C6.93007031,9.41800781 7.03585547,9.22985156 7.20924609,9.12452344 C7.38267187,9.01919531 7.59839062,9.01198828 7.77832031,9.10546875 L11.5547344,11.0664141 C11.7468633,11.1661523 11.8675195,11.3645039 11.8678008,11.5809258 C11.8680469,11.7975586 11.747918,11.9961914 11.5560703,12.0963867 Z"></path> </g> </g> </g></svg></a></li>
            
        </ul>
    </div>
</div>

<style>

.ux3 .footer__logo svg {
    max-width: 160px !important;
}

.ux3 .footer__social-links a svg {
    max-width: 26px;
    height: 1.15rem;
    width: auto;
}

.ux3 .footer__social-links a:hover svg path {
    fill: #353535;
}

</style></div>

            

        

    

        


    

            

            
                <div class="footer__bottom text-onDark">
            

            <div data-widget-id="06227714-c621-4651-9879-b0ce5176cccc" data-widget-name="ux3-layout-widget"><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="07e1d276-b4dd-4870-b858-ed74e70d64ef" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Life &amp; medical sciences journals</h2>
		<ul class="rlist clearfix sided">
		<li>
			<a alt="Cell" href="/cell/home">Cell</a>
		</li>
		<li>
			<a alt="Cancer Cell" href="/cancer-cell/home">Cancer Cell</a>
		</li>
		<li>
			<a alt="Cell Chemical Biology" href="/cell-chemical-biology">Cell Chemical Biology</a>
		</li>
		<li>
			<a alt="Cell Genomics" href="/cell-genomics/home">Cell Genomics</a>
		</li>
		<li>
			<a alt="Cell Host and Microbe" href="/cell-host-microbe/home">Cell Host &amp; Microbe</a>
		</li>
		<li>
			<a alt="Cell Metabolism" href="/cell-metabolism/home">Cell Metabolism</a>
		</li>
		<li>
			<a alt="Cell Reports" href="/cell-reports/home">Cell Reports</a>
		</li>
		<li>
			<a alt="Cell Reports Medicine" href="/cell-reports-medicine/home">Cell Reports Medicine</a>
		</li>
		<li>
			<a alt="Cell Stem Cell" href="/cell-stem-cell/home">Cell Stem Cell</a>
		</li>
		<li>
			<a alt="Cell Systems" href="/cell-systems/home">Cell Systems</a>
		</li>
		<li>
			<a alt="Current Biology" href="/current-biology/home">Current Biology</a>
		</li>
		<li>
			<a alt="Developmental Cell" href="/developmental-cell/home">Developmental Cell</a>
		</li>
		<li>
			<a alt="Immunity" href="/immunity/home">Immunity</a>
		</li>
		<li>
			<a alt="Med" href="/med/home">Med</a>
		</li>
		<li>
			<a alt="Molecular Cell" href="/molecular-cell/home">Molecular Cell</a>
		</li>
		<li>
			<a alt="Neuron" href="/neuron/home">Neuron</a>
		</li>
		<li>
			<a alt="Structure" href="/structure/home">Structure</a>
		</li>
		<li>
			<a alt="American Journal of Human Genetics" href="/ajhg/home">American Journal of Human Genetics (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Journal" href="/biophysj/home">Biophysical Journal (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Reports" href="/biophysreports/home">Biophysical Reports (<i>partner</i>)</a>
		</li>	
		<li>
			<a alt="HGG Advances" href="/hgg-advances/home">Human Genetics and Genomics Advances (<i>partner</i>)</a></li>
		<li>
			<a alt="Molecular Plant" href="/molecular-plant/home">Molecular Plant (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy" href="/molecular-therapy-family/molecular-therapy/home">Molecular Therapy (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Methods and Clinical Development" href="/molecular-therapy-family/methods/home">Molecular Therapy Methods &amp; Clinical Development (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Nucleic Acids" href="/molecular-therapy-family/nucleic-acids/home">Molecular Therapy Nucleic Acids (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Oncology" href="/molecular-therapy-family/oncology/home">Molecular Therapy Oncology (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Plant Communications" href="/plant-communications/home">Plant Communications (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Stem Cell Reports" href="/stem-cell-reports/home">Stem Cell Reports (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biochemical Sciences" href="/trends/biochemical-sciences/home">Trends in Biochemical Sciences</a>
		</li>
		<li>
		</li><li>
			<a alt="Trends in Cancer" href="/trends/cancer/home">Trends in Cancer</a>
		</li>
		<li>
			<a alt="Trends in Cell Biology" href="/trends/cell-biology/home">Trends in Cell Biology</a>
		</li>
		<li>
			<a alt="Trends in Ecology and Evolution" href="/trends/ecology-evolution/home">Trends in Ecology &amp; Evolution</a>
		</li>
		<li>
			<a alt="Trends in Endocrinology and Metabolism" href="/trends/endocrinology-metabolism/home">Trends in Endocrinology &amp; Metabolism</a>
		</li>
		<li>
			<a alt="Trends in Genetics" href="/trends/genetics/home">Trends in Genetics</a>
		</li>
		<li>
			<a alt="Trends in Immunology" href="/trends/immunology/home">Trends in Immunology</a>
		</li>
		<li>
			<a alt="Trends in Microbiology" href="/trends/microbiology/home">Trends in Microbiology</a>
		</li>
		<li>
			<a alt="Trends in Molecular Medicine" href="/trends/molecular-medicine/home">Trends in Molecular Medicine</a>
		</li>
		<li>
			<a alt="Trends in Neurosciences" href="/trends/neurosciences/home">Trends in Neurosciences</a>
		</li>
		<li>
			<a alt="Trends in Parasitology" href="/trends/parasitology/home">Trends in Parasitology</a>
		</li>
		<li>
			<a alt="Trends in Pharmacological Sciences" href="/trends/pharmacological-sciences/home">Trends in Pharmacological Sciences</a>
		</li>
		<li>
			<a alt="Trends in Plant Science" href="/trends/plant-science/home">Trends in Plant Science</a>
		</li>
		</ul>
	</div>

	<div class="group">
		<h2 class="group__title">Physical sciences &amp; engineering journals</h2>
		<ul class="rlist clearfix sided">
		  <li><a alt="Cell Biomaterials" href="/cell-biomaterials/home">Cell Biomaterials</a></li>
		  <li>
			<a alt="Cell Reports Physical Science" href="/cell-reports-physical-science/home">Cell Reports Physical Science</a>
		</li>
		<li>
			<a alt="Chem" href="/chem/home">Chem</a>
		</li>
		<li>
			<a alt="Chem Catalysis" href="/chem-catalysis/home">Chem Catalysis</a>
		</li>
		<li>
			<a alt="Device" href="/device/home">Device</a>
		</li>
		<li>
			<a alt="Joule" href="/joule/home">Joule</a>
		</li>
		<li>
			<a alt="Matter" href="/matter/home">Matter</a>
		</li>	
		<li><a alt="Matter" href="/newton/home">Newton</a></li>
		<li>
			<a alt="Trends in Chemistry" href="/trends/chemistry/home">Trends in Chemistry</a>
		</li>			
		</ul>
	</div>

<div class="group">
	<h2 class="group__title">Multidisciplinary journals</h2>
	<ul class="rlist clearfix sided">
	  		<li>
			<a alt="Cell Reports Methods" href="/cell-reports-methods/home">Cell Reports Methods</a>
		</li>
		<li>
			<a alt="Cell Reports Sustainability" href="/cell-reports-sustainability/home">Cell Reports Sustainability</a>
		</li>
		<li>
			<a alt="Heliyon" href="/heliyon/home">Heliyon</a>
		</li>	
		<li>
			<a alt="iScience" href="/iscience/home">iScience</a>
		</li>
		<li>
			<a alt="One Earth" href="/one-earth/home">One Earth</a>
		</li>
		<li>
			<a alt="Patterns" href="/patterns/home">Patterns</a>
		</li>
		<li>
			<a alt="STAR Protocols" href="/star-protocols/home">STAR Protocols</a>
		</li>
		<li>
			<a alt="Nexus" href="/nexus/home">Nexus (<i>partner</i>)</a>
		</li>			
        <li>
			<a alt="The Innovation" href="/the-innovation/home">The Innovation (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biotechnology" href="/trends/biotechnology/home">Trends in Biotechnology</a>
		</li>
		<li>
			<a alt="Trends in Cognitive Sciences" href="/trends/cognitive-sciences/home">Trends in Cognitive Sciences</a>
		</li>
	</ul>
</div>

</div>
</div>

            

        
</div><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="850476de-00cb-4c0d-943c-bf1881da24f9" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="clearfix">
		<div class="group sided">
			<h2 class="group__title">Authors</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Submit article" href="/submit-to-cell-press">Submit article</a>
				</li>
				<li>
					<a alt="Multi-Journal Submission" href="/multi-journal-submission">Multi-Journal Submission</a>
				</li>
				<li>
					<a alt="STAR Methods" href="/star-authors-guide">STAR Methods</a>
				</li>
				<li>
					<a alt="Sneak Peek – Preprints" href="/sneakpeek">Sneak Peek – Preprints</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Reviewers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Reviewers" href="/reviewers">Information for reviewers</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">News &amp; events</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Newsroom" href="/newsroom">Newsroom</a>
				</li>
				<li>
					<a alt="Events" href="/events">Events</a>
				</li>
				<li>
					<a alt="Cell Symposia" href="/symposia">Cell Symposia</a>
				</li>
				<li>
					<a alt="Consortia Hub" href="/consortia">Consortia Hub</a>
				</li>
				<li>
					<a alt="Webinars" href="/webinars">Webinars</a>
				</li>
								<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Multimedia</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Podcast" href="/podcast">Cell Press Podcast</a>
				</li>
				<li>
					<a alt="Cell Press Videos" href="/video">Cell Press Videos</a>
				</li>
				<li>
					<a alt="Color and Comics" href="/comics">Coloring and Comics</a>
				</li>
				<li>
					<a alt="Figure360" href="/video-guidelines">Figure360</a>
				</li>
				<li>
					<a alt="Cell Picture Show" href="/pictureshow">Cell Picture Show</a>
				</li>
				<li>
					<a alt="Research Arc" href="/research-arc">Research Arc</a>
				</li>
			</ul>
		</div>

		<div class="group sided">
			<h2 class="group__title">About</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="About Cell Press" href="/about">About Cell Press</a>
				</li>

				<li>
					<a alt="Open access" href="/open-access">Open access</a>
				</li>
				<li>
					<a alt="COVID Hub" href="/covid-19">COVID Hub</a>
				</li>
				<li>
					<a alt="Sustainability" href="/sustainability">Sustainability hub</a>
				</li>
				<li>
					<a alt="Inclusion and diversity" href="/diversity">Inclusion and diversity</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Contact</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Contact us" href="/contact">Contact us</a>
				</li>
				<li>
					<a alt="Help and Support" href="https://service.elsevier.com/app/overview/cell-press/" target="_blank">Help &amp; Support</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Careers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Careers" href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" target="_blank">Cell Press Careers</a>
				</li>
			</ul>
		</div>
	</div>
</div></div>

            

        
</div><div class="col-sm-4 col-md-2 clearfix">
    

        


    

            

            

            <div data-widget-id="beafac41-1cfc-440b-9b55-74aba4a5612c" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Access</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Subscribe" href="/subscribe">Subscribe</a>
			</li>
			<li>
				<a alt="Claim" href="/activate">Claim</a>
			</li>
			<li>
				<a alt="Read It Now" href="/read-it-now">Read-It-Now</a>
			</li>
			<li>
				<a alt="Recommend to Librarian" href="http://info.cell.com/request-access-to-cell-press-content" target="_blank">Recommend to Librarian</a>
			</li>
			<li>
				<a alt="Publication Alerts" href="/action/showPreferences?menuTab=Alerts">Publication Alerts</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Collections</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Best of Cell Press" href="/bestof">Best of Cell Press</a>
			</li>
			<li>
				<a alt="Cell Press Reviews" href="/reviews">Cell Press Reviews</a>
			</li>
			<li>
				<a alt="Cell Selections" href="/selections">Cell Press Selections</a>
			</li>
			<li>
				<a alt="Nucleus Collections" href="/nucleus">Nucleus Collections</a>
			</li>
			<li>
				<a alt="SnapShots" href="/snapshots">SnapShot Archive</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Information</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="For Advertisters" href="/media-kit">For Advertisers</a>
			</li>
			<li>
				<a alt="For Recruiters" target="_blank" href="/pb-assets/Cell/common/CP-RecruitmentKit-US-2018-LowRes-1712070648.pdf">For Recruiters</a>
			</li>
			<li>
				<a alt="For Librarians" target="_blank" href="https://www.elsevier.com/products/sciencedirect/journals/direct-subscription-journals">For Librarians</a>
			</li>
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms and Conditions</a>
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>
			</li>
		</ul>
	</div>
</div></div>

            

        
</div></div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="779ad11f-7bcd-4a2a-a2cd-8c67b649cbb2" data-widget-name="UX3HTMLWidget"><style>
 
button#cookieBtn {
   text-decoration: none;
   background-color: transparent;
   color: #005789;
   font-weight: bold;
   padding: 0;
   margin: 0;
   font-size: 14px;
}
 
button#cookieBtn:hover {
   text-decoration: underline;
}

</style>
<script>
// HIDE ONETRUST BACKGROUND AFTER USER PRESSES ESCAPE KEY
setTimeout(function(){ 
   $("#onetrust-pc-sdk").on("keydown", function(e) { 
      if (e.keyCode == 27) {  // ESC key
         setTimeout(function(){ 
            $(".onetrust-pc-dark-filter").css("display","none");
         }, 100); 
      }
   });
}, 5000);
</script>

<span class="align-center copy-right">
<hr>
<p align="center"><b>The content on this site is intended for healthcare professionals and researchers across all fields of science.</b></p>
<hr>
<div>
<p>We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the 
      <b><button id="cookieBtn" class="ot-sdk-show-settings" type="button" aria-label="Manage cookie consent preferences">Cookie Settings</button></b> for this site.<br>

All content on this site: Copyright © 2025 Elsevier Inc., its licensors, and contributors. <br>All rights are reserved, including those for text and data mining, AI training, and similar technologies. <br>For all open access content, the relevant licensing terms apply.
</p>
<ul class="rlist--inline">
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms &amp; Conditions</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Help and Support" target="_blank" href="https://service.elsevier.com/app/overview/cell-press/">Help &amp; Support</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Contact" href="/contact">Contact</a>
			</li>
			</ul>
<p>
<a href="https://www.relx.com"><img src="/pb/assets/raw/Health%20Advance/images/relx-1554393210983.png" alt="RELX" rel="nofollow" target="_new"></a></p>
</div>

</span></div>

            

        

    

        


    

            

            

            <div data-widget-id="c5e179c1-156e-41e3-af7f-5e307efa8acf" data-widget-name="UX3HTMLWidget"><style>#brandingRow{
    background-color:#fff;
    padding:7px 26px 7px 30px;
    color:#007DBC;
    font-size:14px;
    clear:both;
    width:100%
}
#brandingRow a{
    text-decoration:none;
    color:#007DBC
}
#brandingRow a:hover{
    text-decoration:underline
}
#brandingRowRight{
    display:inline;
    float:right;
    width:auto;
    padding:0;
    margin:0
}
svg#cp_logo {
  float: none;
  height: 36px;
  width: 36px;
  margin-left: 0px;
  margin-top: 0px;
}

footer hr {
  display: block;
}

@media screen and (max-width: 600px){
    #brandingRow{
        font-size:12px
    }
}
@media screen and (max-width: 750px){
    #brandingRow{
        padding:7px 18px 7px 16px
    }
    svg#cp_logo{
        margin-right:10px
    }
}
@media screen and (max-width: 800px) {
   a#cpIconLnk {
      display: none;
   }
}

.header__wrapper.clearfix .col-xs-6:first-of-type{
    width:55%
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2){
    width:45%
}
@media screen and (min-width: 800px) and (max-width: 1000px){
    .header__wrapper.clearfix .col-xs-6:first-of-type{
        width:75%
    }
    .header__wrapper.clearfix .col-xs-6:nth-of-type(2){
        width:25%
    }
}

</style>

<script>
var partnerx = false;
var overrideEndorsement = "";
var tmpj = $("input[name='journalCode']").attr("value");
	
if (window.location.pathname == "/molecular-therapy-family/home") {
	tmpj = "ymthe";
}
	
var ribbonx = "";
if (tmpj == "ajhg" || tmpj == "bpj" || tmpj == "molp" || tmpj == "xplc" || tmpj == "stemcr" || tmpj == "ymthe" || tmpj == "xhgg" || tmpj == "omtn" || tmpj == "omto" || tmpj == "omtm" || tmpj == "biophysreports" ||  tmpj == "bpr" || tmpj == "xinn" || tmpj == "omton") {
	partnerx = true;
	ribbonx = "<a href='https://www.cell.com' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press partner journal</a>";
} else if (tmpj != "" && tmpj != "undefined" && tmpj != undefined) {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press journal</a>";
} else {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press resource</a>";
}
	
if (window.location.pathname == "/") {
	ribbonx = "";
}
if (overrideEndorsement != "") {
	ribbonx = overrideEndorsement;
}

$(".header__wrapper.clearfix").prepend("<div id='brandingRow'><a href='/' data-aa-name='science that inspires' data-aa-region='cp global header' title='Visit Cell.com'>Science that inspires</a><p id='brandingRowRight'>" + ribbonx + "</p></div>");
	
// handle scrolling effect on article pages
if ($("article").length > 0) {
	var scrollx;
	$(window).scroll(function() {
		scrollx = $(window).scrollTop();
		if (scrollx > 0) { 
			$("#brandingRow").css("display","none"); 
		} else {
			$("#brandingRow").css("display","block");
		}
	});
}

if (window.location.pathname == "/" || partnerx == false) {
               $("<a href='/home' id='cpIconLnk' data-aa-name='cell press logo' data-aa-region='cp global header' title='Cell Press' target='_blank'><svg id='cp_logo' version='1.1' xmlns='http://www.w3.org/2000/svg' xmlns:xlink='http://www.w3.org/1999/xlink' x='0px' y='0px' viewBox='0 0 100 98.1' style='enable-background:new 0 0 100 98.1;' xml:space='preserve' height='100' width='98.1'><path style='fill:#FFFFFF;' d='M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z'/></svg></a>").insertBefore(".header__wrapper.clearfix .journal-logos:eq(0)");
}


</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="1af759b7-9bb6-4413-ada9-51a8333e8fb8" data-widget-name="UX3HTMLWidget"><style>
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-444969 - c#4]*/
    [data-tab-id="changelogTab"] {
        display: none !important;
    }
    
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-518839]*/
    @media (min-width: 769px) {
        .ux3 .quick-search .dropBlock [data-db-target-of],
        .quick-search .dropBlock [data-db-target-of] {
            width: 100vw !important;
        }
    }
</style></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="d7e0813b-a300-497a-ab37-9c3ddaf03e71" data-widget-name="UX3HTMLWidget"><!--
<div class="session-reminder hidden">
    <div class="session-reminder__overlay">
        <div class="session-reminder__dialog">
            <div class="session-reminder__dialog-inner">
                <div class="dialog-header" role="dialog" aria-labelledby="dialog-title" aria-describedby="dialog-desc">
                    <h2 class="dialog-header-title" id="dialog-title">
                        <span>Session Timeout</span>
                        <div class="dialog-timer">(2:00)</div>
                    </h2>
                    <button class="dialog-close" type="button" aria-label="close dialog">
                        <i class="icon-tools_close" aria-hidden="true"></i>
                    </button>
                </div>
                <div class="dialog-body">
                    <p class="dialog-desc" id="dialog-desc">Your session will expire shortly. If you are still working, click the ‘Keep Me Logged In’ button below. If you do not respond within the next minute, you will be automatically logged out.</p>
                    <p class="dialog-expired sr-only" aria-live="polite"></p>
                </div>
                <div class="dialog-footer">
                    <button class="session-reset" type="button">Keep Me Logged In</button>
                </div>
            </div>
        </div>
    </div>
</div>
<a class="sr-only" href="javascript:void(0)" aria-hidden="true"></a>
--></div>

            

        
        </div>
    </div>


































    



















        
        
            
                <script src="/products/marlin/cell/releasedAssets/js/main.bundle-90475670808d5d3eee41.js"></script>
            
        
        
        

    




<script type="text/javascript">
    var pageData =  {"journal":{"specialty":"Cell Press","issn":"0092-8674","name":"Cell"},"page":{"loadTimestamp":"1749591307593","server":"cell","environment":"prod","businessUnit":"ELS:RAP:JBS","noTracking":"","name":"fulltext:html","section":"Cell","language":"en","type":"CP-CA","productName":"JB"},"visitor":{"departmentName":"|ae:ScienceDirect Guests","accessType":"ae:ANON_GUEST|ae:ANON_GUEST","accountId":"ae:838949|ae:228598","accountName":"ae:Cell Guest Account|ae:ScienceDirect Guests","departmentId":"ae:977212|ae:291352","ipAddress":"189.120.74.179","loginStatus":"anonymous","userId":"ae:246228266|ae:12975512"},"content":[{"accessType":"article:free:openarchive","volumeNumber":"184","issueNumber":"18","viewState":"fulltext","format":"MIME-HTML","id":"pii:S0092867421008795","coverDate":"202109","type":"XOCS-JOURNAL:SCOPE-FULL","title":"Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy","status":"S300"}]};
</script>

<script type="text/javascript">
    if(typeof pageDataTracker !== "undefined") {
        pageDataTracker.trackPageLoad();
    }
</script>
<script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94dbff203d9b4ee9',t:'MTc0OTU5MTMwNi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;94dbff203d9b4ee9&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.5.0&quot;,&quot;token&quot;:&quot;57a02315956f4b2e82817b3dfa99b1a2&quot;}" crossorigin="anonymous"></script>


<div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">✓</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">More…</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="https://static.addtoany.com/menu/sm.25.html#type=core&amp;event=load" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div><div id="onetrust-consent-sdk" data-nosnippet="true"><div class="onetrust-pc-dark-filter ot-fade-in" style="z-index:2147483645;"></div><div id="onetrust-banner-sdk" class="otFlat bottom ot-wo-title ot-buttons-fw" tabindex="0" role="region" aria-label="Cookie banner"><div role="dialog" aria-modal="true" aria-label="Privacy"><div class="ot-sdk-container"><div class="ot-sdk-row"><div id="onetrust-group-container" class="ot-sdk-eight ot-sdk-columns"><div class="banner_logo"></div><div id="onetrust-policy"><div id="onetrust-policy-text">We use cookies that are necessary to make our site work. We may also use additional cookies to analyze, improve, and personalize our content and your digital experience. For more information, see our<a class="ot-cookie-policy-link" href="https://www.elsevier.com/legal/cookienotice" target="_blank" aria-label=", opens in a new tab" rel="noopener">Cookie Policy</a></div></div></div><div id="onetrust-button-group-parent" class="ot-sdk-three ot-sdk-columns"><div id="onetrust-button-group"><button id="onetrust-pc-btn-handler" class="cookie-setting-link">Cookie Settings</button>  <button id="onetrust-accept-btn-handler">Accept all cookies</button></div></div></div></div><!-- Close Button --><div id="onetrust-close-btn-container"></div><!-- Close Button END--></div></div><div id="onetrust-pc-sdk" class="otPcCenter ot-hide ot-fade-in" lang="en" aria-label="Preference center" role="region"><div role="dialog" aria-modal="true" style="height: 100%;" aria-label="Cookie Preference Center"><!-- Close Button --><div class="ot-pc-header"><!-- Logo Tag --><div class="ot-pc-logo" role="img" aria-label="Company Logo"><img alt="Company Logo" src="https://cdn.cookielaw.org/logos/static/ot_company_logo.png"></div></div><!-- Close Button --><div id="ot-pc-content" class="ot-pc-scrollbar"><div class="ot-optout-signal ot-hide"><div class="ot-optout-icon"><svg xmlns="http://www.w3.org/2000/svg"><path class="ot-floating-button__svg-fill" d="M14.588 0l.445.328c1.807 1.303 3.961 2.533 6.461 3.688 2.015.93 4.576 1.746 7.682 2.446 0 14.178-4.73 24.133-14.19 29.864l-.398.236C4.863 30.87 0 20.837 0 6.462c3.107-.7 5.668-1.516 7.682-2.446 2.709-1.251 5.01-2.59 6.906-4.016zm5.87 13.88a.75.75 0 00-.974.159l-5.475 6.625-3.005-2.997-.077-.067a.75.75 0 00-.983 1.13l4.172 4.16 6.525-7.895.06-.083a.75.75 0 00-.16-.973z" fill="#FFF" fill-rule="evenodd"></path></svg></div><span></span></div><h2 id="ot-pc-title">Cookie Preference Center</h2><div id="ot-pc-desc">We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our <a href="https://www.elsevier.com/legal/cookienotice/_nocache" target="_blank">Cookie Policy</a> and the list of <a href="https://support.google.com/admanager/answer/9012903" target="_blank">Google Ad-Tech Vendors</a>.
<br>
<br>
You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer. See the different category headings below to find out more or change your settings.
<br>
</div><button id="accept-recommended-btn-handler">Allow all</button><section class="ot-sdk-row ot-cat-grp"><h3 id="ot-category-title"> Manage Consent Preferences</h3><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="1"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-1" aria-labelledby="ot-header-id-1 ot-status-id-1"></button><!-- Accordion header --><div class="ot-acc-hdr ot-always-active-group"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-1">Strictly Necessary Cookies</h4><div id="ot-status-id-1" class="ot-always-active">Always active</div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-1">These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
<br><br></p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="1">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="3"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-3" aria-labelledby="ot-header-id-3"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-3">Functional Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-3" id="ot-group-id-3" role="switch" class="category-switch-handler" data-optanongroupid="3" aria-labelledby="ot-header-id-3"> <label class="ot-switch" for="ot-group-id-3"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Functional Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-3">These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="3">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="2"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-2" aria-labelledby="ot-header-id-2"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-2">Performance Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-2" id="ot-group-id-2" role="switch" class="category-switch-handler" data-optanongroupid="2" aria-labelledby="ot-header-id-2"> <label class="ot-switch" for="ot-group-id-2"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Performance Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-2">These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="2">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="4"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-4" aria-labelledby="ot-header-id-4"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-4">Targeting Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-4" id="ot-group-id-4" role="switch" class="category-switch-handler" data-optanongroupid="4" aria-labelledby="ot-header-id-4"> <label class="ot-switch" for="ot-group-id-4"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Targeting Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-4">These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. If you do not allow these cookies, you will experience less targeted advertising.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="4">Cookie Details List‎</button></div></div></div><!-- Groups sections starts --><!-- Group section ends --><!-- Accordion Group section starts --><!-- Accordion Group section ends --></section></div><section id="ot-pc-lst" class="ot-hide ot-hosts-ui ot-pc-scrollbar"><div id="ot-pc-hdr"><div id="ot-lst-title"><button class="ot-link-btn back-btn-handler" aria-label="Back"><svg id="ot-back-arw" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 444.531 444.531" xml:space="preserve"><title>Back Button</title><g><path fill="#656565" d="M213.13,222.409L351.88,83.653c7.05-7.043,10.567-15.657,10.567-25.841c0-10.183-3.518-18.793-10.567-25.835
                    l-21.409-21.416C323.432,3.521,314.817,0,304.637,0s-18.791,3.521-25.841,10.561L92.649,196.425
                    c-7.044,7.043-10.566,15.656-10.566,25.841s3.521,18.791,10.566,25.837l186.146,185.864c7.05,7.043,15.66,10.564,25.841,10.564
                    s18.795-3.521,25.834-10.564l21.409-21.412c7.05-7.039,10.567-15.604,10.567-25.697c0-10.085-3.518-18.746-10.567-25.978
                    L213.13,222.409z"></path></g></svg></button><h3>Cookie List</h3></div><div class="ot-lst-subhdr"><div class="ot-search-cntr"><p role="status" class="ot-scrn-rdr"></p><input id="vendor-search-handler" type="text" name="vendor-search-handler" placeholder="Search…" aria-label="Cookie list search"> <svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 -30 110 110" aria-hidden="true"><title>Search Icon</title><path fill="#2e3644" d="M55.146,51.887L41.588,37.786c3.486-4.144,5.396-9.358,5.396-14.786c0-12.682-10.318-23-23-23s-23,10.318-23,23
            s10.318,23,23,23c4.761,0,9.298-1.436,13.177-4.162l13.661,14.208c0.571,0.593,1.339,0.92,2.162,0.92
            c0.779,0,1.518-0.297,2.079-0.837C56.255,54.982,56.293,53.08,55.146,51.887z M23.984,6c9.374,0,17,7.626,17,17s-7.626,17-17,17
            s-17-7.626-17-17S14.61,6,23.984,6z"></path></svg></div><div class="ot-fltr-cntr"><button id="filter-btn-handler" aria-label="Filter" aria-haspopup="true"><svg role="presentation" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 402.577 402.577" xml:space="preserve"><title>Filter Icon</title><g><path fill="#fff" d="M400.858,11.427c-3.241-7.421-8.85-11.132-16.854-11.136H18.564c-7.993,0-13.61,3.715-16.846,11.136
      c-3.234,7.801-1.903,14.467,3.999,19.985l140.757,140.753v138.755c0,4.955,1.809,9.232,5.424,12.854l73.085,73.083
      c3.429,3.614,7.71,5.428,12.851,5.428c2.282,0,4.66-0.479,7.135-1.43c7.426-3.238,11.14-8.851,11.14-16.845V172.166L396.861,31.413
      C402.765,25.895,404.093,19.231,400.858,11.427z"></path></g></svg></button></div><div id="ot-anchor"></div><section id="ot-fltr-modal"><div id="ot-fltr-cnt"><button id="clear-filters-handler">Clear</button><div class="ot-fltr-scrlcnt ot-pc-scrollbar"><div class="ot-fltr-opts" role="list"><div class="ot-fltr-opt" role="listitem"><div class="ot-chkbox"><input id="chkbox-id" type="checkbox" class="category-filter-handler"> <label for="chkbox-id"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div><div class="ot-fltr-btns"><button id="filter-apply-handler">Apply</button> <button id="filter-cancel-handler">Cancel</button></div></div></div></section></div></div><section id="ot-lst-cnt" class="ot-host-cnt ot-pc-scrollbar"><div id="ot-sel-blk"><div class="ot-sel-all"><div class="ot-sel-all-hdr"><span class="ot-consent-hdr">Consent</span> <span class="ot-li-hdr">Leg.Interest</span></div><div class="ot-sel-all-chkbox"><div class="ot-chkbox" id="ot-selall-hostcntr"><input id="select-all-hosts-groups-handler" type="checkbox"> <label for="select-all-hosts-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-vencntr"><input id="select-all-vendor-groups-handler" type="checkbox"> <label for="select-all-vendor-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-licntr"><input id="select-all-vendor-leg-handler" type="checkbox"> <label for="select-all-vendor-leg-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div></div><div class="ot-sdk-row"><div class="ot-sdk-column"><ul id="ot-host-lst"></ul></div></div></section></section><div class="ot-pc-footer ot-pc-scrollbar"><div class="ot-btn-container"> <button class="save-preference-btn-handler onetrust-close-btn-handler">Confirm my choices</button></div><!-- Footer logo --><div class="ot-pc-footer-logo"><a href="https://www.onetrust.com/products/cookie-consent/" target="_blank" rel="noopener noreferrer" aria-label="Powered by OneTrust Opens in a new Tab"><img alt="Powered by Onetrust" src="https://cdn.cookielaw.org/logos/static/powered_by_logo.svg" title="Powered by OneTrust Opens in a new Tab"></a></div></div><!-- Cookie subgroup container --><!-- Vendor list link --><!-- Cookie lost link --><!-- Toggle HTML element --><!-- Checkbox HTML --><!-- plus minus--><!-- Arrow SVG element --><!-- Accordion basic element --><span class="ot-scrn-rdr" aria-atomic="true" aria-live="polite"></span><!-- Vendor Service container and item template --></div><iframe class="ot-text-resize" sandbox="allow-same-origin" title="onetrust-text-resize" style="position: absolute; top: -50000px; width: 100em;" aria-hidden="true"></iframe></div></div><div id="crossmark-widget" style="display: none;"><div class="crossmark-reset crossmark-overlay"></div><div class="crossmark-reset crossmark-popup"><div class="crossmark-reset crossmark-popup__offset"><div class="crossmark-reset crossmark-popup__inner"><div class="crossmark-reset crossmark-popup__header"><button class="crossmark-reset crossmark-popup__btn-close"><span class="sr-only">__("articleCrossmark.closePopup")</span></button></div><div class="crossmark-reset crossmark-popup__content-wrapper"><iframe class="crossmark-reset crossmark-popup__content" title="Crossmark service - Intentionally blank" aria-hidden="false" tabindex="0" src="https://crossmark.crossref.org/dialog?doi=10.1016%2Fj.cell.2021.07.020&amp;domain=www.cell.com&amp;uri_scheme=https%3A&amp;cm_version=v2.0"></iframe></div></div></div></div></div></body></html>